data_1mdj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mdj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.383 -0.599 . . . . 1.1000000000000001 109.383 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 2.5 109.221 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 1.6100000000000001 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 1.04 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.92000000000000004 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 2.48 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 1.05 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 1.0600000000000001 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.25 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 3.0699999999999998 109.756 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1000000000000001 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 1.04 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 1.27 109.374 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 1.0900000000000001 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0700000000000001 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.31 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 2.4100000000000001 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 1.05 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 1.03 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 1.01 108.796 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 1.02 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.95999999999999996 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.32000000000000001 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.04 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 1.0600000000000001 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 1.0600000000000001 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.51000000000000001 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.34000000000000002 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.40000000000000002 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.47999999999999998 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81000000000000005 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 2.46 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.6600000000000001 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 1.0700000000000001 110.831 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 2.1099999999999999 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.29999999999999999 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.37 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.14999999999999999 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.47999999999999998 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 1.05 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 1.1299999999999999 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.93000000000000005 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.6499999999999999 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.89000000000000001 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 1.03 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 1.05 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 1.04 108.926 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.3100000000000001 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 1.02 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.0800000000000001 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 1.0600000000000001 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.1200000000000001 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 1.01 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' OG ' ' A' ' 67' ' ' SER . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.7799999999999998 110.207 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.1100000000000001 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 1.05 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.79 109.244 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2000000000000002 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.3399999999999999 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 1.05 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.9300000000000002 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 1.0600000000000001 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' N ' ' B' ' 8' ' ' GLU . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.97999999999999998 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.23999999999999999 110.286 -1.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 1.04 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.19 108.868 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.71 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.13 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.22 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 2.0299999999999998 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 2.1600000000000001 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.23000000000000001 110.57 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 83' ' ' GLY . 38.4 mm-40 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.8100000000000001 110.191 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 2.2599999999999998 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 1.05 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.25 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.17999999999999999 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.89000000000000001 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.14000000000000001 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 1.0600000000000001 110.53 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.98 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.72 110.516 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.5600000000000001 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 1.03 108.657 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.1499999999999999 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 1.04 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 1.04 109.804 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.05 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 1.1399999999999999 110.363 -178.64 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.66 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.254 -0.647 . . . . 1.1000000000000001 109.254 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 2.5 109.157 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 1.6100000000000001 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 1.04 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.92000000000000004 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 2.48 109.606 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 1.05 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 1.0600000000000001 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.25 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 1.04 109.147 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 1.27 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 1.0700000000000001 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.31 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 2.4100000000000001 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 1.05 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 1.03 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 1.01 108.683 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 1.02 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.95999999999999996 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.32000000000000001 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.04 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 1.0600000000000001 108.547 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 1.0600000000000001 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.57 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.51000000000000001 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.34000000000000002 109.481 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.40000000000000002 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.47999999999999998 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81000000000000005 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 2.46 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.6600000000000001 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 2.1099999999999999 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.29999999999999999 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.37 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.14999999999999999 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.47999999999999998 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 1.05 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 1.1299999999999999 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.93000000000000005 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.6499999999999999 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.89000000000000001 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.93000000000000005 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.9 t30 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.46999999999999997 108.961 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 1.03 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 1.05 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 1.04 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.3100000000000001 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 1.02 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.0800000000000001 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 110.986 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.1100000000000001 110.461 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.1200000000000001 109.527 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 1.01 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' CB ' HH12 ' B' ' 4' ' ' ARG . 3.9 pp0? -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.7799999999999998 109.952 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.1100000000000001 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 1.05 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 1.0600000000000001 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.79 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' A' ' 8' ' ' LYS . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 109.671 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB2' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 1.0600000000000001 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.3399999999999999 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 1.05 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.9300000000000002 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 1.0600000000000001 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.97999999999999998 108.754 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.23999999999999999 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 1.04 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.19 108.632 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.407 HE22 ' HB2' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.71 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.13 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.22 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 2.0299999999999998 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 2.1600000000000001 109.764 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.23000000000000001 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.8100000000000001 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 2.2599999999999998 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 1.05 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.25 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.17999999999999999 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.89000000000000001 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.14000000000000001 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 1.0600000000000001 110.741 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.98 107.981 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.72 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.5600000000000001 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.03 109.233 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.1499999999999999 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 1.04 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 1.04 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 1.05 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.6599999999999999 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 1.1399999999999999 110.653 -178.181 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' B' ' 4' ' ' ARG . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 94.7 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.317 0.58 . . . . 1.1000000000000001 109.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 2.5 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 1.6100000000000001 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 1.04 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.92000000000000004 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 2.48 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 1.05 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 1.0600000000000001 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.25 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 3.0699999999999998 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 1.04 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 1.27 110.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 1.0900000000000001 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 1.0700000000000001 109.418 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.31 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 2.4100000000000001 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.527 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 1.05 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.527 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 1.03 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 1.01 108.565 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 1.02 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.32000000000000001 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.04 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0600000000000001 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 1.0600000000000001 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.51000000000000001 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.34000000000000002 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.40000000000000002 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.47999999999999998 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81000000000000005 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 2.46 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.6600000000000001 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 110.244 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 2.1099999999999999 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.29999999999999999 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.37 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.14999999999999999 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.47999999999999998 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 1.05 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 1.1299999999999999 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.93000000000000005 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.6499999999999999 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.89000000000000001 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.93000000000000005 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.5 t30 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 109.402 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 1.03 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 1.05 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 1.04 109.065 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.3100000000000001 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 1.02 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 1.0600000000000001 111.316 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.508 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.1100000000000001 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.1200000000000001 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 1.01 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.42 ' O ' ' OG ' ' A' ' 67' ' ' SER . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.7799999999999998 110.681 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.1100000000000001 109.351 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 1.05 108.685 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 1.0600000000000001 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.79 109.316 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2000000000000002 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 1.0600000000000001 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 1.05 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.9300000000000002 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 1.0600000000000001 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 8' ' ' GLU . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.97999999999999998 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.23999999999999999 109.991 -1.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 1.04 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.19 108.999 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.71 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.13 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.22 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 2.0299999999999998 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 2.1600000000000001 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' C ' ' NE2' ' A' ' 84' ' ' GLN . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.23000000000000001 110.467 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.442 ' NE2' ' C ' ' A' ' 83' ' ' GLY . 40.9 mm-40 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.8100000000000001 110.347 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 2.2599999999999998 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 1.05 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.25 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.17999999999999999 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.89000000000000001 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.14000000000000001 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 1.0600000000000001 110.452 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.98 108.173 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.72 110.478 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.5600000000000001 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 1.03 109.309 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.1499999999999999 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 1.04 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 1.04 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 1.05 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.6599999999999999 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 1.1399999999999999 110.49 -178.457 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.641 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.641 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 121.198 0.523 . . . . 1.1000000000000001 109.72 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 2.5 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 1.6100000000000001 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 1.04 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.92000000000000004 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 2.48 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 1.05 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.25 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 3.0699999999999998 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1000000000000001 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 1.04 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 1.27 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.0900000000000001 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 1.0900000000000001 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 1.0700000000000001 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.31 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 2.4100000000000001 109.181 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 1.05 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 1.03 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 1.01 108.831 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 1.02 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.95999999999999996 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.32000000000000001 107.941 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.04 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.445 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.51000000000000001 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.34000000000000002 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.40000000000000002 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.47999999999999998 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81000000000000005 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 2.46 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.6600000000000001 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 1.0700000000000001 110.781 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 2.1099999999999999 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 44' ' ' SER . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.14999999999999999 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.47999999999999998 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 1.05 109.938 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 1.1299999999999999 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.93000000000000005 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.6499999999999999 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.89000000000000001 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.93000000000000005 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.46999999999999997 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 1.03 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 1.05 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 1.04 108.941 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.3100000000000001 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 1.02 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 1.0600000000000001 111.374 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.1100000000000001 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.1200000000000001 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 1.01 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.7799999999999998 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 1.05 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 1.0600000000000001 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.79 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2000000000000002 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.3399999999999999 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.05 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.9300000000000002 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.97999999999999998 108.641 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.23999999999999999 109.909 -1.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 1.04 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.19 108.856 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 11.0 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.71 107.403 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.13 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.22 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 2.0299999999999998 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.23000000000000001 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.8100000000000001 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 2.2599999999999998 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 1.05 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.25 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.17999999999999999 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.89000000000000001 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.14000000000000001 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 1.0600000000000001 110.627 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.98 107.57 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.72 110.494 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.5600000000000001 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 1.03 108.621 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 1.04 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 1.04 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 1.05 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.6599999999999999 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 1.1399999999999999 110.572 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.502 2.158 0 CA-C-O 121.078 0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.416 -0.587 . . . . 1.1000000000000001 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 2.5 109.189 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 1.6100000000000001 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 1.04 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.92000000000000004 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 2.48 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 1.05 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 1.0600000000000001 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.25 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 3.0699999999999998 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 1.04 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 1.27 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 1.0900000000000001 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 1.0700000000000001 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.31 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 2.4100000000000001 109.166 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 1.05 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 1.03 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 1.01 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 1.02 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.95999999999999996 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.32000000000000001 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.04 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 1.0600000000000001 108.704 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 1.0600000000000001 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.51000000000000001 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.34000000000000002 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.40000000000000002 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.47999999999999998 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 2.46 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.6600000000000001 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 1.0700000000000001 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 2.1099999999999999 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.29999999999999999 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.37 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.14999999999999999 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.47999999999999998 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 1.05 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 1.1299999999999999 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.93000000000000005 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.6499999999999999 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.89000000000000001 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.93000000000000005 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.8 t30 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.46999999999999997 109.461 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 1.03 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 1.05 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 1.04 108.783 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.3100000000000001 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 1.02 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.0800000000000001 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 1.0600000000000001 111.342 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 58' ' ' ASP . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.1100000000000001 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.597 ' NE2' HH11 ' B' ' 4' ' ' ARG . 77.3 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.7799999999999998 109.866 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.1100000000000001 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 1.05 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 1.0600000000000001 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.79 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2000000000000002 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.3399999999999999 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 1.05 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.9300000000000002 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 1.0600000000000001 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.97999999999999998 109.148 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.23999999999999999 110.137 -2.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 1.04 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.19 108.797 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.71 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.13 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.22 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 2.0299999999999998 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 2.1600000000000001 109.931 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.23000000000000001 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.8100000000000001 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 1.05 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.25 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.17999999999999999 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.89000000000000001 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.14000000000000001 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 1.0600000000000001 110.332 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.98 108.399 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.72 109.863 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.5600000000000001 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 1.03 108.454 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 1.04 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 1.04 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 1.05 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 110.568 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' NE2' ' A' ' 63' ' ' GLN . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.425 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 92.2 t . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.379 0.609 . . . . 1.1000000000000001 109.696 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.466 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 2.5 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 1.6100000000000001 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 1.04 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.92000000000000004 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 2.48 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 1.05 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0600000000000001 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.25 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 3.0699999999999998 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1000000000000001 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 1.04 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 1.27 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 1.0700000000000001 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.31 109.638 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 2.4100000000000001 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 1.05 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.592 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 1.03 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 1.01 108.402 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 1.02 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.95999999999999996 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.32000000000000001 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.04 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 1.0600000000000001 108.677 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 1.0600000000000001 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.51000000000000001 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 109.626 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.40000000000000002 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.47999999999999998 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 2.46 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.6600000000000001 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 1.0700000000000001 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.29999999999999999 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' LYS . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.37 108.814 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.14999999999999999 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.47999999999999998 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 1.05 109.576 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 1.1299999999999999 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.93000000000000005 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.6499999999999999 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.89000000000000001 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.93000000000000005 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.46999999999999997 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 1.03 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 1.05 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 1.04 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.3100000000000001 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 1.02 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 111.38 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.1100000000000001 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.1200000000000001 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 1.01 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.7799999999999998 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.1100000000000001 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 1.05 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 1.0600000000000001 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.79 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2000000000000002 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 1.0600000000000001 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.3399999999999999 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 1.05 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.9300000000000002 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 1.0600000000000001 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.97999999999999998 108.818 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.23999999999999999 110.204 -1.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 1.04 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.19 108.857 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.71 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.13 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.22 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 2.0299999999999998 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 2.1600000000000001 109.759 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.23000000000000001 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.8100000000000001 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 2.2599999999999998 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 1.05 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.25 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.17999999999999999 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.89000000000000001 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.14000000000000001 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 1.0600000000000001 110.459 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.98 107.889 178.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.72 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.5600000000000001 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 1.03 109.009 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.1499999999999999 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 1.04 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 1.04 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 1.05 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.6599999999999999 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 111.117 -177.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.299 0.571 . . . . 1.1000000000000001 109.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 2.5 109.125 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 1.6100000000000001 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 1.04 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.92000000000000004 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 2.48 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 1.05 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 1.0600000000000001 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.25 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 3.0699999999999998 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 1.04 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 1.27 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 1.0700000000000001 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.31 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 2.4100000000000001 109.505 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 1.03 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 1.01 108.705 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 1.02 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.95999999999999996 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.32000000000000001 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.04 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 1.0600000000000001 108.589 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 1.0600000000000001 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.51000000000000001 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.34000000000000002 109.82 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.40000000000000002 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.47999999999999998 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81000000000000005 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 2.46 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.6600000000000001 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 111.082 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 2.1099999999999999 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.29999999999999999 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.37 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.14999999999999999 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.47999999999999998 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 1.05 110.562 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 1.1299999999999999 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.93000000000000005 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.6499999999999999 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.89000000000000001 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.93000000000000005 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 7.2 t30 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.46999999999999997 109.852 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 1.03 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 1.05 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 1.04 108.989 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.3100000000000001 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 1.02 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 1.0600000000000001 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.1100000000000001 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.1200000000000001 109.409 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 1.01 108.6 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.426 ' O ' ' OG ' ' A' ' 67' ' ' SER . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.7799999999999998 109.958 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 1.05 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 1.0600000000000001 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.79 109.549 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2000000000000002 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 1.0600000000000001 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.3399999999999999 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 1.05 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.9300000000000002 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 1.0600000000000001 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.97999999999999998 108.855 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.23999999999999999 110.008 -1.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 1.04 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.19 108.873 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.71 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.13 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.22 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 2.0299999999999998 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 2.1600000000000001 109.643 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.23000000000000001 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.8100000000000001 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 1.05 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.25 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.17999999999999999 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.89000000000000001 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.14000000000000001 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 1.0600000000000001 110.297 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.98 107.971 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.72 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' NZ ' ' HG1' ' A' ' 100' ' ' THR . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.5600000000000001 109.625 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 1.03 108.827 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.1499999999999999 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 1.04 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.409 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 1.04 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 1.05 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.6599999999999999 109.582 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 1.1399999999999999 110.348 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.272 -0.64 . . . . 1.1000000000000001 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 2.5 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 1.6100000000000001 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 1.04 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.92000000000000004 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 2.48 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 1.05 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 1.0600000000000001 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.25 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 3.0699999999999998 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1000000000000001 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 1.04 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 1.27 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0900000000000001 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 1.0700000000000001 109.576 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.31 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 2.4100000000000001 109.16 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 1.05 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.559 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 1.03 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 1.01 108.875 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 1.02 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.32000000000000001 107.961 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.04 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 1.0600000000000001 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 1.0600000000000001 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.492 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.51000000000000001 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.34000000000000002 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.40000000000000002 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.47999999999999998 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81000000000000005 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 2.46 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' GLY . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.6600000000000001 110.778 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 1.0700000000000001 110.9 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 2.1099999999999999 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.29999999999999999 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 44' ' ' SER . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.37 109.506 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.14999999999999999 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.47999999999999998 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 1.05 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 1.1299999999999999 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.93000000000000005 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.6499999999999999 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.89000000000000001 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.93000000000000005 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.1 t30 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.46999999999999997 109.817 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 1.03 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 1.05 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 1.04 108.934 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.3100000000000001 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 1.02 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.0800000000000001 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 1.0600000000000001 111.156 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.481 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.1200000000000001 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 1.01 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.7799999999999998 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.1100000000000001 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 1.05 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.79 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 1.0600000000000001 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.3399999999999999 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.427 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 1.05 109.137 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.9300000000000002 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 1.0600000000000001 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.97999999999999998 109.019 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.23999999999999999 109.818 -1.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 1.04 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.19 108.875 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.71 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.13 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.22 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 2.0299999999999998 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 2.1600000000000001 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.23000000000000001 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.8100000000000001 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 2.2599999999999998 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 1.05 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.25 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.17999999999999999 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.89000000000000001 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.14000000000000001 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 1.0600000000000001 110.555 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.98 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.72 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.5600000000000001 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 1.03 108.651 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.1499999999999999 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 1.04 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.04 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 1.05 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 1.1399999999999999 110.24 -178.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.427 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.643 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.643 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.3 -0.63 . . . . 1.1000000000000001 109.3 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 2.5 109.048 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 1.6100000000000001 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 1.04 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.92000000000000004 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 2.48 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 1.05 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 1.0600000000000001 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.25 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 3.0699999999999998 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 1.04 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 1.27 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.713 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 1.0900000000000001 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 1.0700000000000001 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.31 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 2.4100000000000001 108.854 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 1.05 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 1.03 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 1.01 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 1.02 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.95999999999999996 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.32000000000000001 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.04 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 1.0600000000000001 108.336 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.51000000000000001 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.34000000000000002 109.814 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.40000000000000002 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.47999999999999998 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81000000000000005 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 2.46 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.6600000000000001 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 1.0700000000000001 111.535 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 2.1099999999999999 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.29999999999999999 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.37 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.14999999999999999 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.47999999999999998 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 1.05 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 1.1299999999999999 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.93000000000000005 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.6499999999999999 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' ASN . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.89000000000000001 109.227 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.93000000000000005 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.4 t30 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.46999999999999997 109.367 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 1.03 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 1.05 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 1.04 108.998 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.3100000000000001 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 1.02 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.0800000000000001 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 110.701 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.1100000000000001 110.891 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.715 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 67' ' ' SER . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.7799999999999998 110.053 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 1.05 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 1.0600000000000001 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.79 109.251 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2000000000000002 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 1.0600000000000001 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.3399999999999999 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 1.05 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.9300000000000002 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 1.0600000000000001 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.23999999999999999 110.134 -2.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 1.04 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.19 108.687 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.71 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.13 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.22 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 2.0299999999999998 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' CB ' ' HZ1' ' A' ' 82' ' ' LYS . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 2.1600000000000001 109.06 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.23000000000000001 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.8100000000000001 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 2.2599999999999998 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 1.05 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.25 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.17999999999999999 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.89000000000000001 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.14000000000000001 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 1.0600000000000001 110.282 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.72 110.702 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.5600000000000001 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 1.03 108.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.1499999999999999 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 1.04 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 1.04 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.05 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.6599999999999999 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 1.1399999999999999 110.325 -178.186 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.195 0.522 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.4 t . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.195 -0.668 . . . . 1.1000000000000001 109.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 2.5 109.305 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 1.6100000000000001 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 1.04 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.92000000000000004 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 2.48 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 1.05 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 1.0600000000000001 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.25 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1000000000000001 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 1.04 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 1.27 109.371 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.0900000000000001 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.0900000000000001 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 1.0700000000000001 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.31 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 2.4100000000000001 108.648 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.538 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 1.05 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.538 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 1.03 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 1.01 108.737 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 1.02 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.95999999999999996 108.959 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.32000000000000001 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.04 109.723 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 108.825 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 1.0600000000000001 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.51000000000000001 110.417 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.34000000000000002 109.941 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.40000000000000002 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.47999999999999998 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81000000000000005 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 39' ' ' LYS . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 2.46 110.013 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.6600000000000001 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 110.56 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 2.1099999999999999 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.37 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.14999999999999999 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 1.05 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 1.1299999999999999 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.93000000000000005 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.6499999999999999 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' ASN . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.89000000000000001 109.299 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.93000000000000005 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 49' ' ' TYR . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.46999999999999997 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 1.03 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 1.05 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 1.04 108.901 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.3100000000000001 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 1.02 110.56 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 1.0600000000000001 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.1200000000000001 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 1.01 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 67' ' ' SER . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.7799999999999998 110.146 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.1100000000000001 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 1.05 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 1.0600000000000001 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.79 109.553 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2000000000000002 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.466 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 1.05 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.9300000000000002 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 1.0600000000000001 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.97999999999999998 108.287 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.23999999999999999 110.048 -1.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 1.04 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.19 109.326 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.71 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.13 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 2.0299999999999998 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 2.1600000000000001 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.23000000000000001 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.8100000000000001 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 2.2599999999999998 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 1.05 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.25 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.17999999999999999 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.89000000000000001 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.14000000000000001 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 1.0600000000000001 110.186 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.98 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.72 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.5600000000000001 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 1.03 108.679 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.1499999999999999 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 1.04 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 1.04 110.404 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 1.05 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.6599999999999999 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 1.1399999999999999 110.528 -178.278 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HB3' ' H ' ' B' ' 5' ' ' TYR . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.466 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.263 -0.643 . . . . 1.1000000000000001 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 2.5 109.087 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 1.6100000000000001 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 1.04 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.92000000000000004 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 2.48 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 1.05 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.25 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 3.0699999999999998 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1000000000000001 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 1.04 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 1.27 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.0900000000000001 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 1.0900000000000001 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 1.0700000000000001 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.31 109.192 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.4100000000000001 109.459 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 1.05 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 1.03 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 1.01 108.588 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 1.02 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.95999999999999996 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.32000000000000001 107.73 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.04 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 108.474 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 1.0600000000000001 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.51000000000000001 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 109.907 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.40000000000000002 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.47999999999999998 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81000000000000005 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 2.46 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.6600000000000001 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 1.0700000000000001 111.559 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 2.1099999999999999 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.29999999999999999 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.37 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.14999999999999999 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.47999999999999998 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.05 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 1.1299999999999999 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.93000000000000005 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.6499999999999999 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.89000000000000001 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.93000000000000005 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 1.03 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 1.05 109.398 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 55' ' ' LEU . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 1.04 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 1.02 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.0800000000000001 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 1.0600000000000001 111.183 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.1100000000000001 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.1200000000000001 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 1.01 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.478 HE21 ' NH2' ' B' ' 4' ' ' ARG . 1.4 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.7799999999999998 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.1100000000000001 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 1.05 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.79 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2000000000000002 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.3399999999999999 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 1.05 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.9300000000000002 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 1.0600000000000001 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.97999999999999998 108.627 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.23999999999999999 110.296 -1.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 1.04 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.19 108.601 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.71 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.13 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.22 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 2.0299999999999998 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 2.1600000000000001 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.23000000000000001 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.8100000000000001 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 2.2599999999999998 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 1.05 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.25 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.17999999999999999 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.89000000000000001 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.14000000000000001 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 1.0600000000000001 110.385 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.98 108.148 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.72 110.787 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.5600000000000001 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 1.03 108.598 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.1499999999999999 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 1.04 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 1.04 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 1.05 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.6599999999999999 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 1.1399999999999999 110.376 -179.06 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.478 ' NH2' HE21 ' A' ' 63' ' ' GLN . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.428 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 98.0 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.2 0.524 . . . . 1.1000000000000001 109.639 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 2.5 109.427 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 1.6100000000000001 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 1.04 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.92000000000000004 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 2.48 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 1.05 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 1.0600000000000001 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.25 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 3.0699999999999998 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 1.04 109.157 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 1.27 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 1.0700000000000001 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.31 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 2.4100000000000001 108.857 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 1.05 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 1.03 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 1.01 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 1.02 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.95999999999999996 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.32000000000000001 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.04 109.715 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 1.0600000000000001 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 1.0600000000000001 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.51000000000000001 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.40000000000000002 111.7 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.47999999999999998 111.461 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81000000000000005 108.665 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 2.46 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.6600000000000001 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 1.0700000000000001 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 2.1099999999999999 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.29999999999999999 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.37 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.14999999999999999 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 1.05 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 1.1299999999999999 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.93000000000000005 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.6499999999999999 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.89000000000000001 109.101 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.93000000000000005 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.3 t30 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 109.39 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 1.03 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 1.05 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 1.04 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 1.02 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.0800000000000001 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 1.0600000000000001 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.1100000000000001 110.974 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.533 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 1.01 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.7799999999999998 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.1100000000000001 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 1.05 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 1.0600000000000001 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.79 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2000000000000002 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 1.0600000000000001 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.3399999999999999 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 1.05 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.9300000000000002 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.489 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 1.0600000000000001 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.97999999999999998 108.684 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.23999999999999999 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 1.04 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.19 108.956 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.598 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.7 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.71 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.13 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.431 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 2.0299999999999998 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.23000000000000001 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.8100000000000001 110.225 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 2.2599999999999998 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 1.05 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.25 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.17999999999999999 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.89000000000000001 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.14000000000000001 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 1.0600000000000001 110.152 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.98 108.405 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' NZ ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.72 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.5600000000000001 109.746 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 1.03 108.856 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.1499999999999999 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 1.04 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 1.04 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 1.05 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.6599999999999999 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 1.1399999999999999 110.289 -178.783 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.309 -0.626 . . . . 1.1000000000000001 109.309 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 2.5 107.91 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 1.6100000000000001 110.431 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 1.04 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.92000000000000004 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 2.48 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 1.05 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 1.0600000000000001 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.25 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 3.0699999999999998 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 1.04 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 1.27 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.0900000000000001 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 1.0900000000000001 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 1.0700000000000001 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.31 109.51 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 2.4100000000000001 108.948 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 1.05 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 1.03 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 1.01 108.562 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 1.02 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.95999999999999996 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.32000000000000001 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.04 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 1.0600000000000001 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.51000000000000001 110.103 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.34000000000000002 109.12 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.47999999999999998 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 2.46 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.6600000000000001 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 1.0700000000000001 110.185 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 2.1099999999999999 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.29999999999999999 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.567 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.37 109.059 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.14999999999999999 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.47999999999999998 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 1.05 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 1.1299999999999999 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.93000000000000005 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.6499999999999999 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.89000000000000001 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.46999999999999997 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 1.03 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 1.05 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 1.04 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.3100000000000001 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 1.02 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' ASP . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.0800000000000001 108.538 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 1.0600000000000001 111.024 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' ASP . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.1100000000000001 110.567 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.1200000000000001 109.683 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 1.01 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.7799999999999998 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 1.05 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.79 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2000000000000002 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 1.0600000000000001 109.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.3399999999999999 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 1.05 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.9300000000000002 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 1.0600000000000001 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.97999999999999998 108.707 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.23999999999999999 110.18 -1.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 1.04 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.19 108.776 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.71 107.65 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.13 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 2.0299999999999998 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 2.1600000000000001 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.23000000000000001 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.8100000000000001 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 2.2599999999999998 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 1.05 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.25 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.17999999999999999 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.89000000000000001 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.14000000000000001 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 1.0600000000000001 110.026 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.98 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.72 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.5600000000000001 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 1.03 108.555 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.1499999999999999 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 1.04 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 1.04 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 1.05 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.6599999999999999 109.372 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 1.1399999999999999 110.343 -178.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.253 0.549 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.646 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t . . . . . 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.302 0.572 . . . . 1.1000000000000001 109.624 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 2.5 109.163 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 1.6100000000000001 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 1.04 108.099 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.92000000000000004 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 2.48 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 1.05 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 1.0600000000000001 109.831 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.25 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 3.0699999999999998 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1000000000000001 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 1.04 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 1.27 109.882 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 1.0700000000000001 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.31 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 2.4100000000000001 108.887 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.568 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 1.05 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.568 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 1.03 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 1.02 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.95999999999999996 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.32000000000000001 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.04 109.46 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 1.0600000000000001 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 1.0600000000000001 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.51000000000000001 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.34000000000000002 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.40000000000000002 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.47999999999999998 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 108.615 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 2.46 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.6600000000000001 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 2.1099999999999999 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.29999999999999999 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.37 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.14999999999999999 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.47999999999999998 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 1.05 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 1.1299999999999999 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.93000000000000005 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.6499999999999999 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 51' ' ' ASN . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.89000000000000001 108.923 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.93000000000000005 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.0 t30 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.46999999999999997 109.307 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 1.03 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 1.05 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 1.04 109.063 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.3100000000000001 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 1.02 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.0800000000000001 107.888 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.178 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.1100000000000001 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 1.01 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.7799999999999998 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 1.05 108.86 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 1.0600000000000001 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.79 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2000000000000002 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.3399999999999999 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.469 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 1.05 109.063 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.9300000000000002 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 1.0600000000000001 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.97999999999999998 109.249 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.23999999999999999 109.892 -1.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 1.04 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.19 108.52 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.71 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.13 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.22 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 2.0299999999999998 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 2.1600000000000001 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.23000000000000001 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.8100000000000001 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 2.2599999999999998 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 1.05 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.25 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.17999999999999999 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.89000000000000001 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.14000000000000001 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 1.0600000000000001 110.743 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.98 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.72 110.915 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.5600000000000001 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 1.03 108.771 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 1.04 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 1.04 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.05 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.6599999999999999 109.837 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 110.262 -178.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.469 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 9' ' ' GLY . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.277 -0.638 . . . . 1.1000000000000001 109.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 2.5 109.568 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 1.6100000000000001 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 1.04 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.92000000000000004 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 2.48 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 1.05 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 1.0600000000000001 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.25 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 3.0699999999999998 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1000000000000001 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 1.04 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 1.27 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 1.0900000000000001 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 1.0700000000000001 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.31 109.228 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 2.4100000000000001 109.015 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 1.05 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.492 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 1.03 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 1.01 108.697 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 1.02 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.95999999999999996 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.32000000000000001 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.04 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 1.0600000000000001 108.831 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.34000000000000002 109.913 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.40000000000000002 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.47999999999999998 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 2.46 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.485 ' O ' ' SD ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.6600000000000001 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 1.0700000000000001 110.846 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 2.1099999999999999 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.29999999999999999 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 44' ' ' SER . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.37 109.68 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.14999999999999999 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.8 t60 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.47999999999999998 110.231 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 1.05 110.262 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 1.1299999999999999 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 43' ' ' HIS . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.93000000000000005 109.45 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.6499999999999999 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.89000000000000001 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.93000000000000005 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.46999999999999997 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 1.03 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 1.05 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 1.04 108.999 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.3100000000000001 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 1.02 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.0800000000000001 108.568 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.1100000000000001 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.1200000000000001 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 1.01 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.7799999999999998 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.1100000000000001 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 1.0600000000000001 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.79 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2000000000000002 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 1.0600000000000001 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 1.05 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.9300000000000002 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 1.0600000000000001 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.97999999999999998 108.587 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.23999999999999999 110.11 -1.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 1.04 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.19 109.0 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.71 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.13 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.22 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 2.0299999999999998 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 2.1600000000000001 109.788 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.23000000000000001 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.8100000000000001 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 2.2599999999999998 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 1.05 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.25 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.17999999999999999 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.89000000000000001 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.14000000000000001 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 1.0600000000000001 110.338 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.98 108.167 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.72 110.606 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.5600000000000001 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 1.03 108.528 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.1499999999999999 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 1.04 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 1.04 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 1.05 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.6599999999999999 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 1.1399999999999999 110.587 -178.414 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.563 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 1.1000000000000001 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 2.5 109.541 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 1.6100000000000001 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 1.04 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.92000000000000004 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 2.48 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 1.05 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 1.0600000000000001 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.25 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 3.0699999999999998 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1000000000000001 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 1.04 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 1.27 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 1.0900000000000001 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 1.0700000000000001 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.31 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 2.4100000000000001 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 1.05 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.539 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 1.03 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 1.01 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.95999999999999996 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.32000000000000001 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.04 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 108.971 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.51000000000000001 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.34000000000000002 109.7 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.47999999999999998 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81000000000000005 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 2.46 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.6600000000000001 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 1.0700000000000001 111.212 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 2.1099999999999999 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.29999999999999999 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.37 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.14999999999999999 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.47999999999999998 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 1.05 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.93000000000000005 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.6499999999999999 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.89000000000000001 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.93000000000000005 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.7 t30 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.46999999999999997 109.627 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 1.03 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 1.05 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 1.04 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 1.02 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.0800000000000001 108.5 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 1.0600000000000001 111.177 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.451 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.1200000000000001 109.846 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 67' ' ' SER . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.7799999999999998 110.336 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 1.05 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 1.0600000000000001 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.79 109.046 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2000000000000002 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 1.0600000000000001 109.259 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.3399999999999999 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 1.05 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.9300000000000002 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 1.0600000000000001 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.97999999999999998 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.23999999999999999 110.437 -1.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 1.04 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.19 109.155 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.71 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.13 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.22 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 2.0299999999999998 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 2.1600000000000001 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.23000000000000001 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.8100000000000001 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 2.2599999999999998 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 1.05 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.25 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.17999999999999999 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.89000000000000001 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.14000000000000001 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 1.0600000000000001 110.645 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.98 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.72 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.5600000000000001 109.799 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 1.03 108.975 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.1499999999999999 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 1.04 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 1.04 110.126 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 1.05 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.6599999999999999 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 1.1399999999999999 110.569 -178.324 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.617 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.016 -0.735 . . . . 1.1000000000000001 109.016 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 2.5 109.408 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 1.6100000000000001 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 1.04 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.92000000000000004 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 2.48 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 1.05 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 1.0600000000000001 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.25 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 3.0699999999999998 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1000000000000001 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 1.04 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 1.27 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.0900000000000001 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 1.0900000000000001 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 1.0700000000000001 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.31 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 2.4100000000000001 108.668 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 1.05 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 1.03 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 1.01 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 1.02 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.95999999999999996 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.32000000000000001 107.762 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.04 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 1.0600000000000001 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 1.0600000000000001 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.51000000000000001 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.447 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.40000000000000002 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.47999999999999998 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81000000000000005 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 2.46 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.6600000000000001 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 1.0700000000000001 111.009 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 2.1099999999999999 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.29999999999999999 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.37 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.14999999999999999 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.47999999999999998 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 1.05 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 1.1299999999999999 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.93000000000000005 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.6499999999999999 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.89000000000000001 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.93000000000000005 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.46999999999999997 109.581 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 1.03 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 1.05 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 1.04 108.509 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.3100000000000001 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 1.02 110.705 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.0800000000000001 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 1.0600000000000001 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.1100000000000001 111.083 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.1200000000000001 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 1.01 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.7799999999999998 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.1100000000000001 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 1.05 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 1.0600000000000001 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.79 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2000000000000002 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 1.0600000000000001 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.3399999999999999 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 1.05 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.9300000000000002 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 1.0600000000000001 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.97999999999999998 108.837 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.23999999999999999 109.848 -1.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 1.04 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.19 109.247 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.71 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.13 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.22 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 2.0299999999999998 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.23000000000000001 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.8100000000000001 110.902 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 2.2599999999999998 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 1.05 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.25 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.17999999999999999 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.89000000000000001 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.14000000000000001 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 1.0600000000000001 110.701 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.417 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.72 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.5600000000000001 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 1.03 108.825 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.1499999999999999 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 1.04 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 1.04 110.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.05 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 1.1399999999999999 110.413 -178.528 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.407 ' OH ' ' CG1' ' A' ' 59' ' ' VAL . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.547 ' CG1' ' H ' ' A' ' 3' ' ' LYS . 18.7 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.336 0.588 . . . . 1.1000000000000001 109.571 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 2.5 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 1.6100000000000001 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 1.04 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.92000000000000004 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 2.48 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 1.05 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.25 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 1.04 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 1.27 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.0900000000000001 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 1.0700000000000001 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.31 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.592 ' HZ3' ' ND2' ' A' ' 51' ' ' ASN . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 2.4100000000000001 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD21 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 1.05 107.833 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.409 ' H ' HD21 ' A' ' 22' ' ' LEU . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 1.03 109.23 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 1.01 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 1.02 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.95999999999999996 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.32000000000000001 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.04 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.545 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.51000000000000001 110.133 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.34000000000000002 109.807 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.40000000000000002 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.47999999999999998 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81000000000000005 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.46 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.465 ' O ' ' SD ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.6600000000000001 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 1.0700000000000001 110.129 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 2.1099999999999999 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.29999999999999999 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.37 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.14999999999999999 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.47999999999999998 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 1.05 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 1.1299999999999999 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.93000000000000005 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.6499999999999999 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.89000000000000001 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.592 ' ND2' ' HZ3' ' A' ' 21' ' ' LYS . 20.1 t-20 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.46999999999999997 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 1.03 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 1.05 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 1.04 108.897 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.3100000000000001 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 1.02 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.0800000000000001 107.515 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 1.0600000000000001 111.306 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.1100000000000001 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.1200000000000001 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 1.01 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.7799999999999998 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 1.05 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 1.0600000000000001 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.79 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 1.0600000000000001 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.3399999999999999 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 1.05 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.9300000000000002 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 1.0600000000000001 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 ' O ' ' N ' ' B' ' 8' ' ' GLU . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.97999999999999998 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.23999999999999999 110.581 -1.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 1.04 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.19 108.43 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.71 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.13 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 2.0299999999999998 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 2.1600000000000001 109.862 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.23000000000000001 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.8100000000000001 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 2.2599999999999998 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 1.05 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.25 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.17999999999999999 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.89000000000000001 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.14000000000000001 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 1.0600000000000001 110.708 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.98 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.72 110.417 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.5600000000000001 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 1.03 108.917 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.1499999999999999 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.04 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 1.04 110.038 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 1.05 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.6599999999999999 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 1.1399999999999999 110.597 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.444 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 70.1 t . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.555 -0.535 . . . . 1.1000000000000001 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 2.5 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 1.6100000000000001 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 1.04 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.92000000000000004 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 2.48 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 1.05 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 1.0600000000000001 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.25 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 3.0699999999999998 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1000000000000001 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 1.04 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 1.27 109.433 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 1.0900000000000001 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 1.0700000000000001 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.31 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 2.4100000000000001 108.809 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 1.05 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.554 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 1.03 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 1.01 108.655 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 1.02 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.95999999999999996 109.176 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.32000000000000001 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.04 109.235 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 1.0600000000000001 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 1.0600000000000001 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.51 ' CH2' ' CD2' ' B' ' 3' ' ' PHE . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.51000000000000001 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.34000000000000002 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.40000000000000002 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.47999999999999998 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81000000000000005 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 2.46 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.6600000000000001 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 1.0700000000000001 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 2.1099999999999999 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.29999999999999999 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' LYS . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.37 109.071 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.14999999999999999 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.47999999999999998 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 1.05 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 1.1299999999999999 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.93000000000000005 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.6499999999999999 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.89000000000000001 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.93000000000000005 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 30.5 t-20 -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.46999999999999997 109.487 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 1.03 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 1.05 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 1.04 108.639 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.3100000000000001 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 1.02 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.0800000000000001 108.209 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 110.35 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.1100000000000001 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.1200000000000001 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 1.01 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.7799999999999998 110.197 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.1100000000000001 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 1.05 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 1.0600000000000001 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.79 109.395 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 1.0600000000000001 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.3399999999999999 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 1.05 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.9300000000000002 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 1.0600000000000001 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.97999999999999998 108.8 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.23999999999999999 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 1.04 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.19 109.169 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.71 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.13 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.22 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 2.0299999999999998 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 2.1600000000000001 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.23000000000000001 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.8100000000000001 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 2.2599999999999998 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 1.05 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.25 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.17999999999999999 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.89000000000000001 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.14000000000000001 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 1.0600000000000001 110.279 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.98 108.484 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.72 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.5600000000000001 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 1.03 108.752 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.1499999999999999 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 1.04 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 1.04 110.385 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 1.05 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.6599999999999999 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 1.1399999999999999 110.795 -177.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 97.3 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.313 0.578 . . . . 1.1000000000000001 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 2.5 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 1.6100000000000001 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 1.04 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.92000000000000004 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 2.48 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 1.05 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 1.0600000000000001 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.25 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 3.0699999999999998 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1000000000000001 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 1.04 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 1.27 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 1.0900000000000001 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 1.0700000000000001 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.31 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 2.4100000000000001 108.996 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 1.05 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 1.03 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 1.01 108.8 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 1.02 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.32000000000000001 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.04 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 1.0600000000000001 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 1.0600000000000001 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.51000000000000001 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.34000000000000002 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.40000000000000002 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.47999999999999998 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81000000000000005 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 2.46 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.6600000000000001 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 1.0700000000000001 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 2.1099999999999999 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 44' ' ' SER . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.37 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.14999999999999999 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.47999999999999998 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 1.05 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 1.1299999999999999 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.93000000000000005 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.6499999999999999 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.89000000000000001 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.46999999999999997 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 1.03 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 1.05 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 1.04 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.3100000000000001 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 1.02 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.0800000000000001 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.39 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.1100000000000001 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 1.01 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.7799999999999998 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 1.05 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 1.0600000000000001 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.79 109.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2000000000000002 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.3399999999999999 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 1.05 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.9300000000000002 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.97999999999999998 108.293 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.23999999999999999 110.105 -1.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 1.04 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.19 109.052 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.71 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.13 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.22 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 2.0299999999999998 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.514 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.23000000000000001 110.183 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 83' ' ' GLY . 35.1 mm-40 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.8100000000000001 109.996 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 2.2599999999999998 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 1.05 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.25 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.17999999999999999 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.89000000000000001 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.14000000000000001 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 1.0600000000000001 110.712 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.98 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.72 110.595 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.5600000000000001 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 1.03 108.82 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.1499999999999999 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 1.04 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 1.04 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 1.05 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.6599999999999999 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 1.1399999999999999 110.587 -178.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' B' ' 8' ' ' GLU . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 76.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.208 0.528 . . . . 1.1000000000000001 109.654 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 2.5 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 1.6100000000000001 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 1.04 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 2.48 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 1.05 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.25 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 3.0699999999999998 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1000000000000001 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 1.04 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 1.27 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.0900000000000001 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 1.0900000000000001 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 1.0700000000000001 109.684 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.31 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 2.4100000000000001 108.718 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 1.05 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 1.03 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 1.01 108.82 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 1.02 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.95999999999999996 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.32000000000000001 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.04 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 1.0600000000000001 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 1.0600000000000001 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.51000000000000001 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.34000000000000002 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.40000000000000002 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.47999999999999998 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81000000000000005 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 2.46 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.6600000000000001 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 1.0700000000000001 111.085 -178.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 2.1099999999999999 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.29999999999999999 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.37 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.14999999999999999 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.47999999999999998 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 1.05 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 1.1299999999999999 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.93000000000000005 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.6499999999999999 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.89000000000000001 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.93000000000000005 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.248 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 1.03 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 1.05 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 1.04 108.984 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.3100000000000001 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 1.02 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.0800000000000001 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.566 -178.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.1100000000000001 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.1200000000000001 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 1.01 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.542 HE22 ' CZ ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.7799999999999998 109.995 -179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.1100000000000001 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 1.05 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 1.0600000000000001 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.79 108.915 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 1.0600000000000001 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.3399999999999999 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 1.05 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.9300000000000002 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 1.0600000000000001 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 8' ' ' GLU . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.97999999999999998 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.23999999999999999 110.364 -2.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 1.04 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.19 108.601 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.71 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.13 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.22 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 2.0299999999999998 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HZ1' ' CB ' ' A' ' 82' ' ' LYS . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 2.1600000000000001 109.541 -178.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.23000000000000001 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.8100000000000001 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 2.2599999999999998 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 1.05 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.25 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.17999999999999999 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.89000000000000001 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.14000000000000001 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 1.0600000000000001 110.162 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.98 108.052 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.72 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.5600000000000001 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 1.03 108.69 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.1499999999999999 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 1.04 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 1.04 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 1.05 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.6599999999999999 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 1.1399999999999999 110.476 -178.741 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.328 0.585 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.542 ' CZ ' HE22 ' A' ' 63' ' ' GLN . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 78.4 t . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.898 -0.778 . . . . 1.1000000000000001 108.898 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.441 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 2.5 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 1.6100000000000001 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 1.04 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.92000000000000004 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 2.48 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 1.05 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.25 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 3.0699999999999998 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1000000000000001 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 1.04 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 1.27 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.0900000000000001 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.31 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 2.4100000000000001 109.135 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 1.05 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 1.03 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 1.01 108.879 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 1.02 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.95999999999999996 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.32000000000000001 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.04 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 1.0600000000000001 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 1.0600000000000001 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.51000000000000001 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.34000000000000002 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.40000000000000002 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.47999999999999998 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81000000000000005 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 2.46 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.6600000000000001 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 1.0700000000000001 111.198 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 2.1099999999999999 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.29999999999999999 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.37 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.14999999999999999 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.47999999999999998 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 1.05 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.93000000000000005 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.6499999999999999 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.89000000000000001 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.93000000000000005 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.46999999999999997 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 1.03 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 1.05 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.04 109.07 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.3100000000000001 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 1.02 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.0800000000000001 107.568 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 1.0600000000000001 110.814 -178.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 1.01 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.7799999999999998 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.1100000000000001 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 1.05 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.79 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2000000000000002 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.3399999999999999 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 1.05 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.9300000000000002 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 1.0600000000000001 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.97999999999999998 108.899 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.23999999999999999 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 1.04 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.19 108.75 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.71 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.13 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.22 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 2.0299999999999998 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 2.1600000000000001 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.23000000000000001 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.8100000000000001 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 2.2599999999999998 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 1.05 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.25 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.17999999999999999 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.89000000000000001 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.14000000000000001 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 1.0600000000000001 110.298 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.98 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.72 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.5600000000000001 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 1.03 108.902 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.1499999999999999 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 1.04 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 1.04 110.205 -178.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 1.05 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.6599999999999999 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 1.1399999999999999 110.676 -178.572 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.434 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.263 0.554 . . . . 1.1000000000000001 109.641 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 2.5 109.24 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 1.6100000000000001 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 1.04 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.92000000000000004 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 2.48 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 1.05 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 1.0600000000000001 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.25 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 3.0699999999999998 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 1.04 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 1.27 109.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 1.0900000000000001 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 1.0700000000000001 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.31 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 2.4100000000000001 109.094 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 1.05 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.544 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 1.03 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 1.01 108.733 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 1.02 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.95999999999999996 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.32000000000000001 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.04 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 1.0600000000000001 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 1.0600000000000001 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.54 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.51000000000000001 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.47999999999999998 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 2.46 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.6600000000000001 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 2.1099999999999999 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.29999999999999999 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.37 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.14999999999999999 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.47999999999999998 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 1.05 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 1.1299999999999999 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.93000000000000005 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.6499999999999999 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.89000000000000001 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.93000000000000005 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.46999999999999997 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 1.03 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 1.05 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 1.04 108.704 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.3100000000000001 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 1.02 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.0800000000000001 108.354 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.0600000000000001 110.752 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.54 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.1200000000000001 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 1.01 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.42 ' O ' ' OG ' ' A' ' 67' ' ' SER . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.7799999999999998 109.961 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 1.05 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 1.0600000000000001 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.79 109.526 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.3399999999999999 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 1.05 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.9300000000000002 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 1.0600000000000001 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.97999999999999998 108.693 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.23999999999999999 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 1.04 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.19 109.128 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.71 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.13 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.22 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 2.0299999999999998 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 82' ' ' LYS . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 2.1600000000000001 109.168 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.23000000000000001 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.8100000000000001 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 1.05 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.25 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.89000000000000001 108.759 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.14000000000000001 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.0600000000000001 110.285 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.98 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.72 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.5600000000000001 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 1.03 108.663 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.1499999999999999 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 1.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 1.04 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 1.05 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.6599999999999999 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 1.1399999999999999 110.283 -178.843 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.0 m-85 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' B' ' 5' ' ' TYR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 90' ' ' SER . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.1 -0.704 . . . . 1.1000000000000001 109.1 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 2.5 109.42 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.6100000000000001 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 1.04 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.92000000000000004 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 2.48 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 1.05 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 1.0600000000000001 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.25 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 1.04 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 1.27 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.0900000000000001 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 1.0700000000000001 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.31 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 2.4100000000000001 109.158 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.567 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 1.05 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 1.03 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 1.01 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 1.02 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.95999999999999996 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.32000000000000001 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.04 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 1.0600000000000001 108.756 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 1.0600000000000001 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.51000000000000001 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.34000000000000002 109.658 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.40000000000000002 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.47999999999999998 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81000000000000005 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 2.46 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.6600000000000001 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 1.0700000000000001 111.174 -177.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 2.1099999999999999 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.29999999999999999 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.37 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.14999999999999999 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.47999999999999998 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 1.05 110.118 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.1299999999999999 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.93000000000000005 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.6499999999999999 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.89000000000000001 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.3 t30 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.46999999999999997 109.362 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 1.03 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 1.04 108.829 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.3100000000000001 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 1.02 110.398 -178.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.0800000000000001 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 111.421 -177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.1100000000000001 111.265 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.1200000000000001 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 1.01 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.7799999999999998 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 1.05 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 1.0600000000000001 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.79 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2000000000000002 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.3399999999999999 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 1.05 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.9300000000000002 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 1.0600000000000001 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.97999999999999998 109.12 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.23999999999999999 110.074 -1.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 1.04 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.19 108.799 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.71 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.13 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.22 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 2.0299999999999998 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 2.1600000000000001 109.989 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.23000000000000001 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.8100000000000001 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 2.2599999999999998 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 1.05 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.25 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.17999999999999999 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.89000000000000001 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.14000000000000001 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 1.0600000000000001 110.235 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.98 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.72 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.5600000000000001 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 1.03 108.211 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.1499999999999999 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 1.04 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 1.04 110.428 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 1.05 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 1.1399999999999999 110.351 -178.531 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.184 0.516 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.434 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 26.7 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.331 0.586 . . . . 1.1000000000000001 109.609 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 2.5 108.925 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 1.6100000000000001 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 5' ' ' ILE . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 1.04 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.92000000000000004 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.48 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 1.05 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.777 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.25 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 3.0699999999999998 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1000000000000001 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 1.04 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 1.27 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.0900000000000001 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 1.0900000000000001 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0700000000000001 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.31 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 1.05 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' H ' HD21 ' A' ' 22' ' ' LEU . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 1.03 109.35 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 1.01 108.549 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 1.02 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.95999999999999996 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.32000000000000001 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.04 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 1.0600000000000001 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 1.0600000000000001 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.51000000000000001 110.114 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.47999999999999998 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81000000000000005 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 2.46 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.6600000000000001 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 1.0700000000000001 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 2.1099999999999999 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.29999999999999999 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.37 109.513 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.14999999999999999 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.47999999999999998 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 1.05 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 1.1299999999999999 109.586 -178.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.6499999999999999 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' ASN . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.89000000000000001 109.52 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.93000000000000005 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' TYR . 6.2 t30 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.46999999999999997 109.573 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 1.03 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 1.05 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 1.04 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.3100000000000001 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 1.02 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.0800000000000001 108.086 178.173 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.1100000000000001 110.68 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.1200000000000001 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 1.01 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.7799999999999998 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.1100000000000001 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 1.05 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 1.0600000000000001 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.79 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 1.0600000000000001 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.3399999999999999 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 1.05 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.9300000000000002 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 1.0600000000000001 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.97999999999999998 108.795 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.23999999999999999 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.19 108.553 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.13 109.712 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.22 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 2.0299999999999998 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.23000000000000001 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.8100000000000001 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HZ2' ' CB ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 2.2599999999999998 109.335 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 1.05 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.25 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.17999999999999999 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.89000000000000001 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.14000000000000001 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 1.0600000000000001 110.703 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.98 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.72 111.003 -178.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.5600000000000001 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 1.03 109.018 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.1499999999999999 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 1.04 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 1.04 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 1.05 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.6599999999999999 109.401 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 1.1399999999999999 110.431 -178.389 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' B' ' 4' ' ' ARG . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 9' ' ' GLY . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.666 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.0 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.166 -0.679 . . . . 1.1000000000000001 109.166 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 2.5 109.254 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 1.6100000000000001 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 1.04 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.92000000000000004 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 2.48 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 1.05 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.25 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 3.0699999999999998 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1000000000000001 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 1.04 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 1.27 110.003 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 1.0900000000000001 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 1.0700000000000001 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.31 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 2.4100000000000001 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 1.05 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.513 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 1.03 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 1.01 108.637 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 1.02 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 28' ' ' SER . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.95999999999999996 109.422 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.32000000000000001 107.973 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 26' ' ' ASP . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.04 109.994 -179.304 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 1.0600000000000001 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.0600000000000001 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.51000000000000001 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.34000000000000002 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.40000000000000002 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.47999999999999998 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81000000000000005 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 2.46 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.6600000000000001 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 1.0700000000000001 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 2.1099999999999999 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.29999999999999999 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.37 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.14999999999999999 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.47999999999999998 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 1.05 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 1.1299999999999999 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.93000000000000005 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.6499999999999999 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.89000000000000001 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.93000000000000005 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.46999999999999997 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 1.03 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 1.05 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 1.04 108.994 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.3100000000000001 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 1.02 110.396 -178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 1.0600000000000001 111.768 -178.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.1100000000000001 110.678 -179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.1200000000000001 109.118 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 1.01 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.7799999999999998 110.362 -179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.1100000000000001 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.79 109.409 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2000000000000002 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 1.0600000000000001 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.3399999999999999 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 1.05 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.9300000000000002 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 1.0600000000000001 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.97999999999999998 108.73 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.23999999999999999 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 1.04 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.19 109.242 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.71 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.13 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.22 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 2.0299999999999998 107.539 -179.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 2.1600000000000001 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.23000000000000001 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.8100000000000001 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.488 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 2.2599999999999998 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 1.05 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.25 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.17999999999999999 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.89000000000000001 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.14000000000000001 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 1.0600000000000001 110.505 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.548 HD21 ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.98 108.235 178.405 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.72 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' H ' HD21 ' A' ' 93' ' ' ASN . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.5600000000000001 110.01 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 1.03 108.517 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.1499999999999999 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 1.04 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 1.04 110.145 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 1.05 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.6599999999999999 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 1.1399999999999999 110.384 -178.595 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.447 ' CE1' ' O ' ' A' ' 71' ' ' VAL . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.362 0.601 . . . . 1.1000000000000001 109.988 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 2.5 108.754 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.92000000000000004 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 2.48 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 1.05 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 1.0600000000000001 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.25 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 3.0699999999999998 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1000000000000001 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 1.04 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 1.27 109.915 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.664 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 1.0700000000000001 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.31 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 2.4100000000000001 109.084 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.496 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 1.05 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.496 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 1.03 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 1.01 108.755 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 1.02 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.95999999999999996 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.32000000000000001 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.04 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 1.0600000000000001 108.719 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.51000000000000001 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.34000000000000002 109.717 -179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.40000000000000002 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.47999999999999998 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81000000000000005 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 2.46 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 1.0700000000000001 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 2.1099999999999999 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.29999999999999999 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.557 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.37 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.14999999999999999 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.47999999999999998 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.607 ' HG ' ' N ' ' A' ' 45' ' ' LEU . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 1.05 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.607 ' N ' ' HG ' ' A' ' 44' ' ' SER . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 1.1299999999999999 109.524 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.93000000000000005 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.6499999999999999 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.89000000000000001 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.93000000000000005 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.5 t30 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.46999999999999997 109.429 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.03 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 1.05 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 1.04 108.563 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.3100000000000001 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 1.02 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.0800000000000001 108.218 178.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 111.211 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.1100000000000001 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.1200000000000001 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 1.01 108.502 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.7799999999999998 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 1.05 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 1.0600000000000001 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.79 109.426 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2000000000000002 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 1.0600000000000001 109.584 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.3399999999999999 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 1.05 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.9300000000000002 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 1.0600000000000001 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.97999999999999998 108.567 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.23999999999999999 110.212 -1.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 1.04 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.19 109.1 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.71 107.771 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.13 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.22 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.401 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 2.0299999999999998 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 2.1600000000000001 109.495 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.23000000000000001 110.471 179.266 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.453 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.6 mm-40 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.8100000000000001 110.188 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HZ2' ' CB ' ' A' ' 85' ' ' LYS . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 2.2599999999999998 109.242 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 1.05 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.25 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.555 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.17999999999999999 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.89000000000000001 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.14000000000000001 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.305 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.98 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.72 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HZ1' ' HG1' ' A' ' 100' ' ' THR . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.5600000000000001 109.595 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 1.03 108.46 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.1499999999999999 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 1.04 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.512 ' HG1' ' HZ1' ' A' ' 96' ' ' LYS . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 1.04 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 1.05 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.6599999999999999 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 110.425 -178.594 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.411 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.65 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.65 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 83.6 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.304 -0.628 . . . . 1.1000000000000001 109.304 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.466 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 2.5 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 1.6100000000000001 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 1.04 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.92000000000000004 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 2.48 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 1.05 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 1.0600000000000001 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.25 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 3.0699999999999998 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1000000000000001 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 1.04 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 1.27 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.0900000000000001 109.073 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0900000000000001 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 1.0700000000000001 109.769 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.31 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.619 ' NZ ' ' ND2' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 2.4100000000000001 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 1.05 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 1.03 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 1.01 108.676 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 1.02 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.95999999999999996 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.32000000000000001 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.04 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 1.0600000000000001 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 1.0600000000000001 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.49 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.51000000000000001 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.34000000000000002 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.40000000000000002 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.47999999999999998 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 2.46 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.6600000000000001 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 1.0700000000000001 110.526 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 2.1099999999999999 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.29999999999999999 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' LYS . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.37 109.315 179.358 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.14999999999999999 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.47999999999999998 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 1.05 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.93000000000000005 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.6499999999999999 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.89000000000000001 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.93000000000000005 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.619 ' ND2' ' NZ ' ' A' ' 21' ' ' LYS . 10.3 t30 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.46999999999999997 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 1.03 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 1.05 109.466 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 1.04 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.3100000000000001 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 1.02 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.0800000000000001 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 1.0600000000000001 110.906 -178.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.1100000000000001 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.1200000000000001 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 1.01 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.7799999999999998 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 109.282 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 1.05 108.788 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 1.0600000000000001 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.79 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2000000000000002 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 1.0600000000000001 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.3399999999999999 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 1.05 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.9300000000000002 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 1.0600000000000001 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.97999999999999998 109.406 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.23999999999999999 109.76 -2.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 1.04 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.19 109.416 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.71 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.13 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 2.0299999999999998 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 2.1600000000000001 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.23000000000000001 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.8100000000000001 110.229 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 2.2599999999999998 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 1.05 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.25 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.17999999999999999 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.89000000000000001 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.14000000000000001 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 1.0600000000000001 110.872 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.98 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.72 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.5600000000000001 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.03 109.142 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.1499999999999999 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 1.04 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 1.04 110.35 -178.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 1.05 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.6599999999999999 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 1.1399999999999999 110.841 -178.299 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.64 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.64 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.116 -0.698 . . . . 1.1000000000000001 109.116 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 2.5 109.443 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 1.6100000000000001 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 1.04 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.92000000000000004 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 2.48 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 1.05 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.25 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 3.0699999999999998 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 1.04 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 1.27 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 1.0700000000000001 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.31 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 2.4100000000000001 109.274 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 1.05 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 1.03 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 1.01 108.732 179.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 1.02 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.95999999999999996 109.398 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.32000000000000001 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.514 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.04 109.813 -179.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 1.0600000000000001 108.448 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 1.0600000000000001 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.51000000000000001 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.34000000000000002 110.052 -178.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.40000000000000002 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.47999999999999998 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81000000000000005 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 2.46 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.6600000000000001 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 1.0700000000000001 110.188 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 2.1099999999999999 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.29999999999999999 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' LYS . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.37 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.14999999999999999 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.47999999999999998 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 1.05 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 1.1299999999999999 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.93000000000000005 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.6499999999999999 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.89000000000000001 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.93000000000000005 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 1.03 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 1.05 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 1.04 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.3100000000000001 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 1.02 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' ASP . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.0800000000000001 107.961 178.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 1.0600000000000001 111.38 -178.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 58' ' ' ASP . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.1100000000000001 111.01 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.1200000000000001 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 1.01 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 67' ' ' SER . 12.1 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.7799999999999998 110.097 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.1100000000000001 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 1.05 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 1.0600000000000001 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.79 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 1.0600000000000001 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.3399999999999999 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 1.05 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.9300000000000002 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 1.0600000000000001 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.97999999999999998 108.757 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.23999999999999999 110.023 -1.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 1.04 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.19 109.116 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.71 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.13 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 2.0299999999999998 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 2.1600000000000001 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.23000000000000001 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.8100000000000001 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 2.2599999999999998 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 1.05 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.25 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.17999999999999999 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.89000000000000001 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.14000000000000001 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 1.0600000000000001 110.54 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.98 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.72 110.523 -178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.5600000000000001 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 1.03 108.587 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.1499999999999999 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 1.04 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 1.04 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 1.05 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.6599999999999999 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 1.1399999999999999 110.625 -178.587 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.47 ' HH ' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' B' ' 9' ' ' GLY . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.219 -0.659 . . . . 1.1000000000000001 109.219 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 2.5 109.464 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 1.6100000000000001 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 1.04 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.92000000000000004 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 2.48 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 1.05 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0600000000000001 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.25 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 3.0699999999999998 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1000000000000001 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 1.04 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 1.27 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.0900000000000001 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 1.0700000000000001 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.31 109.405 -179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 2.4100000000000001 108.752 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 1.05 108.588 -179.35 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 1.03 109.465 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 1.01 108.795 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 1.02 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.95999999999999996 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.32000000000000001 108.091 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.04 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 1.0600000000000001 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 1.0600000000000001 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.518 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.51000000000000001 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.34000000000000002 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.40000000000000002 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.47999999999999998 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 2.46 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.6600000000000001 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 1.0700000000000001 111.261 -178.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 2.1099999999999999 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.29999999999999999 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.37 109.453 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.14999999999999999 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.47999999999999998 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 1.05 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.1299999999999999 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.93000000000000005 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.6499999999999999 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.89000000000000001 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.93000000000000005 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.46999999999999997 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 1.03 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 1.05 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 1.04 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 1.02 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.0800000000000001 108.332 179.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 1.0600000000000001 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.1100000000000001 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.1200000000000001 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 1.01 108.852 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.7799999999999998 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.1100000000000001 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 1.05 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 1.0600000000000001 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.79 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2000000000000002 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 1.0600000000000001 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 1.05 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.9300000000000002 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 1.0600000000000001 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.97999999999999998 108.615 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.23999999999999999 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 1.04 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.19 109.151 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.71 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.13 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.22 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 2.0299999999999998 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 2.1600000000000001 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.23000000000000001 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.8100000000000001 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 2.2599999999999998 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 1.05 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.25 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.17999999999999999 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.89000000000000001 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.14000000000000001 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 1.0600000000000001 110.294 -179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.98 108.15 178.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.72 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.5600000000000001 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 1.03 108.777 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.1499999999999999 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 1.04 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 1.04 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 1.05 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.6599999999999999 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 1.1399999999999999 110.832 -178.176 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.636 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.465 -0.568 . . . . 3.3799999999999999 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -94.65 171.77 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 1.1000000000000001 109.383 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 2.5 109.221 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 1.6100000000000001 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 1.04 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.92000000000000004 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 2.48 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 1.05 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 1.0600000000000001 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.25 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 3.0699999999999998 109.756 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1000000000000001 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 1.04 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 1.27 109.374 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 1.0900000000000001 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0700000000000001 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.31 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 2.4100000000000001 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.545 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 1.05 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 1.03 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 1.01 108.796 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 1.02 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.95999999999999996 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.32000000000000001 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.04 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 1.0600000000000001 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 1.0600000000000001 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.51000000000000001 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.34000000000000002 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.40000000000000002 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.47999999999999998 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81000000000000005 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 2.46 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.6600000000000001 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 1.0700000000000001 110.831 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 2.1099999999999999 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.29999999999999999 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.37 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.14999999999999999 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.47999999999999998 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 1.05 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 1.1299999999999999 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.93000000000000005 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.6499999999999999 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.89000000000000001 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.93000000000000005 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 1.03 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 1.05 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 1.04 108.926 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.3100000000000001 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 1.02 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.0800000000000001 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 1.0600000000000001 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.1200000000000001 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 1.01 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' OG ' ' A' ' 67' ' ' SER . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.7799999999999998 110.207 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.1100000000000001 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 1.05 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.79 109.244 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2000000000000002 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.3399999999999999 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 1.05 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.9300000000000002 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 1.0600000000000001 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' N ' ' B' ' 8' ' ' GLU . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.97999999999999998 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.23999999999999999 110.286 -1.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 1.04 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.19 108.868 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.71 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.13 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.22 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 2.0299999999999998 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 2.1600000000000001 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.23000000000000001 110.57 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 83' ' ' GLY . 38.4 mm-40 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.8100000000000001 110.191 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 2.2599999999999998 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 1.05 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.25 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.17999999999999999 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.89000000000000001 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.14000000000000001 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 1.0600000000000001 110.53 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.98 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.72 110.516 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.5600000000000001 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 1.03 108.657 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.1499999999999999 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 1.04 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 1.04 109.804 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.05 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.28 18.32 8.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 1.1399999999999999 110.363 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.357 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.5 85.84 1.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 109.328 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 -126.13 143.22 51.21 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.092 -1.005 . . . . 0.0 109.274 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.66 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t -100.75 -33.37 10.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -58.63 -94.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.62 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.596 -179.813 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 3.3799999999999999 109.394 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.56 165.27 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.357 -0.839 . . . . 1.1000000000000001 109.254 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 2.5 109.157 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 1.6100000000000001 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 1.04 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.92000000000000004 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HZ2' ' CD ' ' A' ' 68' ' ' GLU . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 2.48 109.606 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 1.05 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 1.0600000000000001 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.25 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 3.0699999999999998 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 1.04 109.147 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 1.27 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 1.0700000000000001 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.31 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 2.4100000000000001 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 1.05 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 1.03 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 1.01 108.683 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 1.02 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.95999999999999996 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.32000000000000001 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.04 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 1.0600000000000001 108.547 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 1.0600000000000001 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.572 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.51000000000000001 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.34000000000000002 109.481 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.40000000000000002 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.47999999999999998 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81000000000000005 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 2.46 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.6600000000000001 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 2.1099999999999999 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.29999999999999999 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.37 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.14999999999999999 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.47999999999999998 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 1.05 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 1.1299999999999999 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.93000000000000005 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.6499999999999999 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.89000000000000001 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.93000000000000005 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.9 t30 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.46999999999999997 108.961 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 1.03 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 1.05 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 1.04 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.3100000000000001 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 1.02 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.0800000000000001 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 110.986 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.65 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.1100000000000001 110.461 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.1200000000000001 109.527 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 1.01 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' CB ' HH12 ' B' ' 4' ' ' ARG . 3.9 pp0? -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.7799999999999998 109.952 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.1100000000000001 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 1.05 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 1.0600000000000001 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.79 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' A' ' 8' ' ' LYS . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 109.671 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB2' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 1.0600000000000001 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.3399999999999999 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 1.05 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.9300000000000002 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 1.0600000000000001 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.97999999999999998 108.754 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.23999999999999999 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 1.04 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.19 108.632 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.407 HE22 ' HB2' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.71 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.13 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.22 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 2.0299999999999998 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 2.1600000000000001 109.764 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.23000000000000001 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.8100000000000001 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 2.2599999999999998 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 1.05 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.25 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.17999999999999999 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.89000000000000001 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.14000000000000001 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 1.0600000000000001 110.741 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.98 107.981 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.72 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.5600000000000001 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 1.03 109.233 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.1499999999999999 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 1.04 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 1.04 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 1.05 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.6599999999999999 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.1 mt -94.13 10.68 32.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 1.1399999999999999 110.653 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.91 -1.119 . . . . 1.1799999999999999 109.174 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.4 p90 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.572 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -127.99 84.16 2.22 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -135.49 137.82 42.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.228 -0.92 . . . . 0.0 109.466 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' B' ' 4' ' ' ARG . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t -78.91 -26.41 43.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -85.28 168.3 14.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.638 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.425 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.65 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.326 -0.62 . . . . 3.3799999999999999 109.326 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 94.7 t -94.94 166.75 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 1.1000000000000001 109.913 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 2.5 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 1.6100000000000001 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 1.04 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.92000000000000004 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 2.48 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 1.05 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 1.0600000000000001 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.25 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 3.0699999999999998 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 1.04 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 1.27 110.005 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 1.0900000000000001 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 1.0700000000000001 109.418 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.31 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 2.4100000000000001 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.527 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 1.05 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.527 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 1.03 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 1.01 108.565 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 1.02 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.32000000000000001 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.04 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 1.0600000000000001 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 1.0600000000000001 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.508 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.51000000000000001 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.34000000000000002 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.40000000000000002 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.47999999999999998 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81000000000000005 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 2.46 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.6600000000000001 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 110.244 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 2.1099999999999999 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.29999999999999999 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.37 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.14999999999999999 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.47999999999999998 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 1.05 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 1.1299999999999999 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.93000000000000005 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.6499999999999999 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.89000000000000001 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.93000000000000005 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.5 t30 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.46999999999999997 109.402 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 1.03 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 1.05 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 1.04 109.065 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.3100000000000001 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 1.02 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 108' ' ' HOH . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 1.0600000000000001 111.316 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.508 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.1100000000000001 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.1200000000000001 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 1.01 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.42 ' O ' ' OG ' ' A' ' 67' ' ' SER . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.7799999999999998 110.681 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.1100000000000001 109.351 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 1.05 108.685 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 1.0600000000000001 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.79 109.316 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2000000000000002 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 1.0600000000000001 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 1.05 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.9300000000000002 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 1.0600000000000001 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.425 ' O ' ' N ' ' B' ' 8' ' ' GLU . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.97999999999999998 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.23999999999999999 109.991 -1.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 1.04 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.19 108.999 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.71 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.13 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.22 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 2.0299999999999998 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 2.1600000000000001 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' C ' ' NE2' ' A' ' 84' ' ' GLN . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.23000000000000001 110.467 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.442 ' NE2' ' C ' ' A' ' 83' ' ' GLY . 40.9 mm-40 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.8100000000000001 110.347 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 2.2599999999999998 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 1.05 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.25 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.17999999999999999 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.89000000000000001 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.14000000000000001 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 1.0600000000000001 110.452 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.98 108.173 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.72 110.478 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.5600000000000001 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 1.03 109.309 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.1499999999999999 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 1.04 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 1.04 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 1.05 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.6599999999999999 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt -91.73 19.68 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 1.1399999999999999 110.49 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.062 . . . . 1.1799999999999999 109.307 179.465 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 2' ' ' ARG . 3.8 ptm180 -164.27 62.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.022 . . . . 0.0 109.661 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 -99.99 162.26 13.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 108.995 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.641 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.641 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t -84.9 -4.05 58.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -141.92 160.55 39.98 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.535 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.441 ' H1 ' ' C ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.407 -0.59 . . . . 3.3799999999999999 109.407 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t -94.79 151.54 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.204 -0.935 . . . . 1.1000000000000001 109.72 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 2.5 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 1.6100000000000001 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 1.04 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.92000000000000004 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 2.48 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 1.05 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 1.0600000000000001 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.25 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 3.0699999999999998 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1000000000000001 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 1.04 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 1.27 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.0900000000000001 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 1.0900000000000001 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 1.0700000000000001 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.31 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.549 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 2.4100000000000001 109.181 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 1.05 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 1.03 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 1.01 108.831 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 1.02 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.95999999999999996 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.32000000000000001 107.941 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.04 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.445 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.51000000000000001 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.34000000000000002 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.40000000000000002 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.47999999999999998 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81000000000000005 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 2.46 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.6600000000000001 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 1.0700000000000001 110.781 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 2.1099999999999999 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 44' ' ' SER . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.14999999999999999 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.47999999999999998 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 1.05 109.938 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 1.1299999999999999 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.93000000000000005 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.6499999999999999 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.89000000000000001 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.93000000000000005 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.46999999999999997 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 1.03 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 1.05 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 1.04 108.941 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.3100000000000001 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 1.02 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 1.0600000000000001 111.374 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.1100000000000001 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.1200000000000001 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 1.01 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.7799999999999998 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 1.05 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 1.0600000000000001 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.79 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2000000000000002 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.3399999999999999 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.05 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.9300000000000002 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 1.0600000000000001 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.97999999999999998 108.641 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.23999999999999999 109.909 -1.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 1.04 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.19 108.856 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 11.0 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.71 107.403 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.13 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.22 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 2.0299999999999998 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 2.1600000000000001 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.23000000000000001 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.8100000000000001 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 2.2599999999999998 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 1.05 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.25 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.17999999999999999 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.89000000000000001 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.14000000000000001 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 1.0600000000000001 110.627 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.98 107.57 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.72 110.494 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.5600000000000001 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 1.03 108.621 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 1.04 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 1.04 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 1.05 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.6599999999999999 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 19.58 5.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 1.1399999999999999 110.572 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.86 -1.15 . . . . 1.1799999999999999 109.272 179.409 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' B' ' 2' ' ' ARG . 15.1 ttm180 -167.74 21.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.697 1.237 . . . . 0.0 109.177 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -103.55 157.95 16.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.681 -1.262 . . . . 0.0 109.918 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -87.93 -7.85 56.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 35.8 t60 -156.17 -122.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.385 -0.822 . . . . 0.0 109.373 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.554 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.549 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtp . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.497 -0.556 . . . . 3.3799999999999999 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.72 156.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.241 -0.912 . . . . 1.1000000000000001 109.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 2.5 109.189 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 1.6100000000000001 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 1.04 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.92000000000000004 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 2.48 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 1.05 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 1.0600000000000001 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.25 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 3.0699999999999998 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 1.04 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 1.27 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 1.0900000000000001 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 1.0700000000000001 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.31 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 2.4100000000000001 109.166 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 1.05 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 1.03 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 1.01 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 1.02 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.95999999999999996 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.32000000000000001 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.04 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 1.0600000000000001 108.704 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 1.0600000000000001 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.51000000000000001 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.34000000000000002 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.40000000000000002 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.47999999999999998 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 2.46 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.6600000000000001 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 1.0700000000000001 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 2.1099999999999999 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.29999999999999999 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.37 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.14999999999999999 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.47999999999999998 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 1.05 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 1.1299999999999999 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.93000000000000005 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.6499999999999999 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.89000000000000001 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.93000000000000005 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.8 t30 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.46999999999999997 109.461 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 1.03 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 1.05 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 1.04 108.783 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.3100000000000001 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 1.02 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.0800000000000001 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 1.0600000000000001 111.342 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.828 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.1100000000000001 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.597 ' NE2' HH11 ' B' ' 4' ' ' ARG . 77.3 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.7799999999999998 109.866 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.1100000000000001 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 1.05 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 1.0600000000000001 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.79 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2000000000000002 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.3399999999999999 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 1.05 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.9300000000000002 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 1.0600000000000001 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.97999999999999998 109.148 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.23999999999999999 110.137 -2.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 1.04 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.19 108.797 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.71 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.13 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.22 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 2.0299999999999998 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.482 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 2.1600000000000001 109.931 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.23000000000000001 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.8100000000000001 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 2.2599999999999998 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 1.05 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.25 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.17999999999999999 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.89000000000000001 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.14000000000000001 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 1.0600000000000001 110.332 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.98 108.399 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.72 109.863 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.5600000000000001 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 1.03 108.454 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 1.04 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 1.04 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 1.05 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt -93.79 22.81 5.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 110.568 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.176 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.7 mtp180 -120.01 75.12 1.07 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.525 -0.735 . . . . 0.0 109.395 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 -130.05 159.18 37.54 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.316 -0.865 . . . . 0.0 109.239 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' NE2' ' A' ' 63' ' ' GLN . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.425 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t -89.42 -57.2 2.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -79.66 131.47 35.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.612 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.576 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.482 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.828 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.471 -0.566 . . . . 3.3799999999999999 109.471 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 92.2 t -94.68 168.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.295 -0.878 . . . . 1.1000000000000001 109.696 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.466 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 2.5 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 1.6100000000000001 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 1.04 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.92000000000000004 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 2.48 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 1.05 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 1.0600000000000001 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.25 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 3.0699999999999998 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1000000000000001 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 1.04 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 1.27 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 1.0700000000000001 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' H ' ' H2 ' ' A' ' 110' ' ' HOH . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.31 109.638 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 2.4100000000000001 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.592 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 1.05 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.592 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 1.03 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 1.01 108.402 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 1.02 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.95999999999999996 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.32000000000000001 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.04 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 1.0600000000000001 108.677 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 1.0600000000000001 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.51000000000000001 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 109.626 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.40000000000000002 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.47999999999999998 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 2.46 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.6600000000000001 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 1.0700000000000001 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.29999999999999999 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' LYS . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.37 108.814 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.14999999999999999 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.47999999999999998 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 1.05 109.576 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 1.1299999999999999 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.93000000000000005 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.6499999999999999 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.89000000000000001 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.93000000000000005 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.46999999999999997 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 1.03 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 1.05 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 1.04 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.3100000000000001 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 1.02 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 111.38 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.578 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.1100000000000001 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.1200000000000001 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 1.01 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.7799999999999998 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.1100000000000001 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 1.05 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 1.0600000000000001 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.79 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2000000000000002 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 1.0600000000000001 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.3399999999999999 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 1.05 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.9300000000000002 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 1.0600000000000001 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.97999999999999998 108.818 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.23999999999999999 110.204 -1.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 1.04 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.19 108.857 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.71 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.13 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.22 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 2.0299999999999998 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.596 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 2.1600000000000001 109.759 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.23000000000000001 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.8100000000000001 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 2.2599999999999998 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 1.05 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.25 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.17999999999999999 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.89000000000000001 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.14000000000000001 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 1.0600000000000001 110.459 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.98 107.889 178.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.72 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.5600000000000001 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 1.03 109.009 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.1499999999999999 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 1.04 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 1.04 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 1.05 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.6599999999999999 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt -92.6 19.2 7.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 111.117 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 1.1799999999999999 109.137 179.22 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 8.5 mmm-85 -127.39 79.68 1.9 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.547 -0.721 . . . . 0.0 109.142 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 -137.76 151.91 48.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.207 -0.933 . . . . 0.0 109.269 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t -96.57 -47.23 6.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -144.13 134.88 25.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.532 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.596 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.578 ' H2 ' ' N ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.451 ' H2 ' ' H ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.289 0.566 . . . . 3.3799999999999999 109.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -94.77 167.13 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 1.1000000000000001 109.483 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 2.5 109.125 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 1.6100000000000001 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 1.04 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.92000000000000004 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 2.48 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 1.05 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 1.0600000000000001 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.25 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 3.0699999999999998 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 1.04 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 1.27 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 1.0700000000000001 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.31 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 2.4100000000000001 109.505 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 1.03 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 1.01 108.705 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 1.02 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.95999999999999996 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.32000000000000001 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.04 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 1.0600000000000001 108.589 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 1.0600000000000001 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.51000000000000001 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.34000000000000002 109.82 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.40000000000000002 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.47999999999999998 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81000000000000005 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 2.46 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.6600000000000001 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 111.082 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 2.1099999999999999 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.29999999999999999 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.37 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.14999999999999999 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.47999999999999998 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 1.05 110.562 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 1.1299999999999999 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.93000000000000005 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.6499999999999999 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.89000000000000001 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.93000000000000005 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 7.2 t30 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.46999999999999997 109.852 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 1.03 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 1.05 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 1.04 108.989 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.3100000000000001 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 1.02 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.625 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 1.0600000000000001 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.1100000000000001 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.1200000000000001 109.409 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 1.01 108.6 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' O ' ' OG ' ' A' ' 67' ' ' SER . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.7799999999999998 109.958 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 1.05 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 1.0600000000000001 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.79 109.549 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2000000000000002 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 1.0600000000000001 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.3399999999999999 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 1.05 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.9300000000000002 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 1.0600000000000001 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.97999999999999998 108.855 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.23999999999999999 110.008 -1.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 1.04 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.19 108.873 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.71 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.13 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.22 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 2.0299999999999998 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 2.1600000000000001 109.643 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.23000000000000001 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.8100000000000001 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 2.2599999999999998 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 1.05 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.25 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.17999999999999999 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.89000000000000001 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.14000000000000001 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 1.0600000000000001 110.297 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.98 107.971 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.72 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' NZ ' ' HG1' ' A' ' 100' ' ' THR . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.5600000000000001 109.625 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 1.03 108.827 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.1499999999999999 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 1.04 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.409 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 1.04 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 1.05 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.6599999999999999 109.582 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.35 22.43 3.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 1.1399999999999999 110.348 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.308 179.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 27.9 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.3 mtt-85 -121.88 72.68 1.04 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -124.06 154.57 39.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.783 . . . . 0.0 109.03 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t -89.8 -18.64 25.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -55.58 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 109.63 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.606 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.449 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.625 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.478 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.439 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 3.3799999999999999 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.57 153.74 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.205 -0.934 . . . . 1.1000000000000001 109.272 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 2.5 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 1.6100000000000001 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 1.04 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.92000000000000004 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 2.48 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 1.05 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 1.0600000000000001 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.25 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 3.0699999999999998 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1000000000000001 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 1.04 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 1.27 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0900000000000001 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 1.0700000000000001 109.576 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.31 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 2.4100000000000001 109.16 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 1.05 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.559 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 1.03 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 1.01 108.875 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 1.02 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.32000000000000001 107.961 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.04 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 1.0600000000000001 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 1.0600000000000001 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.51000000000000001 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.34000000000000002 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.40000000000000002 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.47999999999999998 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81000000000000005 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 2.46 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.416 ' N ' ' O ' ' A' ' 33' ' ' GLY . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.6600000000000001 110.778 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 1.0700000000000001 110.9 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 2.1099999999999999 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.29999999999999999 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' A' ' 44' ' ' SER . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.37 109.506 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.14999999999999999 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.47999999999999998 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 1.05 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 1.1299999999999999 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.93000000000000005 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.6499999999999999 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.89000000000000001 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.93000000000000005 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.1 t30 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.46999999999999997 109.817 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 1.03 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 1.05 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 1.04 108.934 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.3100000000000001 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 1.02 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.0800000000000001 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 108' ' ' HOH . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 1.0600000000000001 111.156 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.536 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.481 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.1200000000000001 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 1.01 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.7799999999999998 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.1100000000000001 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 1.05 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.79 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 1.0600000000000001 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.3399999999999999 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 1.05 109.137 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.9300000000000002 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 1.0600000000000001 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.97999999999999998 109.019 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.23999999999999999 109.818 -1.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 1.04 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.19 108.875 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.71 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.13 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.22 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 2.0299999999999998 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 2.1600000000000001 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.23000000000000001 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.8100000000000001 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 2.2599999999999998 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 1.05 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.25 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.17999999999999999 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.89000000000000001 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.14000000000000001 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 1.0600000000000001 110.555 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.98 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.72 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.5600000000000001 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 1.03 108.651 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.1499999999999999 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 1.04 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.04 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 1.05 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.21 21.37 4.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 1.1399999999999999 110.24 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.124 . . . . 1.1799999999999999 109.294 179.553 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.1 p90 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 84.6 mtt180 -147.07 55.01 1.1 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.089 -1.007 . . . . 0.0 109.467 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -103.96 159.01 16.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.33 -0.856 . . . . 0.0 109.09 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.427 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.643 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.643 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t -87.61 -18.45 29.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -74.97 129.16 37.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 109.604 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.606 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.536 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.4 mpt? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 3.3799999999999999 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.52 158.03 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.366 -0.834 . . . . 1.1000000000000001 109.3 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 2.5 109.048 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 1.6100000000000001 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 1.04 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.92000000000000004 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 2.48 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 1.05 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 1.0600000000000001 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.25 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 3.0699999999999998 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 1.04 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 1.27 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.443 ' C ' ' H2 ' ' A' ' 110' ' ' HOH . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.713 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 1.0900000000000001 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 1.0700000000000001 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.31 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.634 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 2.4100000000000001 108.854 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 1.05 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 1.03 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 1.01 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 1.02 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.95999999999999996 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.32000000000000001 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.04 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 1.0600000000000001 108.336 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.51000000000000001 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.34000000000000002 109.814 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.40000000000000002 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.47999999999999998 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81000000000000005 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 2.46 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.6600000000000001 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 1.0700000000000001 111.535 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 2.1099999999999999 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.29999999999999999 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.37 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.14999999999999999 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.47999999999999998 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 1.05 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 1.1299999999999999 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.93000000000000005 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.6499999999999999 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' ASN . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.89000000000000001 109.227 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.93000000000000005 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.4 t30 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.46999999999999997 109.367 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 1.03 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 1.05 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 1.04 108.998 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.3100000000000001 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 1.02 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.0800000000000001 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 110.701 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.1100000000000001 110.891 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.715 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 67' ' ' SER . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.7799999999999998 110.053 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 1.05 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 1.0600000000000001 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.79 109.251 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2000000000000002 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 1.0600000000000001 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.3399999999999999 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 1.05 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.9300000000000002 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 1.0600000000000001 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.97999999999999998 108.605 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.23999999999999999 110.134 -2.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 1.04 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.19 108.687 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.71 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.13 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.22 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 2.0299999999999998 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' CB ' ' HZ1' ' A' ' 82' ' ' LYS . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 2.1600000000000001 109.06 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.23000000000000001 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.8100000000000001 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 2.2599999999999998 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 1.05 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.25 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.17999999999999999 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.89000000000000001 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.14000000000000001 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 1.0600000000000001 110.282 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.98 108.415 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.72 110.702 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.5600000000000001 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 1.03 108.904 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.1499999999999999 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 1.04 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 1.04 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 1.05 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.6599999999999999 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -90.74 22.14 3.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 1.1399999999999999 110.325 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.007 . . . . 1.1799999999999999 109.172 179.432 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.553 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -131.22 75.49 1.66 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 -134.65 150.59 50.67 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.15 -0.969 . . . . 0.0 109.68 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t -86.36 -5.97 59.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.674 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 1.3 t60 -65.4 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.333 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.674 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.634 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.443 ' H2 ' ' C ' ' A' ' 16' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.505 -0.554 . . . . 3.3799999999999999 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.55 158.04 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 1.1000000000000001 109.195 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 2.5 109.305 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 1.6100000000000001 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 1.04 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.92000000000000004 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 2.48 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 1.05 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 1.0600000000000001 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.25 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 3.0699999999999998 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1000000000000001 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 1.04 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 1.27 109.371 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.0900000000000001 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.0900000000000001 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 1.0700000000000001 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.31 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.643 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' HOH . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 2.4100000000000001 108.648 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.657 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 1.05 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.538 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 1.03 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 1.01 108.737 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 1.02 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.95999999999999996 108.959 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.32000000000000001 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.04 109.723 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 108.825 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 1.0600000000000001 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.51000000000000001 110.417 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.34000000000000002 109.941 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.40000000000000002 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.47999999999999998 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81000000000000005 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 39' ' ' LYS . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 2.46 110.013 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.6600000000000001 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 110.56 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 2.1099999999999999 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.37 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.14999999999999999 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 1.05 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 1.1299999999999999 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.93000000000000005 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.6499999999999999 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 51' ' ' ASN . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.89000000000000001 109.299 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.93000000000000005 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 49' ' ' TYR . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.46999999999999997 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 1.03 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 1.05 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 1.04 108.901 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.3100000000000001 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 1.02 110.56 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 1.0600000000000001 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.1200000000000001 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 1.01 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 67' ' ' SER . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.7799999999999998 110.146 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.1100000000000001 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 1.05 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 1.0600000000000001 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.79 109.553 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2000000000000002 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.466 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 1.05 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.9300000000000002 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 1.0600000000000001 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.97999999999999998 108.287 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.23999999999999999 110.048 -1.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 1.04 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.19 109.326 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.71 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.13 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 2.0299999999999998 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 2.1600000000000001 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.23000000000000001 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.8100000000000001 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 2.2599999999999998 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 1.05 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.25 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.17999999999999999 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.89000000000000001 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.14000000000000001 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 1.0600000000000001 110.186 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.98 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.72 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.5600000000000001 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 1.03 108.679 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.1499999999999999 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 1.04 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 1.04 110.404 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 1.05 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.6599999999999999 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -92.7 24.83 3.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 1.1399999999999999 110.528 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.043 -1.036 . . . . 1.1799999999999999 109.271 179.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -159.13 61.96 0.4 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.54 156.49 17.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.062 -1.023 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.41 ' HB3' ' H ' ' B' ' 5' ' ' TYR . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.466 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t -85.88 -41.46 14.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.82 122.79 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.415 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.518 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.643 ' H1 ' ' N ' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.657 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.43 -0.582 . . . . 3.3799999999999999 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.8 t -94.58 173.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.846 . . . . 1.1000000000000001 109.263 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 2.5 109.087 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 1.6100000000000001 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 1.04 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.92000000000000004 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 2.48 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 1.05 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.25 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 3.0699999999999998 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1000000000000001 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 1.04 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 1.27 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.0900000000000001 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 1.0900000000000001 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 1.0700000000000001 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.594 ' N ' ' H2 ' ' A' ' 110' ' ' HOH . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.31 109.192 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 2.4100000000000001 109.459 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.734 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 1.05 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 1.03 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 1.01 108.588 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 1.02 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.95999999999999996 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.32000000000000001 107.73 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.04 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.0600000000000001 108.474 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 1.0600000000000001 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.51000000000000001 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 109.907 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.40000000000000002 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.47999999999999998 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81000000000000005 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 2.46 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.6600000000000001 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 1.0700000000000001 111.559 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 2.1099999999999999 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.29999999999999999 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.37 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.14999999999999999 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.47999999999999998 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.05 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 1.1299999999999999 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.93000000000000005 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.6499999999999999 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.89000000000000001 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.93000000000000005 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 1.03 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 1.05 109.398 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 1.04 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 1.02 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.0800000000000001 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 1.0600000000000001 111.183 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.1100000000000001 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.1200000000000001 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 1.01 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.478 HE21 ' NH2' ' B' ' 4' ' ' ARG . 1.4 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.7799999999999998 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.1100000000000001 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 1.05 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.79 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2000000000000002 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.3399999999999999 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 1.05 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.9300000000000002 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 1.0600000000000001 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.97999999999999998 108.627 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.23999999999999999 110.296 -1.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 1.04 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.19 108.601 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.71 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.13 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.22 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 2.0299999999999998 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 2.1600000000000001 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.23000000000000001 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.8100000000000001 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 2.2599999999999998 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 1.05 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.25 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.17999999999999999 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.89000000000000001 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.14000000000000001 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 1.0600000000000001 110.385 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.98 108.148 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.72 110.787 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.5600000000000001 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 1.03 108.598 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.1499999999999999 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 1.04 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 1.04 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 1.05 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.6599999999999999 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.43 23.28 4.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 1.1399999999999999 110.376 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.268 179.554 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 88.2 mtt180 -141.89 76.04 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.249 -0.907 . . . . 0.0 109.186 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -126.97 145.58 50.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.478 ' NH2' HE21 ' A' ' 63' ' ' GLN . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.428 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t -101.93 3.77 39.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -160.72 -61.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.8 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.411 ' H2 ' ' N ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.421 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.594 ' H2 ' ' N ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.734 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.373 -0.602 . . . . 3.3799999999999999 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 98.0 t -94.63 162.12 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 1.1000000000000001 109.639 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 2.5 109.427 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 1.6100000000000001 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 1.04 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.92000000000000004 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 2.48 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 1.05 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 1.0600000000000001 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.25 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 3.0699999999999998 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 1.04 109.157 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 1.27 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 1.0700000000000001 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.31 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 2.4100000000000001 108.857 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 1.05 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 1.03 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 1.01 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 1.02 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.95999999999999996 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.32000000000000001 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.04 109.715 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 1.0600000000000001 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 1.0600000000000001 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.51000000000000001 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.40000000000000002 111.7 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.47999999999999998 111.461 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81000000000000005 108.665 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 2.46 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.6600000000000001 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 1.0700000000000001 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 2.1099999999999999 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.29999999999999999 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.37 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.14999999999999999 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.47999999999999998 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 1.05 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 1.1299999999999999 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.93000000000000005 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.6499999999999999 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.89000000000000001 109.101 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.93000000000000005 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.3 t30 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.46999999999999997 109.39 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 1.03 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 1.05 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 1.04 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 1.02 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.0800000000000001 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 1.0600000000000001 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.671 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.1100000000000001 110.974 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.533 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 1.01 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.7799999999999998 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.1100000000000001 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 1.05 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 1.0600000000000001 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.79 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2000000000000002 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 1.0600000000000001 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.3399999999999999 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 1.05 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.9300000000000002 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.489 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 1.0600000000000001 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.97999999999999998 108.684 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.23999999999999999 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 1.04 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.19 108.956 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.598 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.7 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.71 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.13 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.431 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 2.0299999999999998 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.23000000000000001 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.8100000000000001 110.225 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 2.2599999999999998 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 1.05 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.25 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.17999999999999999 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.89000000000000001 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.14000000000000001 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 1.0600000000000001 110.152 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.98 108.405 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' NZ ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.72 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.5600000000000001 109.746 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 1.03 108.856 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.1499999999999999 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 1.04 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 1.04 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 1.05 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.6599999999999999 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt -91.58 20.9 5.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 1.1399999999999999 110.289 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.928 -1.108 . . . . 1.1799999999999999 109.367 179.495 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.1 p90 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.498 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 55.3 mtm180 -152.01 62.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.034 -1.041 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 -103.45 157.41 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t -81.2 -15.76 54.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 51.54 -92.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 11' ' ' SER . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.671 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.482 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.507 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.328 -0.619 . . . . 3.3799999999999999 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.85 153.38 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 1.1000000000000001 109.309 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 2.5 107.91 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 1.6100000000000001 110.431 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 1.04 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.92000000000000004 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 2.48 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 1.05 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 1.0600000000000001 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.25 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 3.0699999999999998 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 1.04 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 1.27 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.0900000000000001 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 1.0900000000000001 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 1.0700000000000001 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.31 109.51 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 2.4100000000000001 108.948 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.683 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 1.05 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 1.03 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 1.01 108.562 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 1.02 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.95999999999999996 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.32000000000000001 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.04 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 1.0600000000000001 108.747 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 1.0600000000000001 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.51000000000000001 110.103 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.34000000000000002 109.12 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.47999999999999998 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 2.46 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.6600000000000001 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 1.0700000000000001 110.185 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 2.1099999999999999 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.29999999999999999 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.567 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.37 109.059 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.14999999999999999 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.47999999999999998 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 1.05 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 1.1299999999999999 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.93000000000000005 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.6499999999999999 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.89000000000000001 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.46999999999999997 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 1.03 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 1.05 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 1.04 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.3100000000000001 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 1.02 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 60' ' ' ASP . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.0800000000000001 108.538 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 108' ' ' HOH . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 1.0600000000000001 111.024 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 58' ' ' ASP . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.1100000000000001 110.567 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.1200000000000001 109.683 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 1.01 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.7799999999999998 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 1.05 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.79 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2000000000000002 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 1.0600000000000001 109.753 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.3399999999999999 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 1.05 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.9300000000000002 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 1.0600000000000001 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.97999999999999998 108.707 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.23999999999999999 110.18 -1.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 1.04 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.19 108.776 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.71 107.65 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.13 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.22 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 2.0299999999999998 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 2.1600000000000001 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.23000000000000001 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.8100000000000001 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 2.2599999999999998 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 1.05 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.25 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.17999999999999999 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.89000000000000001 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.14000000000000001 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 1.0600000000000001 110.026 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.98 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.72 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.5600000000000001 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 1.03 108.555 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.1499999999999999 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 1.04 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 1.04 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 1.05 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.6599999999999999 109.372 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -92.2 21.02 5.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 1.1399999999999999 110.343 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.024 -1.047 . . . . 1.1799999999999999 109.246 179.514 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 mtm180 -171.53 78.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.249 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 50.7 m-85 -100.11 162.26 13.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.953 -1.092 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.646 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t -89.15 -49.97 6.43 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.406 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 7.3 t60 -69.87 172.26 8.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 109.468 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.496 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.6 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.683 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.445 -0.576 . . . . 3.3799999999999999 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -94.83 161.54 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 1.1000000000000001 109.624 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 2.5 109.163 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 1.6100000000000001 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 1.04 108.099 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.92000000000000004 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 2.48 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 1.05 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 1.0600000000000001 109.831 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.25 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 3.0699999999999998 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1000000000000001 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 1.04 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 1.27 109.882 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 1.0700000000000001 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.31 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.524 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 2.4100000000000001 108.887 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.568 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 1.05 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.568 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 1.03 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 1.01 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 1.02 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.95999999999999996 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.32000000000000001 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.04 109.46 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 1.0600000000000001 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 1.0600000000000001 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.51000000000000001 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.34000000000000002 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.40000000000000002 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.47999999999999998 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 108.615 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 2.46 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.6600000000000001 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.404 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 1.0700000000000001 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 2.1099999999999999 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.29999999999999999 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.37 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.14999999999999999 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.47999999999999998 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 1.05 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 1.1299999999999999 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.93000000000000005 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.6499999999999999 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 51' ' ' ASN . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.89000000000000001 108.923 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.93000000000000005 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.0 t30 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.46999999999999997 109.307 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 1.03 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 1.05 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 1.04 109.063 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.3100000000000001 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 1.02 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.0800000000000001 107.888 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 1.0600000000000001 111.178 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.1100000000000001 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 1.01 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.7799999999999998 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 1.05 108.86 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 1.0600000000000001 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.79 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2000000000000002 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.3399999999999999 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.469 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 1.05 109.063 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.9300000000000002 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 1.0600000000000001 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.97999999999999998 109.249 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.23999999999999999 109.892 -1.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 1.04 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.19 108.52 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.71 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.13 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.22 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 2.0299999999999998 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 2.1600000000000001 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.23000000000000001 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.8100000000000001 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 2.2599999999999998 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 1.05 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.25 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.17999999999999999 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.89000000000000001 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.14000000000000001 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 1.0600000000000001 110.743 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.98 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.72 110.915 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.5600000000000001 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 1.03 108.771 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 1.04 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 1.04 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.05 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.6599999999999999 109.837 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.82 16.98 11.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 1.1399999999999999 110.262 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.903 -1.046 . . . . 1.1799999999999999 109.288 179.586 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 48.4 mtm180 -138.01 67.2 1.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 -102.47 157.68 16.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.376 -0.828 . . . . 0.0 109.21 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.469 ' HH ' ' CG1' ' A' ' 71' ' ' VAL . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' B' ' 9' ' ' GLY . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m -97.06 2.53 51.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.668 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 2.6 t60 -165.79 -144.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.937 -1.102 . . . . 0.0 109.561 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.668 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.469 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.542 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.449 -0.574 . . . . 3.3799999999999999 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.35 165.82 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.244 -0.91 . . . . 1.1000000000000001 109.277 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 2.5 109.568 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 1.6100000000000001 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 1.04 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.92000000000000004 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 2.48 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 1.05 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 1.0600000000000001 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.25 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 3.0699999999999998 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1000000000000001 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 1.04 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 1.27 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 1.0900000000000001 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 1.0700000000000001 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.31 109.228 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 2.4100000000000001 109.015 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 1.05 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.492 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 1.03 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 1.01 108.697 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 1.02 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.95999999999999996 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.32000000000000001 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.04 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 1.0600000000000001 108.831 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.34000000000000002 109.913 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.40000000000000002 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.47999999999999998 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 2.46 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.485 ' O ' ' SD ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.6600000000000001 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 1.0700000000000001 110.846 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 2.1099999999999999 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.29999999999999999 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.433 ' O ' ' OG ' ' A' ' 44' ' ' SER . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.37 109.68 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.14999999999999999 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.8 t60 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.47999999999999998 110.231 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 1.05 110.262 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 1.1299999999999999 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 43' ' ' HIS . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.93000000000000005 109.45 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.6499999999999999 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.89000000000000001 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.93000000000000005 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.46999999999999997 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 1.03 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 1.05 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 1.04 108.999 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.3100000000000001 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 1.02 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.0800000000000001 108.568 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.1100000000000001 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.1200000000000001 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 1.01 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.7799999999999998 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.1100000000000001 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 1.0600000000000001 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.79 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2000000000000002 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 1.0600000000000001 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 1.05 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.9300000000000002 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 1.0600000000000001 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.97999999999999998 108.587 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.23999999999999999 110.11 -1.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 1.04 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.19 109.0 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.71 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.13 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.22 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 2.0299999999999998 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.671 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 2.1600000000000001 109.788 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.23000000000000001 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.8100000000000001 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 2.2599999999999998 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 1.05 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.25 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.17999999999999999 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.89000000000000001 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.14000000000000001 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 1.0600000000000001 110.338 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.98 108.167 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.72 110.606 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.5600000000000001 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 1.03 108.528 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.1499999999999999 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 1.04 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 1.04 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 1.05 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.6599999999999999 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -90.29 21.0 4.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 1.1399999999999999 110.587 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.903 -1.123 . . . . 1.1799999999999999 109.222 179.532 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 92.0 mtt180 -144.97 73.56 1.37 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 -131.15 148.94 52.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.593 -0.692 . . . . 0.0 109.244 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.563 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t -88.91 5.78 42.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -164.18 132.9 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.671 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.535 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.482 ' H1 ' ' C ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.455 ' H2 ' ' H ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 3.3799999999999999 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.4 169.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 1.1000000000000001 108.838 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 2.5 109.541 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 1.6100000000000001 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 1.04 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.92000000000000004 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 2.48 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 1.05 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 1.0600000000000001 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.25 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 3.0699999999999998 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1000000000000001 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 1.04 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 1.27 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 1.0900000000000001 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 1.0700000000000001 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.31 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 2.4100000000000001 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.539 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 1.05 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.539 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 1.03 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 1.01 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 1.02 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.95999999999999996 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.32000000000000001 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.04 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 108.971 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.51000000000000001 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.34000000000000002 109.7 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.47999999999999998 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81000000000000005 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 2.46 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.6600000000000001 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 1.0700000000000001 111.212 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 2.1099999999999999 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.29999999999999999 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.37 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.14999999999999999 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.47999999999999998 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 1.05 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 1.1299999999999999 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.93000000000000005 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.6499999999999999 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.89000000000000001 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.93000000000000005 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.7 t30 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.46999999999999997 109.627 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 1.03 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 1.05 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 1.04 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 1.02 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.614 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.0800000000000001 108.5 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 108' ' ' HOH . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 1.0600000000000001 111.177 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.1200000000000001 109.846 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 1.01 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 67' ' ' SER . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.7799999999999998 110.336 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 1.05 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 1.0600000000000001 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.79 109.046 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2000000000000002 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 1.0600000000000001 109.259 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.3399999999999999 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 1.05 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.9300000000000002 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 1.0600000000000001 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.97999999999999998 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.23999999999999999 110.437 -1.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 1.04 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.19 109.155 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.71 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.13 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.22 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 2.0299999999999998 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 2.1600000000000001 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.23000000000000001 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.8100000000000001 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 2.2599999999999998 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 1.05 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.25 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.17999999999999999 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.89000000000000001 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.14000000000000001 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 1.0600000000000001 110.645 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.98 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.72 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.5600000000000001 109.799 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 1.03 108.975 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.1499999999999999 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 1.04 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 1.04 110.126 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 1.05 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.6599999999999999 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 mt -94.83 12.27 28.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 1.1399999999999999 110.569 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 109.291 -179.733 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.53 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 11.5 mtt-85 -127.15 68.36 1.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.285 -0.885 . . . . 0.0 109.983 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 -123.97 141.34 52.13 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.315 -0.866 . . . . 0.0 109.832 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.617 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t -88.5 -35.19 17.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.419 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 38.2 t-80 -81.06 159.29 24.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.341 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.367 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.614 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.507 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.335 0.588 . . . . 3.3799999999999999 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 79.6 t -94.62 161.19 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.248 -0.907 . . . . 1.1000000000000001 109.016 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 2.5 109.408 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 1.6100000000000001 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 1.04 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.92000000000000004 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 2.48 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 1.05 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 1.0600000000000001 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.25 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 3.0699999999999998 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1000000000000001 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 1.04 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 1.27 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.0900000000000001 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 1.0900000000000001 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 1.0700000000000001 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.31 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 2.4100000000000001 108.668 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 1.05 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 1.03 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 1.01 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 1.02 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.95999999999999996 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.32000000000000001 107.762 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.04 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 1.0600000000000001 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 1.0600000000000001 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.51000000000000001 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.447 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.40000000000000002 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.47999999999999998 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81000000000000005 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 2.46 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.6600000000000001 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 1.0700000000000001 111.009 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 2.1099999999999999 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.29999999999999999 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.37 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.14999999999999999 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.47999999999999998 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 1.05 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 1.1299999999999999 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.93000000000000005 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.6499999999999999 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.89000000000000001 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.93000000000000005 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.553 ' ND2' ' H1 ' ' A' ' 111' ' ' HOH . 2.7 t30 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.46999999999999997 109.581 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 1.03 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 1.05 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 1.04 108.509 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.3100000000000001 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 1.02 110.705 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.0800000000000001 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 1.0600000000000001 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.1100000000000001 111.083 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.1200000000000001 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 1.01 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.7799999999999998 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.1100000000000001 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 1.05 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 1.0600000000000001 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.79 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2000000000000002 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 1.0600000000000001 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.3399999999999999 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 1.05 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.9300000000000002 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 1.0600000000000001 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.97999999999999998 108.837 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.23999999999999999 109.848 -1.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 1.04 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.19 109.247 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.71 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.13 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.22 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 2.0299999999999998 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 2.1600000000000001 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.23000000000000001 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.8100000000000001 110.902 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 2.2599999999999998 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 1.05 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.25 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.17999999999999999 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.89000000000000001 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.14000000000000001 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 1.0600000000000001 110.701 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.98 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.417 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.72 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.5600000000000001 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 1.03 108.825 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.1499999999999999 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 1.04 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 1.04 110.331 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.05 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.6599999999999999 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.92 20.1 5.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 1.1399999999999999 110.413 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.986 -1.071 . . . . 1.1799999999999999 109.197 179.477 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.6 mtt180 -140.56 70.69 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 -122.08 151.95 40.35 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.407 ' OH ' ' CG1' ' A' ' 59' ' ' VAL . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t -83.67 -31.83 25.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -52.31 161.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.416 -0.803 . . . . 0.0 109.541 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.92 -1.489 . . . . 0.0 109.586 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.462 ' H2 ' ' N ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.553 ' H1 ' ' ND2' ' A' ' 51' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.35 -0.611 . . . . 3.3799999999999999 109.35 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.547 ' CG1' ' H ' ' A' ' 3' ' ' LYS . 18.7 t -97.22 -178.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.359 -0.838 . . . . 1.1000000000000001 109.571 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.547 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 2.5 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 1.6100000000000001 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 1.04 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.92000000000000004 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 2.48 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 1.05 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 1.0600000000000001 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.25 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 3.0699999999999998 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 1.04 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 1.27 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.0900000000000001 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 1.0900000000000001 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 1.0700000000000001 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.31 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.661 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 2.4100000000000001 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 1.05 107.833 179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.409 ' H ' HD21 ' A' ' 22' ' ' LEU . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 1.03 109.23 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 1.01 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 1.02 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.95999999999999996 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.32000000000000001 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.04 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.545 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 1.0600000000000001 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.51000000000000001 110.133 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.34000000000000002 109.807 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.40000000000000002 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.47999999999999998 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81000000000000005 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.46 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.465 ' O ' ' SD ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.6600000000000001 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 1.0700000000000001 110.129 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 2.1099999999999999 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.29999999999999999 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.37 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.14999999999999999 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.47999999999999998 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 1.05 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 1.1299999999999999 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.93000000000000005 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.6499999999999999 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.89000000000000001 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.93000000000000005 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.592 ' ND2' ' HZ3' ' A' ' 21' ' ' LYS . 20.1 t-20 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.46999999999999997 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 1.03 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 1.05 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 1.04 108.897 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.3100000000000001 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 1.02 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' H ' ' H1 ' ' A' ' 107' ' ' HOH . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.0800000000000001 107.515 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.472 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 1.0600000000000001 111.306 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.1100000000000001 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.1200000000000001 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 1.01 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.7799999999999998 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 1.05 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 1.0600000000000001 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.79 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 1.0600000000000001 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.3399999999999999 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 1.05 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.9300000000000002 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 1.0600000000000001 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 ' O ' ' N ' ' B' ' 8' ' ' GLU . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.97999999999999998 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.23999999999999999 110.581 -1.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 1.04 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.19 108.43 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.71 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.13 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 2.0299999999999998 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.44 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 2.1600000000000001 109.862 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.23000000000000001 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.8100000000000001 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 2.2599999999999998 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 1.05 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.25 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.17999999999999999 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.89000000000000001 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.14000000000000001 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 1.0600000000000001 110.708 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.98 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.72 110.417 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.5600000000000001 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 1.03 108.917 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.1499999999999999 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 1.04 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 1.04 110.038 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 1.05 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.6599999999999999 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.89 21.51 4.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 1.1399999999999999 110.597 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 1.1799999999999999 109.311 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 15.5 mtt-85 -140.71 79.86 1.72 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.04 133.68 49.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.871 . . . . 0.0 108.671 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.444 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t -91.73 12.46 21.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.449 ' ND1' ' OXT' ' B' ' 13' ' ' GLY . 39.3 t-80 -161.54 -70.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.398 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.449 ' OXT' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.597 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.44 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.485 ' H1 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.472 ' H2 ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.661 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.433 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.441 -0.578 . . . . 3.3799999999999999 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.464 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 70.1 t -94.77 166.99 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.23 -0.919 . . . . 1.1000000000000001 109.555 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 2.5 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 1.6100000000000001 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 1.04 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.92000000000000004 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 2.48 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 1.05 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 1.0600000000000001 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.25 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 3.0699999999999998 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1000000000000001 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 1.04 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 1.27 109.433 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 1.0900000000000001 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 1.0700000000000001 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.31 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 2.4100000000000001 108.809 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 1.05 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.554 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 1.03 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 1.01 108.655 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 1.02 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.95999999999999996 109.176 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.32000000000000001 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.04 109.235 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 1.0600000000000001 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 1.0600000000000001 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.51 ' CH2' ' CD2' ' B' ' 3' ' ' PHE . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.51000000000000001 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.34000000000000002 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.40000000000000002 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.47999999999999998 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81000000000000005 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 2.46 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.6600000000000001 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 1.0700000000000001 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 2.1099999999999999 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.29999999999999999 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' LYS . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.37 109.071 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.14999999999999999 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.47999999999999998 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 1.05 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 1.1299999999999999 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.93000000000000005 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.6499999999999999 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.89000000000000001 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.93000000000000005 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 30.5 t-20 -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.46999999999999997 109.487 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 1.03 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 1.05 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 1.04 108.639 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.3100000000000001 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 1.02 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.642 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.0800000000000001 108.209 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 110.35 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.1100000000000001 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.1200000000000001 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 1.01 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.7799999999999998 110.197 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.1100000000000001 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 1.05 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 1.0600000000000001 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.79 109.395 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 1.0600000000000001 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.3399999999999999 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 1.05 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.9300000000000002 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 1.0600000000000001 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.97999999999999998 108.8 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.23999999999999999 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 1.04 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.19 109.169 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.71 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.13 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.22 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 2.0299999999999998 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 2.1600000000000001 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.23000000000000001 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.8100000000000001 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 2.2599999999999998 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 1.05 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.25 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.17999999999999999 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.89000000000000001 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.14000000000000001 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 1.0600000000000001 110.279 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.98 108.484 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.72 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.5600000000000001 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 1.03 108.752 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.1499999999999999 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 1.04 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 1.04 110.385 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 1.05 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.6599999999999999 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.19 19.25 7.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 1.1399999999999999 110.795 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.061 . . . . 1.1799999999999999 109.361 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.408 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -169.2 94.48 0.31 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 -102.49 171.77 7.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t -93.57 -6.4 46.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -163.61 133.12 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.393 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.642 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.465 ' H1 ' ' CG ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.426 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.327 0.584 . . . . 3.3799999999999999 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 97.3 t -94.79 164.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 1.1000000000000001 109.511 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 2.5 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 1.6100000000000001 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 1.04 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.92000000000000004 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 2.48 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 1.05 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 1.0600000000000001 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.25 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 3.0699999999999998 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1000000000000001 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 1.04 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 1.27 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 1.0900000000000001 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 1.0700000000000001 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.31 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 2.4100000000000001 108.996 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 1.05 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 1.03 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 1.01 108.8 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 1.02 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.32000000000000001 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.04 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 1.0600000000000001 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 1.0600000000000001 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.51000000000000001 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.34000000000000002 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.40000000000000002 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.47999999999999998 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81000000000000005 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 2.46 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.6600000000000001 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 1.0700000000000001 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 2.1099999999999999 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.29999999999999999 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 44' ' ' SER . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.37 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.14999999999999999 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.47999999999999998 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 1.05 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 1.1299999999999999 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.93000000000000005 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.6499999999999999 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.89000000000000001 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.93000000000000005 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.46999999999999997 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 1.03 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 1.05 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 1.04 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.3100000000000001 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 1.02 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.0800000000000001 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.39 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.1100000000000001 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 1.01 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.7799999999999998 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 1.05 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 1.0600000000000001 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.79 109.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2000000000000002 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.3399999999999999 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 1.05 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.9300000000000002 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.97999999999999998 108.293 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.23999999999999999 110.105 -1.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 1.04 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.19 109.052 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.71 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.13 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.22 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 2.0299999999999998 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.514 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.23000000000000001 110.183 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 83' ' ' GLY . 35.1 mm-40 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.8100000000000001 109.996 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 2.2599999999999998 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 1.05 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.25 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.17999999999999999 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.89000000000000001 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.14000000000000001 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 1.0600000000000001 110.712 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.98 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.72 110.595 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.5600000000000001 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 1.03 108.82 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.1499999999999999 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 1.04 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 1.04 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 1.05 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.6599999999999999 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 mt -93.63 13.21 22.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 1.1399999999999999 110.587 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.493 1.722 0 O-C-N 120.878 -1.139 . . . . 1.1799999999999999 109.296 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 29.5 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 4.4 mtt-85 -123.73 46.71 2.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 -103.61 155.51 18.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.873 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.408 ' O ' ' OE1' ' B' ' 8' ' ' GLU . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t -85.11 -7.56 59.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.663 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 10.2 t-160 51.56 -127.67 2.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.663 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.056 -1.413 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.476 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.406 -0.59 . . . . 3.3799999999999999 109.406 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 76.4 t -94.76 161.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.191 -0.943 . . . . 1.1000000000000001 109.654 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 2.5 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 1.6100000000000001 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 1.04 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.92000000000000004 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 2.48 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 1.05 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.25 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 3.0699999999999998 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1000000000000001 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 1.04 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 1.27 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.0900000000000001 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 1.0900000000000001 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.413 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 1.0700000000000001 109.684 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.31 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 2.4100000000000001 108.718 179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 1.05 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 1.03 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 1.01 108.82 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 1.02 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.95999999999999996 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.32000000000000001 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.04 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 1.0600000000000001 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 1.0600000000000001 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.51000000000000001 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.34000000000000002 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.483 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.40000000000000002 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.47999999999999998 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81000000000000005 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 2.46 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.6600000000000001 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 1.0700000000000001 111.085 -178.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 2.1099999999999999 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.29999999999999999 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.37 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.14999999999999999 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.47999999999999998 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 1.05 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 1.1299999999999999 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.93000000000000005 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.6499999999999999 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.89000000000000001 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.93000000000000005 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.46999999999999997 109.248 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 1.03 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 1.05 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 1.04 108.984 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.3100000000000001 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 1.02 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.0800000000000001 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.566 -178.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.1100000000000001 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.1200000000000001 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 1.01 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.542 HE22 ' CZ ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.7799999999999998 109.995 -179.606 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.1100000000000001 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 1.05 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 1.0600000000000001 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.79 108.915 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 1.0600000000000001 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.3399999999999999 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 1.05 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.9300000000000002 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 1.0600000000000001 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 8' ' ' GLU . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.97999999999999998 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.23999999999999999 110.364 -2.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 1.04 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.19 108.601 179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.71 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.13 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.22 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 2.0299999999999998 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HZ1' ' CB ' ' A' ' 82' ' ' LYS . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 2.1600000000000001 109.541 -178.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.23000000000000001 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.8100000000000001 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 2.2599999999999998 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 1.05 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.25 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.17999999999999999 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.89000000000000001 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.14000000000000001 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 1.0600000000000001 110.162 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.98 108.052 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.72 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.5600000000000001 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 1.03 108.69 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.1499999999999999 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 1.04 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 1.04 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 1.05 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.6599999999999999 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -91.15 21.18 4.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 1.1399999999999999 110.476 -178.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 1.1799999999999999 109.132 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.5 t80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 29.9 mtm180 -154.1 69.06 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 108.812 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 -103.6 156.12 18.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.554 -0.716 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.542 ' CZ ' HE22 ' A' ' 63' ' ' GLN . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.657 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.657 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t -86.96 -33.46 19.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -55.83 140.72 41.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.636 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.999 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.452 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 3.3799999999999999 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 78.4 t -94.42 166.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 1.1000000000000001 108.898 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 2.5 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 1.6100000000000001 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 1.04 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.92000000000000004 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 2.48 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 1.05 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.25 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 3.0699999999999998 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1000000000000001 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 1.04 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 1.27 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.0900000000000001 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 1.0900000000000001 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.31 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.587 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 2.4100000000000001 109.135 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 1.05 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 1.03 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 1.01 108.879 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 1.02 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.95999999999999996 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.32000000000000001 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.04 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 1.0600000000000001 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 1.0600000000000001 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.51000000000000001 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.34000000000000002 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.40000000000000002 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.47999999999999998 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81000000000000005 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 2.46 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.6600000000000001 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 1.0700000000000001 111.198 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 2.1099999999999999 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.29999999999999999 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.37 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.14999999999999999 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.47999999999999998 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 1.05 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.93000000000000005 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.6499999999999999 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.89000000000000001 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.93000000000000005 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.46999999999999997 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 1.03 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 1.05 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.04 109.07 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.3100000000000001 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 1.02 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' CB ' ' H2 ' ' A' ' 107' ' ' HOH . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.0800000000000001 107.568 178.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 1.0600000000000001 110.814 -178.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 1.01 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.7799999999999998 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.1100000000000001 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 1.05 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.79 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2000000000000002 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.3399999999999999 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 1.05 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.9300000000000002 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 1.0600000000000001 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.97999999999999998 108.899 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.23999999999999999 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 1.04 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.19 108.75 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.71 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.13 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.22 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 2.0299999999999998 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 2.1600000000000001 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.23000000000000001 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.8100000000000001 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 2.2599999999999998 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 1.05 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.25 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.17999999999999999 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.89000000000000001 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.14000000000000001 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 1.0600000000000001 110.298 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.98 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.72 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.5600000000000001 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 1.03 108.902 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.1499999999999999 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 1.04 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 1.04 110.205 -178.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 1.05 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.6599999999999999 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt -90.71 21.92 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 1.1399999999999999 110.676 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.867 -1.146 . . . . 1.1799999999999999 109.462 179.594 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 17.0 mmt180 -121.13 60.34 0.92 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -105.89 152.64 23.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.434 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t -84.01 -31.92 25.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -98.86 -163.38 1.03 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.29 -0.881 . . . . 0.0 109.379 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.628 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.474 ' H2 ' ' CB ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.444 ' H2 ' ' N ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.587 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.469 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.371 -0.603 . . . . 3.3799999999999999 109.371 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.6 t -94.73 157.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 1.1000000000000001 109.641 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 2.5 109.24 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 1.6100000000000001 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 1.04 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.92000000000000004 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 2.48 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 1.05 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 1.0600000000000001 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.25 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 3.0699999999999998 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 1.04 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 1.27 109.235 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 1.0900000000000001 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 1.0700000000000001 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.31 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 2.4100000000000001 109.094 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.644 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 1.05 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.544 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 1.03 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 1.01 108.733 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 1.02 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.95999999999999996 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.32000000000000001 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.04 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 1.0600000000000001 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 1.0600000000000001 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.51000000000000001 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.34000000000000002 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.40000000000000002 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.47999999999999998 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 2.46 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.6600000000000001 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 2.1099999999999999 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.29999999999999999 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.37 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.14999999999999999 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.47999999999999998 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 1.05 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 1.1299999999999999 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.93000000000000005 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.6499999999999999 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.89000000000000001 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.93000000000000005 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.46999999999999997 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 1.03 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 1.05 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 1.04 108.704 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.3100000000000001 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 1.02 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.623 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.0800000000000001 108.354 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 108' ' ' HOH . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 1.0600000000000001 110.752 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.684 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.1200000000000001 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 1.01 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.42 ' O ' ' OG ' ' A' ' 67' ' ' SER . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.7799999999999998 109.961 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 1.05 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 1.0600000000000001 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.79 109.526 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 1.0600000000000001 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.3399999999999999 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 1.05 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.9300000000000002 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 1.0600000000000001 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.97999999999999998 108.693 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.23999999999999999 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 1.04 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.19 109.128 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.71 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.13 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.22 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 2.0299999999999998 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' CB ' ' HZ1' ' A' ' 82' ' ' LYS . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 2.1600000000000001 109.168 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.23000000000000001 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.8100000000000001 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 2.2599999999999998 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 1.05 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.25 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.89000000000000001 108.759 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.14000000000000001 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 1.0600000000000001 110.285 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.98 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.72 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.5600000000000001 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 1.03 108.663 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.1499999999999999 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 1.04 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 1.04 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 1.05 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.6599999999999999 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -93.22 19.5 8.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 1.1399999999999999 110.283 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.978 -1.076 . . . . 1.1799999999999999 109.221 179.607 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 94.98 4.2 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.978 -1.076 . . . . 0.0 108.681 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 32.0 m-85 -99.09 164.87 11.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.458 -0.776 . . . . 0.0 109.906 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' B' ' 5' ' ' TYR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 90' ' ' SER . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t -83.22 -45.66 13.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.665 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 33.3 t-80 -90.51 -176.57 4.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.665 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 118.065 -1.408 . . . . 0.0 109.664 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.623 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.684 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.619 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.644 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 3.3799999999999999 109.501 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.36 159.97 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 1.1000000000000001 109.1 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 2.5 109.42 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.6100000000000001 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 1.04 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.92000000000000004 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 2.48 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 1.05 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 1.0600000000000001 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.25 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 3.0699999999999998 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 1.04 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 1.27 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.0900000000000001 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 1.0700000000000001 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.31 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 2.4100000000000001 109.158 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.567 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 1.05 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 1.03 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 1.01 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 1.02 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.95999999999999996 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.32000000000000001 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.04 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 1.0600000000000001 108.756 179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 1.0600000000000001 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.51000000000000001 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.34000000000000002 109.658 -179.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.40000000000000002 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.47999999999999998 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81000000000000005 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 2.46 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.6600000000000001 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 1.0700000000000001 111.174 -177.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 2.1099999999999999 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.29999999999999999 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.37 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.14999999999999999 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.47999999999999998 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 1.05 110.118 -179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 1.1299999999999999 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.93000000000000005 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.6499999999999999 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.89000000000000001 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.3 t30 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.46999999999999997 109.362 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 1.03 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 1.05 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 1.04 108.829 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.3100000000000001 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 1.02 110.398 -178.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.0800000000000001 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.505 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 1.0600000000000001 111.421 -177.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.1100000000000001 111.265 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.1200000000000001 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 1.01 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.7799999999999998 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 1.05 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 1.0600000000000001 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.79 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2000000000000002 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.3399999999999999 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 1.05 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.9300000000000002 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 1.0600000000000001 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.97999999999999998 109.12 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.23999999999999999 110.074 -1.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 1.04 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.19 108.799 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.71 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.13 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.22 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 2.0299999999999998 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.598 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 2.1600000000000001 109.989 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.23000000000000001 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.8100000000000001 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 2.2599999999999998 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 1.05 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.25 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.17999999999999999 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.89000000000000001 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.14000000000000001 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 1.0600000000000001 110.235 -179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.98 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.72 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.5600000000000001 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 1.03 108.211 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.1499999999999999 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 1.04 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 1.04 110.428 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 1.05 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.68 22.03 3.74 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 1.1399999999999999 110.351 -178.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.019 -1.051 . . . . 1.1799999999999999 109.078 179.323 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -147.52 76.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.302 -0.874 . . . . 0.0 108.926 -179.891 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -110.17 148.7 31.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.901 -1.125 . . . . 0.0 109.753 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.654 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.654 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t -80.55 -25.94 38.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -168.11 96.64 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.848 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.598 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.505 ' H2 ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.386 -0.598 . . . . 3.3799999999999999 109.386 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 26.7 t -95.46 171.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 1.1000000000000001 109.609 -179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 2.5 108.925 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 1.6100000000000001 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 5' ' ' ILE . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 1.04 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.92000000000000004 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 2.48 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 1.05 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.777 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.25 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 3.0699999999999998 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1000000000000001 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 1.04 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 1.27 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.0900000000000001 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 1.0900000000000001 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 1.0700000000000001 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.31 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 2.4100000000000001 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 1.05 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' H ' HD21 ' A' ' 22' ' ' LEU . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 1.03 109.35 179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 1.01 108.549 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 1.02 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.95999999999999996 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.32000000000000001 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.04 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 1.0600000000000001 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 1.0600000000000001 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.51000000000000001 110.114 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.34000000000000002 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.40000000000000002 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.47999999999999998 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81000000000000005 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 2.46 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.6600000000000001 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 1.0700000000000001 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 2.1099999999999999 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.29999999999999999 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.37 109.513 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.14999999999999999 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.47999999999999998 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 1.05 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 1.1299999999999999 109.586 -178.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.93000000000000005 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.6499999999999999 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 51' ' ' ASN . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.89000000000000001 109.52 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.93000000000000005 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 49' ' ' TYR . 6.2 t30 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.46999999999999997 109.573 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 1.03 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 1.05 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 1.04 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.3100000000000001 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 1.02 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.512 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.0800000000000001 108.086 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.606 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.1100000000000001 110.68 -178.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.1200000000000001 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 1.01 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.7799999999999998 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.1100000000000001 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 1.05 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 1.0600000000000001 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.79 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 1.0600000000000001 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.3399999999999999 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 1.05 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.9300000000000002 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 1.0600000000000001 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.97999999999999998 108.795 179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.23999999999999999 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 1.04 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.19 108.553 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.71 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.13 109.712 -177.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.22 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 2.0299999999999998 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.23000000000000001 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.8100000000000001 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HZ2' ' CB ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 2.2599999999999998 109.335 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 1.05 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.25 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.17999999999999999 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.89000000000000001 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.14000000000000001 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 1.0600000000000001 110.703 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.98 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.72 111.003 -178.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.5600000000000001 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 1.03 109.018 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.1499999999999999 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 1.04 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 1.04 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 1.05 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.6599999999999999 109.401 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -91.82 18.95 7.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 1.1399999999999999 110.431 -178.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 1.1799999999999999 109.392 179.723 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 13.5 p90 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.5 mtt180 -145.58 56.19 1.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -108.69 144.02 37.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.503 -0.748 . . . . 0.0 109.204 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.623 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' B' ' 4' ' ' ARG . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 9' ' ' GLY . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.666 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t -90.18 -38.23 13.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.47 ' HD1' ' H ' ' B' ' 13' ' ' GLY . 2.2 t60 -46.79 155.5 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 109.739 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.47 ' H ' ' HD1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.512 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.606 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.504 -0.554 . . . . 3.3799999999999999 109.504 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.0 t -94.44 164.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 1.1000000000000001 109.166 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 2.5 109.254 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 1.6100000000000001 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 1.04 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.92000000000000004 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 2.48 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 1.05 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.25 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 3.0699999999999998 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1000000000000001 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 1.04 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 1.27 110.003 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 1.0900000000000001 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 1.0700000000000001 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.31 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 2.4100000000000001 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 1.05 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.513 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 1.03 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 1.01 108.637 179.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 1.02 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 28' ' ' SER . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.95999999999999996 109.422 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.32000000000000001 107.973 179.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 26' ' ' ASP . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.04 109.994 -179.304 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 1.0600000000000001 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 1.0600000000000001 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.51000000000000001 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.34000000000000002 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.40000000000000002 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.47999999999999998 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81000000000000005 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 2.46 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.6600000000000001 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 1.0700000000000001 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 2.1099999999999999 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.29999999999999999 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.37 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.14999999999999999 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.47999999999999998 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 1.05 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 1.1299999999999999 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.93000000000000005 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.6499999999999999 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.89000000000000001 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.93000000000000005 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.46999999999999997 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 1.03 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 1.05 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 1.04 108.994 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.3100000000000001 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 1.02 110.396 -178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' C ' ' H2 ' ' A' ' 108' ' ' HOH . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.645 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 1.0600000000000001 111.768 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.691 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.1100000000000001 110.678 -179.279 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' HB2' HH11 ' B' ' 2' ' ' ARG . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.1200000000000001 109.118 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 1.01 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.7799999999999998 110.362 -179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.1100000000000001 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.79 109.409 -179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2000000000000002 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 1.0600000000000001 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.3399999999999999 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 1.05 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.9300000000000002 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 1.0600000000000001 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.97999999999999998 108.73 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.23999999999999999 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 1.04 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.19 109.242 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.71 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.13 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.22 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 2.0299999999999998 107.539 -179.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 2.1600000000000001 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.23000000000000001 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.8100000000000001 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.488 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 2.2599999999999998 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 1.05 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.25 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.17999999999999999 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.89000000000000001 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.14000000000000001 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 1.0600000000000001 110.505 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.548 HD21 ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.98 108.235 178.405 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.72 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' H ' HD21 ' A' ' 93' ' ' ASN . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.5600000000000001 110.01 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 1.03 108.517 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.1499999999999999 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 1.04 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 1.04 110.145 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 1.05 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.6599999999999999 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt -92.07 18.88 7.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 1.1399999999999999 110.384 -178.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 1.1799999999999999 109.302 179.51 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 26.6 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 40.6 mtm180 -150.87 72.17 1.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.199 -0.938 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 -123.39 158.79 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.447 ' CE1' ' O ' ' A' ' 71' ' ' VAL . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -92.13 -50.15 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -92.68 158.59 15.85 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.54 179.864 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.418 ' H2 ' ' N ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.691 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.499 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 3.3799999999999999 109.372 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 67.6 t -94.93 162.34 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 1.1000000000000001 109.988 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 2.5 108.754 179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 1.6100000000000001 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.92000000000000004 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 2.48 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 1.05 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 1.0600000000000001 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.25 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 3.0699999999999998 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1000000000000001 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 1.04 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 1.27 109.915 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.414 ' C ' ' H1 ' ' A' ' 110' ' ' HOH . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.664 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 1.0700000000000001 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.31 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 2.4100000000000001 109.084 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.496 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 1.05 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.496 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 1.03 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 1.01 108.755 179.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 1.02 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.95999999999999996 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.32000000000000001 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.04 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 1.0600000000000001 108.719 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.51000000000000001 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.34000000000000002 109.717 -179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.40000000000000002 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.47999999999999998 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81000000000000005 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 2.46 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.6600000000000001 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 1.0700000000000001 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 2.1099999999999999 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.29999999999999999 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.557 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.37 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.14999999999999999 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.47999999999999998 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.607 ' HG ' ' N ' ' A' ' 45' ' ' LEU . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 1.05 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.607 ' N ' ' HG ' ' A' ' 44' ' ' SER . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 1.1299999999999999 109.524 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.93000000000000005 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.6499999999999999 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.89000000000000001 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.93000000000000005 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.5 t30 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.46999999999999997 109.429 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 1.03 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 1.05 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 1.04 108.563 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.3100000000000001 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 1.02 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.0800000000000001 108.218 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 111.211 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.1100000000000001 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.1200000000000001 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 1.01 108.502 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.7799999999999998 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 1.05 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 1.0600000000000001 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.79 109.426 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2000000000000002 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 1.0600000000000001 109.584 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.3399999999999999 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 1.05 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.9300000000000002 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 1.0600000000000001 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.97999999999999998 108.567 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.23999999999999999 110.212 -1.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 1.04 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.19 109.1 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.71 107.771 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.13 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.22 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.401 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 2.0299999999999998 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 2.1600000000000001 109.495 -178.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.23000000000000001 110.471 179.266 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.453 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.6 mm-40 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.8100000000000001 110.188 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HZ2' ' CB ' ' A' ' 85' ' ' LYS . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 2.2599999999999998 109.242 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 1.05 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.25 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.555 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.17999999999999999 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.89000000000000001 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.14000000000000001 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.305 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.98 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.72 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.512 ' HZ1' ' HG1' ' A' ' 100' ' ' THR . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.5600000000000001 109.595 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 1.03 108.46 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.1499999999999999 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 1.04 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.512 ' HG1' ' HZ1' ' A' ' 96' ' ' LYS . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 1.04 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 1.05 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.6599999999999999 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.41 19.67 6.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 1.1399999999999999 110.425 -178.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 1.1799999999999999 109.284 179.506 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 54.4 mtp180 -135.3 67.23 1.49 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 -118.77 156.03 30.09 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.477 -0.765 . . . . 0.0 109.005 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.597 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.411 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.65 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.65 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.9 -14.76 33.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.568 ' HD1' ' N ' ' B' ' 13' ' ' GLY . 15.3 t-80 -146.83 140.02 25.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.145 -0.972 . . . . 0.0 109.533 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.568 ' N ' ' HD1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.448 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.482 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.414 ' H1 ' ' C ' ' A' ' 16' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.356 -0.609 . . . . 3.3799999999999999 109.356 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 83.6 t -94.49 167.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 1.1000000000000001 109.304 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.466 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 2.5 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 1.6100000000000001 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 1.04 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.92000000000000004 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 2.48 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 1.05 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 1.0600000000000001 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.25 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 3.0699999999999998 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1000000000000001 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 1.04 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 1.27 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.466 ' C ' ' H1 ' ' A' ' 110' ' ' HOH . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.0900000000000001 109.073 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0900000000000001 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 1.0700000000000001 109.769 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.31 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' NZ ' ' ND2' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 2.4100000000000001 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 1.05 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 1.03 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 1.01 108.676 179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 1.02 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.95999999999999996 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.32000000000000001 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.04 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 1.0600000000000001 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 1.0600000000000001 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.53 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.51000000000000001 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.34000000000000002 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.40000000000000002 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.47999999999999998 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 2.46 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.6600000000000001 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 1.0700000000000001 110.526 -179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 2.1099999999999999 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.29999999999999999 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 39' ' ' LYS . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.37 109.315 179.358 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.14999999999999999 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.47999999999999998 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 1.05 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.93000000000000005 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.6499999999999999 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.89000000000000001 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.93000000000000005 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.619 ' ND2' ' NZ ' ' A' ' 21' ' ' LYS . 10.3 t30 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.46999999999999997 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 1.03 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 1.05 109.466 -179.167 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 1.04 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.3100000000000001 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 1.02 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.0800000000000001 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' N ' ' H1 ' ' A' ' 108' ' ' HOH . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 1.0600000000000001 110.906 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.1100000000000001 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.1200000000000001 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 1.01 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.7799999999999998 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 109.282 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 1.05 108.788 179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 1.0600000000000001 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.79 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2000000000000002 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 1.0600000000000001 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.3399999999999999 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 1.05 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.9300000000000002 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 1.0600000000000001 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.97999999999999998 109.406 -179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.23999999999999999 109.76 -2.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 1.04 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.19 109.416 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.71 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.13 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.22 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 2.0299999999999998 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 2.1600000000000001 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.23000000000000001 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.8100000000000001 110.229 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 2.2599999999999998 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 1.05 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.25 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.17999999999999999 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.89000000000000001 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.14000000000000001 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 1.0600000000000001 110.872 -179.117 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.98 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.72 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.5600000000000001 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 1.03 109.142 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.1499999999999999 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 1.04 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 1.04 110.35 -178.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 1.05 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.6599999999999999 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.25 20.05 6.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 1.1399999999999999 110.841 -178.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.889 -1.132 . . . . 1.1799999999999999 109.361 179.821 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.647 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -132.39 76.23 1.68 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.145 179.479 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 -130.31 143.67 50.91 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.64 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.64 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t -84.15 -43.43 14.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.537 ' CD2' ' H ' ' B' ' 13' ' ' GLY . 11.2 t-80 -58.57 169.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.372 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.537 ' H ' ' CD2' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.489 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.466 ' H1 ' ' C ' ' A' ' 16' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.564 -0.532 . . . . 3.3799999999999999 109.564 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 t -94.42 169.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -0.914 . . . . 1.1000000000000001 109.116 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 2.5 109.443 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 1.6100000000000001 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 1.04 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.92000000000000004 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 2.48 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 1.05 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.25 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 3.0699999999999998 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 1.04 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 1.27 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 1.0700000000000001 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.31 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.568 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 2.4100000000000001 109.274 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 1.05 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 1.03 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 1.01 108.732 179.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 1.02 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.95999999999999996 109.398 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.32000000000000001 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.514 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.04 109.813 -179.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 1.0600000000000001 108.448 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 1.0600000000000001 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.51000000000000001 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.34000000000000002 110.052 -178.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.40000000000000002 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.47999999999999998 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81000000000000005 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 2.46 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.6600000000000001 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 1.0700000000000001 110.188 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 2.1099999999999999 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.29999999999999999 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' LYS . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.37 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.14999999999999999 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.47999999999999998 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 1.05 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 1.1299999999999999 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.93000000000000005 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.6499999999999999 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.89000000000000001 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.93000000000000005 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 1.03 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 1.05 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 1.04 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.3100000000000001 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 1.02 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.497 ' H ' ' H1 ' ' A' ' 107' ' ' HOH . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.0800000000000001 107.961 178.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 1.0600000000000001 111.38 -178.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 58' ' ' ASP . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.1100000000000001 111.01 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.1200000000000001 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 1.01 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 67' ' ' SER . 12.1 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.7799999999999998 110.097 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.1100000000000001 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 1.05 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 1.0600000000000001 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.79 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 1.0600000000000001 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.3399999999999999 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 1.05 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.9300000000000002 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 1.0600000000000001 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.97999999999999998 108.757 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.23999999999999999 110.023 -1.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 1.04 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.19 109.116 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.71 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.13 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.22 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 2.0299999999999998 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 2.1600000000000001 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.23000000000000001 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.8100000000000001 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 2.2599999999999998 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 1.05 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.25 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.17999999999999999 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.89000000000000001 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.14000000000000001 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 1.0600000000000001 110.54 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.98 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.72 110.523 -178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.5600000000000001 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 1.03 108.587 -179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.1499999999999999 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 1.04 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 1.04 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 1.05 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.6599999999999999 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 mt -91.37 15.62 11.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 1.1399999999999999 110.625 -178.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.301 -1.5 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.301 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.556 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 73.8 mtt180 -157.39 60.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.85 . . . . 0.0 109.162 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 -98.28 161.92 13.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.102 -0.999 . . . . 0.0 109.183 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.47 ' HH ' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' B' ' 9' ' ' GLY . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t -86.0 -23.4 26.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -68.09 161.2 27.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.497 ' H1 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.568 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.468 -0.568 . . . . 3.3799999999999999 109.468 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.4 t -94.5 166.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 1.1000000000000001 109.219 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 2.5 109.464 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 1.6100000000000001 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 1.04 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.92000000000000004 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 2.48 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 1.05 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 1.0600000000000001 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.25 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 3.0699999999999998 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1000000000000001 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 1.04 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 1.27 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.0900000000000001 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 1.0700000000000001 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.618 ' N ' ' H2 ' ' A' ' 110' ' ' HOH . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.31 109.405 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 2.4100000000000001 108.752 179.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 1.05 108.588 -179.35 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 1.03 109.465 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 1.01 108.795 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 1.02 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.95999999999999996 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.32000000000000001 108.091 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.04 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 1.0600000000000001 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 1.0600000000000001 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.51000000000000001 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.34000000000000002 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.40000000000000002 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.47999999999999998 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 2.46 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.6600000000000001 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 1.0700000000000001 111.261 -178.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 2.1099999999999999 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.29999999999999999 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.37 109.453 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.14999999999999999 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.47999999999999998 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 1.05 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 1.1299999999999999 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.93000000000000005 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.6499999999999999 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.89000000000000001 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.93000000000000005 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.46999999999999997 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 1.03 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 1.05 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 1.04 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 1.02 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.518 ' CG ' HH21 ' B' ' 2' ' ' ARG . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.0800000000000001 108.332 179.027 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 1.0600000000000001 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.1100000000000001 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.1200000000000001 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 1.01 108.852 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.7799999999999998 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.1100000000000001 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 1.05 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 1.0600000000000001 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.79 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2000000000000002 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 1.0600000000000001 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 1.05 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.9300000000000002 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 1.0600000000000001 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.97999999999999998 108.615 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.23999999999999999 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 1.04 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.19 109.151 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.71 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.13 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.22 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 2.0299999999999998 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 2.1600000000000001 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.23000000000000001 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.8100000000000001 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 2.2599999999999998 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 1.05 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.25 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.17999999999999999 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.89000000000000001 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.14000000000000001 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 1.0600000000000001 110.294 -179.457 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.98 108.15 178.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.72 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.5600000000000001 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 1.03 108.777 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.1499999999999999 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 1.04 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 1.04 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 1.05 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.6599999999999999 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt -91.63 20.08 5.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 1.1399999999999999 110.832 -178.176 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 109.376 179.852 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 34.6 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.55 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 43.1 mtp180 -140.56 76.86 1.57 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.276 -0.89 . . . . 0.0 109.313 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -129.73 143.18 50.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.636 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t -83.09 -9.55 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.49 ' C ' ' HD1' ' B' ' 12' ' ' HIS . 5.2 t-80 -159.35 108.14 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.099 -1.389 . . . . 0.0 109.735 -179.931 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.494 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.618 ' H2 ' ' N ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.6 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.383 -0.599 . . . . 0.29999999999999999 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 2' ' ' VAL . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 1.97 109.221 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.97999999999999998 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.19 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.23000000000000001 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 1.8999999999999999 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 0.25 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.20000000000000001 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.20999999999999999 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 12' ' ' GLN . 4.1 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 2.4700000000000002 109.756 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1000000000000001 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 0.20000000000000001 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 0.62 109.374 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 0.29999999999999999 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.28000000000000003 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 1.8999999999999999 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 0.17000000000000001 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 0.12 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 0.089999999999999997 108.796 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.17000000000000001 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.95999999999999996 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.23999999999999999 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.03 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 0.26000000000000001 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 0.32000000000000001 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.44 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.32000000000000001 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.35999999999999999 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.44 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81000000000000005 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 1.9199999999999999 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.1299999999999999 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.831 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 1.6200000000000001 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.25 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.29999999999999999 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.13 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.40999999999999998 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 0.96999999999999997 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 0.5 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.51000000000000001 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.1600000000000001 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.23999999999999999 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.17000000000000001 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.34000000000000002 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 0.12 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 0.17000000000000001 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.519 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 0.12 108.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.3100000000000001 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 0.14000000000000001 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.0800000000000001 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 0.27000000000000002 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.1200000000000001 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 0.17000000000000001 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.2200000000000002 110.207 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.1100000000000001 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 0.19 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.22 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.29 109.244 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2000000000000002 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.3399999999999999 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.28000000000000003 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.3999999999999999 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 0.22 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.673 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.22 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.20000000000000001 110.286 -1.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 0.17999999999999999 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.14999999999999999 108.868 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.03 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.11 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.17000000000000001 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 1.48 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 1.6699999999999999 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.22 110.57 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.0800000000000001 110.191 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 1.7 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.26000000000000001 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.17999999999999999 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.14000000000000001 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.17000000000000001 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.13 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 0.20000000000000001 110.53 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.1499999999999999 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.1899999999999999 110.516 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.0499999999999998 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 0.14999999999999999 108.657 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.1499999999999999 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 0.14999999999999999 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.13 109.804 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.17999999999999999 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.03 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 0.34999999999999998 110.363 -178.64 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.645 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.626 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.626 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.254 -0.647 . . . . 0.29999999999999999 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 2' ' ' VAL . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 1.97 109.157 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 0.97999999999999998 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 0.19 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.23000000000000001 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 1.8999999999999999 109.606 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 0.25 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.20000000000000001 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.20999999999999999 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 2.4700000000000002 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.20000000000000001 109.147 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.62 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.29999999999999999 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.23999999999999999 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.28000000000000003 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 1.8999999999999999 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.17000000000000001 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 0.12 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 0.089999999999999997 108.683 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 0.17000000000000001 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.95999999999999996 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.23999999999999999 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.03 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 0.26000000000000001 108.547 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.32000000000000001 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.57 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.44 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.32000000000000001 109.481 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.35999999999999999 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.44 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81000000000000005 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 1.9199999999999999 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.1299999999999999 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 1.6200000000000001 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.25 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.29999999999999999 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.13 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 0.96999999999999997 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 0.5 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.51000000000000001 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.1600000000000001 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.23999999999999999 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.17000000000000001 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.34000000000000002 108.961 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 0.12 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 0.17000000000000001 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.63 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 0.12 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.3100000000000001 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.14000000000000001 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.0800000000000001 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.27000000000000002 110.986 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.1100000000000001 110.461 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.1200000000000001 109.527 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 0.17000000000000001 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.422 ' CB ' HH12 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.2200000000000002 109.952 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.1100000000000001 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.19 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.22 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.29 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 109.671 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 0.33000000000000002 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.3399999999999999 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 0.28000000000000003 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.3999999999999999 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 0.22 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.636 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.22 108.754 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.20000000000000001 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 0.17999999999999999 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.14999999999999999 108.632 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.428 HE22 ' HB1' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.03 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.11 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.17000000000000001 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 1.48 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 1.6699999999999999 109.764 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.22 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.0800000000000001 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 1.7 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 0.26000000000000001 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.17999999999999999 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.14000000000000001 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.17000000000000001 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 0.20000000000000001 110.741 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.1499999999999999 107.981 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.1899999999999999 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.0499999999999998 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.14999999999999999 109.233 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.1499999999999999 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 0.14999999999999999 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.13 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 0.17999999999999999 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.03 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 22' ' ' LEU . 18.1 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 0.34999999999999998 110.653 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.636 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 3' ' ' LYS . 94.7 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.317 0.58 . . . . 0.29999999999999999 109.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.601 ' N ' HG12 ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 1.97 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 0.97999999999999998 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 0.19 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.23000000000000001 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 1.8999999999999999 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 0.25 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.20000000000000001 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.20999999999999999 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 2.4700000000000002 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.20000000000000001 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 0.62 110.005 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 0.23999999999999999 109.418 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.28000000000000003 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 1.8999999999999999 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 0.17000000000000001 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 0.12 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 0.089999999999999997 108.565 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 0.17000000000000001 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.23999999999999999 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.03 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 0.26000000000000001 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 0.32000000000000001 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.553 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.44 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.32000000000000001 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.35999999999999999 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.44 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81000000000000005 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 1.9199999999999999 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.1299999999999999 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 75' ' ' PRO . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 110.244 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 1.6200000000000001 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.25 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.29999999999999999 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.13 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.40999999999999998 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 0.96999999999999997 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 0.5 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.51000000000000001 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.1600000000000001 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.23999999999999999 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.17000000000000001 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.34000000000000002 109.402 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 0.17000000000000001 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 0.12 109.065 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.3100000000000001 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 0.14000000000000001 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.27000000000000002 111.316 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.1100000000000001 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.1200000000000001 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 0.17000000000000001 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.2200000000000002 110.681 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.1100000000000001 109.351 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 0.19 108.685 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.22 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.29 109.316 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2000000000000002 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.33000000000000002 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.28000000000000003 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 0.22 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.683 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.22 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.20000000000000001 109.991 -1.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 0.17999999999999999 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.14999999999999999 108.999 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.03 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.11 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.17000000000000001 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 1.48 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 1.6699999999999999 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.22 110.467 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.0800000000000001 110.347 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 1.7 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 0.26000000000000001 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.17999999999999999 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.14000000000000001 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.17000000000000001 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.48 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.20000000000000001 110.452 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.1499999999999999 108.173 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.1899999999999999 110.478 -178.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.0499999999999998 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 0.14999999999999999 109.309 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.1499999999999999 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.14999999999999999 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.13 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.17999999999999999 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.03 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.34999999999999998 110.49 -178.457 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.669 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 121.198 0.523 . . . . 0.29999999999999999 109.72 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 1.97 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.97999999999999998 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 0.19 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.23000000000000001 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.25 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.20000000000000001 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.20999999999999999 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 2.4700000000000002 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1000000000000001 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.20000000000000001 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.62 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.0900000000000001 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.29999999999999999 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.23999999999999999 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.28000000000000003 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 1.8999999999999999 109.181 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 0.17000000000000001 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 0.12 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 0.089999999999999997 108.831 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 0.17000000000000001 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.95999999999999996 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.23999999999999999 107.941 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.03 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.26000000000000001 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.32000000000000001 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.444 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.44 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.32000000000000001 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.35999999999999999 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.44 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81000000000000005 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 1.9199999999999999 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.1299999999999999 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 38' ' ' ILE . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.28000000000000003 110.781 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 1.6200000000000001 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.25 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.29999999999999999 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.13 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.40999999999999998 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 0.96999999999999997 109.938 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 0.5 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.51000000000000001 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.1600000000000001 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.23999999999999999 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.17000000000000001 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.34000000000000002 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 0.12 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 0.17000000000000001 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.518 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 0.12 108.941 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.3100000000000001 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 0.14000000000000001 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 74' ' ' THR . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 0.27000000000000002 111.374 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.1100000000000001 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.1200000000000001 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 0.17000000000000001 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.2200000000000002 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 0.19 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.22 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.29 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2000000000000002 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 0.33000000000000002 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.3399999999999999 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 0.28000000000000003 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.3999999999999999 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 0.22 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.638 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.22 108.641 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.571 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.20000000000000001 109.909 -1.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 0.17999999999999999 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 97' ' ' LEU . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.14999999999999999 108.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.03 107.403 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 24' ' ' VAL . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.11 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.17000000000000001 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 1.48 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 1.6699999999999999 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.22 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.0800000000000001 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 1.7 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 0.26000000000000001 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.17999999999999999 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.14000000000000001 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.17000000000000001 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.13 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 0.20000000000000001 110.627 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.1499999999999999 107.57 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.1899999999999999 110.494 -178.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.0499999999999998 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 0.14999999999999999 108.621 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.14999999999999999 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.13 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.17999999999999999 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.03 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 110.572 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.502 2.158 0 CA-C-O 121.078 0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.638 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.426 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.525 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 3' ' ' LYS . 87.6 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.416 -0.587 . . . . 0.29999999999999999 109.416 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 1.97 109.189 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 0.97999999999999998 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 0.19 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.23000000000000001 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 1.8999999999999999 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.25 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 0.20000000000000001 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.20999999999999999 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 2.4700000000000002 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 0.20000000000000001 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 0.62 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 0.29999999999999999 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 0.23999999999999999 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.28000000000000003 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 1.8999999999999999 109.166 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 0.17000000000000001 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.663 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 0.12 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 0.089999999999999997 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 0.17000000000000001 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.95999999999999996 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.23999999999999999 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.03 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.409 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.26000000000000001 108.704 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.32000000000000001 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.44 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.35999999999999999 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.44 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 1.9199999999999999 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.1299999999999999 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 0.28000000000000003 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 1.6200000000000001 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.25 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.29999999999999999 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.13 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.40999999999999998 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 0.96999999999999997 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 0.5 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.51000000000000001 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.1600000000000001 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.23999999999999999 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.17000000000000001 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.34000000000000002 109.461 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 0.12 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.17000000000000001 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 0.12 108.783 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.3100000000000001 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 0.14000000000000001 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.0800000000000001 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.27000000000000002 111.342 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 58' ' ' ASP . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.1100000000000001 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 0.17000000000000001 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.2200000000000002 109.866 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.1100000000000001 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 0.19 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 0.22 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.29 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2000000000000002 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 0.33000000000000002 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.3399999999999999 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.3999999999999999 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 0.22 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE1' ' B' ' 5' ' ' TYR . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.22 109.148 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.20000000000000001 110.137 -2.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 0.17999999999999999 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.581 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.14999999999999999 108.797 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.03 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.11 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.17000000000000001 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 1.48 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.6699999999999999 109.931 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.22 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.0800000000000001 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 1.7 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.17999999999999999 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.14000000000000001 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.17000000000000001 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.13 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.20000000000000001 110.332 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.1499999999999999 108.399 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HZ2' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.1899999999999999 109.863 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.0499999999999998 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.581 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 0.14999999999999999 108.454 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 0.14999999999999999 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.13 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 0.17999999999999999 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.03 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 110.568 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.596 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.2 t . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.379 0.609 . . . . 0.29999999999999999 109.696 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' N ' HG12 ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 1.97 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 0.97999999999999998 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 0.19 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.23000000000000001 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 1.8999999999999999 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.25 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.20000000000000001 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.20999999999999999 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.4700000000000002 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1000000000000001 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 0.20000000000000001 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.62 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.29999999999999999 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.23999999999999999 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.28000000000000003 109.638 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 1.8999999999999999 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 0.17000000000000001 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.695 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 0.12 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.089999999999999997 108.402 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 0.17000000000000001 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.95999999999999996 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.23999999999999999 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.03 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.26000000000000001 108.677 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.32000000000000001 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.44 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.32000000000000001 109.626 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.35999999999999999 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.44 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 1.9199999999999999 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.1299999999999999 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 0.28000000000000003 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 1.6200000000000001 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.25 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.29999999999999999 108.814 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.13 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.40999999999999998 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 0.96999999999999997 109.576 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.5 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.51000000000000001 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.1600000000000001 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.23999999999999999 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.17000000000000001 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.34000000000000002 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 0.12 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 0.17000000000000001 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 0.12 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.3100000000000001 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 0.14000000000000001 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG11 ' OH ' ' B' ' 5' ' ' TYR . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.27000000000000002 111.38 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.1100000000000001 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.1200000000000001 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 0.17000000000000001 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.2200000000000002 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.1100000000000001 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 0.19 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 0.22 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.29 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2000000000000002 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 0.33000000000000002 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.3399999999999999 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 0.28000000000000003 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.3999999999999999 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 0.22 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.575 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.22 108.818 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.20000000000000001 110.204 -1.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 0.17999999999999999 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.14999999999999999 108.857 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.03 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.11 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.17000000000000001 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 1.48 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 1.6699999999999999 109.759 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.0800000000000001 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 1.7 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 0.26000000000000001 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.17999999999999999 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.14000000000000001 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.17000000000000001 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.13 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 0.20000000000000001 110.459 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.6 t-20 -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.1499999999999999 107.889 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.1899999999999999 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.0499999999999998 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 77' ' ' PHE . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 0.14999999999999999 109.009 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.1499999999999999 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.14999999999999999 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 0.13 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.17999999999999999 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.03 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 111.117 -177.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.575 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.583 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 3' ' ' LYS . 42.0 t . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.299 0.571 . . . . 0.29999999999999999 109.483 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 2' ' ' VAL . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 1.97 109.125 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 0.97999999999999998 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 0.19 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.23000000000000001 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.25 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.20000000000000001 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.20999999999999999 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 2.4700000000000002 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 0.20000000000000001 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 0.62 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.29999999999999999 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.28000000000000003 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 1.8999999999999999 109.505 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 0.17000000000000001 108.137 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 0.12 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 0.089999999999999997 108.705 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 0.17000000000000001 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.95999999999999996 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.23999999999999999 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.03 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 0.26000000000000001 108.589 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.32000000000000001 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.44 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.32000000000000001 109.82 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.35999999999999999 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.44 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81000000000000005 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 1.9199999999999999 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.1299999999999999 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 0.28000000000000003 111.082 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 1.6200000000000001 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.25 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.29999999999999999 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.13 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.40999999999999998 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 0.96999999999999997 110.562 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 0.5 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.51000000000000001 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.1600000000000001 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.23999999999999999 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.17000000000000001 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 7.2 t30 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.34000000000000002 109.852 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 0.12 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.17000000000000001 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 0.12 108.989 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.3100000000000001 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 0.14000000000000001 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.27000000000000002 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.1100000000000001 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.1200000000000001 109.409 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 0.17000000000000001 108.6 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.2200000000000002 109.958 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 0.19 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 0.22 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.29 109.549 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2000000000000002 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 0.33000000000000002 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.3399999999999999 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 0.28000000000000003 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.3999999999999999 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 0.22 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.22 108.855 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.20000000000000001 110.008 -1.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 0.17999999999999999 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.14999999999999999 108.873 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.03 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' HG22 ' A' ' 24' ' ' VAL . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.11 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.17000000000000001 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 1.48 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 1.6699999999999999 109.643 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.22 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.0800000000000001 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 1.7 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 0.26000000000000001 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.17999999999999999 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.14000000000000001 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.17000000000000001 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 0.20000000000000001 110.297 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.1499999999999999 107.971 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.1899999999999999 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.0499999999999998 109.625 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 0.14999999999999999 108.827 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.1499999999999999 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.14999999999999999 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 0.13 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.17999999999999999 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.512 HD21 ' C ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.03 109.582 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.34999999999999998 110.348 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.57 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.272 -0.64 . . . . 0.29999999999999999 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 1.97 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.97999999999999998 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 0.19 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.23000000000000001 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 1.8999999999999999 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.25 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 0.20000000000000001 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.20999999999999999 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 2.4700000000000002 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1000000000000001 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.20000000000000001 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.62 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0900000000000001 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.29999999999999999 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.23999999999999999 109.576 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.28000000000000003 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 1.8999999999999999 109.16 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 0.17000000000000001 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 0.12 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 108.875 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 0.17000000000000001 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 74' ' ' THR . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.23999999999999999 107.961 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.03 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 0.26000000000000001 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.32000000000000001 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.492 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.44 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.32000000000000001 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.35999999999999999 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.44 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81000000000000005 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 1.9199999999999999 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.1299999999999999 110.778 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 0.28000000000000003 110.9 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 1.6200000000000001 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.25 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.29999999999999999 109.506 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.13 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.40999999999999998 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 46' ' ' SER . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.96999999999999997 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.5 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.51000000000000001 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.1600000000000001 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.23999999999999999 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.17000000000000001 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.34000000000000002 109.817 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 0.12 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 0.17000000000000001 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 0.12 108.934 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.3100000000000001 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 0.14000000000000001 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.0800000000000001 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 0.27000000000000002 111.156 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.481 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.1200000000000001 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.2200000000000002 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.1100000000000001 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.19 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.22 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.29 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 0.33000000000000002 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.3399999999999999 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.28000000000000003 109.137 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.3999999999999999 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 0.22 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.22 109.019 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.20000000000000001 109.818 -1.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 0.17999999999999999 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.14999999999999999 108.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.03 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 24' ' ' VAL . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.11 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.17000000000000001 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 1.48 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 1.6699999999999999 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.22 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.0800000000000001 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 1.7 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 0.26000000000000001 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.17999999999999999 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.14000000000000001 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.17000000000000001 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.13 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.542 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.20000000000000001 110.555 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.1499999999999999 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.1899999999999999 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.0499999999999998 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.14999999999999999 108.651 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.1499999999999999 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 0.14999999999999999 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 0.13 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.17999999999999999 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.03 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 0.34999999999999998 110.24 -178.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.4 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.3 -0.63 . . . . 0.29999999999999999 109.3 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 1.97 109.048 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 0.97999999999999998 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 0.19 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.23000000000000001 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 1.8999999999999999 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.25 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.20000000000000001 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.20999999999999999 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 2.4700000000000002 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.20000000000000001 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.62 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.713 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.29999999999999999 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.23999999999999999 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.28000000000000003 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 1.8999999999999999 108.854 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 0.17000000000000001 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 0.12 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 0.089999999999999997 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 0.17000000000000001 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.95999999999999996 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.23999999999999999 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.03 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.26000000000000001 108.336 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.32000000000000001 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.44 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.32000000000000001 109.814 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.35999999999999999 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.44 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81000000000000005 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 1.9199999999999999 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.1299999999999999 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.535 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 1.6200000000000001 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.25 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.29999999999999999 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.13 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.40999999999999998 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 0.96999999999999997 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.5 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.51000000000000001 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.1600000000000001 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.23999999999999999 109.227 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.17000000000000001 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.34000000000000002 109.367 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 0.12 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.12 108.998 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.3100000000000001 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.14000000000000001 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.0800000000000001 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 110.701 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.1100000000000001 110.891 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.715 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 0.17000000000000001 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.2200000000000002 110.053 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 0.19 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.22 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.29 109.251 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2000000000000002 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 0.33000000000000002 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.3399999999999999 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 0.28000000000000003 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 0.22 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.22 108.605 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.20000000000000001 110.134 -2.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 0.17999999999999999 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.14999999999999999 108.687 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.03 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.11 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.17000000000000001 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 1.6699999999999999 109.06 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.0800000000000001 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 1.7 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 0.26000000000000001 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.17999999999999999 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.14000000000000001 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.17000000000000001 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.13 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 0.20000000000000001 110.282 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.1499999999999999 108.415 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.1899999999999999 110.702 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.0499999999999998 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.14999999999999999 108.904 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.1499999999999999 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.14999999999999999 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 0.13 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 0.17999999999999999 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.03 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 0.34999999999999998 110.325 -178.186 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.195 0.522 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 3' ' ' LYS . 65.4 t . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.195 -0.668 . . . . 0.29999999999999999 109.195 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 2' ' ' VAL . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 1.97 109.305 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.97999999999999998 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 0.19 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.23000000000000001 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 1.8999999999999999 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.25 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.20000000000000001 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.20999999999999999 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 2.4700000000000002 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1000000000000001 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 0.20000000000000001 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 0.62 109.371 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.0900000000000001 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.29999999999999999 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.23999999999999999 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.28000000000000003 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 1.8999999999999999 108.648 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 0.17000000000000001 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 0.12 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 0.089999999999999997 108.737 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.17000000000000001 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.95999999999999996 108.959 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' THR . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.23999999999999999 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.03 109.723 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.26000000000000001 108.825 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.32000000000000001 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.44 110.417 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32000000000000001 109.941 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.35999999999999999 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.44 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81000000000000005 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 1.9199999999999999 110.013 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.1299999999999999 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 38' ' ' ILE . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.56 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 1.6200000000000001 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.25 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.29999999999999999 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.13 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.40999999999999998 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 0.96999999999999997 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.5 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.51000000000000001 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.23999999999999999 109.299 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.17000000000000001 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.34000000000000002 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 0.12 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 0.17000000000000001 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 0.12 108.901 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.3100000000000001 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 0.14000000000000001 110.56 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 0.27000000000000002 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.1200000000000001 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 0.17000000000000001 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.146 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.1100000000000001 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.19 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 0.22 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.29 109.553 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2000000000000002 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 0.33000000000000002 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 0.28000000000000003 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.3999999999999999 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 0.22 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.558 HG23 ' HE1' ' B' ' 5' ' ' TYR . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HG3' HD12 ' A' ' 38' ' ' ILE . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.20000000000000001 110.048 -1.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 0.17999999999999999 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.755 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.14999999999999999 109.326 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.03 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.11 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.17000000000000001 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 1.6699999999999999 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.22 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.0800000000000001 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 1.7 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 0.26000000000000001 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.17999999999999999 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.14000000000000001 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.17000000000000001 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.13 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.20000000000000001 110.186 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.1499999999999999 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.1899999999999999 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.0499999999999998 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' A' ' 77' ' ' PHE . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 0.14999999999999999 108.679 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.1499999999999999 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.14999999999999999 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 0.13 110.404 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 0.17999999999999999 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.03 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 0.34999999999999998 110.528 -178.278 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.558 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 3' ' ' LYS . 12.8 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.263 -0.643 . . . . 0.29999999999999999 109.263 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' H ' HG12 ' A' ' 2' ' ' VAL . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 1.97 109.087 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.97999999999999998 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 0.19 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.23000000000000001 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 1.8999999999999999 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.25 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 0.20000000000000001 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.20999999999999999 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 2.4700000000000002 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1000000000000001 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 0.20000000000000001 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 0.62 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.0900000000000001 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 0.29999999999999999 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.23999999999999999 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.28000000000000003 109.192 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.715 ' CE ' HD11 ' A' ' 53' ' ' ILE . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 1.8999999999999999 109.459 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.511 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 0.12 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 0.089999999999999997 108.588 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 0.17000000000000001 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.95999999999999996 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 74' ' ' THR . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.23999999999999999 107.73 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.03 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.26000000000000001 108.474 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 0.32000000000000001 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.44 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.32000000000000001 109.907 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.35999999999999999 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.44 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81000000000000005 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 1.9199999999999999 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.1299999999999999 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 38' ' ' ILE . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 0.28000000000000003 111.559 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 1.6200000000000001 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.25 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.13 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.40999999999999998 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.96999999999999997 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.5 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.1600000000000001 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.23999999999999999 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.17000000000000001 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.34000000000000002 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 0.12 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.715 HD11 ' CE ' ' A' ' 21' ' ' LYS . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 109.398 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.577 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 0.12 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 0.14000000000000001 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.0800000000000001 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' B' ' 5' ' ' TYR . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.27000000000000002 111.183 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.1100000000000001 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.1200000000000001 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 0.17000000000000001 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 67' ' ' SER . 13.8 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.2200000000000002 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.1100000000000001 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 0.19 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.22 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.29 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2000000000000002 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.3399999999999999 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 0.28000000000000003 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.3999999999999999 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 0.22 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.722 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.563 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.20000000000000001 110.296 -1.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 0.17999999999999999 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.14999999999999999 108.601 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.03 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.11 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.17000000000000001 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 1.48 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 1.6699999999999999 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.22 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.0800000000000001 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 1.7 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 0.26000000000000001 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.17999999999999999 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.17000000000000001 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.13 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 0.20000000000000001 110.385 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.1499999999999999 108.148 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.1899999999999999 110.787 -178.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.0499999999999998 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 77' ' ' PHE . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 0.14999999999999999 108.598 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.1499999999999999 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.14999999999999999 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.13 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.17999999999999999 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.03 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 0.34999999999999998 110.376 -179.06 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.722 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 3' ' ' LYS . 98.0 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.2 0.524 . . . . 0.29999999999999999 109.639 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 2' ' ' VAL . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 1.97 109.427 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.97999999999999998 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 0.19 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.23000000000000001 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 1.8999999999999999 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.25 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.20000000000000001 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.20999999999999999 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.4700000000000002 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 0.20000000000000001 109.157 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 0.62 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.29999999999999999 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.23999999999999999 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.28000000000000003 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 1.8999999999999999 108.857 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 0.17000000000000001 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.12 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 0.089999999999999997 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 0.17000000000000001 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.95999999999999996 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.23999999999999999 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.03 109.715 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 0.26000000000000001 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 0.32000000000000001 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.44 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.35999999999999999 111.7 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.44 111.461 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81000000000000005 108.665 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 1.9199999999999999 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.1299999999999999 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' A' ' 94' ' ' LYS . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 0.28000000000000003 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 1.6200000000000001 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.25 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.29999999999999999 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.13 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.40999999999999998 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 0.96999999999999997 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 0.5 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.51000000000000001 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.23999999999999999 109.101 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.17000000000000001 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.34000000000000002 109.39 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.12 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 0.17000000000000001 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 0.12 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 0.14000000000000001 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.0800000000000001 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.27000000000000002 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.424 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.1100000000000001 110.974 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.533 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 0.17000000000000001 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.2200000000000002 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.1100000000000001 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.19 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.22 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.29 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2000000000000002 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 0.33000000000000002 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.3399999999999999 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.28000000000000003 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.3999999999999999 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.22 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.694 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.22 108.684 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.20000000000000001 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 0.17999999999999999 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.14999999999999999 108.956 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.0 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.03 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.11 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.17000000000000001 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 1.48 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 1.6699999999999999 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.22 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.0800000000000001 110.225 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 1.7 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 0.26000000000000001 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.17999999999999999 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.14000000000000001 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.17000000000000001 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.13 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 0.20000000000000001 110.152 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.1499999999999999 108.405 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.1899999999999999 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.0499999999999998 109.746 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 0.14999999999999999 108.856 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.1499999999999999 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.14999999999999999 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.13 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.17999999999999999 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.03 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.34999999999999998 110.289 -178.783 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.694 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.608 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.309 -0.626 . . . . 0.29999999999999999 109.309 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 1.97 107.91 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 3' ' ' LYS . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.97999999999999998 110.431 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 0.19 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.23000000000000001 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.25 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.20000000000000001 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.20999999999999999 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 2.4700000000000002 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 0.20000000000000001 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 0.62 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.0900000000000001 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.29999999999999999 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.23999999999999999 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.28000000000000003 109.51 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 1.8999999999999999 108.948 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 0.17000000000000001 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.647 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 0.12 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 0.089999999999999997 108.562 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 0.17000000000000001 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.95999999999999996 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.23999999999999999 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.03 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.26000000000000001 108.747 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.32000000000000001 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.44 110.103 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.32000000000000001 109.12 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.35999999999999999 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.44 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 1.9199999999999999 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.1299999999999999 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 0.28000000000000003 110.185 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 1.6200000000000001 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.25 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.29999999999999999 109.059 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.13 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.40999999999999998 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 0.96999999999999997 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 0.5 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.51000000000000001 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.1600000000000001 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.23999999999999999 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.34000000000000002 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 0.12 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 0.17000000000000001 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.12 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.3100000000000001 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 0.14000000000000001 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.0800000000000001 108.538 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 0.27000000000000002 111.024 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.1100000000000001 110.567 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.1200000000000001 109.683 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 0.17000000000000001 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.2200000000000002 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.19 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.22 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.29 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2000000000000002 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 0.33000000000000002 109.753 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.3399999999999999 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.28000000000000003 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.3999999999999999 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.22 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.506 HG23 ' HE1' ' B' ' 5' ' ' TYR . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.22 108.707 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.20000000000000001 110.18 -1.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 0.17999999999999999 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.14999999999999999 108.776 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.03 107.65 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.11 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 1.48 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 1.6699999999999999 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.22 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.0800000000000001 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 1.7 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.26000000000000001 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.17999999999999999 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.14000000000000001 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.17000000000000001 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.13 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 0.20000000000000001 110.026 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.1499999999999999 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.1899999999999999 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.0499999999999998 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 0.14999999999999999 108.555 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.1499999999999999 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.14999999999999999 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.13 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 0.17999999999999999 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.03 109.372 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.34999999999999998 110.343 -178.822 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.253 0.549 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t . . . . . 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.8 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.302 0.572 . . . . 0.29999999999999999 109.624 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 1.97 109.163 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 0.97999999999999998 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 10' ' ' ALA . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 0.19 108.099 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.23000000000000001 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.8999999999999999 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 0.25 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 109.831 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.20999999999999999 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 2.4700000000000002 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1000000000000001 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.20000000000000001 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 0.62 109.882 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.29999999999999999 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.23999999999999999 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.28000000000000003 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.8999999999999999 108.887 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 0.17000000000000001 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.12 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 0.089999999999999997 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 0.17000000000000001 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.95999999999999996 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.23999999999999999 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.03 109.46 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 0.26000000000000001 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 0.32000000000000001 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.44 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.32000000000000001 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.35999999999999999 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.44 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 108.615 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 1.9199999999999999 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.1299999999999999 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 38' ' ' ILE . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 1.6200000000000001 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.25 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.29999999999999999 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.13 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.40999999999999998 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 0.96999999999999997 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.5 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.51000000000000001 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.1600000000000001 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.23999999999999999 108.923 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.17000000000000001 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.34000000000000002 109.307 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 0.12 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 0.17000000000000001 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 0.12 109.063 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.3100000000000001 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 0.14000000000000001 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.0800000000000001 107.888 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.403 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.27000000000000002 111.178 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.1100000000000001 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 0.17000000000000001 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.2200000000000002 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 65' ' ' VAL . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 0.19 108.86 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 0.22 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.29 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2000000000000002 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.3399999999999999 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 0.28000000000000003 109.063 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.3999999999999999 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.22 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.642 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.22 109.249 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.542 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.20000000000000001 109.892 -1.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 0.17999999999999999 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.14999999999999999 108.52 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.03 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.11 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.17000000000000001 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 1.48 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 1.6699999999999999 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.22 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.0800000000000001 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.7 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 0.26000000000000001 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.17999999999999999 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.14000000000000001 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.17000000000000001 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 0.20000000000000001 110.743 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.1499999999999999 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.1899999999999999 110.915 -178.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.0499999999999998 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 77' ' ' PHE . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 0.14999999999999999 108.771 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.14999999999999999 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.13 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.17999999999999999 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.03 109.837 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 110.262 -178.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.5 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.277 -0.638 . . . . 0.29999999999999999 109.277 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 1.97 109.568 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.97999999999999998 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 0.19 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.23000000000000001 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 1.8999999999999999 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 0.25 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.20000000000000001 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.20999999999999999 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 2.4700000000000002 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1000000000000001 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.20000000000000001 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 0.62 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.29999999999999999 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.23999999999999999 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.28000000000000003 109.228 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 1.8999999999999999 109.015 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 0.17000000000000001 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.605 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 0.12 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.089999999999999997 108.697 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 0.17000000000000001 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.95999999999999996 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.23999999999999999 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.03 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 0.26000000000000001 108.831 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.44 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.32000000000000001 109.913 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.35999999999999999 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.44 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 1.9199999999999999 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.485 ' O ' ' SD ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.1299999999999999 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 0.28000000000000003 110.846 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 1.6200000000000001 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.25 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.29999999999999999 109.68 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.13 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.40999999999999998 110.231 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 0.96999999999999997 110.262 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 0.5 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.45 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.23999999999999999 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.17000000000000001 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.34000000000000002 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 0.12 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.17000000000000001 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 0.12 108.999 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.3100000000000001 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 0.14000000000000001 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.0800000000000001 108.568 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.27000000000000002 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.1100000000000001 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.1200000000000001 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 0.17000000000000001 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.2200000000000002 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.1100000000000001 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 0.19 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.22 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.29 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2000000000000002 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 0.33000000000000002 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.28000000000000003 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 0.22 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.577 HG23 ' CE2' ' B' ' 5' ' ' TYR . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.22 108.587 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.20000000000000001 110.11 -1.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 0.17999999999999999 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.14999999999999999 109.0 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.03 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.11 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.17000000000000001 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 1.48 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.6699999999999999 109.788 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.22 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.0800000000000001 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 1.7 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 0.26000000000000001 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.17999999999999999 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.14000000000000001 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.17000000000000001 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.13 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 0.20000000000000001 110.338 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.1499999999999999 108.167 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.1899999999999999 110.606 -178.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.0499999999999998 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 0.14999999999999999 108.528 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.1499999999999999 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 0.13 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 0.17999999999999999 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.03 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 0.34999999999999998 110.587 -178.414 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 0.29999999999999999 108.838 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 1.97 109.541 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.97999999999999998 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 0.19 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.23000000000000001 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 1.8999999999999999 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 0.25 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.20000000000000001 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.20999999999999999 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 2.4700000000000002 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1000000000000001 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 0.20000000000000001 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.62 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.29999999999999999 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.23999999999999999 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.28000000000000003 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 1.8999999999999999 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 0.17000000000000001 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.655 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.12 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 0.089999999999999997 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 0.17000000000000001 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.95999999999999996 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.23999999999999999 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.03 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.26000000000000001 108.971 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.32000000000000001 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.44 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.32000000000000001 109.7 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.44 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81000000000000005 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 1.9199999999999999 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.1299999999999999 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 75' ' ' PRO . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 0.28000000000000003 111.212 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 1.6200000000000001 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.25 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.29999999999999999 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.13 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.40999999999999998 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 0.96999999999999997 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.5 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.51000000000000001 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.1600000000000001 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.23999999999999999 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.17000000000000001 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.34000000000000002 109.627 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.12 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 0.17000000000000001 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 0.12 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 0.14000000000000001 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.0800000000000001 108.5 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 0.27000000000000002 111.177 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.493 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.1200000000000001 109.846 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 0.17000000000000001 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.2200000000000002 110.336 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 0.19 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 0.22 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.29 109.046 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2000000000000002 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.33000000000000002 109.259 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.3399999999999999 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.28000000000000003 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.3999999999999999 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.22 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.22 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.20000000000000001 110.437 -1.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 0.17999999999999999 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.14999999999999999 109.155 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.491 HE22 ' HB1' ' A' ' 69' ' ' ALA . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.03 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 100' ' ' THR . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.11 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.17000000000000001 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 1.48 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 1.6699999999999999 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.22 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.0800000000000001 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 1.7 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 0.26000000000000001 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.17999999999999999 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.14000000000000001 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.17000000000000001 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.13 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 0.20000000000000001 110.645 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.1899999999999999 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.0499999999999998 109.799 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.14999999999999999 108.975 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.1499999999999999 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.14999999999999999 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.443 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.13 110.126 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 0.17999999999999999 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.03 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 22' ' ' LEU . 10.3 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 0.34999999999999998 110.569 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.6 t . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.016 -0.735 . . . . 0.29999999999999999 109.016 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 1.97 109.408 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.97999999999999998 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 0.19 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.23000000000000001 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 1.8999999999999999 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.25 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.20000000000000001 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.20999999999999999 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 2.4700000000000002 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1000000000000001 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.20000000000000001 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 0.62 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.0900000000000001 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.29999999999999999 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.28000000000000003 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 1.8999999999999999 108.668 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 0.17000000000000001 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 0.12 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.089999999999999997 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 0.17000000000000001 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.95999999999999996 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 74' ' ' THR . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.23999999999999999 107.762 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.03 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 0.26000000000000001 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 0.32000000000000001 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.44 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.35999999999999999 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.44 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81000000000000005 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 1.9199999999999999 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.1299999999999999 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 38' ' ' ILE . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 0.28000000000000003 111.009 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 1.6200000000000001 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.25 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.29999999999999999 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.13 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.40999999999999998 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 0.96999999999999997 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 0.5 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.51000000000000001 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.1600000000000001 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.23999999999999999 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.17000000000000001 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.34000000000000002 109.581 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 0.12 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 0.17000000000000001 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.567 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 0.12 108.509 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.3100000000000001 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE2' ' A' ' 27' ' ' PHE . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 0.14000000000000001 110.705 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.0800000000000001 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.27000000000000002 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.1100000000000001 111.083 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.1200000000000001 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 0.17000000000000001 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.2200000000000002 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.1100000000000001 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 0.19 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 0.22 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.29 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2000000000000002 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 0.33000000000000002 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.3399999999999999 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 0.28000000000000003 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.3999999999999999 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 27' ' ' PHE . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.22 108.837 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.20000000000000001 109.848 -1.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 0.17999999999999999 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.526 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.14999999999999999 109.247 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.03 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.11 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.17000000000000001 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 1.48 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 1.6699999999999999 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.22 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.0800000000000001 110.902 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 1.7 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 0.26000000000000001 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.17999999999999999 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.14000000000000001 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.17000000000000001 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.13 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 0.20000000000000001 110.701 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.1499999999999999 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.1899999999999999 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.0499999999999998 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.14999999999999999 108.825 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.1499999999999999 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 0.14999999999999999 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 0.13 110.331 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.17999999999999999 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.03 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 0.34999999999999998 110.413 -178.528 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.49 ' HE1' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 3' ' ' LYS . 18.7 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.336 0.588 . . . . 0.29999999999999999 109.571 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.782 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 1.97 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 0.97999999999999998 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 0.19 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 1.8999999999999999 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 0.25 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.20000000000000001 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.20999999999999999 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 2.4700000000000002 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.20000000000000001 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 0.62 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.0900000000000001 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.29999999999999999 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.23999999999999999 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.28000000000000003 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' NZ ' ' CG ' ' A' ' 51' ' ' ASN . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 1.8999999999999999 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 0.17000000000000001 107.833 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 0.12 109.23 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 0.089999999999999997 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 0.17000000000000001 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.95999999999999996 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.23999999999999999 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.03 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.26000000000000001 108.545 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.44 110.133 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.32000000000000001 109.807 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.35999999999999999 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.44 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81000000000000005 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 1.9199999999999999 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.465 ' O ' ' SD ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.1299999999999999 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 38' ' ' ILE . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.28000000000000003 110.129 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 1.6200000000000001 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.25 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.29999999999999999 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.13 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.40999999999999998 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 0.96999999999999997 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.5 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.51000000000000001 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.1600000000000001 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.23999999999999999 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.17000000000000001 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.2 t30 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.34000000000000002 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 0.12 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 0.17000000000000001 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.545 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 0.12 108.897 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.3100000000000001 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 0.14000000000000001 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.0800000000000001 107.515 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.27000000000000002 111.306 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.1100000000000001 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.1200000000000001 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.17000000000000001 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.2200000000000002 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 0.19 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 0.22 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.29 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 0.33000000000000002 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.3399999999999999 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.3999999999999999 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 0.22 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.651 HG23 ' CE2' ' B' ' 5' ' ' TYR . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.20000000000000001 110.581 -1.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 0.17999999999999999 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.14999999999999999 108.43 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.03 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.11 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.17000000000000001 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 1.48 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 1.6699999999999999 109.862 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.22 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.0800000000000001 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.7 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 0.26000000000000001 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.17999999999999999 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.14000000000000001 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.17000000000000001 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 0.20000000000000001 110.708 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.1499999999999999 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.1899999999999999 110.417 -178.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.0499999999999998 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.14999999999999999 108.917 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.1499999999999999 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.14999999999999999 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 0.13 110.038 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 0.17999999999999999 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.03 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 0.34999999999999998 110.597 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.651 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.651 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.615 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 3' ' ' LYS . 70.1 t . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.555 -0.535 . . . . 0.29999999999999999 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 1.97 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 0.97999999999999998 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 0.19 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.23000000000000001 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 0.25 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.20000000000000001 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.20999999999999999 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 2.4700000000000002 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1000000000000001 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 0.20000000000000001 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.62 109.433 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 0.29999999999999999 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 0.23999999999999999 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.28000000000000003 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 1.8999999999999999 108.809 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 0.17000000000000001 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 0.12 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 0.089999999999999997 108.655 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 0.17000000000000001 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.95999999999999996 109.176 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.23999999999999999 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.03 109.235 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 0.26000000000000001 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.32000000000000001 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.549 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.44 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.32000000000000001 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.35999999999999999 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.44 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81000000000000005 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 1.9199999999999999 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.1299999999999999 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 0.28000000000000003 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 1.6200000000000001 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.25 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.29999999999999999 109.071 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.13 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.40999999999999998 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 0.96999999999999997 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 0.5 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.51000000000000001 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.1600000000000001 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.23999999999999999 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.34000000000000002 109.487 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 0.12 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 0.17000000000000001 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 0.12 108.639 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.3100000000000001 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 0.14000000000000001 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.0800000000000001 108.209 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 74' ' ' THR . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.27000000000000002 110.35 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.549 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.1100000000000001 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.1200000000000001 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 0.17000000000000001 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.2200000000000002 110.197 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.1100000000000001 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.19 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 0.22 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.29 109.395 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.33000000000000002 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.3399999999999999 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.3999999999999999 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.22 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.56 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.22 108.8 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.20000000000000001 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 0.17999999999999999 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.14999999999999999 109.169 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.03 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.11 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.17000000000000001 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 1.48 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 1.6699999999999999 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.22 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.0800000000000001 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 1.7 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 0.26000000000000001 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.17999999999999999 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.14000000000000001 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.17000000000000001 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.13 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 0.20000000000000001 110.279 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.1499999999999999 108.484 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.1899999999999999 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.0499999999999998 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 0.14999999999999999 108.752 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.1499999999999999 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 0.14999999999999999 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 0.13 110.385 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.17999999999999999 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.03 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 0.34999999999999998 110.795 -177.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.629 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 3' ' ' LYS . 97.3 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.313 0.578 . . . . 0.29999999999999999 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 0.97999999999999998 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.19 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.23000000000000001 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 1.8999999999999999 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.25 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.20000000000000001 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.20999999999999999 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 2.4700000000000002 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1000000000000001 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.20000000000000001 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.62 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.29999999999999999 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 0.23999999999999999 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.28000000000000003 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 1.8999999999999999 108.996 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 0.17000000000000001 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 0.12 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 0.089999999999999997 108.8 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 0.17000000000000001 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.23999999999999999 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.03 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.26000000000000001 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.32000000000000001 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.44 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.32000000000000001 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.35999999999999999 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.44 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81000000000000005 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 1.9199999999999999 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.1299999999999999 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 0.28000000000000003 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 1.6200000000000001 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.25 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.29999999999999999 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.13 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.40999999999999998 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' SER . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 0.96999999999999997 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 0.5 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.51000000000000001 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.1600000000000001 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.23999999999999999 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.34000000000000002 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 0.12 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.17000000000000001 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 0.12 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.3100000000000001 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 0.14000000000000001 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.0800000000000001 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 74' ' ' THR . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.39 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.1100000000000001 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 0.17000000000000001 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB3' HH12 ' B' ' 4' ' ' ARG . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.2200000000000002 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 0.19 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.22 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.29 109.143 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2000000000000002 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.33000000000000002 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.3399999999999999 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.3999999999999999 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 0.22 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.22 108.293 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.20000000000000001 110.105 -1.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 0.17999999999999999 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.052 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.03 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.11 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.17000000000000001 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 1.48 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 1.6699999999999999 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.22 110.183 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.0800000000000001 109.996 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 1.7 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 0.26000000000000001 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.17999999999999999 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.14000000000000001 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.17000000000000001 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.13 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 0.20000000000000001 110.712 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.1499999999999999 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.1899999999999999 110.595 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.0499999999999998 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 0.14999999999999999 108.82 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.1499999999999999 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.14999999999999999 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.13 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 0.17999999999999999 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.03 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 22' ' ' LEU . 20.6 mt . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.34999999999999998 110.587 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.431 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.208 0.528 . . . . 0.29999999999999999 109.654 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 1.97 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.97999999999999998 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 0.19 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.23000000000000001 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 1.8999999999999999 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.25 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.20000000000000001 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.20999999999999999 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 2.4700000000000002 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1000000000000001 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.20000000000000001 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.62 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.0900000000000001 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.29999999999999999 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.23999999999999999 109.684 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.28000000000000003 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 1.8999999999999999 108.718 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 0.17000000000000001 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 0.12 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 0.089999999999999997 108.82 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 0.17000000000000001 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.95999999999999996 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.23999999999999999 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.03 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 0.26000000000000001 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.32000000000000001 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.44 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.32000000000000001 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.35999999999999999 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.44 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81000000000000005 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 1.9199999999999999 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.1299999999999999 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 38' ' ' ILE . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 0.28000000000000003 111.085 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 1.6200000000000001 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.25 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.29999999999999999 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.13 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.40999999999999998 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 0.96999999999999997 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 0.5 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.51000000000000001 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.1600000000000001 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.23999999999999999 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.17000000000000001 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 109.248 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 0.12 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 0.12 108.984 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.3100000000000001 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 0.14000000000000001 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.0800000000000001 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.566 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.1100000000000001 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.1200000000000001 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 0.17000000000000001 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.2200000000000002 109.995 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.1100000000000001 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 0.19 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 0.22 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.29 108.915 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 0.33000000000000002 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.3399999999999999 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.28000000000000003 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.3999999999999999 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 0.22 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.701 HG23 ' CE2' ' B' ' 5' ' ' TYR . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.22 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.20000000000000001 110.364 -2.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 0.17999999999999999 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.14999999999999999 108.601 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.11 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.17000000000000001 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 1.48 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 1.6699999999999999 109.541 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.22 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.0800000000000001 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.7 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.26000000000000001 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.17999999999999999 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.14000000000000001 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.17000000000000001 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.13 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.527 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 0.20000000000000001 110.162 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.1499999999999999 108.052 178.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.1899999999999999 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.0499999999999998 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 77' ' ' PHE . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.14999999999999999 108.69 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.1499999999999999 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 0.14999999999999999 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 0.13 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.17999999999999999 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.03 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.34999999999999998 110.476 -178.741 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.328 0.585 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.701 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.4 t . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.898 -0.778 . . . . 0.29999999999999999 108.898 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 1.97 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.97999999999999998 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 0.19 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.23000000000000001 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 1.8999999999999999 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.25 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.20000000000000001 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.20999999999999999 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 2.4700000000000002 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1000000000000001 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 0.20000000000000001 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.62 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.0900000000000001 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.29999999999999999 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.23999999999999999 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.28000000000000003 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 1.8999999999999999 109.135 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 0.17000000000000001 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.594 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 0.12 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 0.089999999999999997 108.879 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 0.17000000000000001 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.95999999999999996 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.23999999999999999 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.03 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 0.26000000000000001 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 0.32000000000000001 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.44 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.32000000000000001 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.35999999999999999 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.44 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81000000000000005 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 1.9199999999999999 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.1299999999999999 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.606 ' O ' HG22 ' A' ' 38' ' ' ILE . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 0.28000000000000003 111.198 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 1.6200000000000001 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.25 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.29999999999999999 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.13 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.40999999999999998 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 0.96999999999999997 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.5 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.51000000000000001 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.1600000000000001 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.23999999999999999 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.17000000000000001 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.34000000000000002 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 0.12 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 0.17000000000000001 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 0.12 109.07 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.3100000000000001 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 0.14000000000000001 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.0800000000000001 107.568 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 0.27000000000000002 110.814 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 0.17000000000000001 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.2200000000000002 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.1100000000000001 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.19 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.22 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.29 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2000000000000002 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.3399999999999999 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.28000000000000003 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.3999999999999999 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 0.22 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.702 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.22 108.899 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.20000000000000001 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 0.17999999999999999 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.14999999999999999 108.75 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.11 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.17000000000000001 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 1.48 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 1.6699999999999999 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.22 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.0800000000000001 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 1.7 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 0.26000000000000001 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.17999999999999999 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.14000000000000001 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.17000000000000001 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.496 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 0.20000000000000001 110.298 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.1899999999999999 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.0499999999999998 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 0.14999999999999999 108.902 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.1499999999999999 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.14999999999999999 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 0.13 110.205 -178.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 0.17999999999999999 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.03 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 0.34999999999999998 110.676 -178.572 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.702 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.604 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 3' ' ' LYS . 61.6 t . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.263 0.554 . . . . 0.29999999999999999 109.641 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 1.97 109.24 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 0.97999999999999998 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 0.19 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.23000000000000001 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 1.8999999999999999 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.25 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.20000000000000001 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.20999999999999999 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 2.4700000000000002 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 0.20000000000000001 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 0.62 109.235 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.29999999999999999 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.28000000000000003 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 1.8999999999999999 109.094 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 0.17000000000000001 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 0.12 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 0.089999999999999997 108.733 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 0.17000000000000001 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.95999999999999996 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.23999999999999999 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.03 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 0.26000000000000001 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 0.32000000000000001 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.577 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.44 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.32000000000000001 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.35999999999999999 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.44 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 1.9199999999999999 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.1299999999999999 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 0.28000000000000003 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 1.6200000000000001 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.25 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.29999999999999999 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.13 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.40999999999999998 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.96999999999999997 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.5 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.51000000000000001 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.1600000000000001 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.23999999999999999 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.17000000000000001 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.34000000000000002 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 0.12 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.17000000000000001 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 0.12 108.704 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.3100000000000001 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 0.14000000000000001 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.0800000000000001 108.354 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 0.27000000000000002 110.752 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.577 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.1200000000000001 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 0.17000000000000001 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.2200000000000002 109.961 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 0.19 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.22 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.29 109.526 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.33000000000000002 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.3399999999999999 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.28000000000000003 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.3999999999999999 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 0.22 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.689 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.22 108.693 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.20000000000000001 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 0.17999999999999999 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.14999999999999999 109.128 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.11 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.17000000000000001 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 1.48 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 1.6699999999999999 109.168 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.22 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.0800000000000001 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 1.7 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 0.26000000000000001 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.17999999999999999 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.14000000000000001 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.17000000000000001 108.759 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.13 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 0.20000000000000001 110.285 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.1499999999999999 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.0499999999999998 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 0.14999999999999999 108.663 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.1499999999999999 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.14999999999999999 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.13 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.17999999999999999 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.03 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 0.34999999999999998 110.283 -178.843 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.0 m-85 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 3' ' ' LYS . 86.1 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.1 -0.704 . . . . 0.29999999999999999 109.1 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 1.97 109.42 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.97999999999999998 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 0.19 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.23000000000000001 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 1.8999999999999999 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 0.25 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.20000000000000001 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.20999999999999999 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 2.4700000000000002 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.20000000000000001 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.62 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.0900000000000001 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.29999999999999999 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.23999999999999999 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.28000000000000003 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 1.8999999999999999 109.158 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 0.17000000000000001 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 0.12 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 0.089999999999999997 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 0.17000000000000001 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.95999999999999996 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.23999999999999999 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.03 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.26000000000000001 108.756 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 0.32000000000000001 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.44 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.32000000000000001 109.658 -179.036 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.35999999999999999 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.44 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81000000000000005 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 1.9199999999999999 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.1299999999999999 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 0.28000000000000003 111.174 -177.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 1.6200000000000001 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.25 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.29999999999999999 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.13 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.40999999999999998 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 0.96999999999999997 110.118 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 0.5 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.51000000000000001 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.1600000000000001 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.23999999999999999 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.17000000000000001 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.3 t30 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.34000000000000002 109.362 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 0.12 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 0.17000000000000001 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 0.12 108.829 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.3100000000000001 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 27' ' ' PHE . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.14000000000000001 110.398 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.0800000000000001 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.27000000000000002 111.421 -177.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.1100000000000001 111.265 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.1200000000000001 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 0.17000000000000001 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.2200000000000002 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.19 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 0.22 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.29 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2000000000000002 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.33000000000000002 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.3399999999999999 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.3999999999999999 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 0.22 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.538 HG23 ' CE2' ' B' ' 5' ' ' TYR . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.22 109.12 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.20000000000000001 110.074 -1.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 0.17999999999999999 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.14999999999999999 108.799 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.11 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.17000000000000001 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 1.48 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.989 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.22 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.0800000000000001 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 1.7 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 0.26000000000000001 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.17999999999999999 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.14000000000000001 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.17000000000000001 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.13 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.534 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 0.20000000000000001 110.235 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.1499999999999999 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.1899999999999999 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.0499999999999998 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 77' ' ' PHE . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 0.14999999999999999 108.211 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.1499999999999999 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.14999999999999999 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.13 110.428 -178.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.17999999999999999 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.03 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 0.34999999999999998 110.351 -178.531 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.184 0.516 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 26.7 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.331 0.586 . . . . 0.29999999999999999 109.609 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 1.97 108.925 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 0.19 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.23000000000000001 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 1.8999999999999999 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 0.25 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.777 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.20999999999999999 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1000000000000001 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.20000000000000001 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.62 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.0900000000000001 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.29999999999999999 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.28000000000000003 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 1.8999999999999999 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 0.17000000000000001 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.12 109.35 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 0.089999999999999997 108.549 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 0.17000000000000001 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.95999999999999996 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.23999999999999999 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.03 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 0.26000000000000001 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.32000000000000001 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.44 110.114 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.35999999999999999 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.44 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81000000000000005 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 1.9199999999999999 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.1299999999999999 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.28000000000000003 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 1.6200000000000001 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.25 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.29999999999999999 109.513 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.13 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 0.96999999999999997 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 0.5 109.586 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.51000000000000001 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.1600000000000001 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.23999999999999999 109.52 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.17000000000000001 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.34000000000000002 109.573 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 0.12 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 0.17000000000000001 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.12 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.3100000000000001 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.14000000000000001 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.0800000000000001 108.086 178.173 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.1100000000000001 110.68 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.1200000000000001 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 0.17000000000000001 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.1100000000000001 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.19 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 0.22 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.29 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 0.33000000000000002 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.3399999999999999 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 0.28000000000000003 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.3999999999999999 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.22 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.773 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.22 108.795 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.20000000000000001 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 0.17999999999999999 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CD1' HD21 ' A' ' 97' ' ' LEU . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.14999999999999999 108.553 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.03 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 24' ' ' VAL . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.11 109.712 -177.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.17000000000000001 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 1.48 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.22 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.0800000000000001 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 1.7 109.335 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 0.26000000000000001 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.17999999999999999 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.14000000000000001 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.17000000000000001 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.13 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 0.20000000000000001 110.703 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.1499999999999999 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.1899999999999999 111.003 -178.317 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.0499999999999998 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.48 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.14999999999999999 109.018 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.1499999999999999 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.14999999999999999 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.13 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 0.17999999999999999 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.03 109.401 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.34999999999999998 110.431 -178.389 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.773 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.612 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 3' ' ' LYS . 88.0 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.166 -0.679 . . . . 0.29999999999999999 109.166 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 1.97 109.254 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 0.97999999999999998 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 0.19 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.23000000000000001 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 1.8999999999999999 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.25 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.20000000000000001 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.20999999999999999 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 2.4700000000000002 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1000000000000001 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 0.20000000000000001 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 0.62 110.003 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.29999999999999999 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.23999999999999999 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 1.8999999999999999 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 0.17000000000000001 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.626 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 0.12 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 0.089999999999999997 108.637 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 0.17000000000000001 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.95999999999999996 109.422 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.23999999999999999 107.973 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.03 109.994 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.26000000000000001 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 0.32000000000000001 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.44 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.32000000000000001 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.35999999999999999 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.44 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81000000000000005 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 1.9199999999999999 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.1299999999999999 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 1.6200000000000001 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.25 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.29999999999999999 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.13 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.40999999999999998 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.96999999999999997 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 0.5 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.456 ' N ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.51000000000000001 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.1600000000000001 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.23999999999999999 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.17000000000000001 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.34000000000000002 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 0.12 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 0.17000000000000001 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 0.12 108.994 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.3100000000000001 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 0.14000000000000001 110.396 -178.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.407 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 59' ' ' VAL . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 0.27000000000000002 111.768 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.1100000000000001 110.678 -179.279 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.1200000000000001 109.118 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 0.17000000000000001 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.2200000000000002 110.362 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.1100000000000001 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 65' ' ' VAL . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 0.19 108.746 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 0.22 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.29 109.409 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2000000000000002 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 0.33000000000000002 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.3399999999999999 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.28000000000000003 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.3999999999999999 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 0.22 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.22 108.73 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.20000000000000001 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 0.17999999999999999 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.14999999999999999 109.242 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD2' HG22 ' A' ' 24' ' ' VAL . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.11 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.17000000000000001 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 1.48 107.539 -179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 1.6699999999999999 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.22 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.0800000000000001 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.488 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 1.7 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 0.26000000000000001 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.17999999999999999 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.14000000000000001 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.17000000000000001 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 0.20000000000000001 110.505 -179.371 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.1499999999999999 108.235 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.0499999999999998 110.01 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 77' ' ' PHE . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 0.14999999999999999 108.517 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.1499999999999999 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 0.14999999999999999 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.13 110.145 -179.071 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 0.17999999999999999 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.03 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 0.34999999999999998 110.384 -178.595 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.528 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 67.6 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.362 0.601 . . . . 0.29999999999999999 109.988 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 1.97 108.754 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 0.19 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 1.8999999999999999 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.25 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.20000000000000001 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.20999999999999999 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 2.4700000000000002 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1000000000000001 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 0.20000000000000001 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.62 109.915 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.664 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.29999999999999999 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.23999999999999999 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.28000000000000003 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 1.8999999999999999 109.084 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 0.12 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 79' ' ' PHE . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 0.089999999999999997 108.755 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 0.17000000000000001 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.95999999999999996 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.23999999999999999 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.03 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.26000000000000001 108.719 179.349 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.32000000000000001 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.44 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.32000000000000001 109.717 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.35999999999999999 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.44 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81000000000000005 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 1.9199999999999999 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.1299999999999999 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 0.28000000000000003 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 1.6200000000000001 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.25 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.29999999999999999 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.13 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.40999999999999998 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.96999999999999997 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 0.5 109.524 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.51000000000000001 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.1600000000000001 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.23999999999999999 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.17000000000000001 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.34000000000000002 109.429 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 0.12 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 0.17000000000000001 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 0.12 108.563 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.3100000000000001 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.14000000000000001 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.0800000000000001 108.218 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG11 ' OH ' ' B' ' 5' ' ' TYR . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 111.211 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.1100000000000001 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.1200000000000001 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 0.17000000000000001 108.502 179.035 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB3' HH12 ' B' ' 4' ' ' ARG . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.2200000000000002 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 0.19 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.22 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.29 109.426 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2000000000000002 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 0.33000000000000002 109.584 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.3399999999999999 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.28000000000000003 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.3999999999999999 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 0.22 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.22 108.567 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.20000000000000001 110.212 -1.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.17999999999999999 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.14999999999999999 109.1 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 69' ' ' ALA . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 24' ' ' VAL . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.11 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.17000000000000001 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 1.48 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 1.6699999999999999 109.495 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.22 110.471 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.0800000000000001 110.188 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 1.7 109.242 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 0.26000000000000001 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.17999999999999999 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.555 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.14000000000000001 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.17000000000000001 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.13 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.305 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.1499999999999999 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.517 ' NZ ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.1899999999999999 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.0499999999999998 109.595 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 0.14999999999999999 108.46 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.1499999999999999 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 0.14999999999999999 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.418 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.13 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.17999999999999999 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.03 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.458 ' HB2' HD11 ' A' ' 22' ' ' LEU . 54.1 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.34999999999999998 110.425 -178.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.605 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.6 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.304 -0.628 . . . . 0.29999999999999999 109.304 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 1.97 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.97999999999999998 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 0.19 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.23000000000000001 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 1.8999999999999999 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 0.25 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.20000000000000001 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.20999999999999999 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 2.4700000000000002 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1000000000000001 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 0.20000000000000001 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 0.62 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.0900000000000001 109.073 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 0.23999999999999999 109.769 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.28000000000000003 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 1.8999999999999999 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 0.17000000000000001 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 0.12 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 0.089999999999999997 108.676 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 0.17000000000000001 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.95999999999999996 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.23999999999999999 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.03 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 0.26000000000000001 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.32000000000000001 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.44 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.32000000000000001 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.35999999999999999 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.44 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 1.9199999999999999 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.1299999999999999 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' ILE . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 0.28000000000000003 110.526 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 1.6200000000000001 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.25 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.29999999999999999 109.315 179.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.13 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.40999999999999998 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 0.96999999999999997 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 0.5 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.51000000000000001 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.1600000000000001 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.23999999999999999 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.17000000000000001 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.471 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 26.5 t-20 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.34000000000000002 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 0.12 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 0.17000000000000001 109.466 -179.167 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.12 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.3100000000000001 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 0.14000000000000001 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.0800000000000001 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 74' ' ' THR . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.906 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.1100000000000001 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.1200000000000001 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 0.17000000000000001 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.2200000000000002 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 109.282 -179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG23 ' OD2' ' A' ' 64' ' ' ASP . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 0.19 108.788 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.22 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2000000000000002 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 0.33000000000000002 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.3399999999999999 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.28000000000000003 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.3999999999999999 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 0.22 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.628 HG23 ' CE2' ' B' ' 5' ' ' TYR . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.22 109.406 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.20000000000000001 109.76 -2.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 0.17999999999999999 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.14999999999999999 109.416 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.03 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.11 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.17000000000000001 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 1.6699999999999999 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.22 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.0800000000000001 110.229 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 1.7 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 0.26000000000000001 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.17999999999999999 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.14000000000000001 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.17000000000000001 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.13 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 0.20000000000000001 110.872 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.1499999999999999 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.1899999999999999 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.0499999999999998 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.14999999999999999 109.142 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.1499999999999999 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.14999999999999999 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 0.13 110.35 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.17999999999999999 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.03 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 0.34999999999999998 110.841 -178.299 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.628 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.593 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 3' ' ' LYS . 35.7 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.116 -0.698 . . . . 0.29999999999999999 109.116 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 1.97 109.443 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 0.97999999999999998 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 0.19 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.23000000000000001 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 1.8999999999999999 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 0.25 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.20000000000000001 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.20999999999999999 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 2.4700000000000002 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.20000000000000001 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 0.62 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.29999999999999999 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.23999999999999999 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.28000000000000003 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 1.8999999999999999 109.274 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 0.17000000000000001 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.12 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 0.089999999999999997 108.732 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 0.17000000000000001 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.95999999999999996 109.398 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.23999999999999999 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.03 109.813 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 0.26000000000000001 108.448 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 0.32000000000000001 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.44 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.32000000000000001 110.052 -178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.35999999999999999 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.44 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81000000000000005 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 1.9199999999999999 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.1299999999999999 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.467 HD12 ' HG3' ' A' ' 75' ' ' PRO . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 0.28000000000000003 110.188 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 1.6200000000000001 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.25 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.29999999999999999 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.13 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.40999999999999998 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 0.96999999999999997 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 0.5 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.51000000000000001 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.1600000000000001 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.23999999999999999 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.17000000000000001 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.34000000000000002 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 0.12 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.17000000000000001 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 0.12 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.3100000000000001 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 0.14000000000000001 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.0800000000000001 107.961 178.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.27000000000000002 111.38 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.1100000000000001 111.01 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.1200000000000001 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 0.17000000000000001 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.2200000000000002 110.097 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.1100000000000001 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 0.19 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 0.22 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.29 109.387 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.33000000000000002 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.3399999999999999 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 0.28000000000000003 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.3999999999999999 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 0.22 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.22 108.757 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.20000000000000001 110.023 -1.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 0.17999999999999999 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.781 ' CD1' HD21 ' A' ' 97' ' ' LEU . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.14999999999999999 109.116 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.03 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.11 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.17000000000000001 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 1.48 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 1.6699999999999999 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.22 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.0800000000000001 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 1.7 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 0.26000000000000001 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.17999999999999999 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.14000000000000001 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.17000000000000001 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.13 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 0.20000000000000001 110.54 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.1499999999999999 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.1899999999999999 110.523 -178.637 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.0499999999999998 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 0.14999999999999999 108.587 -179.864 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.1499999999999999 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 0.14999999999999999 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 0.13 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 0.17999999999999999 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.03 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 22' ' ' LEU . 14.3 mt . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.34999999999999998 110.625 -178.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.629 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 3' ' ' LYS . 14.4 t . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.219 -0.659 . . . . 0.29999999999999999 109.219 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 1.97 109.464 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 0.97999999999999998 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 0.19 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.23000000000000001 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 1.8999999999999999 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 0.25 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.20000000000000001 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.20999999999999999 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 2.4700000000000002 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1000000000000001 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 0.62 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.0900000000000001 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.29999999999999999 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.23999999999999999 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.28000000000000003 109.405 -179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 1.8999999999999999 108.752 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 0.17000000000000001 108.588 -179.35 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.434 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 0.12 109.465 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 0.089999999999999997 108.795 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 0.17000000000000001 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.95999999999999996 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' THR . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.23999999999999999 108.091 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.03 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 0.26000000000000001 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 0.32000000000000001 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.518 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.44 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.32000000000000001 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.35999999999999999 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.44 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 1.9199999999999999 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.1299999999999999 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 38' ' ' ILE . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 111.261 -178.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 1.6200000000000001 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.25 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.29999999999999999 109.453 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.13 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.40999999999999998 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 0.96999999999999997 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.5 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.51000000000000001 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.1600000000000001 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.23999999999999999 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.17000000000000001 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.34000000000000002 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 0.12 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 0.17000000000000001 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.528 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.528 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 0.12 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.0800000000000001 108.332 179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 0.27000000000000002 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.1100000000000001 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.1200000000000001 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 0.17000000000000001 108.852 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.2200000000000002 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.1100000000000001 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 0.19 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.22 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.29 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2000000000000002 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 0.33000000000000002 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 0.28000000000000003 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.3999999999999999 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 0.22 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.553 HG23 ' HE2' ' B' ' 5' ' ' TYR . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.22 108.615 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.20000000000000001 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 0.17999999999999999 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.14999999999999999 109.151 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.03 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.11 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.17000000000000001 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 1.48 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 1.6699999999999999 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.22 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.0800000000000001 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 1.7 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 0.26000000000000001 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.17999999999999999 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.14000000000000001 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.17000000000000001 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.13 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 0.20000000000000001 110.294 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.1499999999999999 108.15 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.1899999999999999 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.0499999999999998 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.14999999999999999 108.777 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.1499999999999999 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 0.14999999999999999 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 0.13 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.17999999999999999 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.03 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.832 -178.176 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.553 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.465 -0.568 . . . . 2.8900000000000001 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.6 t -94.65 171.77 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.29999999999999999 109.383 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 2' ' ' VAL . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 1.97 109.221 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.97999999999999998 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.19 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.23000000000000001 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 1.8999999999999999 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 0.25 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.20000000000000001 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.20999999999999999 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 12' ' ' GLN . 4.1 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 2.4700000000000002 109.756 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1000000000000001 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 0.20000000000000001 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 0.62 109.374 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.0900000000000001 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 0.29999999999999999 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.28000000000000003 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 1.8999999999999999 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 0.17000000000000001 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 0.12 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 0.089999999999999997 108.796 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.17000000000000001 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.95999999999999996 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.23999999999999999 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.03 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 0.26000000000000001 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 0.32000000000000001 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.44 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.32000000000000001 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.35999999999999999 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.44 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81000000000000005 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 1.9199999999999999 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.1299999999999999 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.831 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 1.6200000000000001 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.25 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.29999999999999999 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.13 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.40999999999999998 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 0.96999999999999997 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 0.5 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.51000000000000001 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.1600000000000001 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.23999999999999999 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.17000000000000001 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.34000000000000002 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 0.12 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 0.17000000000000001 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 0.12 108.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.3100000000000001 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 0.14000000000000001 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.0800000000000001 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 0.27000000000000002 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.1200000000000001 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 0.17000000000000001 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.2200000000000002 110.207 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.1100000000000001 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 0.19 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.22 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.29 109.244 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2000000000000002 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.3399999999999999 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.28000000000000003 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.3999999999999999 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 0.22 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.673 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.22 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.20000000000000001 110.286 -1.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 0.17999999999999999 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.14999999999999999 108.868 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.03 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.11 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.17000000000000001 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 1.48 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 1.6699999999999999 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.22 110.57 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.0800000000000001 110.191 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 1.7 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.26000000000000001 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.17999999999999999 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.14000000000000001 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.17000000000000001 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.13 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 0.20000000000000001 110.53 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.1499999999999999 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.1899999999999999 110.516 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.0499999999999998 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 0.14999999999999999 108.657 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.1499999999999999 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 0.14999999999999999 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.13 109.804 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.17999999999999999 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.03 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.28 18.32 8.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 0.34999999999999998 110.363 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.357 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.5 85.84 1.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 109.328 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 -126.13 143.22 51.21 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.092 -1.005 . . . . 0.0 109.274 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.645 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.626 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.626 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t -100.75 -33.37 10.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -58.63 -94.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.62 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.596 -179.813 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 2.8900000000000001 109.394 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t -94.56 165.27 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.357 -0.839 . . . . 0.29999999999999999 109.254 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 2' ' ' VAL . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 1.97 109.157 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 0.97999999999999998 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 0.19 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.23000000000000001 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 1.8999999999999999 109.606 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 0.25 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.20000000000000001 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.20999999999999999 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 2.4700000000000002 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.20000000000000001 109.147 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.62 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.29999999999999999 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.23999999999999999 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.28000000000000003 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 1.8999999999999999 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.17000000000000001 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 0.12 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 0.089999999999999997 108.683 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 0.17000000000000001 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.95999999999999996 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.23999999999999999 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.03 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 0.26000000000000001 108.547 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.32000000000000001 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.572 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.44 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.32000000000000001 109.481 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.35999999999999999 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.44 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81000000000000005 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 1.9199999999999999 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.1299999999999999 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 1.6200000000000001 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.25 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.29999999999999999 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.13 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.40999999999999998 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 0.96999999999999997 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 0.5 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.51000000000000001 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.1600000000000001 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.23999999999999999 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.17000000000000001 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.34000000000000002 108.961 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 0.12 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 0.17000000000000001 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.63 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 0.12 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.3100000000000001 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.14000000000000001 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.0800000000000001 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.478 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.27000000000000002 110.986 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.1100000000000001 110.461 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.1200000000000001 109.527 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 0.17000000000000001 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.422 ' CB ' HH12 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.2200000000000002 109.952 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.1100000000000001 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.19 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.22 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.29 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2000000000000002 109.671 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 0.33000000000000002 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.3399999999999999 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 0.28000000000000003 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.3999999999999999 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 0.22 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.636 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.22 108.754 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.20000000000000001 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 0.17999999999999999 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.14999999999999999 108.632 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.428 HE22 ' HB1' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.03 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.11 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.17000000000000001 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 1.48 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 1.6699999999999999 109.764 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.22 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.0800000000000001 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.469 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 1.7 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 0.26000000000000001 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.17999999999999999 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.14000000000000001 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.17000000000000001 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 0.20000000000000001 110.741 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.1499999999999999 107.981 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.1899999999999999 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.0499999999999998 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.14999999999999999 109.233 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.1499999999999999 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 0.14999999999999999 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.13 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 0.17999999999999999 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.03 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 22' ' ' LEU . 18.1 mt -94.13 10.68 32.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 0.34999999999999998 110.653 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.91 -1.119 . . . . 1.1799999999999999 109.174 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.4 p90 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.572 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -127.99 84.16 2.22 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -135.49 137.82 42.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.228 -0.92 . . . . 0.0 109.466 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.636 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t -78.91 -26.41 43.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -85.28 168.3 14.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.638 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.326 -0.62 . . . . 2.8900000000000001 109.326 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 3' ' ' LYS . 94.7 t -94.94 166.75 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.29999999999999999 109.913 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.601 ' N ' HG12 ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 1.97 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 0.97999999999999998 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 0.19 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.23000000000000001 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 1.8999999999999999 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 0.25 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.20000000000000001 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.20999999999999999 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 2.4700000000000002 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.20000000000000001 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 0.62 110.005 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 0.23999999999999999 109.418 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.28000000000000003 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 1.8999999999999999 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 0.17000000000000001 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 0.12 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 0.089999999999999997 108.565 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 0.17000000000000001 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.23999999999999999 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.03 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 0.26000000000000001 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 0.32000000000000001 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.44 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.32000000000000001 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.35999999999999999 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.44 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81000000000000005 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 1.9199999999999999 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.1299999999999999 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 75' ' ' PRO . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 110.244 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 1.6200000000000001 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.25 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.29999999999999999 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.13 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.40999999999999998 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 0.96999999999999997 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 0.5 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.51000000000000001 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.1600000000000001 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.23999999999999999 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.17000000000000001 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.34000000000000002 109.402 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 0.17000000000000001 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 0.12 109.065 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.3100000000000001 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 0.14000000000000001 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 108' ' ' HOH . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.27000000000000002 111.316 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.1100000000000001 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.1200000000000001 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 0.17000000000000001 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.2200000000000002 110.681 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.1100000000000001 109.351 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 0.19 108.685 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.22 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.29 109.316 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2000000000000002 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.33000000000000002 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.28000000000000003 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.3999999999999999 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 0.22 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.683 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.22 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.20000000000000001 109.991 -1.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 0.17999999999999999 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.14999999999999999 108.999 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.03 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.11 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.17000000000000001 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 1.48 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 1.6699999999999999 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.22 110.467 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.0800000000000001 110.347 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 1.7 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 0.26000000000000001 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.17999999999999999 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.14000000000000001 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.17000000000000001 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.48 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.20000000000000001 110.452 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.1499999999999999 108.173 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.1899999999999999 110.478 -178.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.0499999999999998 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 0.14999999999999999 109.309 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.1499999999999999 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.14999999999999999 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.13 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.17999999999999999 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.03 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt -91.73 19.68 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.34999999999999998 110.49 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.062 . . . . 1.1799999999999999 109.307 179.465 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 2' ' ' ARG . 3.8 ptm180 -164.27 62.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.022 . . . . 0.0 109.661 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 -99.99 162.26 13.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 108.995 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.669 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t -84.9 -4.05 58.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -141.92 160.55 39.98 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.535 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.407 -0.59 . . . . 2.8900000000000001 109.407 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t -94.79 151.54 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.204 -0.935 . . . . 0.29999999999999999 109.72 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 1.97 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.97999999999999998 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 0.19 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.23000000000000001 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.25 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.20000000000000001 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.20999999999999999 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 2.4700000000000002 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1000000000000001 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.20000000000000001 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.62 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.0900000000000001 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.29999999999999999 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.23999999999999999 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.28000000000000003 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 1.8999999999999999 109.181 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 0.17000000000000001 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 0.12 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 0.089999999999999997 108.831 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 0.17000000000000001 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.95999999999999996 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.23999999999999999 107.941 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.03 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.26000000000000001 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.32000000000000001 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.444 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.44 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.32000000000000001 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.35999999999999999 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.44 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81000000000000005 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 1.9199999999999999 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.1299999999999999 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 38' ' ' ILE . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.28000000000000003 110.781 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 1.6200000000000001 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.25 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.29999999999999999 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.13 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.40999999999999998 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 0.96999999999999997 109.938 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 0.5 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.51000000000000001 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.1600000000000001 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.23999999999999999 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.17000000000000001 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.34000000000000002 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 0.12 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 0.17000000000000001 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.518 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 0.12 108.941 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.3100000000000001 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 0.14000000000000001 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 74' ' ' THR . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 0.27000000000000002 111.374 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.1100000000000001 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.1200000000000001 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 0.17000000000000001 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.2200000000000002 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 0.19 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.22 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.29 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2000000000000002 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 0.33000000000000002 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.3399999999999999 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 0.28000000000000003 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.3999999999999999 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 0.22 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.638 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.22 108.641 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.571 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.20000000000000001 109.909 -1.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 0.17999999999999999 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 97' ' ' LEU . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.14999999999999999 108.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.03 107.403 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 24' ' ' VAL . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.11 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.17000000000000001 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 1.48 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 1.6699999999999999 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.22 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.0800000000000001 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 1.7 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 0.26000000000000001 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.17999999999999999 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.14000000000000001 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.17000000000000001 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.13 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 0.20000000000000001 110.627 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.1499999999999999 107.57 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.1899999999999999 110.494 -178.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.0499999999999998 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 0.14999999999999999 108.621 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.1499999999999999 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.14999999999999999 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.13 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.17999999999999999 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.03 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 19.58 5.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 110.572 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.86 -1.15 . . . . 1.1799999999999999 109.272 179.409 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.412 ' H3 ' ' HD1' ' B' ' 1' ' ' PHE . 8.8 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' B' ' 2' ' ' ARG . 15.1 ttm180 -167.74 21.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.697 1.237 . . . . 0.0 109.177 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -103.55 157.95 16.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.681 -1.262 . . . . 0.0 109.918 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.638 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.426 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.525 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -87.93 -7.85 56.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.503 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 35.8 t60 -156.17 -122.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.385 -0.822 . . . . 0.0 109.373 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtp . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.497 -0.556 . . . . 2.8900000000000001 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 3' ' ' LYS . 87.6 t -94.72 156.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.241 -0.912 . . . . 0.29999999999999999 109.416 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 1.97 109.189 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 0.97999999999999998 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 0.19 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.23000000000000001 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 1.8999999999999999 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.25 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 0.20000000000000001 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.20999999999999999 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 2.4700000000000002 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 0.20000000000000001 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 0.62 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 0.29999999999999999 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 0.23999999999999999 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.28000000000000003 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 1.8999999999999999 109.166 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 0.17000000000000001 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.663 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 0.12 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 0.089999999999999997 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 0.17000000000000001 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.95999999999999996 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.23999999999999999 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.03 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.409 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.26000000000000001 108.704 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.32000000000000001 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.44 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.35999999999999999 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.44 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 1.9199999999999999 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.1299999999999999 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.7 ' O ' HG22 ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 0.28000000000000003 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 1.6200000000000001 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.25 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.29999999999999999 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.13 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.40999999999999998 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 0.96999999999999997 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 0.5 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.51000000000000001 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.1600000000000001 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.23999999999999999 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.17000000000000001 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.34000000000000002 109.461 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 0.12 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.17000000000000001 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 0.12 108.783 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.3100000000000001 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 0.14000000000000001 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.0800000000000001 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.27000000000000002 111.342 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 58' ' ' ASP . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.1100000000000001 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 0.17000000000000001 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.2200000000000002 109.866 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.1100000000000001 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 0.19 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 0.22 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.29 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2000000000000002 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 0.33000000000000002 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.3399999999999999 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.3999999999999999 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 0.22 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE1' ' B' ' 5' ' ' TYR . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.22 109.148 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.20000000000000001 110.137 -2.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 0.17999999999999999 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.581 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.14999999999999999 108.797 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.03 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.11 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.17000000000000001 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 1.48 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.6699999999999999 109.931 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.22 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.0800000000000001 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 1.7 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.17999999999999999 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.14000000000000001 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.17000000000000001 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.13 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.20000000000000001 110.332 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.1499999999999999 108.399 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HZ2' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.1899999999999999 109.863 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.0499999999999998 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.581 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 0.14999999999999999 108.454 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.1499999999999999 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 0.14999999999999999 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.13 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 0.17999999999999999 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.03 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt -93.79 22.81 5.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 110.568 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.176 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.7 mtp180 -120.01 75.12 1.07 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.525 -0.735 . . . . 0.0 109.395 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 -130.05 159.18 37.54 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.316 -0.865 . . . . 0.0 109.239 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.596 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t -89.42 -57.2 2.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -79.66 131.47 35.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.612 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.576 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.471 -0.566 . . . . 2.8900000000000001 109.471 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.2 t -94.68 168.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.295 -0.878 . . . . 0.29999999999999999 109.696 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' N ' HG12 ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 1.97 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 0.97999999999999998 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 0.19 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.23000000000000001 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 1.8999999999999999 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.25 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.20000000000000001 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.20999999999999999 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.4700000000000002 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1000000000000001 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 0.20000000000000001 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.62 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.0900000000000001 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.29999999999999999 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.23999999999999999 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.28000000000000003 109.638 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 1.8999999999999999 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 0.17000000000000001 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 0.12 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.089999999999999997 108.402 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 0.17000000000000001 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.95999999999999996 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.23999999999999999 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.03 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.26000000000000001 108.677 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.32000000000000001 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.44 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.32000000000000001 109.626 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.35999999999999999 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.44 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 1.9199999999999999 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.1299999999999999 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 0.28000000000000003 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 1.6200000000000001 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.25 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.29999999999999999 108.814 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.13 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.40999999999999998 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 0.96999999999999997 109.576 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.5 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.51000000000000001 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.1600000000000001 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.23999999999999999 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.17000000000000001 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.34000000000000002 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 0.12 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 0.17000000000000001 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 0.12 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.3100000000000001 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 0.14000000000000001 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.0800000000000001 108.06 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG11 ' OH ' ' B' ' 5' ' ' TYR . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.27000000000000002 111.38 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.1100000000000001 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.1200000000000001 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 0.17000000000000001 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.2200000000000002 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.1100000000000001 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 0.19 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 0.22 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.29 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2000000000000002 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 0.33000000000000002 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.3399999999999999 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 0.28000000000000003 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.3999999999999999 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 0.22 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.575 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.22 108.818 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.20000000000000001 110.204 -1.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 0.17999999999999999 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.14999999999999999 108.857 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.03 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.11 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.17000000000000001 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 1.48 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 1.6699999999999999 109.759 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.0800000000000001 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 1.7 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 0.26000000000000001 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.17999999999999999 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.14000000000000001 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.17000000000000001 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.13 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 0.20000000000000001 110.459 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.6 t-20 -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.1499999999999999 107.889 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.1899999999999999 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.0499999999999998 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 77' ' ' PHE . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 0.14999999999999999 109.009 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.1499999999999999 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.14999999999999999 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 0.13 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.17999999999999999 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.03 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt -92.6 19.2 7.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 111.117 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 1.1799999999999999 109.137 179.22 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 8.5 mmm-85 -127.39 79.68 1.9 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.547 -0.721 . . . . 0.0 109.142 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 -137.76 151.91 48.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.207 -0.933 . . . . 0.0 109.269 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.575 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.583 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t -96.57 -47.23 6.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -144.13 134.88 25.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.532 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.289 0.566 . . . . 2.8900000000000001 109.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 3' ' ' LYS . 42.0 t -94.77 167.13 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 0.29999999999999999 109.483 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 2' ' ' VAL . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 1.97 109.125 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 0.97999999999999998 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 0.19 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.23000000000000001 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 1.8999999999999999 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.25 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.20000000000000001 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.20999999999999999 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 2.4700000000000002 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 0.20000000000000001 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 0.62 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.29999999999999999 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.28000000000000003 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 1.8999999999999999 109.505 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 0.17000000000000001 108.137 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 0.12 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 0.089999999999999997 108.705 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 0.17000000000000001 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.95999999999999996 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.23999999999999999 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.03 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 0.26000000000000001 108.589 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.32000000000000001 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.44 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.32000000000000001 109.82 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.35999999999999999 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.44 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81000000000000005 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 1.9199999999999999 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.1299999999999999 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 38' ' ' ILE . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 0.28000000000000003 111.082 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 1.6200000000000001 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.25 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.29999999999999999 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.13 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.40999999999999998 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 0.96999999999999997 110.562 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 0.5 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.51000000000000001 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.1600000000000001 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.23999999999999999 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.17000000000000001 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.34000000000000002 109.852 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 0.12 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.17000000000000001 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 0.12 108.989 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.3100000000000001 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 0.14000000000000001 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.0800000000000001 108.286 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.27000000000000002 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.1100000000000001 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB2' HH12 ' B' ' 2' ' ' ARG . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.1200000000000001 109.409 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 0.17000000000000001 108.6 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.2200000000000002 109.958 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 0.19 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 0.22 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.29 109.549 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2000000000000002 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 0.33000000000000002 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.3399999999999999 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 0.28000000000000003 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.3999999999999999 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 0.22 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.22 108.855 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.20000000000000001 110.008 -1.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 0.17999999999999999 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.14999999999999999 108.873 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.03 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' HG22 ' A' ' 24' ' ' VAL . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.11 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.17000000000000001 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 1.48 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 1.6699999999999999 109.643 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.22 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.0800000000000001 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 1.7 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 0.26000000000000001 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.17999999999999999 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.14000000000000001 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.17000000000000001 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 0.20000000000000001 110.297 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.1499999999999999 107.971 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.1899999999999999 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.0499999999999998 109.625 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 0.14999999999999999 108.827 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.1499999999999999 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.14999999999999999 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 0.13 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.17999999999999999 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.512 HD21 ' C ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.03 109.582 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.35 22.43 3.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.34999999999999998 110.348 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.308 179.638 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 27.9 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.3 mtt-85 -121.88 72.68 1.04 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -124.06 154.57 39.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.783 . . . . 0.0 109.03 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.57 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t -89.8 -18.64 25.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -55.58 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 109.63 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.606 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 2.8900000000000001 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.57 153.74 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.205 -0.934 . . . . 0.29999999999999999 109.272 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 1.97 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.97999999999999998 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 0.19 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.23000000000000001 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 1.8999999999999999 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.25 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 0.20000000000000001 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.20999999999999999 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 2.4700000000000002 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1000000000000001 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.20000000000000001 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.62 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.0900000000000001 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.29999999999999999 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.23999999999999999 109.576 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.28000000000000003 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 1.8999999999999999 109.16 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 0.17000000000000001 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 0.12 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 108.875 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 0.17000000000000001 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 74' ' ' THR . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.23999999999999999 107.961 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.03 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 0.26000000000000001 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.32000000000000001 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.44 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.32000000000000001 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.35999999999999999 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.44 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81000000000000005 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 1.9199999999999999 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.1299999999999999 110.778 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 0.28000000000000003 110.9 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 1.6200000000000001 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.25 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.29999999999999999 109.506 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.13 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.40999999999999998 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 46' ' ' SER . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.96999999999999997 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.5 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.51000000000000001 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.1600000000000001 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.23999999999999999 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.17000000000000001 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.34000000000000002 109.817 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 0.12 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 0.17000000000000001 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 0.12 108.934 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.3100000000000001 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 0.14000000000000001 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.0800000000000001 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 108' ' ' HOH . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 0.27000000000000002 111.156 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.481 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.1200000000000001 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.2200000000000002 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.1100000000000001 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.19 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.22 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.29 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2000000000000002 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 0.33000000000000002 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.3399999999999999 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.28000000000000003 109.137 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.3999999999999999 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 0.22 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.22 109.019 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.20000000000000001 109.818 -1.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 0.17999999999999999 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.14999999999999999 108.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.03 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 24' ' ' VAL . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.11 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.17000000000000001 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 1.48 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 1.6699999999999999 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.22 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.0800000000000001 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 1.7 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 0.26000000000000001 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.17999999999999999 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.14000000000000001 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.17000000000000001 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.13 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.542 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.20000000000000001 110.555 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.1499999999999999 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.1899999999999999 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.0499999999999998 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.14999999999999999 108.651 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.1499999999999999 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 0.14999999999999999 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 0.13 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.17999999999999999 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.03 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.21 21.37 4.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 0.34999999999999998 110.24 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.124 . . . . 1.1799999999999999 109.294 179.553 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.1 p90 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 84.6 mtt180 -147.07 55.01 1.1 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.089 -1.007 . . . . 0.0 109.467 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -103.96 159.01 16.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.33 -0.856 . . . . 0.0 109.09 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t -87.61 -18.45 29.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -74.97 129.16 37.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 109.604 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.606 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.438 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 2.8900000000000001 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.4 t -96.52 158.03 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.366 -0.834 . . . . 0.29999999999999999 109.3 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 1.97 109.048 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 0.97999999999999998 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 0.19 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.23000000000000001 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 1.8999999999999999 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.25 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.20000000000000001 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.20999999999999999 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 2.4700000000000002 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1000000000000001 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.20000000000000001 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.62 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.0900000000000001 109.713 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.29999999999999999 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.23999999999999999 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.28000000000000003 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 1.8999999999999999 108.854 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 0.17000000000000001 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 0.12 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 0.089999999999999997 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 0.17000000000000001 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.95999999999999996 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.23999999999999999 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.03 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.26000000000000001 108.336 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.32000000000000001 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.44 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.32000000000000001 109.814 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.35999999999999999 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.44 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81000000000000005 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 1.9199999999999999 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.482 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.1299999999999999 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.535 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 1.6200000000000001 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.25 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.29999999999999999 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.13 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.40999999999999998 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 0.96999999999999997 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.5 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.51000000000000001 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.1600000000000001 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.23999999999999999 109.227 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.17000000000000001 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.34000000000000002 109.367 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 0.12 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.12 108.998 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.3100000000000001 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.14000000000000001 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.0800000000000001 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 110.701 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.1100000000000001 110.891 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.715 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 0.17000000000000001 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.2200000000000002 110.053 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 0.19 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.22 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.29 109.251 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2000000000000002 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 0.33000000000000002 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.3399999999999999 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 0.28000000000000003 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.3999999999999999 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 0.22 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.22 108.605 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.20000000000000001 110.134 -2.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 0.17999999999999999 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.14999999999999999 108.687 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.03 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.11 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.17000000000000001 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 1.6699999999999999 109.06 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.0800000000000001 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 1.7 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 0.26000000000000001 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.17999999999999999 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.14000000000000001 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.17000000000000001 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.13 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 0.20000000000000001 110.282 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.1499999999999999 108.415 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.1899999999999999 110.702 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.0499999999999998 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.14999999999999999 108.904 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.1499999999999999 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.14999999999999999 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 0.13 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 0.17999999999999999 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.03 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -90.74 22.14 3.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 0.34999999999999998 110.325 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.007 . . . . 1.1799999999999999 109.172 179.432 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.553 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -131.22 75.49 1.66 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 -134.65 150.59 50.67 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.15 -0.969 . . . . 0.0 109.68 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t -86.36 -5.97 59.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.64 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 1.3 t60 -65.4 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.333 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.64 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.505 -0.554 . . . . 2.8900000000000001 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 3' ' ' LYS . 65.4 t -94.55 158.04 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.29999999999999999 109.195 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 2' ' ' VAL . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 1.97 109.305 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.97999999999999998 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 0.19 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.23000000000000001 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 1.8999999999999999 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.25 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.20000000000000001 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.20999999999999999 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 2.4700000000000002 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1000000000000001 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 0.20000000000000001 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 0.62 109.371 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.0900000000000001 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.29999999999999999 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.23999999999999999 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.28000000000000003 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' HOH . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 1.8999999999999999 108.648 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 0.17000000000000001 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 0.12 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 0.089999999999999997 108.737 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.17000000000000001 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.95999999999999996 108.959 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' THR . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.23999999999999999 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.03 109.723 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.26000000000000001 108.825 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.32000000000000001 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.44 110.417 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32000000000000001 109.941 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.35999999999999999 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.44 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81000000000000005 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 1.9199999999999999 110.013 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.1299999999999999 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.623 ' O ' HG22 ' A' ' 38' ' ' ILE . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.56 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 1.6200000000000001 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.25 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.29999999999999999 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.13 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.40999999999999998 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 0.96999999999999997 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.5 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.51000000000000001 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.1600000000000001 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.23999999999999999 109.299 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.17000000000000001 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.34000000000000002 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 0.12 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 0.17000000000000001 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 0.12 108.901 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.3100000000000001 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 0.14000000000000001 110.56 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.0800000000000001 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 0.27000000000000002 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.1200000000000001 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 0.17000000000000001 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.146 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.1100000000000001 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.19 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 0.22 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.29 109.553 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2000000000000002 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 0.33000000000000002 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.3399999999999999 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 0.28000000000000003 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.3999999999999999 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 0.22 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.558 HG23 ' HE1' ' B' ' 5' ' ' TYR . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HG3' HD12 ' A' ' 38' ' ' ILE . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.20000000000000001 110.048 -1.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 0.17999999999999999 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.755 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.14999999999999999 109.326 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.03 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.11 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.17000000000000001 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 1.6699999999999999 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.22 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.0800000000000001 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 1.7 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 0.26000000000000001 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.17999999999999999 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.14000000000000001 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.17000000000000001 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.13 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.20000000000000001 110.186 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.1499999999999999 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.1899999999999999 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.0499999999999998 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' A' ' 77' ' ' PHE . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 0.14999999999999999 108.679 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.1499999999999999 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.14999999999999999 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 0.13 110.404 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 0.17999999999999999 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.03 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -92.7 24.83 3.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 0.34999999999999998 110.528 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.043 -1.036 . . . . 1.1799999999999999 109.271 179.517 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -159.13 61.96 0.4 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.54 156.49 17.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.062 -1.023 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.558 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t -85.88 -41.46 14.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.82 122.79 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.415 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.518 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.43 -0.582 . . . . 2.8900000000000001 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 3' ' ' LYS . 12.8 t -94.58 173.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.846 . . . . 0.29999999999999999 109.263 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' H ' HG12 ' A' ' 2' ' ' VAL . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 1.97 109.087 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.97999999999999998 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 0.19 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.23000000000000001 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 1.8999999999999999 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.25 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 0.20000000000000001 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.20999999999999999 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 2.4700000000000002 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1000000000000001 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 0.20000000000000001 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 0.62 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.0900000000000001 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 0.29999999999999999 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.23999999999999999 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.28000000000000003 109.192 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.715 ' CE ' HD11 ' A' ' 53' ' ' ILE . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 1.8999999999999999 109.459 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.511 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 0.12 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 0.089999999999999997 108.588 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 0.17000000000000001 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.95999999999999996 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 74' ' ' THR . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.23999999999999999 107.73 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.03 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.26000000000000001 108.474 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 0.32000000000000001 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.44 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.32000000000000001 109.907 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.35999999999999999 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.44 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81000000000000005 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 1.9199999999999999 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.1299999999999999 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 38' ' ' ILE . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 0.28000000000000003 111.559 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 1.6200000000000001 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.25 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.13 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.40999999999999998 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.96999999999999997 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.5 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.1600000000000001 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.23999999999999999 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.17000000000000001 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.34000000000000002 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 0.12 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.715 HD11 ' CE ' ' A' ' 21' ' ' LYS . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 109.398 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.577 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 0.12 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 0.14000000000000001 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.0800000000000001 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' B' ' 5' ' ' TYR . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.27000000000000002 111.183 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.1100000000000001 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.1200000000000001 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 0.17000000000000001 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 67' ' ' SER . 13.8 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.2200000000000002 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.1100000000000001 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 0.19 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.22 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.29 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2000000000000002 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.3399999999999999 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 0.28000000000000003 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.3999999999999999 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 0.22 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.722 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.563 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.20000000000000001 110.296 -1.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 0.17999999999999999 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.14999999999999999 108.601 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.03 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.11 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.17000000000000001 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 1.48 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 1.6699999999999999 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.22 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.0800000000000001 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 1.7 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 0.26000000000000001 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.17999999999999999 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.14000000000000001 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.17000000000000001 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.13 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 0.20000000000000001 110.385 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.1499999999999999 108.148 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.1899999999999999 110.787 -178.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.0499999999999998 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 77' ' ' PHE . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 0.14999999999999999 108.598 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.1499999999999999 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.14999999999999999 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.13 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.17999999999999999 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.03 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.43 23.28 4.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 0.34999999999999998 110.376 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.268 179.554 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 88.2 mtt180 -141.89 76.04 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.249 -0.907 . . . . 0.0 109.186 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -126.97 145.58 50.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.722 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t -101.93 3.77 39.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -160.72 -61.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.8 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.373 -0.602 . . . . 2.8900000000000001 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 3' ' ' LYS . 98.0 t -94.63 162.12 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.29999999999999999 109.639 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 2' ' ' VAL . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 1.97 109.427 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.97999999999999998 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 0.19 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.23000000000000001 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 1.8999999999999999 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.25 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.20000000000000001 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.20999999999999999 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.4700000000000002 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 0.20000000000000001 109.157 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 0.62 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.0900000000000001 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.29999999999999999 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.23999999999999999 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.28000000000000003 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 1.8999999999999999 108.857 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 0.17000000000000001 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.12 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 0.089999999999999997 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 0.17000000000000001 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.95999999999999996 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.23999999999999999 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.03 109.715 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 0.26000000000000001 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 0.32000000000000001 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.44 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.35999999999999999 111.7 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.44 111.461 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81000000000000005 108.665 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 1.9199999999999999 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.1299999999999999 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' A' ' 94' ' ' LYS . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 0.28000000000000003 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 1.6200000000000001 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.25 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.29999999999999999 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.13 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.40999999999999998 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 0.96999999999999997 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 0.5 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.51000000000000001 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.23999999999999999 109.101 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.17000000000000001 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.34000000000000002 109.39 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.12 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 0.17000000000000001 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 0.12 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.3100000000000001 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 0.14000000000000001 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.0800000000000001 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.27000000000000002 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.1100000000000001 110.974 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB2' HH11 ' B' ' 2' ' ' ARG . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.1200000000000001 109.533 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 0.17000000000000001 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.2200000000000002 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.1100000000000001 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.19 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.22 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.29 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2000000000000002 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 0.33000000000000002 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.3399999999999999 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.28000000000000003 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.3999999999999999 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.22 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.694 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.22 108.684 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.20000000000000001 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 0.17999999999999999 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.14999999999999999 108.956 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.448 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.0 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.03 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.11 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.17000000000000001 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 1.48 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 1.6699999999999999 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.22 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.0800000000000001 110.225 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 1.7 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 0.26000000000000001 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.17999999999999999 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.14000000000000001 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.17000000000000001 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.13 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 0.20000000000000001 110.152 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.1499999999999999 108.405 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.1899999999999999 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.0499999999999998 109.746 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 0.14999999999999999 108.856 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.1499999999999999 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.14999999999999999 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.13 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.17999999999999999 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.03 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt -91.58 20.9 5.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.34999999999999998 110.289 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.928 -1.108 . . . . 1.1799999999999999 109.367 179.495 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.1 p90 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.498 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 55.3 mtm180 -152.01 62.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.034 -1.041 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 -103.45 157.41 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.694 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.608 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t -81.2 -15.76 54.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 51.54 -92.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 11' ' ' SER . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.41 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.328 -0.619 . . . . 2.8900000000000001 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.85 153.38 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.29999999999999999 109.309 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 1.97 107.91 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 3' ' ' LYS . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.97999999999999998 110.431 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 0.19 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.23000000000000001 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 1.8999999999999999 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.25 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.20000000000000001 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.20999999999999999 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 2.4700000000000002 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1000000000000001 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 0.20000000000000001 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 0.62 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.0900000000000001 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.29999999999999999 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.23999999999999999 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.28000000000000003 109.51 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 1.8999999999999999 108.948 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 0.17000000000000001 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.647 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 0.12 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 0.089999999999999997 108.562 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 0.17000000000000001 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.95999999999999996 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.23999999999999999 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.03 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.26000000000000001 108.747 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.32000000000000001 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.44 110.103 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.32000000000000001 109.12 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.35999999999999999 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.44 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81000000000000005 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 1.9199999999999999 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.1299999999999999 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 0.28000000000000003 110.185 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 1.6200000000000001 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.25 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.29999999999999999 109.059 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.13 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.40999999999999998 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 0.96999999999999997 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 0.5 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.51000000000000001 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.1600000000000001 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.23999999999999999 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.34000000000000002 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 0.12 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 0.17000000000000001 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.12 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.3100000000000001 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 0.14000000000000001 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.0800000000000001 108.538 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 108' ' ' HOH . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 0.27000000000000002 111.024 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.1100000000000001 110.567 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB2' HH11 ' B' ' 2' ' ' ARG . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.1200000000000001 109.683 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 0.17000000000000001 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.2200000000000002 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.19 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.22 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.29 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2000000000000002 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 0.33000000000000002 109.753 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.3399999999999999 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.28000000000000003 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.3999999999999999 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.22 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.506 HG23 ' HE1' ' B' ' 5' ' ' TYR . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.22 108.707 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.20000000000000001 110.18 -1.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 0.17999999999999999 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.14999999999999999 108.776 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.03 107.65 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.11 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 1.48 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 1.6699999999999999 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.22 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.0800000000000001 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 1.7 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.26000000000000001 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.17999999999999999 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.14000000000000001 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.17000000000000001 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.13 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 0.20000000000000001 110.026 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.1499999999999999 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.1899999999999999 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.0499999999999998 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 0.14999999999999999 108.555 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.1499999999999999 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.14999999999999999 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.13 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 0.17999999999999999 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.03 109.372 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -92.2 21.02 5.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.34999999999999998 110.343 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.024 -1.047 . . . . 1.1799999999999999 109.246 179.514 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 mtm180 -171.53 78.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.249 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 50.7 m-85 -100.11 162.26 13.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.953 -1.092 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.476 ' HG2' HH11 ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t -89.15 -49.97 6.43 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -69.87 172.26 8.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.496 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.445 -0.576 . . . . 2.8900000000000001 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.8 t -94.83 161.54 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.29999999999999999 109.624 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 1.97 109.163 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 0.97999999999999998 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 10' ' ' ALA . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 0.19 108.099 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.23000000000000001 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.8999999999999999 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 0.25 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.20000000000000001 109.831 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.20999999999999999 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 2.4700000000000002 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1000000000000001 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.20000000000000001 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 0.62 109.882 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.29999999999999999 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.23999999999999999 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.28000000000000003 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.8999999999999999 108.887 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 0.17000000000000001 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.12 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 0.089999999999999997 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 0.17000000000000001 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.95999999999999996 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.23999999999999999 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.03 109.46 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 0.26000000000000001 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 0.32000000000000001 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.44 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.32000000000000001 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.35999999999999999 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.44 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81000000000000005 108.615 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 1.9199999999999999 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.1299999999999999 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.631 ' O ' HG22 ' A' ' 38' ' ' ILE . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 0.28000000000000003 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 1.6200000000000001 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.25 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.29999999999999999 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.13 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.40999999999999998 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 0.96999999999999997 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.5 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.51000000000000001 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.1600000000000001 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.23999999999999999 108.923 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.17000000000000001 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.34000000000000002 109.307 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 0.12 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 0.17000000000000001 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 0.12 109.063 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.3100000000000001 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 0.14000000000000001 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.0800000000000001 107.888 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.403 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.27000000000000002 111.178 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.1100000000000001 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.1200000000000001 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 0.17000000000000001 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.2200000000000002 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 65' ' ' VAL . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 0.19 108.86 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 0.22 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.29 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2000000000000002 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.3399999999999999 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 0.28000000000000003 109.063 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.3999999999999999 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.22 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.642 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.22 109.249 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.542 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.20000000000000001 109.892 -1.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 0.17999999999999999 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.14999999999999999 108.52 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.03 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.11 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.17000000000000001 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 1.48 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 1.6699999999999999 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.22 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.0800000000000001 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.7 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 0.26000000000000001 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.17999999999999999 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.14000000000000001 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.17000000000000001 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 0.20000000000000001 110.743 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.1499999999999999 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.1899999999999999 110.915 -178.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.0499999999999998 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 77' ' ' PHE . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 0.14999999999999999 108.771 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.1499999999999999 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.14999999999999999 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.13 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.17999999999999999 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' O ' HG12 ' A' ' 105' ' ' VAL . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.03 109.837 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.82 16.98 11.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 0.34999999999999998 110.262 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.903 -1.046 . . . . 1.1799999999999999 109.288 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 48.4 mtm180 -138.01 67.2 1.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 -102.47 157.68 16.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.376 -0.828 . . . . 0.0 109.21 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m -97.06 2.53 51.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.666 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 2.6 t60 -165.79 -144.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.937 -1.102 . . . . 0.0 109.561 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.666 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.449 -0.574 . . . . 2.8900000000000001 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.5 t -94.35 165.82 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.244 -0.91 . . . . 0.29999999999999999 109.277 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 1.97 109.568 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.97999999999999998 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 0.19 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.23000000000000001 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 1.8999999999999999 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 0.25 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.20000000000000001 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.20999999999999999 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 2.4700000000000002 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1000000000000001 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.20000000000000001 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 0.62 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.29999999999999999 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.23999999999999999 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.28000000000000003 109.228 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 1.8999999999999999 109.015 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 0.17000000000000001 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.605 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 0.12 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.089999999999999997 108.697 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 0.17000000000000001 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.95999999999999996 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.23999999999999999 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.03 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 0.26000000000000001 108.831 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.44 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.32000000000000001 109.913 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.35999999999999999 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.44 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81000000000000005 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 1.9199999999999999 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.485 ' O ' ' SD ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.1299999999999999 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 0.28000000000000003 110.846 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 1.6200000000000001 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.25 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.29999999999999999 109.68 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.13 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.40999999999999998 110.231 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 0.96999999999999997 110.262 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 0.5 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.45 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.23999999999999999 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.17000000000000001 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.34000000000000002 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 0.12 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.17000000000000001 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 0.12 108.999 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.3100000000000001 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 0.14000000000000001 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.0800000000000001 108.568 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.27000000000000002 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.1100000000000001 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.1200000000000001 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 0.17000000000000001 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.2200000000000002 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.1100000000000001 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 0.19 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.22 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.29 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2000000000000002 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 0.33000000000000002 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.3399999999999999 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.28000000000000003 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 0.22 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.577 HG23 ' CE2' ' B' ' 5' ' ' TYR . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.22 108.587 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.20000000000000001 110.11 -1.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 0.17999999999999999 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.14999999999999999 109.0 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.03 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.11 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.17000000000000001 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 1.48 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.6699999999999999 109.788 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.22 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.0800000000000001 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 1.7 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 0.26000000000000001 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.17999999999999999 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.14000000000000001 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.17000000000000001 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.13 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 0.20000000000000001 110.338 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.1499999999999999 108.167 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.1899999999999999 110.606 -178.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.0499999999999998 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 0.14999999999999999 108.528 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.1499999999999999 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 0.13 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 0.17999999999999999 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.03 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -90.29 21.0 4.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 0.34999999999999998 110.587 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.903 -1.123 . . . . 1.1799999999999999 109.222 179.532 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 92.0 mtt180 -144.97 73.56 1.37 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 -131.15 148.94 52.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.593 -0.692 . . . . 0.0 109.244 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t -88.91 5.78 42.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -164.18 132.9 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 2.8900000000000001 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t -94.4 169.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 0.29999999999999999 108.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 1.97 109.541 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.97999999999999998 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 0.19 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.23000000000000001 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 1.8999999999999999 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 0.25 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.20000000000000001 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.20999999999999999 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 2.4700000000000002 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1000000000000001 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 0.20000000000000001 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.62 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.0900000000000001 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.29999999999999999 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.23999999999999999 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.28000000000000003 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 1.8999999999999999 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 0.17000000000000001 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.655 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.12 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 0.089999999999999997 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 0.17000000000000001 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.95999999999999996 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.23999999999999999 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.03 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.26000000000000001 108.971 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.32000000000000001 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.44 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.32000000000000001 109.7 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.44 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81000000000000005 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 1.9199999999999999 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.1299999999999999 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 75' ' ' PRO . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 0.28000000000000003 111.212 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 1.6200000000000001 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.25 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.29999999999999999 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.13 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.40999999999999998 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 0.96999999999999997 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.5 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.51000000000000001 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.1600000000000001 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.23999999999999999 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.17000000000000001 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.34000000000000002 109.627 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.12 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 0.17000000000000001 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 0.12 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 0.14000000000000001 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.0800000000000001 108.5 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 108' ' ' HOH . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 0.27000000000000002 111.177 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.493 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HB2' HH12 ' B' ' 2' ' ' ARG . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.1200000000000001 109.846 -178.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 0.17000000000000001 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.2200000000000002 110.336 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 0.19 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 0.22 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.29 109.046 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2000000000000002 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.33000000000000002 109.259 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.3399999999999999 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.28000000000000003 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.3999999999999999 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.22 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.22 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.20000000000000001 110.437 -1.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 0.17999999999999999 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.14999999999999999 109.155 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.491 HE22 ' HB1' ' A' ' 69' ' ' ALA . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.03 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 100' ' ' THR . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.11 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.17000000000000001 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 1.48 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 1.6699999999999999 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.22 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.0800000000000001 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 1.7 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 0.26000000000000001 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.17999999999999999 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.14000000000000001 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.17000000000000001 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.13 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 0.20000000000000001 110.645 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.1499999999999999 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.1899999999999999 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.0499999999999998 109.799 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.14999999999999999 108.975 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.1499999999999999 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.14999999999999999 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.443 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.13 110.126 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 0.17999999999999999 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.03 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 22' ' ' LEU . 10.3 mt -94.83 12.27 28.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 0.34999999999999998 110.569 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 120.862 -1.149 . . . . 1.1799999999999999 109.291 -179.733 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.53 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 11.5 mtt-85 -127.15 68.36 1.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.285 -0.885 . . . . 0.0 109.983 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 -123.97 141.34 52.13 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.315 -0.866 . . . . 0.0 109.832 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t -88.5 -35.19 17.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.419 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 38.2 t-80 -81.06 159.29 24.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.341 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.367 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.42 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.335 0.588 . . . . 2.8900000000000001 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.6 t -94.62 161.19 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.248 -0.907 . . . . 0.29999999999999999 109.016 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 1.97 109.408 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.97999999999999998 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 0.19 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.23000000000000001 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 1.8999999999999999 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.25 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.20000000000000001 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.20999999999999999 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 2.4700000000000002 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1000000000000001 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.20000000000000001 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 0.62 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.0900000000000001 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.29999999999999999 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.23999999999999999 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.28000000000000003 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 1.8999999999999999 108.668 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 0.17000000000000001 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 0.12 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.089999999999999997 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 0.17000000000000001 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.95999999999999996 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 74' ' ' THR . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.23999999999999999 107.762 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.03 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 0.26000000000000001 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 0.32000000000000001 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.44 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.35999999999999999 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.44 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81000000000000005 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 1.9199999999999999 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.1299999999999999 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG22 ' A' ' 38' ' ' ILE . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 0.28000000000000003 111.009 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 1.6200000000000001 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.25 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.29999999999999999 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.13 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.40999999999999998 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 0.96999999999999997 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 0.5 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.51000000000000001 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.1600000000000001 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.23999999999999999 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.17000000000000001 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.34000000000000002 109.581 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 0.12 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 0.17000000000000001 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.567 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 0.12 108.509 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.3100000000000001 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE2' ' A' ' 27' ' ' PHE . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 0.14000000000000001 110.705 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.0800000000000001 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.27000000000000002 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.1100000000000001 111.083 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.1200000000000001 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 0.17000000000000001 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.2200000000000002 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.1100000000000001 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 0.19 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 0.22 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.29 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2000000000000002 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 0.33000000000000002 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.3399999999999999 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 0.28000000000000003 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.3999999999999999 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 27' ' ' PHE . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.22 108.837 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.20000000000000001 109.848 -1.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 0.17999999999999999 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.526 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.14999999999999999 109.247 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.03 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.11 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.17000000000000001 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 1.48 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 1.6699999999999999 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.22 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.0800000000000001 110.902 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 1.7 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 0.26000000000000001 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.17999999999999999 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.14000000000000001 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.17000000000000001 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.13 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 0.20000000000000001 110.701 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.1499999999999999 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.1899999999999999 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.0499999999999998 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.14999999999999999 108.825 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.1499999999999999 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 0.14999999999999999 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 0.13 110.331 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.17999999999999999 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.03 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.92 20.1 5.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 0.34999999999999998 110.413 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.986 -1.071 . . . . 1.1799999999999999 109.197 179.477 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.6 mtt180 -140.56 70.69 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 -122.08 151.95 40.35 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.49 ' HE1' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t -83.67 -31.83 25.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -52.31 161.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.416 -0.803 . . . . 0.0 109.541 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.92 -1.489 . . . . 0.0 109.586 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.35 -0.611 . . . . 2.8900000000000001 109.35 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 3' ' ' LYS . 18.7 t -97.22 -178.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.359 -0.838 . . . . 0.29999999999999999 109.571 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.782 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 1.97 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 0.97999999999999998 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 0.19 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 1.8999999999999999 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 0.25 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.20000000000000001 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.20999999999999999 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 2.4700000000000002 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.20000000000000001 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 0.62 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.0900000000000001 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.29999999999999999 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.23999999999999999 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.28000000000000003 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' NZ ' ' CG ' ' A' ' 51' ' ' ASN . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 1.8999999999999999 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 0.17000000000000001 107.833 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 0.12 109.23 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 0.089999999999999997 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 0.17000000000000001 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.95999999999999996 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.23999999999999999 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.03 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.26000000000000001 108.545 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.32000000000000001 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.44 110.133 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.32000000000000001 109.807 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.35999999999999999 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.44 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81000000000000005 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' CB ' ' NZ ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 1.9199999999999999 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.465 ' O ' ' SD ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.1299999999999999 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.489 ' O ' HG22 ' A' ' 38' ' ' ILE . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.28000000000000003 110.129 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 1.6200000000000001 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.25 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.29999999999999999 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.13 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.40999999999999998 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 0.96999999999999997 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.5 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.51000000000000001 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.1600000000000001 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.23999999999999999 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.17000000000000001 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.2 t30 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.34000000000000002 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 0.12 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 0.17000000000000001 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.545 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 0.12 108.897 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.3100000000000001 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 0.14000000000000001 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.0800000000000001 107.515 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' HOH . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.27000000000000002 111.306 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.1100000000000001 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.1200000000000001 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.17000000000000001 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.2200000000000002 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 0.19 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 0.22 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.29 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 0.33000000000000002 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.3399999999999999 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.28000000000000003 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.3999999999999999 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 0.22 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.651 HG23 ' CE2' ' B' ' 5' ' ' TYR . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.20000000000000001 110.581 -1.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 0.17999999999999999 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.14999999999999999 108.43 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.03 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.11 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.17000000000000001 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 1.48 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 1.6699999999999999 109.862 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.22 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.0800000000000001 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.7 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 0.26000000000000001 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.17999999999999999 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.14000000000000001 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.17000000000000001 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 0.20000000000000001 110.708 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.1499999999999999 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.1899999999999999 110.417 -178.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.0499999999999998 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.14999999999999999 108.917 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.1499999999999999 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.14999999999999999 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 0.13 110.038 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 0.17999999999999999 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.03 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.89 21.51 4.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 0.34999999999999998 110.597 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 1.1799999999999999 109.311 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 15.5 mtt-85 -140.71 79.86 1.72 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.04 133.68 49.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.871 . . . . 0.0 108.671 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.651 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.651 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.615 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t -91.73 12.46 21.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.449 ' ND1' ' OXT' ' B' ' 13' ' ' GLY . 39.3 t-80 -161.54 -70.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.398 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.449 ' OXT' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.597 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.441 -0.578 . . . . 2.8900000000000001 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 3' ' ' LYS . 70.1 t -94.77 166.99 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.23 -0.919 . . . . 0.29999999999999999 109.555 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 1.97 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 0.97999999999999998 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 0.19 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.23000000000000001 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 1.8999999999999999 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 0.25 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.20000000000000001 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.20999999999999999 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 2.4700000000000002 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1000000000000001 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 0.20000000000000001 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.62 109.433 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 0.29999999999999999 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 0.23999999999999999 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.28000000000000003 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 1.8999999999999999 108.809 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 0.17000000000000001 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 0.12 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 0.089999999999999997 108.655 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 0.17000000000000001 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.95999999999999996 109.176 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.23999999999999999 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.03 109.235 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 0.26000000000000001 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.32000000000000001 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.549 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.44 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.32000000000000001 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.35999999999999999 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.44 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81000000000000005 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 1.9199999999999999 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.1299999999999999 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 0.28000000000000003 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 1.6200000000000001 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.25 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.29999999999999999 109.071 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.13 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.40999999999999998 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 0.96999999999999997 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 0.5 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.51000000000000001 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.1600000000000001 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.23999999999999999 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.34000000000000002 109.487 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 0.12 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 0.17000000000000001 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 0.12 108.639 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.3100000000000001 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 0.14000000000000001 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.0800000000000001 108.209 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 74' ' ' THR . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.27000000000000002 110.35 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.549 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.1100000000000001 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.1200000000000001 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 0.17000000000000001 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.2200000000000002 110.197 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.1100000000000001 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.19 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 0.22 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.29 109.395 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.33000000000000002 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.3399999999999999 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.3999999999999999 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.22 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.56 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.22 108.8 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.20000000000000001 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 0.17999999999999999 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.14999999999999999 109.169 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.03 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.11 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.17000000000000001 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 1.48 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 1.6699999999999999 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.22 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.0800000000000001 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 1.7 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 0.26000000000000001 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.17999999999999999 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.14000000000000001 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.17000000000000001 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.13 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 0.20000000000000001 110.279 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.1499999999999999 108.484 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.1899999999999999 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.0499999999999998 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 0.14999999999999999 108.752 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.1499999999999999 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 0.14999999999999999 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 0.13 110.385 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.17999999999999999 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.03 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.19 19.25 7.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 0.34999999999999998 110.795 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.061 . . . . 1.1799999999999999 109.361 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.408 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -169.2 94.48 0.31 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 -102.49 171.77 7.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.629 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t -93.57 -6.4 46.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -163.61 133.12 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.393 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.327 0.584 . . . . 2.8900000000000001 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 3' ' ' LYS . 97.3 t -94.79 164.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.29999999999999999 109.511 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 0.97999999999999998 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.19 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.23000000000000001 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 1.8999999999999999 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.25 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.20000000000000001 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.20999999999999999 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 2.4700000000000002 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1000000000000001 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.20000000000000001 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.62 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.0900000000000001 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.29999999999999999 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 0.23999999999999999 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.28000000000000003 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 1.8999999999999999 108.996 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 0.17000000000000001 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 0.12 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 0.089999999999999997 108.8 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 0.17000000000000001 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.95999999999999996 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.23999999999999999 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.03 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.26000000000000001 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.32000000000000001 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.44 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.32000000000000001 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.35999999999999999 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.44 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81000000000000005 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 1.9199999999999999 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.1299999999999999 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 0.28000000000000003 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 1.6200000000000001 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.25 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.29999999999999999 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.13 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.40999999999999998 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' SER . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 0.96999999999999997 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 0.5 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.51000000000000001 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.1600000000000001 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.23999999999999999 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.34000000000000002 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 0.12 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.17000000000000001 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 0.12 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.3100000000000001 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 0.14000000000000001 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.0800000000000001 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 74' ' ' THR . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.39 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.1100000000000001 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 0.17000000000000001 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB3' HH12 ' B' ' 4' ' ' ARG . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.2200000000000002 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 0.19 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.22 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.29 109.143 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2000000000000002 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.33000000000000002 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.3399999999999999 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.3999999999999999 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 0.22 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.22 108.293 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.20000000000000001 110.105 -1.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 0.17999999999999999 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.14999999999999999 109.052 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.03 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.11 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.17000000000000001 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 1.48 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 1.6699999999999999 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.22 110.183 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.0800000000000001 109.996 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 1.7 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 0.26000000000000001 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.17999999999999999 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.14000000000000001 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.17000000000000001 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.13 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 0.20000000000000001 110.712 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.1499999999999999 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.1899999999999999 110.595 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.0499999999999998 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 0.14999999999999999 108.82 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.1499999999999999 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.14999999999999999 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.13 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 0.17999999999999999 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.03 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 22' ' ' LEU . 20.6 mt -93.63 13.21 22.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.34999999999999998 110.587 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.493 1.722 0 O-C-N 120.878 -1.139 . . . . 1.1799999999999999 109.296 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 29.5 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 4.4 mtt-85 -123.73 46.71 2.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 -103.61 155.51 18.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.873 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.431 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t -85.11 -7.56 59.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.621 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 10.2 t-160 51.56 -127.67 2.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.621 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.056 -1.413 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.406 -0.59 . . . . 2.8900000000000001 109.406 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.4 t -94.76 161.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.191 -0.943 . . . . 0.29999999999999999 109.654 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 1.97 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.97999999999999998 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 0.19 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.23000000000000001 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 1.8999999999999999 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.25 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.20000000000000001 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.20999999999999999 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 2.4700000000000002 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1000000000000001 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.20000000000000001 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.62 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.0900000000000001 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.29999999999999999 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.23999999999999999 109.684 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.28000000000000003 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 1.8999999999999999 108.718 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 0.17000000000000001 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 0.12 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 0.089999999999999997 108.82 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 0.17000000000000001 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.95999999999999996 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.23999999999999999 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.03 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 0.26000000000000001 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.32000000000000001 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.44 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.32000000000000001 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.35999999999999999 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.44 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81000000000000005 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 1.9199999999999999 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.1299999999999999 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 38' ' ' ILE . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 0.28000000000000003 111.085 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 1.6200000000000001 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.25 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.29999999999999999 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.13 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.40999999999999998 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 0.96999999999999997 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 0.5 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.51000000000000001 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.1600000000000001 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.23999999999999999 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.17000000000000001 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 109.248 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 0.12 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 0.12 108.984 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.3100000000000001 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 0.14000000000000001 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.0800000000000001 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.566 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.1100000000000001 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.1200000000000001 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 0.17000000000000001 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.2200000000000002 109.995 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.1100000000000001 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 0.19 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 0.22 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.29 108.915 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 0.33000000000000002 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.3399999999999999 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.28000000000000003 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.3999999999999999 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 0.22 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.701 HG23 ' CE2' ' B' ' 5' ' ' TYR . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.22 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.20000000000000001 110.364 -2.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 0.17999999999999999 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.14999999999999999 108.601 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.11 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.17000000000000001 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 1.48 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 1.6699999999999999 109.541 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.22 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.0800000000000001 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.7 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.26000000000000001 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.17999999999999999 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.14000000000000001 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.17000000000000001 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.13 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.527 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 0.20000000000000001 110.162 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.1499999999999999 108.052 178.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.1899999999999999 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.0499999999999998 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 77' ' ' PHE . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.14999999999999999 108.69 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.1499999999999999 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 0.14999999999999999 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 0.13 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.17999999999999999 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.03 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -91.15 21.18 4.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.34999999999999998 110.476 -178.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 1.1799999999999999 109.132 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.5 t80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 29.9 mtm180 -154.1 69.06 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 108.812 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 -103.6 156.12 18.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.554 -0.716 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.701 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t -86.96 -33.46 19.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -55.83 140.72 41.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.636 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.999 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 2.8900000000000001 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.4 t -94.42 166.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.29999999999999999 108.898 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 1.97 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.97999999999999998 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 0.19 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.23000000000000001 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 1.8999999999999999 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.25 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.20000000000000001 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.20999999999999999 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 2.4700000000000002 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1000000000000001 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 0.20000000000000001 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.62 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.0900000000000001 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.29999999999999999 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.23999999999999999 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.28000000000000003 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 109' ' ' HOH . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 1.8999999999999999 109.135 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 0.17000000000000001 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.594 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 0.12 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 0.089999999999999997 108.879 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 0.17000000000000001 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.95999999999999996 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.23999999999999999 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.03 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 0.26000000000000001 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 0.32000000000000001 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.44 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.32000000000000001 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.35999999999999999 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.44 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81000000000000005 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 1.9199999999999999 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.1299999999999999 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.606 ' O ' HG22 ' A' ' 38' ' ' ILE . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 0.28000000000000003 111.198 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 1.6200000000000001 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.25 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.29999999999999999 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.13 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.40999999999999998 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 0.96999999999999997 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.5 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.51000000000000001 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.1600000000000001 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.23999999999999999 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.17000000000000001 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.34000000000000002 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 0.12 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 0.17000000000000001 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 0.12 109.07 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.3100000000000001 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 0.14000000000000001 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.0800000000000001 107.568 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 0.27000000000000002 110.814 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.1200000000000001 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 0.17000000000000001 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.2200000000000002 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.1100000000000001 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.19 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.22 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.29 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2000000000000002 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.3399999999999999 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.28000000000000003 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.3999999999999999 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 0.22 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.702 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.22 108.899 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.20000000000000001 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 0.17999999999999999 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.14999999999999999 108.75 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.11 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.17000000000000001 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 1.48 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 1.6699999999999999 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.22 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.0800000000000001 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 1.7 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 0.26000000000000001 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.17999999999999999 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.14000000000000001 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.17000000000000001 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.496 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 0.20000000000000001 110.298 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.1899999999999999 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.0499999999999998 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 0.14999999999999999 108.902 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.1499999999999999 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.14999999999999999 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 0.13 110.205 -178.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 0.17999999999999999 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.03 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt -90.71 21.92 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 0.34999999999999998 110.676 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.867 -1.146 . . . . 1.1799999999999999 109.462 179.594 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 17.0 mmt180 -121.13 60.34 0.92 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -105.89 152.64 23.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.702 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.604 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t -84.01 -31.92 25.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -98.86 -163.38 1.03 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.29 -0.881 . . . . 0.0 109.379 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.371 -0.603 . . . . 2.8900000000000001 109.371 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 3' ' ' LYS . 61.6 t -94.73 157.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.29999999999999999 109.641 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 1.97 109.24 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 0.97999999999999998 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 0.19 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.23000000000000001 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 1.8999999999999999 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.25 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.20000000000000001 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.20999999999999999 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 2.4700000000000002 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1000000000000001 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 0.20000000000000001 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 0.62 109.235 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.29999999999999999 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.28000000000000003 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' HOH . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 1.8999999999999999 109.094 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 0.17000000000000001 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 0.12 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 0.089999999999999997 108.733 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 0.17000000000000001 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.95999999999999996 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.23999999999999999 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.03 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 0.26000000000000001 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 0.32000000000000001 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.577 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.44 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.32000000000000001 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.35999999999999999 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.44 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 1.9199999999999999 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.1299999999999999 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 0.28000000000000003 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 1.6200000000000001 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.25 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.29999999999999999 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.13 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.40999999999999998 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.96999999999999997 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.5 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.51000000000000001 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.1600000000000001 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.23999999999999999 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.17000000000000001 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.34000000000000002 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 0.12 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.17000000000000001 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 0.12 108.704 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.3100000000000001 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 0.14000000000000001 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.0800000000000001 108.354 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 108' ' ' HOH . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 0.27000000000000002 110.752 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.577 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.1100000000000001 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.1200000000000001 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 0.17000000000000001 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.2200000000000002 109.961 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 0.19 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.22 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.29 109.526 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2000000000000002 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.33000000000000002 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.3399999999999999 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.28000000000000003 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.3999999999999999 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 0.22 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.689 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.22 108.693 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.20000000000000001 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 0.17999999999999999 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.14999999999999999 109.128 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.11 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.17000000000000001 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 1.48 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 1.6699999999999999 109.168 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.22 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.0800000000000001 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 1.7 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 0.26000000000000001 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.17999999999999999 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.14000000000000001 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.17000000000000001 108.759 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.13 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 0.20000000000000001 110.285 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.1499999999999999 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.1899999999999999 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.0499999999999998 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 0.14999999999999999 108.663 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.1499999999999999 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.14999999999999999 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.13 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.17999999999999999 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.03 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -93.22 19.5 8.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 0.34999999999999998 110.283 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.978 -1.076 . . . . 1.1799999999999999 109.221 179.607 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 94.98 4.2 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.978 -1.076 . . . . 0.0 108.681 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 32.0 m-85 -99.09 164.87 11.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.458 -0.776 . . . . 0.0 109.906 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t -83.22 -45.66 13.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 33.3 t-80 -90.51 -176.57 4.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.63 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 118.065 -1.408 . . . . 0.0 109.664 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 2.8900000000000001 109.501 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 3' ' ' LYS . 86.1 t -94.36 159.97 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.29999999999999999 109.1 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 1.97 109.42 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.97999999999999998 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 0.19 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.23000000000000001 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 1.8999999999999999 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 0.25 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.20000000000000001 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.20999999999999999 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 2.4700000000000002 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.20000000000000001 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.62 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.0900000000000001 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.29999999999999999 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.23999999999999999 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.28000000000000003 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 1.8999999999999999 109.158 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 0.17000000000000001 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 0.12 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 0.089999999999999997 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 0.17000000000000001 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.95999999999999996 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.23999999999999999 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.03 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.26000000000000001 108.756 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 0.32000000000000001 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.44 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.32000000000000001 109.658 -179.036 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.35999999999999999 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.44 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81000000000000005 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 1.9199999999999999 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.1299999999999999 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 0.28000000000000003 111.174 -177.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 1.6200000000000001 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.25 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.29999999999999999 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.13 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.40999999999999998 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 0.96999999999999997 110.118 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 0.5 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.51000000000000001 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.1600000000000001 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.23999999999999999 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.17000000000000001 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.34000000000000002 109.362 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 0.12 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 0.17000000000000001 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 0.12 108.829 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.3100000000000001 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 27' ' ' PHE . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.14000000000000001 110.398 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.0800000000000001 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.27000000000000002 111.421 -177.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.1100000000000001 111.265 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.1200000000000001 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 0.17000000000000001 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.2200000000000002 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.1100000000000001 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.19 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 0.22 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.29 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2000000000000002 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.33000000000000002 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.3399999999999999 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.3999999999999999 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 0.22 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.538 HG23 ' CE2' ' B' ' 5' ' ' TYR . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.22 109.12 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.20000000000000001 110.074 -1.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 0.17999999999999999 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.14999999999999999 108.799 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.11 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.17000000000000001 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 1.48 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 1.6699999999999999 109.989 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.22 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.0800000000000001 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 1.7 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 0.26000000000000001 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.17999999999999999 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.14000000000000001 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.17000000000000001 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.13 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.534 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 0.20000000000000001 110.235 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.1499999999999999 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.1899999999999999 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.0499999999999998 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 77' ' ' PHE . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 0.14999999999999999 108.211 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.1499999999999999 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.14999999999999999 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.13 110.428 -178.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.17999999999999999 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.03 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.68 22.03 3.74 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 0.34999999999999998 110.351 -178.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.019 -1.051 . . . . 1.1799999999999999 109.078 179.323 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -147.52 76.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.302 -0.874 . . . . 0.0 108.926 -179.891 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -110.17 148.7 31.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.901 -1.125 . . . . 0.0 109.753 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t -80.55 -25.94 38.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -168.11 96.64 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.848 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.386 -0.598 . . . . 2.8900000000000001 109.386 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 26.7 t -95.46 171.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.29999999999999999 109.609 -179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 1.97 108.925 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.97999999999999998 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 0.19 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.23000000000000001 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 1.8999999999999999 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 0.25 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.777 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.20999999999999999 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 2.4700000000000002 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1000000000000001 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.20000000000000001 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.62 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.0900000000000001 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.29999999999999999 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.28000000000000003 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 1.8999999999999999 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 0.17000000000000001 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.12 109.35 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 0.089999999999999997 108.549 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 0.17000000000000001 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.95999999999999996 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.23999999999999999 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.03 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 0.26000000000000001 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.32000000000000001 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.44 110.114 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.32000000000000001 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.35999999999999999 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.44 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81000000000000005 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 1.9199999999999999 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.1299999999999999 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 38' ' ' ILE . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.28000000000000003 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 1.6200000000000001 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.25 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.29999999999999999 109.513 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.13 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.40999999999999998 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 0.96999999999999997 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 0.5 109.586 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.51000000000000001 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.1600000000000001 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.23999999999999999 109.52 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.17000000000000001 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.34000000000000002 109.573 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 0.12 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 0.17000000000000001 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.12 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.3100000000000001 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.14000000000000001 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.0800000000000001 108.086 178.173 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.1100000000000001 110.68 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.1200000000000001 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 0.17000000000000001 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.2200000000000002 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.1100000000000001 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.19 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 0.22 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.29 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 0.33000000000000002 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.3399999999999999 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 0.28000000000000003 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.3999999999999999 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.22 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.773 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.22 108.795 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.20000000000000001 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 0.17999999999999999 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CD1' HD21 ' A' ' 97' ' ' LEU . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.14999999999999999 108.553 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.03 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 24' ' ' VAL . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.11 109.712 -177.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.17000000000000001 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 1.48 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.22 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.0800000000000001 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 1.7 109.335 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 0.26000000000000001 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.17999999999999999 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.14000000000000001 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.17000000000000001 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.13 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 0.20000000000000001 110.703 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.1499999999999999 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.1899999999999999 111.003 -178.317 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.0499999999999998 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.48 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.14999999999999999 109.018 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.1499999999999999 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.14999999999999999 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.13 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 0.17999999999999999 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 105' ' ' VAL . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.03 109.401 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -91.82 18.95 7.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.34999999999999998 110.431 -178.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.4 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 1.1799999999999999 109.392 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 13.5 p90 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.5 mtt180 -145.58 56.19 1.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -108.69 144.02 37.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.503 -0.748 . . . . 0.0 109.204 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.635 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.773 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.612 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t -90.18 -38.23 13.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.404 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 2.2 t60 -46.79 155.5 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 109.739 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.404 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.504 -0.554 . . . . 2.8900000000000001 109.504 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 3' ' ' LYS . 88.0 t -94.44 164.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.29999999999999999 109.166 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 1.97 109.254 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 0.97999999999999998 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 0.19 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.23000000000000001 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 1.8999999999999999 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.25 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.20000000000000001 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.20999999999999999 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 2.4700000000000002 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1000000000000001 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 0.20000000000000001 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 0.62 110.003 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.0900000000000001 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.29999999999999999 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.23999999999999999 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 1.8999999999999999 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 0.17000000000000001 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.626 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 0.12 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 0.089999999999999997 108.637 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 0.17000000000000001 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.95999999999999996 109.422 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.23999999999999999 107.973 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.03 109.994 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.26000000000000001 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 0.32000000000000001 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.44 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.32000000000000001 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.35999999999999999 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.44 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81000000000000005 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 1.9199999999999999 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.1299999999999999 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 1.6200000000000001 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.25 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.29999999999999999 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.13 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.40999999999999998 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.96999999999999997 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 0.5 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.456 ' N ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.51000000000000001 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.1600000000000001 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.23999999999999999 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.17000000000000001 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.34000000000000002 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 0.12 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 0.17000000000000001 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 0.12 108.994 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.3100000000000001 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 0.14000000000000001 110.396 -178.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.0800000000000001 108.118 178.407 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 59' ' ' VAL . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 0.27000000000000002 111.768 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.1100000000000001 110.678 -179.279 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB2' HH11 ' B' ' 2' ' ' ARG . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.1200000000000001 109.118 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 0.17000000000000001 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.2200000000000002 110.362 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.1100000000000001 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 65' ' ' VAL . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 0.19 108.746 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 0.22 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.29 109.409 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2000000000000002 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 0.33000000000000002 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.3399999999999999 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.28000000000000003 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.3999999999999999 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 0.22 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.22 108.73 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.20000000000000001 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 0.17999999999999999 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.14999999999999999 109.242 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD2' HG22 ' A' ' 24' ' ' VAL . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.11 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.17000000000000001 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 1.48 107.539 -179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 1.6699999999999999 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.22 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.0800000000000001 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.488 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 1.7 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 0.26000000000000001 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.17999999999999999 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.14000000000000001 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.17000000000000001 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 0.20000000000000001 110.505 -179.371 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.1499999999999999 108.235 178.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.1899999999999999 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.0499999999999998 110.01 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 77' ' ' PHE . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 0.14999999999999999 108.517 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.1499999999999999 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 0.14999999999999999 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.13 110.145 -179.071 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 0.17999999999999999 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.03 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt -92.07 18.88 7.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 0.34999999999999998 110.384 -178.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 1.1799999999999999 109.302 179.51 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 26.6 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 40.6 mtm180 -150.87 72.17 1.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.199 -0.938 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 -123.39 158.79 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.528 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -92.13 -50.15 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -92.68 158.59 15.85 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.54 179.864 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 2.8900000000000001 109.372 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 67.6 t -94.93 162.34 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.29999999999999999 109.988 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 1.97 108.754 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 0.97999999999999998 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 0.19 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 1.8999999999999999 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.25 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.20000000000000001 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.20999999999999999 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 2.4700000000000002 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1000000000000001 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 0.20000000000000001 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.62 109.915 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.0900000000000001 109.664 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.29999999999999999 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.23999999999999999 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.28000000000000003 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 1.8999999999999999 109.084 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 0.12 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 79' ' ' PHE . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 0.089999999999999997 108.755 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 0.17000000000000001 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.95999999999999996 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.23999999999999999 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.03 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.26000000000000001 108.719 179.349 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.32000000000000001 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.44 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.32000000000000001 109.717 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.35999999999999999 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.44 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81000000000000005 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 1.9199999999999999 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.1299999999999999 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.68 ' O ' HG22 ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 0.28000000000000003 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 1.6200000000000001 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.25 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.29999999999999999 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.13 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.40999999999999998 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.96999999999999997 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 0.5 109.524 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.51000000000000001 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.1600000000000001 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.23999999999999999 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.17000000000000001 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.34000000000000002 109.429 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 0.12 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 0.17000000000000001 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 0.12 108.563 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.3100000000000001 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.14000000000000001 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.0800000000000001 108.218 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.402 HG11 ' OH ' ' B' ' 5' ' ' TYR . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 111.211 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.1100000000000001 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.1200000000000001 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 0.17000000000000001 108.502 179.035 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB3' HH12 ' B' ' 4' ' ' ARG . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.2200000000000002 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 0.19 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.22 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.29 109.426 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2000000000000002 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 0.33000000000000002 109.584 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.3399999999999999 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.28000000000000003 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.3999999999999999 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 0.22 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.22 108.567 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.20000000000000001 110.212 -1.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.17999999999999999 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.14999999999999999 109.1 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 69' ' ' ALA . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 24' ' ' VAL . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.11 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.17000000000000001 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 1.48 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 1.6699999999999999 109.495 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.22 110.471 179.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.0800000000000001 110.188 -179.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 1.7 109.242 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 0.26000000000000001 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.17999999999999999 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.555 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.14000000000000001 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.17000000000000001 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.13 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.305 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.1499999999999999 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.517 ' NZ ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.1899999999999999 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.0499999999999998 109.595 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 0.14999999999999999 108.46 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.1499999999999999 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 0.14999999999999999 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.418 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.13 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.17999999999999999 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.03 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.458 ' HB2' HD11 ' A' ' 22' ' ' LEU . 54.1 mt -92.41 19.67 6.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.34999999999999998 110.425 -178.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 1.1799999999999999 109.284 179.506 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 54.4 mtp180 -135.3 67.23 1.49 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 -118.77 156.03 30.09 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.477 -0.765 . . . . 0.0 109.005 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.605 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.9 -14.76 33.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 15.3 t-80 -146.83 140.02 25.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.145 -0.972 . . . . 0.0 109.533 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.402 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.356 -0.609 . . . . 2.8900000000000001 109.356 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.6 t -94.49 167.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.29999999999999999 109.304 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 1.97 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.97999999999999998 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 0.19 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.23000000000000001 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 1.8999999999999999 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 0.25 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.20000000000000001 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.20999999999999999 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 2.4700000000000002 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1000000000000001 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 0.20000000000000001 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 0.62 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.0900000000000001 109.073 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 0.23999999999999999 109.769 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.28000000000000003 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 1.8999999999999999 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 0.17000000000000001 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 0.12 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 0.089999999999999997 108.676 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 0.17000000000000001 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.95999999999999996 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.23999999999999999 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.03 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 0.26000000000000001 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.32000000000000001 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.44 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.32000000000000001 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.35999999999999999 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.44 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81000000000000005 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 1.9199999999999999 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.1299999999999999 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 38' ' ' ILE . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 0.28000000000000003 110.526 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 1.6200000000000001 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.25 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.29999999999999999 109.315 179.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.13 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.40999999999999998 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 0.96999999999999997 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 0.5 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.51000000000000001 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.1600000000000001 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.23999999999999999 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.17000000000000001 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.471 ' OD1' ' NZ ' ' A' ' 21' ' ' LYS . 26.5 t-20 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.34000000000000002 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 0.12 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 0.17000000000000001 109.466 -179.167 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.12 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.3100000000000001 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 0.14000000000000001 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.0800000000000001 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 74' ' ' THR . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.906 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.1100000000000001 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.1200000000000001 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 0.17000000000000001 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.2200000000000002 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 109.282 -179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG23 ' OD2' ' A' ' 64' ' ' ASP . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 0.19 108.788 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.22 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2000000000000002 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 0.33000000000000002 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.3399999999999999 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.28000000000000003 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.3999999999999999 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 0.22 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.628 HG23 ' CE2' ' B' ' 5' ' ' TYR . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.22 109.406 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.20000000000000001 109.76 -2.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 0.17999999999999999 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.14999999999999999 109.416 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.03 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.11 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.17000000000000001 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 1.6699999999999999 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.22 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.0800000000000001 110.229 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 1.7 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 0.26000000000000001 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.17999999999999999 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.14000000000000001 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.17000000000000001 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.13 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 0.20000000000000001 110.872 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.1499999999999999 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.1899999999999999 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.0499999999999998 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.14999999999999999 109.142 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.1499999999999999 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.14999999999999999 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 0.13 110.35 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.17999999999999999 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.03 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.25 20.05 6.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 0.34999999999999998 110.841 -178.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.889 -1.132 . . . . 1.1799999999999999 109.361 179.821 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.672 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -132.39 76.23 1.68 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.145 179.479 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 -130.31 143.67 50.91 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.628 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.593 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t -84.15 -43.43 14.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.436 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 31.0 t60 -58.57 169.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.372 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.564 -0.532 . . . . 2.8900000000000001 109.564 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 3' ' ' LYS . 35.7 t -94.42 169.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -0.914 . . . . 0.29999999999999999 109.116 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 1.97 109.443 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 0.97999999999999998 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 0.19 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.23000000000000001 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 1.8999999999999999 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 0.25 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.20000000000000001 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.20999999999999999 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 2.4700000000000002 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1000000000000001 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.20000000000000001 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 0.62 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.29999999999999999 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.23999999999999999 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.28000000000000003 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 1.8999999999999999 109.274 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 0.17000000000000001 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.12 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 0.089999999999999997 108.732 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 0.17000000000000001 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.95999999999999996 109.398 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.23999999999999999 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.03 109.813 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 0.26000000000000001 108.448 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 0.32000000000000001 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.44 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.32000000000000001 110.052 -178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.35999999999999999 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.44 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81000000000000005 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 1.9199999999999999 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.1299999999999999 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.467 HD12 ' HG3' ' A' ' 75' ' ' PRO . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 0.28000000000000003 110.188 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 1.6200000000000001 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.25 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.29999999999999999 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.13 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.40999999999999998 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 0.96999999999999997 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 0.5 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.51000000000000001 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.1600000000000001 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.23999999999999999 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.17000000000000001 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.34000000000000002 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 0.12 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.17000000000000001 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 0.12 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.3100000000000001 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 0.14000000000000001 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.0800000000000001 107.961 178.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.27000000000000002 111.38 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.1100000000000001 111.01 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.1200000000000001 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 0.17000000000000001 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.2200000000000002 110.097 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.1100000000000001 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 0.19 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 0.22 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.29 109.387 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.33000000000000002 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.3399999999999999 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 0.28000000000000003 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.3999999999999999 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 0.22 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.22 108.757 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.20000000000000001 110.023 -1.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 0.17999999999999999 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.781 ' CD1' HD21 ' A' ' 97' ' ' LEU . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.14999999999999999 109.116 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.03 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.11 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.17000000000000001 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 1.48 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 1.6699999999999999 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.22 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.0800000000000001 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 1.7 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 0.26000000000000001 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.17999999999999999 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.14000000000000001 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.17000000000000001 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.13 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 0.20000000000000001 110.54 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.1499999999999999 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.1899999999999999 110.523 -178.637 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.0499999999999998 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 0.14999999999999999 108.587 -179.864 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.1499999999999999 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 0.14999999999999999 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 0.13 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 0.17999999999999999 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.03 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 22' ' ' LEU . 14.3 mt -91.37 15.62 11.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.34999999999999998 110.625 -178.587 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.301 -1.5 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.301 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.556 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 73.8 mtt180 -157.39 60.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.85 . . . . 0.0 109.162 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 -98.28 161.92 13.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.102 -0.999 . . . . 0.0 109.183 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.629 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t -86.0 -23.4 26.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -68.09 161.2 27.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.468 -0.568 . . . . 2.8900000000000001 109.468 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 3' ' ' LYS . 14.4 t -94.5 166.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.29999999999999999 109.219 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 1.97 109.464 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 0.97999999999999998 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 0.19 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.23000000000000001 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 1.8999999999999999 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 0.25 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.20000000000000001 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.20999999999999999 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 2.4700000000000002 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1000000000000001 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 0.62 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.0900000000000001 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.29999999999999999 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.23999999999999999 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.28000000000000003 109.405 -179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 1.8999999999999999 108.752 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 0.17000000000000001 108.588 -179.35 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.434 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 0.12 109.465 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 0.089999999999999997 108.795 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 0.17000000000000001 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.95999999999999996 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' THR . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.23999999999999999 108.091 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.03 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 0.26000000000000001 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 0.32000000000000001 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.44 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.32000000000000001 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.35999999999999999 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.44 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81000000000000005 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 1.9199999999999999 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.1299999999999999 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 38' ' ' ILE . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 111.261 -178.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 1.6200000000000001 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.25 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.29999999999999999 109.453 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.13 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.40999999999999998 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 0.96999999999999997 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.5 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.51000000000000001 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.1600000000000001 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.23999999999999999 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.17000000000000001 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.42 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.34000000000000002 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 0.12 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 0.17000000000000001 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.528 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.528 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 0.12 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' CG ' HH21 ' B' ' 2' ' ' ARG . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.0800000000000001 108.332 179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 0.27000000000000002 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.1100000000000001 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.1200000000000001 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 0.17000000000000001 108.852 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.2200000000000002 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.1100000000000001 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 0.19 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.22 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.29 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2000000000000002 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 0.33000000000000002 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.3399999999999999 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 0.28000000000000003 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.3999999999999999 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 0.22 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.553 HG23 ' HE2' ' B' ' 5' ' ' TYR . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.22 108.615 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.20000000000000001 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 0.17999999999999999 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.14999999999999999 109.151 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.03 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.11 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.17000000000000001 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 1.48 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 1.6699999999999999 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.22 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.0800000000000001 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 1.7 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 0.26000000000000001 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.17999999999999999 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.14000000000000001 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.17000000000000001 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.13 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 0.20000000000000001 110.294 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.1499999999999999 108.15 178.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.1899999999999999 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.0499999999999998 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.14999999999999999 108.777 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.1499999999999999 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 0.14999999999999999 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 0.13 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.17999999999999999 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.03 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt -91.63 20.08 5.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.832 -178.176 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.184 . . . . 1.1799999999999999 109.376 179.852 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 34.6 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.55 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 43.1 mtp180 -140.56 76.86 1.57 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.276 -0.89 . . . . 0.0 109.313 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -129.73 143.18 50.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.553 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t -83.09 -9.55 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.415 ' C ' ' ND1' ' B' ' 12' ' ' HIS . 5.2 t-80 -159.35 108.14 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.099 -1.389 . . . . 0.0 109.735 -179.931 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.6 t . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.383 -0.599 . . . . 0.3 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 2' ' ' VAL . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 1.97 109.221 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.98 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.19 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.23 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 1.9 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 0.25 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.2 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.21 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 12' ' ' GLN . 1.6 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 2.47 109.756 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 0.2 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 0.62 109.374 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.09 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 0.3 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.24 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.28 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 1.9 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 0.17 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 0.12 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 0.09 108.796 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.17 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.96 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.24 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.03 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 0.26 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 0.32 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.44 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.32 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.36 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.44 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 1.92 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.13 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 0.28 110.831 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 1.62 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.25 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.3 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.13 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.41 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 0.97 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 0.5 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.51 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.16 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.24 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.17 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.34 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 0.12 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 0.17 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.519 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 0.12 108.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.31 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 0.14 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.08 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 0.27 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.11 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.12 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 0.17 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.22 110.207 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.11 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 0.19 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.22 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.29 109.244 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.33 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.34 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.28 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.4 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 0.22 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.673 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.22 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.2 110.286 -1.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 0.18 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.15 108.868 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.03 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.11 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.17 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 1.48 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 1.67 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.519 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.22 110.57 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.519 HE21 ' C ' ' A' ' 83' ' ' GLY . 38.4 mm-40 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.08 110.191 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 1.7 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.26 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.18 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.14 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.17 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.13 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 0.2 110.53 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.15 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.19 110.516 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.05 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 0.15 108.657 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.15 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 0.15 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.13 109.804 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.18 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.03 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 0.35 110.363 -178.64 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.645 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.626 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.626 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.254 -0.647 . . . . 0.3 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 2' ' ' VAL . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 1.97 109.157 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 0.98 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 0.19 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.23 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 1.9 109.606 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 0.25 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.2 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.21 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 2.47 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.2 109.147 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.62 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.09 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.3 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.24 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.28 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 1.9 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.17 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 0.12 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 0.09 108.683 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 0.17 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.96 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.24 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.03 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 0.26 108.547 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.32 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.57 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.44 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.32 109.481 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.36 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.44 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 1.92 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.13 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 0.28 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 1.62 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.25 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.3 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.13 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.41 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 0.97 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 0.5 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.51 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.16 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.24 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.17 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.9 t30 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.34 108.961 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 0.12 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 0.17 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.63 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 0.12 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.31 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.14 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.08 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.27 110.986 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.11 110.461 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.12 109.527 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 0.17 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.422 ' CB ' HH12 ' B' ' 4' ' ' ARG . 3.9 pp0? -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.22 109.952 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.11 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.19 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.22 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.29 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2 109.671 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 0.33 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.34 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 0.28 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.4 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 0.22 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.636 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.22 108.754 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.2 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 0.18 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.15 108.632 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.428 HE22 ' HB1' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.03 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.11 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.17 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 1.48 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 1.67 109.764 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.22 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.08 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 1.7 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 0.26 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.18 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.14 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.17 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 0.2 110.741 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.15 107.981 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.19 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.05 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.15 109.233 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.15 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 0.15 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.13 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 0.18 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.03 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 22' ' ' LEU . 18.1 mt . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 0.35 110.653 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.636 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 3' ' ' LYS . 94.7 t . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.317 0.58 . . . . 0.3 109.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.601 ' N ' HG12 ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 1.97 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 0.98 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 0.19 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.23 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 1.9 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 0.25 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.2 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.21 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 2.47 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.2 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 0.62 110.005 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.09 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.3 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 0.24 109.418 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.28 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 1.9 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 0.17 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.625 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 0.12 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 0.09 108.565 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 0.17 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.96 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.24 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.03 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 0.26 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 0.32 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.553 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.44 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.32 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.36 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.44 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 1.92 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.13 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 75' ' ' PRO . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 0.28 110.244 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 1.62 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.25 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.3 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.13 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.41 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 0.97 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 0.5 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.51 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.16 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.24 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.17 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.5 t30 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.34 109.402 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 0.17 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 0.12 109.065 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.31 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 0.14 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.08 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.27 111.316 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.553 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.11 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.12 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 0.17 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.22 110.681 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.11 109.351 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 0.19 108.685 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.22 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.29 109.316 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.33 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.34 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.28 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.4 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 0.22 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.683 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.22 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.2 109.991 -1.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 0.18 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.15 108.999 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.03 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.11 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 1.48 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 1.67 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' C ' ' NE2' ' A' ' 84' ' ' GLN . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.22 110.467 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.442 ' NE2' ' C ' ' A' ' 83' ' ' GLY . 40.9 mm-40 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.08 110.347 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 1.7 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 0.26 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.18 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.14 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.17 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.48 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.2 110.452 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.15 108.173 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.19 110.478 -178.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.05 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 0.15 109.309 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.15 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.15 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.13 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.18 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.03 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.35 110.49 -178.457 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.669 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t . . . . . 0 N--CA 1.496 1.84 0 CA-C-O 121.198 0.523 . . . . 0.3 109.72 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 1.97 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.98 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 0.19 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.23 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 1.9 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.25 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.2 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.21 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 2.47 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.2 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.62 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.09 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.3 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.24 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.28 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 1.9 109.181 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 0.17 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 0.12 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 0.09 108.831 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 0.17 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.96 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.24 107.941 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.03 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.26 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.32 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.444 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.44 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.32 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.36 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.44 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 1.92 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.13 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 38' ' ' ILE . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.28 110.781 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 1.62 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.25 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.3 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.13 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.41 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 0.97 109.938 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 0.5 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.51 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.16 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.24 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.17 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.34 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 0.12 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 0.17 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.518 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 0.12 108.941 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.31 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 0.14 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.08 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 74' ' ' THR . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 0.27 111.374 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.11 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.12 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 0.17 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.22 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.11 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 0.19 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.22 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.29 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 0.33 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.34 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 0.28 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.4 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 0.22 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.638 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.22 108.641 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.571 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.2 109.909 -1.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 0.18 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 97' ' ' LEU . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.15 108.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 11.0 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.03 107.403 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 24' ' ' VAL . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.11 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.17 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 1.48 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 1.67 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.22 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.08 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 1.7 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 0.26 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.18 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.14 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.17 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.13 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 0.2 110.627 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.15 107.57 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.19 110.494 -178.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.05 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 0.15 108.621 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.15 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.15 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.13 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.18 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.03 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 0.35 110.572 -178.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.502 2.158 0 CA-C-O 121.078 0.466 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.638 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.426 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.525 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 3' ' ' LYS . 87.6 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.416 -0.587 . . . . 0.3 109.416 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 1.97 109.189 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 0.98 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 0.19 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.23 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 1.9 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.25 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 0.2 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.21 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 2.47 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 0.2 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 0.62 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.09 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 0.3 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 0.24 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.28 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 1.9 109.166 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 0.17 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.663 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 0.12 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 0.09 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 0.17 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.96 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.24 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.03 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.409 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.26 108.704 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.32 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.44 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.32 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.36 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.44 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 1.92 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.13 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 0.28 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 1.62 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.25 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.3 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.13 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.41 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 0.97 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 0.5 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.51 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.16 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.24 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.17 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.8 t30 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.34 109.461 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 0.12 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.17 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 0.12 108.783 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.31 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 0.14 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.08 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.27 111.342 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 58' ' ' ASP . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.11 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.12 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 0.17 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.603 ' NE2' HH11 ' B' ' 4' ' ' ARG . 77.3 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.22 109.866 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.11 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 0.19 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 0.22 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.29 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 0.33 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.34 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.28 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.4 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 0.22 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE1' ' B' ' 5' ' ' TYR . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.22 109.148 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.2 110.137 -2.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 0.18 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.581 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.15 108.797 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.03 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.11 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.17 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 1.48 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.67 109.931 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.22 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.08 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 1.7 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.26 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.18 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.14 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.17 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.13 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.2 110.332 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.15 108.399 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HZ2' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.19 109.863 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.05 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.581 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 0.15 108.454 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.15 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 0.15 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.13 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 0.18 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.03 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 0.35 110.568 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.603 HH11 ' NE2' ' A' ' 63' ' ' GLN . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.596 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.2 t . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.379 0.609 . . . . 0.3 109.696 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.612 ' N ' HG12 ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 1.97 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 0.98 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 0.19 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.23 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 1.9 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.25 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.2 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.21 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.47 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 0.2 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.62 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.09 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.3 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.24 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.28 109.638 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 1.9 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 0.17 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.695 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 0.12 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.09 108.402 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 0.17 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.96 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.24 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.03 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.26 108.677 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.32 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.44 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.32 109.626 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.36 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.44 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 1.92 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.13 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 0.28 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 1.62 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.25 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.3 108.814 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.13 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.41 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 0.97 109.576 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.5 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.51 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.16 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.24 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.17 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.34 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 0.12 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 0.17 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 0.12 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.31 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 0.14 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.08 108.06 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG11 ' OH ' ' B' ' 5' ' ' TYR . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.27 111.38 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.507 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.11 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.12 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 0.17 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.22 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.11 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 0.19 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 0.22 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.29 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 0.33 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.34 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 0.28 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.4 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 0.22 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.575 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.22 108.818 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.2 110.204 -1.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 0.18 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.15 108.857 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.03 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.11 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.17 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 1.48 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 1.67 109.759 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.08 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 1.7 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 0.26 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.18 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.14 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.17 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.13 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 0.2 110.459 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.15 107.889 178.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.19 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.05 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 77' ' ' PHE . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 0.15 109.009 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.15 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.15 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 0.13 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.18 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.03 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 0.35 111.117 -177.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.575 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.583 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 3' ' ' LYS . 42.0 t . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.299 0.571 . . . . 0.3 109.483 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 2' ' ' VAL . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 1.97 109.125 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 0.98 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 0.19 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.23 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 1.9 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.25 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.2 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.21 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 2.47 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 0.2 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 0.62 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.09 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.3 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.24 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.28 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 1.9 109.505 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 0.17 108.137 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 0.12 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 0.09 108.705 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 0.17 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.96 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.24 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.03 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 0.26 108.589 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.32 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.44 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.32 109.82 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.36 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.44 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 1.92 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.13 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 38' ' ' ILE . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 0.28 111.082 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 1.62 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.25 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.3 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.13 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.41 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 0.97 110.562 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 0.5 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.51 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.16 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.24 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.17 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 7.2 t30 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.34 109.852 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 0.12 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.17 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 0.12 108.989 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.31 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 0.14 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.08 108.286 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.27 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.11 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.12 109.409 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 0.17 108.6 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.22 109.958 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.11 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 0.19 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 0.22 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.29 109.549 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 0.33 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.34 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 0.28 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.4 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 0.22 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.22 108.855 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.2 110.008 -1.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 0.18 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.15 108.873 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.03 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' HG22 ' A' ' 24' ' ' VAL . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.11 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.17 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 1.48 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 1.67 109.643 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.22 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.08 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 1.7 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 0.26 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.18 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.14 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.17 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 0.2 110.297 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.15 107.971 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.19 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.05 109.625 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 0.15 108.827 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.15 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.15 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 0.13 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.18 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.03 109.582 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.35 110.348 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.57 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.272 -0.64 . . . . 0.3 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 1.97 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.98 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 0.19 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.23 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 1.9 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.25 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 0.2 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.21 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 2.47 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.2 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.62 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.09 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.3 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.24 109.576 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.28 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 1.9 109.16 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 0.17 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 0.12 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 0.09 108.875 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 0.17 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.96 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 74' ' ' THR . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.24 107.961 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.03 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 0.26 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.32 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.492 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.44 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.32 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.36 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.44 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 1.92 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.13 110.778 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 0.28 110.9 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 1.62 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.25 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.3 109.506 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.13 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.41 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 46' ' ' SER . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.97 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.5 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.51 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.16 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.24 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.17 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.1 t30 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.34 109.817 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 0.12 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 0.17 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 0.12 108.934 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.31 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 0.14 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.08 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 0.27 111.156 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.11 110.481 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.12 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 0.17 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.22 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.11 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.19 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.22 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.29 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 0.33 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.34 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.28 109.137 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.4 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 0.22 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.22 109.019 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.2 109.818 -1.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 0.18 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.15 108.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.03 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 24' ' ' VAL . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.11 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.17 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 1.48 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 1.67 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.22 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.08 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 1.7 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 0.26 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.18 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.14 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.17 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.13 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.542 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.2 110.555 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.15 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.19 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.05 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.15 108.651 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.15 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 0.15 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 0.13 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.18 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.03 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 0.35 110.24 -178.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.4 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.3 -0.63 . . . . 0.3 109.3 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 1.97 109.048 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 0.98 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 0.19 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.23 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 1.9 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.25 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.2 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.21 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 2.47 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.2 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.62 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.09 109.713 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.3 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.24 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.28 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 1.9 108.854 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 0.17 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 0.12 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 0.09 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 0.17 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.96 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.24 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.03 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.26 108.336 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.32 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.44 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.32 109.814 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.36 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.44 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 1.92 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.13 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 0.28 111.535 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 1.62 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.25 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.3 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.13 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.41 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 0.97 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.5 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.51 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.16 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.24 109.227 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.17 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.4 t30 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.34 109.367 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 0.12 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 0.17 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.12 108.998 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.31 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.14 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.08 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.27 110.701 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.11 110.891 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.12 109.715 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 0.17 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.22 110.053 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.11 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 0.19 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.22 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.29 109.251 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 0.33 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.34 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 0.28 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.4 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 0.22 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.22 108.605 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.2 110.134 -2.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 0.18 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.15 108.687 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.03 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.11 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.17 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 1.67 109.06 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.08 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 1.7 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 0.26 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.18 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.14 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.17 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.13 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 0.2 110.282 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.15 108.415 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.19 110.702 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.05 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.15 108.904 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.15 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.15 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 0.13 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 0.18 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.03 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 0.35 110.325 -178.186 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.195 0.522 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 3' ' ' LYS . 65.4 t . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.195 -0.668 . . . . 0.3 109.195 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 2' ' ' VAL . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 1.97 109.305 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.98 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 0.19 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.23 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 1.9 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.25 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.2 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.21 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 2.47 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 0.2 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 0.62 109.371 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.09 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.3 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.24 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.28 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 1.9 108.648 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 0.17 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 0.12 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 0.09 108.737 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.17 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.96 108.959 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' THR . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.24 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.03 109.723 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.26 108.825 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.32 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.44 110.417 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32 109.941 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.36 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.44 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 1.92 110.013 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.13 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 38' ' ' ILE . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.28 110.56 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 1.62 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.25 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.3 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.13 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.41 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 0.97 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.5 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.51 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.16 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.24 109.299 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.17 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.34 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 0.12 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 0.17 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 0.12 108.901 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.31 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 0.14 110.56 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.08 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 0.27 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.11 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.12 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.22 110.146 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.11 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.19 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 0.22 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.29 109.553 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 0.33 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.34 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 0.28 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.4 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 0.22 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.558 HG23 ' HE1' ' B' ' 5' ' ' TYR . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HG3' HD12 ' A' ' 38' ' ' ILE . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.2 110.048 -1.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 0.18 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.755 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.15 109.326 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.03 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.11 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.17 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 1.67 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.22 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.08 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 1.7 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 0.26 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.18 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.14 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.17 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.13 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.2 110.186 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.15 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.19 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.05 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' A' ' 77' ' ' PHE . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 0.15 108.679 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.15 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.15 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 0.13 110.404 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 0.18 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.03 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 0.35 110.528 -178.278 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.558 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 3' ' ' LYS . 12.8 t . . . . . 0 N--CA 1.496 1.842 0 N-CA-C 109.263 -0.643 . . . . 0.3 109.263 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' H ' HG12 ' A' ' 2' ' ' VAL . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 1.97 109.087 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.98 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 0.19 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.23 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 1.9 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.25 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 0.2 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.21 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 2.47 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 0.2 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 0.62 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.09 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 0.3 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.24 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.28 109.192 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.715 ' CE ' HD11 ' A' ' 53' ' ' ILE . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 1.9 109.459 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 0.17 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.511 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 0.12 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 0.09 108.588 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 0.17 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.96 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 74' ' ' THR . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.24 107.73 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.03 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.26 108.474 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 0.32 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.44 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.32 109.907 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.36 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.44 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 1.92 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.13 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 38' ' ' ILE . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 0.28 111.559 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 1.62 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.25 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.3 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.13 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.41 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.97 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.5 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.51 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.16 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.24 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.17 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.34 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 0.12 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.715 HD11 ' CE ' ' A' ' 21' ' ' LYS . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 0.17 109.398 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.577 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 0.12 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.31 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 0.14 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.08 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' B' ' 5' ' ' TYR . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.27 111.183 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.11 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.12 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 0.17 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.509 HE21 ' NH2' ' B' ' 4' ' ' ARG . 1.4 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.22 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.11 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 0.19 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.22 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.29 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.33 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.34 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 0.28 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.4 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 0.22 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.722 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.563 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.2 110.296 -1.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 0.18 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.15 108.601 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.03 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.11 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.17 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 1.48 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 1.67 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.22 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.08 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 1.7 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 0.26 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.18 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.14 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.17 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.13 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 0.2 110.385 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.15 108.148 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.19 110.787 -178.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.05 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 77' ' ' PHE . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 0.15 108.598 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.15 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.15 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.13 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.18 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.03 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 0.35 110.376 -179.06 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.509 ' NH2' HE21 ' A' ' 63' ' ' GLN . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.722 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 3' ' ' LYS . 98.0 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.2 0.524 . . . . 0.3 109.639 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 2' ' ' VAL . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 1.97 109.427 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.98 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 0.19 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.23 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 1.9 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.25 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.2 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.21 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.47 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 0.2 109.157 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 0.62 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.09 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.3 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.24 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.28 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 1.9 108.857 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 0.17 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.12 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 0.09 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 0.17 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.96 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.24 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.03 109.715 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 0.26 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 0.32 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.44 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.32 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.36 111.7 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.44 111.461 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81 108.665 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 1.92 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.13 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' A' ' 94' ' ' LYS . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 0.28 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 1.62 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.25 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.3 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.13 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.41 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 0.97 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 0.5 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.51 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.16 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.24 109.101 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.17 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.3 t30 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.34 109.39 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.12 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 0.17 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 0.12 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.31 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 0.14 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.08 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.27 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.424 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.11 110.974 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.12 109.533 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 0.17 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.22 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.11 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.19 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.22 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.29 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 0.33 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.34 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.28 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.4 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.22 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.694 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.22 108.684 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.2 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 0.18 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.15 108.956 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.598 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.7 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.03 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.11 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.17 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 1.48 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 1.67 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.22 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.08 110.225 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 1.7 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 0.26 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.18 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.14 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.17 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.13 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 0.2 110.152 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.455 HD22 ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.15 108.405 178.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.19 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' H ' HD22 ' A' ' 93' ' ' ASN . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.05 109.746 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 0.15 108.856 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.15 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.15 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.13 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.18 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.03 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.35 110.289 -178.783 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.694 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.608 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.309 -0.626 . . . . 0.3 109.309 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 1.97 107.91 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 3' ' ' LYS . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.98 110.431 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 0.19 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.23 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 1.9 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.25 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.2 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.21 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 2.47 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 0.2 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 0.62 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.09 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.3 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.24 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.28 109.51 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 1.9 108.948 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 0.17 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.647 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 0.12 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 0.09 108.562 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 0.17 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.96 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.24 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.03 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.26 108.747 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.32 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.44 110.103 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.32 109.12 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.36 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.44 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 1.92 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.13 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 0.28 110.185 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 1.62 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.25 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.3 109.059 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.13 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.41 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 0.97 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 0.5 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.51 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.16 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.24 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.17 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.34 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 0.12 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 0.17 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.573 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.12 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.31 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 0.14 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.08 108.538 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 0.27 111.024 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.11 110.567 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.12 109.683 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 0.17 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.22 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.11 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.19 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.22 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.29 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 0.33 109.753 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.34 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.28 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.4 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.22 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.506 HG23 ' HE1' ' B' ' 5' ' ' TYR . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.22 108.707 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.2 110.18 -1.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 0.18 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.15 108.776 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.03 107.65 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.11 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 1.48 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 1.67 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.22 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.08 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 1.7 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.26 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.18 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.14 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.17 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.13 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 0.2 110.026 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.15 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.19 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.05 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 0.15 108.555 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.15 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.15 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.13 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 0.18 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.03 109.372 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.35 110.343 -178.822 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.253 0.549 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t . . . . . 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.8 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.302 0.572 . . . . 0.3 109.624 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 1.97 109.163 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 0.98 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 10' ' ' ALA . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 0.19 108.099 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.23 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.9 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 0.25 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.2 109.831 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.21 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 2.47 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.2 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 0.62 109.882 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.09 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.3 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.24 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.28 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.9 108.887 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 0.17 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.12 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 0.09 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 0.17 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.96 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.24 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.03 109.46 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 0.26 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 0.32 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.44 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.32 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.36 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.44 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81 108.615 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 1.92 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.13 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' ILE . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 0.28 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 1.62 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.25 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.3 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.13 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.41 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 0.97 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.5 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.51 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.16 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.24 108.923 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.17 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.0 t30 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.34 109.307 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 0.12 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 0.17 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 0.12 109.063 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.31 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 0.14 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.08 107.888 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.403 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.27 111.178 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.11 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.12 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 0.17 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.22 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.11 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 65' ' ' VAL . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 0.19 108.86 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 0.22 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.29 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 0.33 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.34 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 0.28 109.063 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.4 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.22 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.642 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.22 109.249 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.542 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.2 109.892 -1.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 0.18 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.15 108.52 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.03 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.11 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.17 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 1.48 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 1.67 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.22 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.08 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.7 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 0.26 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.18 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.14 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.17 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 0.2 110.743 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.15 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.19 110.915 -178.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.05 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 77' ' ' PHE . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 0.15 108.771 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.15 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.15 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.13 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.18 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.03 109.837 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 0.35 110.262 -178.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.5 t . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.277 -0.638 . . . . 0.3 109.277 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 1.97 109.568 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.98 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 0.19 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.23 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 1.9 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 0.25 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.2 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.21 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 2.47 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.2 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 0.62 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.09 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.3 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.24 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.28 109.228 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 1.9 109.015 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 0.17 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.605 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 0.12 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.09 108.697 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 0.17 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.96 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.24 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.03 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 0.26 108.831 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.32 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.451 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.44 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.32 109.913 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.36 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.44 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 1.92 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.13 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 0.28 110.846 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 1.62 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.25 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.3 109.68 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.13 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.41 110.231 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 0.97 110.262 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 0.5 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.51 109.45 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.16 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.24 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.17 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.34 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 0.12 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.17 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 0.12 108.999 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.31 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 0.14 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.08 108.568 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.27 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.11 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.12 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 0.17 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.22 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.11 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 0.19 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.22 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.29 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 0.33 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.34 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.28 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.4 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 0.22 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.577 HG23 ' CE2' ' B' ' 5' ' ' TYR . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.22 108.587 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.2 110.11 -1.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 0.18 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.15 109.0 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.03 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.11 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.17 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 1.48 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.67 109.788 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.22 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.08 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 1.7 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 0.26 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.18 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.14 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.17 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.13 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 0.2 110.338 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.15 108.167 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.19 110.606 -178.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.05 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 0.15 108.528 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.15 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.15 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 0.13 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 0.18 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.03 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 0.35 110.587 -178.414 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 0.3 108.838 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 1.97 109.541 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.98 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 0.19 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.23 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 1.9 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 0.25 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.2 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.21 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 2.47 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 0.2 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.62 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.09 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.3 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.24 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.28 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 1.9 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 0.17 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.655 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.12 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 0.09 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 0.17 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.96 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.24 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.03 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.26 108.971 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.32 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.44 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.32 109.7 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.36 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.44 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 1.92 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.13 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 75' ' ' PRO . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 0.28 111.212 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 1.62 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.25 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.3 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.13 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.41 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 0.97 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.5 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.51 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.16 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.24 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.17 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.7 t30 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.34 109.627 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.12 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 0.17 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 0.12 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.31 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 0.14 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.08 108.5 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 0.27 111.177 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.493 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.11 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.12 109.846 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 0.17 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.22 110.336 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.11 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 0.19 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 0.22 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.29 109.046 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.33 109.259 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.34 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.28 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.4 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.22 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.22 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.2 110.437 -1.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 0.18 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.15 109.155 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.491 HE22 ' HB1' ' A' ' 69' ' ' ALA . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.03 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 100' ' ' THR . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.11 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.17 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 1.48 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 1.67 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.22 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.08 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 1.7 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 0.26 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.18 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.14 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.17 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.13 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 0.2 110.645 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.15 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.19 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.05 109.799 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.15 108.975 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.15 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.15 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.443 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.13 110.126 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 0.18 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.03 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 22' ' ' LEU . 10.3 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 0.35 110.569 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 121.301 0.572 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.6 t . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.016 -0.735 . . . . 0.3 109.016 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 1.97 109.408 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.98 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 0.19 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.23 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 1.9 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.25 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.2 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.21 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 2.47 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.2 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 0.62 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.09 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.3 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.24 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.28 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 1.9 108.668 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 0.17 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 0.12 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.09 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 0.17 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.96 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 74' ' ' THR . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.24 107.762 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.03 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 0.26 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 0.32 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.44 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.32 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.36 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.44 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 1.92 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.13 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 38' ' ' ILE . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 0.28 111.009 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 1.62 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.25 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.3 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.13 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.41 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 0.97 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 0.5 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.51 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.16 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.24 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.17 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.34 109.581 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 0.12 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 0.17 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.567 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 0.12 108.509 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.31 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE2' ' A' ' 27' ' ' PHE . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 0.14 110.705 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.08 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.27 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.11 111.083 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.12 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 0.17 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.476 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.22 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.11 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 0.19 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 0.22 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.29 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 0.33 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.34 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 0.28 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.4 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 27' ' ' PHE . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.22 108.837 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.2 109.848 -1.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 0.18 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.526 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.15 109.247 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.03 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.11 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.17 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 1.48 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 1.67 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.22 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.08 110.902 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 1.7 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 0.26 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.18 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.14 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.17 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.13 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 0.2 110.701 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.15 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.19 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.05 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.15 108.825 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.15 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 0.15 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 0.13 110.331 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.18 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.03 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 0.35 110.413 -178.528 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.49 ' HE1' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 3' ' ' LYS . 18.7 t . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.336 0.588 . . . . 0.3 109.571 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.782 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 1.97 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 0.98 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 0.19 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.23 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 1.9 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 0.25 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.2 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.21 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 2.47 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.2 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 0.62 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.09 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.3 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.24 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.28 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.612 ' HZ1' ' ND2' ' A' ' 51' ' ' ASN . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 1.9 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 0.17 107.833 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 0.12 109.23 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 0.09 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 0.17 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.96 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.24 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.03 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.26 108.545 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.32 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.44 110.133 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.32 109.807 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.44 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' CB ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 1.92 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.13 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 38' ' ' ILE . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.28 110.129 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 1.62 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.25 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.3 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.13 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.41 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 0.97 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.5 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.51 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.16 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.24 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.17 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.612 ' ND2' ' HZ1' ' A' ' 21' ' ' LYS . 20.1 t-20 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.34 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 0.12 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 0.17 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.545 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 0.12 108.897 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.31 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 0.14 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.08 107.515 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.27 111.306 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.11 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.12 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.17 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.22 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.11 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 0.19 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 0.22 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.29 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 0.33 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.34 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.28 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.4 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 0.22 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.651 HG23 ' CE2' ' B' ' 5' ' ' TYR . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.2 110.581 -1.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 0.18 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.15 108.43 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.03 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.11 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.17 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 1.48 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 1.67 109.862 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.22 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.08 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.7 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 0.26 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.18 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.14 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.17 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 0.2 110.708 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.15 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.19 110.417 -178.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.05 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.15 108.917 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.15 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.15 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 0.13 110.038 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 0.18 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.03 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 0.35 110.597 -178.577 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.651 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.651 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.615 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 3' ' ' LYS . 70.1 t . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 109.555 -0.535 . . . . 0.3 109.555 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 1.97 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 0.98 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 0.19 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.23 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 1.9 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 0.25 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.2 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.21 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 2.47 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 0.2 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.62 109.433 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.09 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 0.3 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 0.24 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.28 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 1.9 108.809 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 0.17 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 0.12 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 0.09 108.655 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 0.17 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.96 109.176 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.24 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.03 109.235 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 0.26 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.32 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.549 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.44 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.32 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.36 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.44 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 1.92 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.13 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 0.28 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 1.62 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.25 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.3 109.071 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.13 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.41 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 0.97 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 0.5 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.51 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.16 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.24 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.17 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 30.5 t-20 -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.34 109.487 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 0.12 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 0.17 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 0.12 108.639 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.31 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 0.14 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.08 108.209 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 74' ' ' THR . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.27 110.35 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.549 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.11 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.12 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 0.17 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.22 110.197 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.11 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.19 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 0.22 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.29 109.395 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.33 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.34 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 0.28 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.4 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.22 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.56 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.22 108.8 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.2 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 0.18 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.15 109.169 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.03 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.11 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.17 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 1.48 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 1.67 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.22 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.08 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 1.7 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 0.26 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.18 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.14 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.17 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.13 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 0.2 110.279 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.15 108.484 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.19 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.05 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 0.15 108.752 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.15 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 0.15 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 0.13 110.385 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.18 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.03 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt . . . . . 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 0.35 110.795 -177.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.629 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 3' ' ' LYS . 97.3 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.313 0.578 . . . . 0.3 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.574 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 0.98 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.19 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.23 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 1.9 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.25 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.2 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.21 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 2.47 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.2 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.62 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.09 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.3 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 0.24 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.28 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 1.9 108.996 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 0.17 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 0.12 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 0.09 108.8 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 0.17 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.96 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.24 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.03 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.26 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.32 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.508 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.44 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.32 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.36 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.44 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 1.92 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.13 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 0.28 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 1.62 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.25 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.3 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.13 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.41 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' SER . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 0.97 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 0.5 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.51 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.16 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.24 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.17 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.34 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 0.12 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.17 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 0.12 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.31 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 0.14 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.08 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 74' ' ' THR . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.27 111.39 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.11 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.12 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 0.17 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB3' HH12 ' B' ' 4' ' ' ARG . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.22 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.11 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 0.19 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.22 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.29 109.143 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.33 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.34 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.28 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.4 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 0.22 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.22 108.293 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.2 110.105 -1.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 0.18 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.15 109.052 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.03 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.11 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.17 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 1.48 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 1.67 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.535 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.22 110.183 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.535 HE21 ' C ' ' A' ' 83' ' ' GLY . 35.1 mm-40 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.08 109.996 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 1.7 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 0.26 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.18 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.14 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.17 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.13 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 0.2 110.712 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.15 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.19 110.595 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.05 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 0.15 108.82 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.15 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.15 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.13 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 0.18 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.03 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 22' ' ' LEU . 20.6 mt . . . . . 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.35 110.587 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.431 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.4 t . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.208 0.528 . . . . 0.3 109.654 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 1.97 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.98 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 0.19 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.23 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 1.9 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.25 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.2 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.21 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 2.47 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.2 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.62 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.09 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.3 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.24 109.684 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.28 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 1.9 108.718 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 0.17 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 0.12 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 0.09 108.82 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 0.17 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.96 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.24 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.03 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 0.26 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.32 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.44 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.32 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.36 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.44 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 1.92 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.13 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 38' ' ' ILE . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 0.28 111.085 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 1.62 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.25 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.3 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.13 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.41 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 0.97 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 0.5 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.51 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.16 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.24 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.17 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.34 109.248 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 0.12 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 0.17 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 0.12 108.984 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.31 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 0.14 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.08 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.27 111.566 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.11 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.12 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 0.17 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.559 HE22 ' CZ ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.22 109.995 -179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.11 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 0.19 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 0.22 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.29 108.915 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 0.33 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.34 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.28 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.4 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 0.22 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.701 HG23 ' CE2' ' B' ' 5' ' ' TYR . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.22 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.2 110.364 -2.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 0.18 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.15 108.601 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.11 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.17 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 1.48 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 1.67 109.541 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.22 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.08 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.7 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.26 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.18 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.14 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.17 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.13 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.527 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 0.2 110.162 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.15 108.052 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.19 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.05 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 77' ' ' PHE . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.15 108.69 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.15 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 0.15 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 0.13 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.18 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.03 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.35 110.476 -178.741 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.328 0.585 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.559 ' CZ ' HE22 ' A' ' 63' ' ' GLN . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.701 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.4 t . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.898 -0.778 . . . . 0.3 108.898 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 1.97 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.98 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 0.19 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.23 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 1.9 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.25 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.2 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.21 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 2.47 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 0.2 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.62 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.09 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.3 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.24 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.28 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 1.9 109.135 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 0.17 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.594 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 0.12 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 0.09 108.879 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 0.17 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.96 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.24 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.03 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 0.26 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 0.32 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.487 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.44 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.32 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.36 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.44 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 1.92 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.13 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 38' ' ' ILE . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 0.28 111.198 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 1.62 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.25 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.3 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.13 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.41 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 0.97 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.5 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.51 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.16 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.24 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.17 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.34 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 0.12 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 0.17 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 0.12 109.07 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.31 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 0.14 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.08 107.568 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 0.27 110.814 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.11 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.12 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 0.17 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.22 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.11 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.19 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.22 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.29 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 0.33 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.34 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.28 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.4 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 0.22 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.702 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.22 108.899 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.2 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 0.18 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.15 108.75 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.11 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.17 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 1.48 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 1.67 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.22 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.08 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 1.7 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 0.26 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.18 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.14 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.17 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.496 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 0.2 110.298 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.15 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.19 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.05 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 0.15 108.902 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.15 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.15 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 0.13 110.205 -178.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 0.18 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.03 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 0.35 110.676 -178.572 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.702 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.604 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 3' ' ' LYS . 61.6 t . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.263 0.554 . . . . 0.3 109.641 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 1.97 109.24 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 0.98 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 0.19 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.23 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 1.9 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.25 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.2 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.21 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 2.47 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 0.2 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 0.62 109.235 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.09 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.3 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.24 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.28 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 1.9 109.094 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 0.17 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 0.12 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 0.09 108.733 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 0.17 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.96 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.24 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.03 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 0.26 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 0.32 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.577 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.44 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.32 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.36 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.44 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 1.92 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.13 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 0.28 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 1.62 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.25 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.3 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.13 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.41 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.97 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.5 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.51 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.16 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.24 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.17 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.34 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 0.12 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.17 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 0.12 108.704 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.31 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 0.14 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.08 108.354 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 0.27 110.752 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.577 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.11 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.12 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 0.17 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.22 109.961 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.11 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 0.19 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.22 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.29 109.526 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.33 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.34 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.28 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.4 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 0.22 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.689 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.22 108.693 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.2 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 0.18 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.15 109.128 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.11 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.17 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 1.48 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 1.67 109.168 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.22 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.08 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 1.7 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 0.26 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.18 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.14 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.17 108.759 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.13 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 0.2 110.285 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.15 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.19 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.05 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 0.15 108.663 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.15 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.15 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.13 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.18 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.03 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 0.35 110.283 -178.843 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.408 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.0 m-85 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.364 0.602 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 3' ' ' LYS . 86.1 t . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.1 -0.704 . . . . 0.3 109.1 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 1.97 109.42 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.98 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 0.19 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.23 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 1.9 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 0.25 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.2 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.21 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 2.47 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.2 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.62 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.09 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.3 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.24 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.28 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 1.9 109.158 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 0.17 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.668 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 0.12 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 0.09 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 0.17 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.96 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.24 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.03 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.26 108.756 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 0.32 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.44 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.32 109.658 -179.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.36 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.44 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 1.92 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.13 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 0.28 111.174 -177.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 1.62 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.25 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.3 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.13 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.41 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 0.97 110.118 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 0.5 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.51 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.16 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.24 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.17 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.3 t30 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.34 109.362 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 0.12 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 0.17 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 0.12 108.829 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.31 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 27' ' ' PHE . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.14 110.398 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.08 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.27 111.421 -177.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.11 111.265 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.12 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 0.17 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.22 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.11 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.19 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 0.22 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.29 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.33 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.34 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.28 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.4 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 0.22 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.538 HG23 ' CE2' ' B' ' 5' ' ' TYR . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.22 109.12 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.2 110.074 -1.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 0.18 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.15 108.799 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.11 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.17 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 1.48 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 1.67 109.989 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.22 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.08 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 1.7 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 0.26 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.18 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.14 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.17 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.13 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.534 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 0.2 110.235 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.15 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.19 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.05 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 77' ' ' PHE . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 0.15 108.211 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.15 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.15 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.13 110.428 -178.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.18 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.03 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 0.35 110.351 -178.531 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.184 0.516 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 26.7 t . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.331 0.586 . . . . 0.3 109.609 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 1.97 108.925 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.98 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 0.19 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.23 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 1.9 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 0.25 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.2 109.777 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.21 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 2.47 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.2 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.62 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.09 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.3 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.24 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.28 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 1.9 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 0.17 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.12 109.35 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 0.09 108.549 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 0.17 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.96 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.24 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.03 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 0.26 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.32 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.44 110.114 -179.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.32 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.36 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.44 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 1.92 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.13 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ILE . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.28 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 1.62 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.25 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.3 109.513 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.13 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.41 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 0.97 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 0.5 109.586 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.51 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.16 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.24 109.52 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.17 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.34 109.573 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 0.12 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 0.17 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.12 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.31 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.14 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.08 108.086 178.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.27 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.11 110.68 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.12 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 0.17 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.22 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.11 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.19 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 0.22 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.29 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 0.33 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.34 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 0.28 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.4 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.22 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.773 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.22 108.795 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.2 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 0.18 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CD1' HD21 ' A' ' 97' ' ' LEU . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.15 108.553 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.03 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 24' ' ' VAL . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.11 109.712 -177.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.17 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 1.48 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 1.67 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.22 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.08 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 1.7 109.335 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 0.26 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.18 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.14 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.17 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.13 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 0.2 110.703 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.15 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.19 111.003 -178.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.05 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.48 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.15 109.018 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.15 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.15 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.13 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 0.18 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.03 109.401 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.35 110.431 -178.389 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.773 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.612 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 3' ' ' LYS . 88.0 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.166 -0.679 . . . . 0.3 109.166 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 1.97 109.254 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 0.98 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 0.19 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.23 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 1.9 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.25 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.2 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.21 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 2.47 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 0.2 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 0.62 110.003 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.09 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.3 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.24 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.28 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 1.9 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 0.17 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.626 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 0.12 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 0.09 108.637 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 0.17 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.96 109.422 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.24 107.973 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.03 109.994 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.26 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 0.32 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.44 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.32 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.36 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.44 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 1.92 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.13 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 0.28 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 1.62 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.25 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.3 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.13 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.41 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.97 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 0.5 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.456 ' N ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.51 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.16 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.24 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.17 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.34 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 0.12 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 0.17 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 0.12 108.994 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.31 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 0.14 110.396 -178.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.08 108.118 178.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 59' ' ' VAL . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 0.27 111.768 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.11 110.678 -179.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.12 109.118 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 0.17 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.22 110.362 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.11 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 65' ' ' VAL . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 0.19 108.746 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 0.22 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.29 109.409 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 0.33 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.34 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.28 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.4 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 0.22 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.22 108.73 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.2 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 0.18 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.15 109.242 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD2' HG22 ' A' ' 24' ' ' VAL . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.11 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.17 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 1.48 107.539 -179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 1.67 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.22 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.08 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.488 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 1.7 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 0.26 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.18 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.14 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.17 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 0.2 110.505 -179.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.15 108.235 178.405 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.19 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.604 ' H ' HD22 ' A' ' 93' ' ' ASN . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.05 110.01 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 77' ' ' PHE . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 0.15 108.517 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.15 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 0.15 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.13 110.145 -179.071 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 0.18 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.03 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 0.35 110.384 -178.595 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.528 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 67.6 t . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.362 0.601 . . . . 0.3 109.988 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 1.97 108.754 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 0.98 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 0.19 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.23 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 1.9 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.25 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.2 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.21 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 2.47 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 0.2 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.62 109.915 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.09 109.664 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.3 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.24 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 1.9 109.084 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 0.17 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 0.12 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 79' ' ' PHE . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 0.09 108.755 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 0.17 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.96 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.24 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.03 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.26 108.719 179.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.32 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.44 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.32 109.717 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.36 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.44 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 1.92 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.13 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 0.28 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 1.62 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.25 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.3 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.13 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.41 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.97 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 0.5 109.524 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.51 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.16 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.24 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.17 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.5 t30 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.34 109.429 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 0.12 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 0.17 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 0.12 108.563 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.31 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.14 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.08 108.218 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG11 ' OH ' ' B' ' 5' ' ' TYR . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 0.27 111.211 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.11 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.12 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 0.17 108.502 179.035 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB3' HH12 ' B' ' 4' ' ' ARG . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.22 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.11 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 0.19 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.22 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.29 109.426 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 0.33 109.584 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.34 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.28 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.4 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 0.22 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.22 108.567 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.2 110.212 -1.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.18 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.15 109.1 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 69' ' ' ALA . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 24' ' ' VAL . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.11 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.17 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 1.48 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 1.67 109.495 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.467 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.22 110.471 179.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.467 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.6 mm-40 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.08 110.188 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 1.7 109.242 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 0.26 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.18 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.14 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.17 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.13 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.2 110.305 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.15 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.517 ' NZ ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.19 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.05 109.595 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 0.15 108.46 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.15 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 0.15 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.418 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.13 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.18 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.03 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.458 ' HB2' HD11 ' A' ' 22' ' ' LEU . 54.1 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.35 110.425 -178.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.605 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.6 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.304 -0.628 . . . . 0.3 109.304 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 1.97 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.98 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 0.19 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.23 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 1.9 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 0.25 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.2 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.21 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 2.47 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 0.2 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 0.62 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.09 109.073 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.3 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 0.24 109.769 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.28 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.619 ' NZ ' ' ND2' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 1.9 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 0.17 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 0.12 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 0.09 108.676 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 0.17 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.96 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.24 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.03 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 0.26 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.32 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.534 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.44 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.32 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.36 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.44 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 1.92 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.13 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 38' ' ' ILE . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 0.28 110.526 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 1.62 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.25 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.3 109.315 179.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.13 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.41 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 0.97 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 0.5 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.51 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.16 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.24 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.17 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.619 ' ND2' ' NZ ' ' A' ' 21' ' ' LYS . 10.3 t30 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.34 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 0.12 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 53' ' ' ILE . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 0.17 109.466 -179.167 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.12 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.31 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 0.14 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.08 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 74' ' ' THR . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.27 110.906 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.534 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.11 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.12 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 0.17 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.22 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.11 109.282 -179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG23 ' OD2' ' A' ' 64' ' ' ASP . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 0.19 108.788 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.22 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 0.33 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.34 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.28 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.4 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 0.22 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.628 HG23 ' CE2' ' B' ' 5' ' ' TYR . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.22 109.406 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.2 109.76 -2.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 0.18 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.15 109.416 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.03 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.11 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.17 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 1.67 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.22 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.08 110.229 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 1.7 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 0.26 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.18 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.14 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.17 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.13 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 0.2 110.872 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.15 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.19 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.05 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.15 109.142 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.15 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.15 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 0.13 110.35 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.18 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.03 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 0.35 110.841 -178.299 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.628 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.593 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 3' ' ' LYS . 35.7 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.116 -0.698 . . . . 0.3 109.116 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 1.97 109.443 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 0.98 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 0.19 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.23 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 1.9 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 0.25 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.2 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.21 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 2.47 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.2 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 0.62 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.09 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.3 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.24 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.28 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 1.9 109.274 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 0.17 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.12 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 0.09 108.732 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 0.17 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.96 109.398 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.24 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.03 109.813 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 0.26 108.448 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 0.32 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.44 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.32 110.052 -178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.36 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.44 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 1.92 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.13 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.467 HD12 ' HG3' ' A' ' 75' ' ' PRO . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 0.28 110.188 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 1.62 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.25 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.3 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.13 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.41 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 0.97 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 0.5 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.51 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.16 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.24 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.17 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.34 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 0.12 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.17 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 0.12 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.31 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 0.14 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.08 107.961 178.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.27 111.38 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.11 111.01 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.12 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 0.17 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.22 110.097 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.11 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 0.19 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 0.22 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.29 109.387 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.33 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.34 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 0.28 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.4 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 0.22 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.22 108.757 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.2 110.023 -1.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 0.18 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.781 ' CD1' HD21 ' A' ' 97' ' ' LEU . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.15 109.116 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.03 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.11 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.17 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 1.48 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 1.67 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.22 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.08 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 1.7 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 0.26 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.18 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.14 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.17 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.13 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 0.2 110.54 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.15 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.19 110.523 -178.637 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.05 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 0.15 108.587 -179.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.15 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 0.15 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 0.13 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 0.18 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.03 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 22' ' ' LEU . 14.3 mt . . . . . 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.35 110.625 -178.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.629 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 3' ' ' LYS . 14.4 t . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.219 -0.659 . . . . 0.3 109.219 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 1.97 109.464 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 0.98 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 0.19 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.23 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 1.9 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 0.25 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.2 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.21 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 2.47 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 0.2 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 0.62 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.09 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.3 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.24 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.28 109.405 -179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 1.9 108.752 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 0.17 108.588 -179.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.434 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 0.12 109.465 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 0.09 108.795 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 0.17 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.96 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' THR . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.24 108.091 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.03 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 0.26 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 0.32 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.518 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.44 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.32 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.36 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.44 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 1.92 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.13 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 38' ' ' ILE . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 0.28 111.261 -178.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 1.62 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.25 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.3 109.453 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.13 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.41 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 0.97 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.5 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.51 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.16 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.24 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.17 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.34 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 0.12 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 0.17 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.528 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.528 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 0.12 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.31 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.14 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.08 108.332 179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 0.27 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.11 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.12 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 0.17 108.852 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.22 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.11 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 0.19 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.22 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.29 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 0.33 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.34 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 0.28 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.4 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 0.22 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.553 HG23 ' HE2' ' B' ' 5' ' ' TYR . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.22 108.615 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.2 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 0.18 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.15 109.151 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.03 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.11 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.17 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 1.48 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 1.67 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.22 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.08 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 1.7 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 0.26 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.18 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.14 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.17 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.13 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 0.2 110.294 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.15 108.15 178.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.19 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.05 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.15 108.777 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.15 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 0.15 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 0.13 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.18 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.03 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.35 110.832 -178.176 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.553 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.465 -0.568 . . . . 2.89 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.6 t -94.65 171.77 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.378 -0.826 . . . . 0.3 109.383 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' N ' HG12 ' A' ' 2' ' ' VAL . 41.7 tptt -154.36 120.24 5.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.257 -0.902 . . . . 1.97 109.221 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -90.19 131.17 36.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.98 109.763 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -107.38 109.7 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.276 -1.009 . . . . 0.19 108.276 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -100.39 -6.99 24.88 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.277 -0.89 . . . . 1.97 109.675 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.8 p -153.04 149.24 27.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.108 -0.995 . . . . 0.23 109.703 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 5.4 ttpm? -53.44 -25.9 17.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.37 -0.831 . . . . 1.9 109.59 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 m -61.7 -43.56 98.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.999 -1.063 . . . . 0.25 109.064 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.95 -23.74 62.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.2 109.643 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -59.82 -67.37 0.39 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.957 . . . . 0.21 109.856 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 12' ' ' GLN . 1.6 pt20 -55.27 -43.13 74.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 2.47 109.756 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.88 -36.54 77.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.954 -1.091 . . . . 2.1 109.683 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -46.95 87.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.037 -1.04 . . . . 0.2 109.085 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.35 -40.34 95.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.468 -0.77 . . . . 0.62 109.374 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.12 -43.49 91.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.366 -0.834 . . . . 1.09 110.033 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -12.69 59.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.997 -1.064 . . . . 0.3 109.805 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.48 -7.11 29.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.24 109.965 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.83 -117.1 6.33 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.855 -1.298 . . . . 0.28 109.855 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -136.6 5.36 2.91 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.273 -1.134 . . . . 2.21 109.4 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -69.88 167.79 16.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.01 . . . . 1.9 108.773 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.678 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.51 161.17 12.36 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.797 -1.186 . . . . 0.17 107.797 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -145.21 109.56 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.858 -1.151 . . . . 0.12 110.003 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.9 t -105.88 132.94 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.796 -0.816 . . . . 0.09 108.796 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -108.1 137.85 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.574 -0.704 . . . . 0.17 109.606 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -108.02 98.31 7.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.668 -0.645 . . . . 0.96 109.328 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -84.83 81.9 8.68 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.641 -1.244 . . . . 0.24 107.641 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -110.51 -162.67 0.81 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.576 -0.702 . . . . 1.03 109.467 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.14 120.96 14.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.322 -0.992 . . . . 0.26 108.322 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -63.75 -26.2 68.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.474 -0.766 . . . . 0.32 110.791 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.573 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.5 p-90 -89.67 -14.69 34.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.963 -1.086 . . . . 0.44 110.391 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -94.98 125.06 39.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.879 . . . . 0.32 109.895 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -63.46 -58.74 10.35 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 111.209 -0.756 . . . . 0.36 111.209 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -47.66 -34.95 22.0 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.956 1.77 . . . . 0.44 111.397 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.43 -60.27 2.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.907 -1.121 . . . . 0.81 108.893 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -60.11 -18.85 50.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 1.92 110.063 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -59.27 -22.03 60.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.082 -1.011 . . . . 3.13 110.061 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.9 mt -96.37 8.36 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.178 -0.951 . . . . 0.28 110.831 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.21 -31.91 3.58 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.243 -1.536 . . . . 1.62 112.282 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -62.84 -6.25 8.92 Favored 'Trans proline' 0 C--N 1.321 -0.911 0 CA-C-N 119.706 0.931 . . . . 0.25 109.77 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -110.1 -76.94 0.6 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.089 -0.708 . . . . 0.3 109.089 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -42.59 -55.76 3.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.615 -0.678 . . . . 0.13 110.782 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.17 -32.32 73.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.979 -1.075 . . . . 0.41 109.865 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.0 m -64.36 -41.83 96.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.829 -1.169 . . . . 0.97 110.133 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 mt -50.34 -14.79 0.19 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.864 -1.147 . . . . 0.5 109.772 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.12 -28.7 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.51 109.709 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -96.89 -24.4 15.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.245 -0.909 . . . . 2.0 110.454 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -89.77 -19.54 24.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.995 -1.066 . . . . 2.16 109.678 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -133.66 67.08 1.53 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.473 -0.767 . . . . 0.24 109.066 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.6 p -67.44 -4.99 12.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.464 -0.772 . . . . 0.17 109.201 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.9 t-20 -94.59 -1.25 53.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.364 -0.835 . . . . 0.34 109.282 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.82 146.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 109.236 -0.653 . . . . 0.12 109.236 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.44 129.81 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 0.17 109.374 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.519 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.9 m-85 -115.63 131.34 56.96 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.497 -0.752 . . . . 0.11 109.247 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.54 171.74 7.34 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.926 -0.768 . . . . 0.12 108.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -144.14 144.68 31.69 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.586 -0.894 . . . . 1.31 108.586 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.1 t -139.88 139.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.156 -0.965 . . . . 0.14 110.358 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -97.08 97.24 9.05 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.428 -1.323 . . . . 1.08 107.428 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.6 m -56.19 -12.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.151 -0.968 . . . . 0.27 111.218 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.34 -41.24 6.41 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.089 -1.007 . . . . 1.11 111.332 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.52 -14.36 26.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.021 -1.049 . . . . 1.12 109.329 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.38 47.29 1.95 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.468 -0.938 . . . . 0.17 108.468 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -56.01 -13.47 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.516 -0.74 . . . . 2.22 110.207 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.03 -39.36 75.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.006 -1.059 . . . . 1.11 109.23 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.38 -49.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.277 -0.889 . . . . 0.19 108.604 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.7 -34.04 76.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.22 109.415 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.6 m -63.43 -52.39 61.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.223 -0.923 . . . . 1.29 109.244 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -64.19 -31.25 72.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 2.2 109.411 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.96 -3.03 58.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 0.33 109.643 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 46.95 52.96 11.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 2.34 110.338 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.4 t -80.55 128.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.28 108.961 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -122.0 1.85 9.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.48 -0.762 . . . . 2.4 109.996 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.44 129.86 11.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.944 -1.098 . . . . 0.22 109.413 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.673 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.5 p -114.77 150.27 43.76 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.631 -0.877 . . . . 0.22 108.631 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.9 Cg_endo -77.31 146.4 82.82 Favored 'Cis proline' 0 C--N 1.32 -0.968 0 C-N-CA 124.864 -0.89 . . . . 0.2 110.286 -1.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.31 113.63 21.75 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.803 -1.184 . . . . 0.18 107.803 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.8 m-85 -88.88 126.63 35.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.034 . . . . 0.15 108.868 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -124.55 137.55 54.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.03 107.95 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.1 m-85 -110.29 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.473 0.654 . . . . 0.11 110.057 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -128.26 159.34 35.56 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.674 -0.862 . . . . 0.17 108.674 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -155.43 121.53 5.15 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.623 -1.251 . . . . 1.48 107.623 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.84 25.82 10.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.496 -0.753 . . . . 1.67 109.759 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.519 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 87.91 1.35 82.51 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.055 -1.028 . . . . 0.22 110.57 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.519 HE21 ' C ' ' A' ' 83' ' ' GLY . 38.4 mm-40 -109.87 146.06 35.75 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.225 -1.162 . . . . 2.08 110.191 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -86.29 145.48 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.556 -0.715 . . . . 1.7 109.624 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.84 -28.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.505 -0.747 . . . . 0.26 110.204 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.84 179.03 45.48 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.602 -1.285 . . . . 0.18 110.305 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -173.01 158.07 3.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.336 -1.096 . . . . 2.04 110.241 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -168.86 133.33 1.51 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.288 -0.882 . . . . 0.14 110.466 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -169.7 1.7 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.703 -0.851 . . . . 0.17 108.703 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.6 128.28 3.81 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.44 -1.464 . . . . 0.13 109.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.01 94.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -1.134 . . . . 0.2 110.53 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -140.87 77.15 1.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.032 -1.099 . . . . 1.15 108.032 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.71 -35.12 79.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.711 . . . . 1.19 110.516 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.35 -27.18 68.4 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.012 . . . . 1.95 109.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -67.96 -35.87 79.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.324 -0.86 . . . . 2.05 109.549 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.0 mt -53.93 -35.79 62.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.868 -1.145 . . . . 0.15 108.657 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.16 -55.89 12.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 2.15 109.421 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.13 -42.44 90.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.823 . . . . 0.15 110.36 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 13.5 m -66.81 -45.81 77.19 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.13 109.804 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.0 mt -61.66 -51.15 76.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 0.18 109.07 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -61.91 -16.05 47.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 1.03 109.64 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.14 -58.47 3.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.225 -0.922 . . . . 2.02 110.04 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.4 mt -92.28 18.32 8.46 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.449 -0.782 . . . . 0.35 110.363 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.489 1.492 0 O-C-N 120.957 -1.089 . . . . 1.18 109.357 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.5 85.84 1.86 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 109.328 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.573 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 24.4 m-85 -126.13 143.22 51.21 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.092 -1.005 . . . . 0.0 109.274 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -142.08 -105.0 0.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.46 -0.775 . . . . 0.0 109.521 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.673 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -109.74 -169.81 1.54 Allowed 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.165 -0.96 . . . . 0.0 110.734 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.46 148.71 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.787 0.803 . . . . 0.0 112.392 -177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.91 96.62 7.39 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.645 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.17 44.63 0.96 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.145 -0.972 . . . . 0.0 110.246 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.626 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.31 -130.76 0.09 OUTLIER Glycine 0 N--CA 1.483 1.83 0 N-CA-C 106.799 -2.521 . . . . 0.0 106.799 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.33 25.76 0.12 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 CA-C-N 118.836 1.318 . . . . 0.0 109.147 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.626 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.5 t -100.75 -33.37 10.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.493 -0.754 . . . . 0.0 109.598 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -58.63 -94.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.62 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.596 -179.813 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 2.89 109.394 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.0 t -94.56 165.27 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.357 -0.839 . . . . 0.3 109.254 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.547 ' N ' HG12 ' A' ' 2' ' ' VAL . 59.7 tttp -155.06 123.74 6.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.123 -0.986 . . . . 1.97 109.157 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -90.91 135.7 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.381 -0.825 . . . . 0.98 109.994 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.7 110.92 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.617 -1.253 . . . . 0.19 107.617 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -99.86 -11.75 20.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 1.97 109.784 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.8 p -153.64 156.39 37.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.96 . . . . 0.23 109.68 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -52.2 -26.41 11.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 1.9 109.606 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.1 m -60.08 -46.84 88.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.967 . . . . 0.25 109.608 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -25.09 63.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -0.83 . . . . 0.2 109.833 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -58.52 -66.63 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.006 -1.059 . . . . 0.21 110.153 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -56.55 -43.71 80.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.178 -0.951 . . . . 2.47 109.635 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.75 -35.98 73.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.257 -0.902 . . . . 2.1 109.649 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.64 -47.63 85.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.2 109.147 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.08 -43.19 96.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.62 109.641 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -64.89 -43.75 91.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.15 -0.969 . . . . 1.09 109.99 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.07 -13.63 59.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.993 . . . . 0.3 109.761 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -6.1 23.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.24 109.526 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -116.51 6.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.439 -1.465 . . . . 0.28 109.439 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -136.24 5.29 2.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.177 -1.19 . . . . 2.21 109.389 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mttt -70.92 169.01 15.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.915 . . . . 1.9 108.979 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.14 160.82 14.59 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.073 -1.017 . . . . 0.17 108.463 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.3 t -144.04 106.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.077 -1.014 . . . . 0.12 109.634 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.4 t -103.2 132.93 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.683 -0.858 . . . . 0.09 108.683 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.43 139.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.542 -0.723 . . . . 0.17 109.722 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -108.32 102.6 11.71 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.985 -0.746 . . . . 0.96 108.985 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -87.38 77.32 8.92 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.82 -1.178 . . . . 0.24 107.82 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.2 m -112.97 149.43 33.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.778 -0.576 . . . . 1.03 109.583 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.78 125.67 35.78 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.547 -0.909 . . . . 0.26 108.547 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -65.51 -23.26 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.306 -0.871 . . . . 0.32 110.371 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.572 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 48.7 p-90 -90.14 -12.89 36.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.059 -1.026 . . . . 0.44 110.007 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -96.29 128.75 43.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.235 -0.915 . . . . 0.32 109.481 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.23 -55.77 9.87 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.709 -0.757 . . . . 0.36 111.285 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 14.1 Cg_exo -49.48 -32.1 25.97 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.891 1.727 . . . . 0.44 111.096 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.63 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.014 -1.054 . . . . 0.81 108.773 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -59.78 -19.18 48.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.455 -0.778 . . . . 1.92 110.232 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.8 ttt -58.61 -15.88 13.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 3.13 110.561 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -101.62 4.88 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.244 -0.91 . . . . 0.28 110.447 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.86 -35.22 19.95 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 120.662 -1.274 . . . . 1.62 112.384 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -59.68 -8.16 6.93 Favored 'Trans proline' 0 C--O 1.212 -0.8 0 CA-C-N 119.319 0.793 . . . . 0.25 110.264 -177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 46.3 m-85 -108.19 -70.3 0.81 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.928 -0.767 . . . . 0.3 108.928 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.57 -56.7 6.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.619 -0.676 . . . . 0.13 110.446 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -66.0 -30.84 71.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.41 110.029 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.5 m -63.53 -43.66 96.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.936 -1.102 . . . . 0.97 109.725 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 47.1 mt -51.94 -16.49 0.74 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.165 -0.96 . . . . 0.5 109.971 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.6 m -56.68 -33.82 66.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.135 -0.978 . . . . 0.51 110.013 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -94.9 -17.62 21.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.284 -0.885 . . . . 2.0 110.159 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -91.1 -23.11 20.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.999 -1.063 . . . . 2.16 109.233 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -134.09 68.18 1.49 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.574 -0.704 . . . . 0.24 109.468 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 p -67.34 -3.55 8.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.849 . . . . 0.17 109.013 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.9 t30 -93.46 -1.14 56.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.4 -0.812 . . . . 0.34 108.961 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.51 150.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.282 -1.007 . . . . 0.12 108.282 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -101.67 127.9 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.39 -0.819 . . . . 0.17 109.463 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.63 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -114.18 132.72 56.0 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.347 -0.845 . . . . 0.11 109.184 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -115.86 173.49 6.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.458 -0.776 . . . . 0.12 108.95 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.64 142.18 30.91 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.087 -1.079 . . . . 1.31 108.087 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.4 t -141.1 138.72 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.158 -0.964 . . . . 0.14 110.573 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.94 103.42 15.38 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.501 -0.925 . . . . 1.08 108.501 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.478 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.6 m -61.06 -6.98 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.947 . . . . 0.27 110.986 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.79 -43.24 5.16 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.07 -1.019 . . . . 1.11 110.461 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.4 OUTLIER -94.03 -10.98 31.71 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 1.12 109.527 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.97 44.23 2.84 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.674 -0.861 . . . . 0.17 108.674 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.422 ' CB ' HH12 ' B' ' 4' ' ' ARG . 3.9 pp0? -55.34 -13.52 1.43 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.36 -0.838 . . . . 2.22 109.952 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.08 -40.42 75.02 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.116 -0.99 . . . . 1.11 108.984 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.5 -46.3 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.19 108.787 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.53 70.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.22 109.181 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -64.21 -57.17 10.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.312 -0.867 . . . . 1.29 109.334 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 2.2 109.671 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.35 -4.57 58.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.15 -0.969 . . . . 0.33 109.657 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 47.06 52.14 12.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.271 -0.893 . . . . 2.34 110.474 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 t -79.41 132.29 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.112 -0.992 . . . . 0.28 109.116 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -124.77 -1.14 7.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.409 -0.807 . . . . 2.4 109.627 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.59 137.85 18.42 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.142 -0.974 . . . . 0.22 109.495 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.636 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.7 p -119.37 151.08 50.78 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.754 -0.832 . . . . 0.22 108.754 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -76.61 148.22 88.47 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 124.378 -1.093 . . . . 0.2 110.245 -2.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -117.21 115.41 25.26 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.95 -1.13 . . . . 0.18 107.95 178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.2 m-85 -90.97 122.0 33.27 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.368 -0.933 . . . . 0.15 108.632 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.428 HE22 ' HB1' ' A' ' 69' ' ' ALA . 36.2 mt-30 -121.1 137.83 54.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.104 -1.073 . . . . 1.03 108.104 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.9 m-85 -110.96 129.91 55.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.599 -0.688 . . . . 0.11 109.923 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -126.02 156.85 39.25 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.551 -0.907 . . . . 0.17 108.551 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -156.07 119.98 4.44 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.852 -1.166 . . . . 1.48 107.852 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 57.54 28.07 15.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 1.67 109.764 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.34 8.94 85.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.923 -1.271 . . . . 0.22 109.923 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -115.56 144.79 43.36 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.444 -1.033 . . . . 2.08 109.817 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.469 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 5.7 ttpm? -87.03 141.21 28.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.286 -0.884 . . . . 1.7 109.154 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.0 m -128.86 -16.67 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.323 -0.86 . . . . 0.26 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.43 172.29 45.06 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 119.211 -1.471 . . . . 0.18 110.62 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -174.05 153.65 2.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.436 -1.038 . . . . 2.04 109.929 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.1 p90 -169.51 132.61 1.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.14 110.003 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 p -103.97 -163.83 1.01 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.021 -1.049 . . . . 0.17 109.13 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 126.77 1.04 Allowed Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.18 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -1.178 . . . . 0.2 110.741 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.46 72.07 1.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.981 -1.118 . . . . 1.15 107.981 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.95 -33.27 75.0 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.304 -0.872 . . . . 1.19 110.899 -178.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -65.55 -26.13 67.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.756 -1.215 . . . . 1.95 109.129 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -68.39 -35.35 77.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.819 . . . . 2.05 109.419 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 33.9 mt -51.61 -39.42 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.15 109.233 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.02 -56.34 12.08 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.709 -0.796 . . . . 2.15 109.371 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.23 83.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.43 -0.794 . . . . 0.15 110.318 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 m -68.18 -46.78 69.74 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.188 -0.945 . . . . 0.13 109.912 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.96 -48.63 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.113 -0.992 . . . . 0.18 108.718 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -62.0 -17.88 58.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 1.03 109.275 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.16 -54.3 6.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 2.02 110.411 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 22' ' ' LEU . 18.1 mt -94.13 10.68 32.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.336 -0.853 . . . . 0.35 110.653 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.91 -1.119 . . . . 1.18 109.174 179.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.4 p90 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.572 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.6 OUTLIER -127.99 84.16 2.22 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 -179.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.57 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -135.49 137.82 42.51 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.228 -0.92 . . . . 0.0 109.466 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -138.7 -86.48 0.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.504 -0.748 . . . . 0.0 109.34 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.636 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.38 -175.42 3.25 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.193 -0.942 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -70.09 148.4 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.913 0.863 . . . . 0.0 112.495 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 m -100.96 95.55 6.67 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.92 45.0 1.04 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.926 -1.109 . . . . 0.0 110.149 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -133.99 0.06 OUTLIER Glycine 0 N--CA 1.483 1.773 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.47 22.99 0.1 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 N-CA-C 109.233 -1.103 . . . . 0.0 109.233 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.7 t -78.91 -26.41 43.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -85.28 168.3 14.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.136 -0.977 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.638 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.326 -0.62 . . . . 2.89 109.326 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 3' ' ' LYS . 94.7 t -94.94 166.75 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.3 109.913 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.601 ' N ' HG12 ' A' ' 2' ' ' VAL . 75.5 tttt -152.28 121.21 6.59 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.326 -0.858 . . . . 1.97 108.735 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -88.55 134.61 33.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.892 . . . . 0.98 110.009 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.9 mm -106.8 108.69 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.131 -1.063 . . . . 0.19 108.131 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -98.58 -7.07 28.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 1.97 109.407 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.8 p -153.8 149.64 27.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.196 -0.94 . . . . 0.23 109.654 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -52.65 -26.72 14.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.456 -0.778 . . . . 1.9 109.603 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.0 m -60.96 -42.56 98.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.052 . . . . 0.25 109.274 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.25 61.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.425 -0.797 . . . . 0.2 109.766 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -60.74 -69.23 0.24 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.148 -0.97 . . . . 0.21 110.289 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -55.16 -41.19 71.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.221 -0.925 . . . . 2.47 109.666 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -59.5 -37.23 77.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.19 -0.944 . . . . 2.1 109.574 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -48.78 80.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.2 109.278 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.9 mt -63.5 -40.6 97.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.481 -0.762 . . . . 0.62 110.005 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.13 -47.74 81.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 1.09 109.784 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.64 -9.81 59.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.3 109.756 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.99 -16.94 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.009 . . . . 0.24 109.418 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.9 -113.5 3.66 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.675 -1.37 . . . . 0.28 109.675 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.57 3.02 2.5 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.453 -1.028 . . . . 2.21 109.305 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -68.37 168.69 12.08 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.114 -0.991 . . . . 1.9 109.13 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.34 161.42 19.67 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.852 -1.166 . . . . 0.17 107.852 179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.625 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.38 105.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.856 -1.153 . . . . 0.12 109.719 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -102.59 130.52 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.565 -0.902 . . . . 0.09 108.565 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.66 140.81 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.586 -0.696 . . . . 0.17 109.601 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -110.08 98.01 7.38 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.164 -0.68 . . . . 0.96 109.164 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.03 81.15 9.01 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.173 -1.047 . . . . 0.24 108.173 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.3 m -107.33 -162.46 0.84 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.595 -0.691 . . . . 1.03 109.17 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.3 125.74 18.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.702 -0.851 . . . . 0.26 108.702 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -64.61 -32.78 74.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.656 -0.653 . . . . 0.32 111.303 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 62.6 p-90 -87.02 -10.35 53.29 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.801 -1.187 . . . . 0.44 110.301 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -98.88 123.59 43.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.265 -0.897 . . . . 0.32 109.722 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.67 -54.65 21.32 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.773 -0.727 . . . . 0.36 111.763 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -47.46 -38.07 26.86 Favored 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 121.61 1.54 . . . . 0.44 111.746 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.96 -61.43 1.98 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.834 -1.167 . . . . 0.81 109.04 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -59.34 -16.4 22.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.441 -0.787 . . . . 1.92 109.959 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.4 ttt -61.72 -19.17 62.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.162 -0.961 . . . . 3.13 110.301 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' HG3' ' A' ' 75' ' ' PRO . 8.8 mt -98.73 12.09 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.184 -0.948 . . . . 0.28 110.244 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.9 -31.92 3.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.095 -1.628 . . . . 1.62 112.613 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -64.28 -5.55 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.775 0 CA-C-N 119.842 0.979 . . . . 0.25 109.802 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -108.77 -78.23 0.59 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.956 -0.757 . . . . 0.3 108.956 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 91.9 t80 -41.36 -57.88 2.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.651 -0.656 . . . . 0.13 110.928 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.5 -29.97 70.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 0.41 110.078 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.3 m -64.81 -43.1 94.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.694 -1.254 . . . . 0.97 109.808 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.7 mt -49.74 -13.27 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.998 -1.064 . . . . 0.5 109.419 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' SER . 75.4 m -57.29 -35.66 70.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.15 -0.969 . . . . 0.51 109.723 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -93.89 -15.6 24.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.232 -0.917 . . . . 2.0 110.129 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -91.16 -24.06 20.07 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.121 -0.987 . . . . 2.16 109.352 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -134.34 69.82 1.46 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.24 109.307 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.4 p -67.06 -5.09 11.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.303 -0.873 . . . . 0.17 109.031 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.5 t30 -94.72 -2.46 51.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.323 -0.86 . . . . 0.34 109.402 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.03 146.39 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mm -98.11 125.52 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 0.17 109.476 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.9 m-85 -113.12 132.1 55.58 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.408 -0.807 . . . . 0.11 108.919 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -113.87 172.09 7.19 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.432 -0.792 . . . . 0.12 109.065 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.78 143.03 33.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.768 -1.197 . . . . 1.31 107.768 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.49 137.24 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.11 -0.994 . . . . 0.14 110.868 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.06 103.31 15.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.754 -1.202 . . . . 1.08 107.754 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 108' ' ' HOH . 19.6 m -61.29 -13.04 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.27 111.316 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.553 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 5.8 m-20 -101.01 -41.11 6.92 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.982 -1.074 . . . . 1.11 111.002 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 -12.96 30.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.945 -1.097 . . . . 1.12 109.27 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.67 46.63 2.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.575 -0.898 . . . . 0.17 108.575 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -56.81 -13.74 2.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 2.22 110.681 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.56 -39.76 77.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.867 -1.146 . . . . 1.11 109.351 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.5 t -74.76 -45.32 44.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.235 -0.916 . . . . 0.19 108.685 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.95 -33.35 75.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.84 . . . . 0.22 108.904 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.2 m -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.381 -0.824 . . . . 1.29 109.316 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 50.5 tt0 -63.69 -36.97 85.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.394 -0.816 . . . . 2.2 109.486 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.43 -2.99 59.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.174 -0.954 . . . . 0.33 109.636 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 68' ' ' GLU . 29.7 mp0 48.69 56.22 7.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.891 . . . . 2.34 110.255 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 t -78.43 131.96 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.28 108.759 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -126.51 -0.5 6.87 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.461 -0.775 . . . . 2.4 109.945 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.81 126.45 9.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.112 -0.992 . . . . 0.22 108.864 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.683 HG23 ' CE2' ' B' ' 5' ' ' TYR . 16.7 p -112.21 150.79 43.03 Favored Pre-proline 0 N--CA 1.501 2.1 0 N-CA-C 108.558 -0.904 . . . . 0.22 108.558 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.417 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.47 146.06 81.54 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 C-N-CA 124.935 -0.86 . . . . 0.2 109.991 -1.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -117.51 117.22 28.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.088 -1.078 . . . . 0.18 108.088 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.4 m-85 -93.71 114.35 26.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.15 108.999 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -114.99 137.57 51.85 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.527 -1.286 . . . . 1.03 107.527 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 24.4 m-85 -107.16 131.19 54.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.11 109.783 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.11 156.28 38.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.735 -0.839 . . . . 0.17 108.735 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -154.99 125.79 7.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.672 -1.232 . . . . 1.48 107.672 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 56.55 17.19 2.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.494 -0.754 . . . . 1.67 109.654 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' C ' ' NE2' ' A' ' 84' ' ' GLN . . . 95.65 -0.66 63.24 Favored Glycine 0 N--CA 1.498 2.818 0 N-CA-C 110.467 -1.053 . . . . 0.22 110.467 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.442 ' NE2' ' C ' ' A' ' 83' ' ' GLY . 40.9 mm-40 -110.09 149.7 29.66 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.237 -1.155 . . . . 2.08 110.347 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -86.2 142.72 28.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.58 -0.7 . . . . 1.7 109.136 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.04 -19.63 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.471 -0.768 . . . . 0.26 110.221 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 173.4 45.96 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.419 -1.372 . . . . 0.18 110.102 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -173.32 154.69 2.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 2.04 110.315 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -168.82 131.74 1.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.5 -0.75 . . . . 0.14 110.092 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -103.36 -167.95 1.45 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.195 -0.941 . . . . 0.17 108.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.33 128.55 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.48 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.28 96.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -1.174 . . . . 0.2 110.452 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.68 70.86 1.36 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.173 -1.047 . . . . 1.15 108.173 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.72 -31.69 71.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.339 -0.851 . . . . 1.19 110.478 -178.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.01 -28.12 69.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.878 -1.139 . . . . 1.95 109.15 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -71.07 -34.54 71.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.539 -0.725 . . . . 2.05 109.678 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -51.2 -38.31 51.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.184 -0.948 . . . . 0.15 109.309 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.0 -56.08 13.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.38 -0.825 . . . . 2.15 109.805 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.15 111.048 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.3 m -66.53 -45.46 79.39 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.99 -1.069 . . . . 0.13 110.282 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.42 -53.73 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.18 109.278 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.23 -17.47 28.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 1.03 109.724 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -76.91 -60.55 2.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 2.02 110.317 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt -91.73 19.68 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.375 -0.828 . . . . 0.35 110.49 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.062 . . . . 1.18 109.307 179.465 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' CG ' ' O ' ' B' ' 2' ' ' ARG . 3.8 ptm180 -164.27 62.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.022 . . . . 0.0 109.661 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.486 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.3 m-85 -99.99 162.26 13.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.03 -1.044 . . . . 0.0 108.995 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -145.69 -110.43 0.1 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.2 -0.938 . . . . 0.0 109.515 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.683 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -110.37 -172.25 2.0 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.999 -1.063 . . . . 0.0 110.828 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.7 t -68.87 148.7 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 121.842 0.83 . . . . 0.0 112.279 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -101.37 95.32 6.42 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.669 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.1 pt-20 -83.25 47.57 1.26 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.07 -1.019 . . . . 0.0 110.393 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.79 -128.53 0.26 Allowed Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -68.38 26.94 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 CA-C-N 119.202 1.501 . . . . 0.0 109.122 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 34.2 t -84.9 -4.05 58.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.331 -0.856 . . . . 0.0 109.514 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -141.92 160.55 39.98 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.349 -0.844 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.535 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.407 -0.59 . . . . 2.89 109.407 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.2 t -94.79 151.54 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.204 -0.935 . . . . 0.3 109.72 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -153.11 135.64 15.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.158 -0.964 . . . . 1.97 108.585 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -86.93 137.55 32.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.98 109.975 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -119.39 85.44 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.489 -0.93 . . . . 0.19 108.489 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -95.77 1.88 53.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 1.97 109.602 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 p -150.5 145.31 25.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 0.23 109.83 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -51.7 -25.13 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.445 -0.784 . . . . 1.9 109.608 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -61.31 -50.71 71.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.25 110.633 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.58 -24.46 64.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.2 110.21 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -59.77 -65.71 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 0.21 110.141 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -55.93 -44.95 78.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.987 . . . . 2.47 109.738 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -58.9 -35.95 73.9 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.359 -0.838 . . . . 2.1 110.151 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.96 96.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.2 109.62 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.62 -49.21 71.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.62 109.797 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -63.37 -39.51 94.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 1.09 109.883 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -16.5 55.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.3 109.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.27 -6.06 21.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.133 -0.98 . . . . 0.24 109.624 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.96 -110.92 3.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.468 -1.453 . . . . 0.28 109.468 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -139.84 3.04 2.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.309 -1.112 . . . . 2.21 109.58 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.47 170.33 10.76 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.099 -1.001 . . . . 1.9 109.181 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.64 159.19 19.5 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.428 -0.953 . . . . 0.17 108.428 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.2 107.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.858 -1.151 . . . . 0.12 109.642 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -105.14 131.5 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.831 -0.803 . . . . 0.09 108.831 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.79 138.08 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.672 -0.643 . . . . 0.17 109.912 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -110.9 101.7 10.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.667 -0.646 . . . . 0.96 109.348 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 47.0 m-85 -84.83 81.42 8.89 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.941 -1.133 . . . . 0.24 107.941 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.2 m -113.26 150.33 32.57 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.696 -0.627 . . . . 1.03 109.897 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.33 127.43 37.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.268 -0.895 . . . . 0.26 109.067 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -67.57 -26.35 66.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.244 -0.91 . . . . 0.32 110.697 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.444 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.7 p-90 -86.84 -14.85 40.9 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.924 -1.11 . . . . 0.44 109.958 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.84 128.77 41.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.32 110.046 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.94 -61.16 5.44 Favored Glycine 0 N--CA 1.489 2.169 0 O-C-N 121.62 -0.675 . . . . 0.36 111.443 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.8 Cg_exo -45.37 -33.78 9.46 Favored 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.04 1.827 . . . . 0.44 111.642 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.79 -61.27 2.03 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.912 -1.117 . . . . 0.81 108.69 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -60.85 -17.63 51.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.63 -0.668 . . . . 1.92 110.307 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -60.86 -21.91 63.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.006 . . . . 3.13 110.198 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 38' ' ' ILE . 52.9 mt -96.99 13.91 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.28 110.781 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.43 -32.03 2.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.46 -1.4 . . . . 1.62 112.295 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.73 -2.59 5.51 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 CA-C-N 119.699 0.928 . . . . 0.25 109.905 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 45.7 m-85 -111.2 -80.61 0.58 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.811 -0.811 . . . . 0.3 108.811 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 82.8 t80 -40.35 -57.06 1.85 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.697 -0.627 . . . . 0.13 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -66.86 -34.26 77.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.052 -1.03 . . . . 0.41 110.189 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.0 p -64.03 -38.41 90.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.694 -1.254 . . . . 0.97 109.938 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.91 -17.28 0.55 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 0.5 109.234 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 49.7 m -57.06 -34.46 68.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.51 109.686 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.22 -15.23 26.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 2.0 109.998 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -91.75 -23.79 19.64 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.129 -0.982 . . . . 2.16 109.225 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -132.92 71.33 1.47 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.542 -0.724 . . . . 0.24 109.067 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p -66.93 -3.79 7.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.17 109.124 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 20.3 t-20 -95.67 -3.43 46.13 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.358 -0.839 . . . . 0.34 109.525 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.5 t -114.19 148.69 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.486 -0.759 . . . . 0.12 109.549 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.31 131.78 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.871 -0.789 . . . . 0.17 108.871 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.518 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.7 m-85 -117.7 131.84 56.56 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.902 . . . . 0.11 109.081 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.5 mp -113.15 170.82 7.94 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.39 -0.819 . . . . 0.12 108.941 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -143.0 140.72 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.39 -0.967 . . . . 1.31 108.39 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.6 t -136.7 140.88 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.892 . . . . 0.14 110.121 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 60' ' ' ASP . 6.9 t70 -99.29 92.41 5.42 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.089 -1.078 . . . . 1.08 108.089 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 74' ' ' THR . 13.0 m -52.06 -0.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.424 -0.797 . . . . 0.27 111.374 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 58' ' ' ASP . 60.1 m-20 -113.47 -50.06 2.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.993 -1.067 . . . . 1.11 111.455 -178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.93 -7.48 52.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.872 -1.143 . . . . 1.12 109.085 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.56 40.0 3.84 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.076 -1.083 . . . . 0.17 108.076 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -54.58 -10.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.503 -0.748 . . . . 2.22 110.164 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.3 77.2 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.11 -0.994 . . . . 1.11 108.645 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.44 -45.61 39.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.688 -0.856 . . . . 0.19 108.688 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.27 -31.05 72.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.22 109.165 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.2 m -63.7 -54.21 39.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 1.29 109.173 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.98 -30.52 71.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 2.2 109.492 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.77 -7.01 56.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.233 -0.917 . . . . 0.33 109.637 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 49.06 55.11 9.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 2.34 110.187 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.32 137.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 0.28 109.143 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -130.42 -1.26 4.44 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.368 -0.832 . . . . 2.4 109.763 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.36 130.1 11.62 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.079 -1.013 . . . . 0.22 109.127 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.638 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.8 p -113.04 151.62 44.3 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 108.641 -0.874 . . . . 0.22 108.641 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.571 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.18 143.5 73.14 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.874 -0.886 . . . . 0.2 109.909 -1.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.58 111.86 22.58 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.38 -0.97 . . . . 0.18 108.38 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' CD1' HD21 ' A' ' 97' ' ' LEU . 89.1 m-85 -87.18 125.74 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.777 -1.202 . . . . 0.15 108.856 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.473 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 11.0 mt-30 -124.3 134.66 53.14 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.403 -1.332 . . . . 1.03 107.403 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 24' ' ' VAL . 27.1 m-85 -106.66 132.7 52.35 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.61 0.719 . . . . 0.11 110.339 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' CZ ' ' NZ ' ' A' ' 85' ' ' LYS . 62.5 m-85 -127.16 154.86 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.874 -0.787 . . . . 0.17 108.874 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -157.69 123.0 4.51 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.395 -1.335 . . . . 1.48 107.395 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 56.0 32.08 19.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.391 -0.818 . . . . 1.67 109.762 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.75 88.93 Favored Glycine 0 N--CA 1.492 2.404 0 C-N-CA 119.929 -1.129 . . . . 0.22 110.646 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -111.18 145.75 38.11 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.263 -1.139 . . . . 2.08 110.215 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.561 ' NZ ' ' CZ ' ' A' ' 80' ' ' PHE . 9.3 ttmm -87.07 136.24 32.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.52 -0.918 . . . . 1.7 108.52 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.81 -14.21 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.408 -0.807 . . . . 0.26 110.941 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -170.13 166.89 40.07 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.078 -1.534 . . . . 0.18 110.475 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -173.71 147.45 1.39 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -1.095 . . . . 2.04 110.145 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -168.97 133.17 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -0.785 . . . . 0.14 110.266 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.76 -167.88 1.45 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.166 -0.959 . . . . 0.17 108.664 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.31 131.63 3.38 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.174 -1.57 . . . . 0.13 109.174 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.81 95.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -1.17 . . . . 0.2 110.627 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.47 71.9 1.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.57 -1.27 . . . . 1.15 107.57 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -60.61 -32.62 71.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.416 -0.803 . . . . 1.19 110.494 -178.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.22 -26.35 68.08 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.055 . . . . 1.95 109.154 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -69.8 -36.39 75.64 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.291 -0.881 . . . . 2.05 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.77 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.9 mt -52.37 -36.2 53.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.779 -1.2 . . . . 0.15 108.621 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.51 -54.63 21.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.418 -0.801 . . . . 2.15 109.258 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.13 93.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.15 110.379 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -65.25 -46.5 80.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.226 -0.921 . . . . 0.13 110.0 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.68 -51.47 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.138 -0.976 . . . . 0.18 108.513 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.86 -16.83 53.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 1.03 109.581 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -76.73 -61.62 1.91 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 2.02 110.406 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.6 mt -90.37 19.58 5.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.475 -0.766 . . . . 0.35 110.572 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.86 -1.15 . . . . 1.18 109.272 179.409 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.412 ' H3 ' ' HD1' ' B' ' 1' ' ' PHE . 8.8 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' B' ' 2' ' ' ARG . 15.1 ttm180 -167.74 21.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 122.697 1.237 . . . . 0.0 109.177 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -103.55 157.95 16.69 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.681 -1.262 . . . . 0.0 109.918 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -150.68 -105.27 0.06 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.007 -1.058 . . . . 0.0 110.301 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.638 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -108.59 -173.55 2.3 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.988 -1.07 . . . . 0.0 111.622 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.426 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -70.25 149.39 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-O 122.008 0.909 . . . . 0.0 112.558 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.2 m -102.18 95.13 6.12 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.525 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.5 pt-20 -83.0 44.18 0.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.041 -1.037 . . . . 0.0 110.09 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.3 -130.73 0.07 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.34 23.13 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 119.242 1.521 . . . . 0.0 109.373 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -87.93 -7.85 56.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.181 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.503 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 35.8 t60 -156.17 -122.04 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.385 -0.822 . . . . 0.0 109.373 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.497 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.4 mtp . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.497 -0.556 . . . . 2.89 109.497 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 3' ' ' LYS . 87.6 t -94.72 156.09 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.241 -0.912 . . . . 0.3 109.416 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.9 tttp -154.68 122.68 5.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.236 -0.915 . . . . 1.97 109.189 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -89.94 135.33 33.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.364 -0.835 . . . . 0.98 109.896 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 mm -104.67 117.94 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.252 -1.388 . . . . 0.19 107.252 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -101.2 -16.3 17.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.013 -1.054 . . . . 1.97 109.571 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -154.43 159.97 41.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.135 -0.978 . . . . 0.23 109.62 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -51.61 -25.58 7.25 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 1.9 109.743 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.93 -50.17 74.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.25 110.25 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.54 -22.49 63.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.403 -0.81 . . . . 0.2 110.01 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.48 -66.23 0.55 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.21 109.844 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -55.45 -45.3 76.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 2.47 109.881 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -58.14 -35.83 72.07 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.196 -0.94 . . . . 2.1 109.806 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.23 86.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.02 -1.05 . . . . 0.2 109.576 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.11 -43.33 95.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.459 -0.776 . . . . 0.62 109.891 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -63.73 -41.23 98.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.09 109.791 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.49 59.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 0.3 109.526 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -6.22 23.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.195 -0.941 . . . . 0.24 109.726 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.97 -111.06 3.7 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.412 -1.475 . . . . 0.28 109.412 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 2.21 2.05 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.344 -1.092 . . . . 2.21 108.797 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 73.4 mttt -69.03 168.05 14.65 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.979 -1.075 . . . . 1.9 109.166 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.01 164.65 7.97 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.872 -1.158 . . . . 0.17 107.872 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.663 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.6 t -145.57 103.73 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.873 -1.142 . . . . 0.12 109.239 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.27 131.19 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.36 -0.838 . . . . 0.09 108.777 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -108.03 136.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.512 -0.742 . . . . 0.17 109.279 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -109.03 101.74 10.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.683 . . . . 0.96 109.158 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.1 m-85 -84.79 80.01 9.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.581 -1.266 . . . . 0.24 107.581 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.1 m -113.39 147.04 38.49 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.469 -0.567 . . . . 1.03 109.469 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.409 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -91.02 123.58 34.6 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.254 -0.904 . . . . 0.26 108.704 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.97 -22.15 66.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.32 110.314 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 56.6 p-90 -89.27 -20.21 24.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.129 -0.982 . . . . 0.44 110.057 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.93 127.04 36.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.32 110.073 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.04 -58.0 12.12 Favored Glycine 0 N--CA 1.492 2.384 0 CA-C-O 119.518 -0.601 . . . . 0.36 111.807 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.6 Cg_exo -47.51 -32.05 14.85 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 121.536 1.49 . . . . 0.44 111.126 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -61.38 2.02 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.06 -1.025 . . . . 0.81 109.085 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -59.18 -20.05 50.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.568 -0.707 . . . . 1.92 110.093 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.1 tpt -58.69 -21.18 53.91 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.071 -1.018 . . . . 3.13 110.289 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 38' ' ' ILE . 91.1 mt -99.95 9.74 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.132 -0.98 . . . . 0.28 111.363 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.31 -33.59 5.87 Favored Pre-proline 0 N--CA 1.486 1.363 0 O-C-N 119.952 -1.717 . . . . 1.62 112.457 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -62.47 -10.67 19.81 Favored 'Trans proline' 0 C--N 1.32 -0.972 0 CA-C-N 119.845 0.98 . . . . 0.25 110.398 -176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -103.54 -70.21 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.412 -0.805 . . . . 0.3 109.234 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -44.06 -50.66 8.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.499 -0.751 . . . . 0.13 110.593 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -68.91 -35.65 77.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.82 -1.175 . . . . 0.41 109.862 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -60.32 -41.53 93.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.825 -1.172 . . . . 0.97 109.874 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.9 mt -52.04 -17.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.074 -1.017 . . . . 0.5 109.423 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.8 m -57.47 -34.4 68.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.955 . . . . 0.51 109.59 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -94.45 -17.46 22.45 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.181 -0.949 . . . . 2.0 110.079 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -90.62 -21.3 21.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.054 -1.029 . . . . 2.16 109.174 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.25 68.65 1.46 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.473 -0.767 . . . . 0.24 109.133 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.8 p -67.01 -4.09 8.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.37 -0.831 . . . . 0.17 109.101 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.8 t30 -94.71 -1.15 53.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.34 109.461 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.8 t -117.53 148.14 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.519 -0.738 . . . . 0.12 109.426 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -98.55 132.46 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.333 -0.854 . . . . 0.17 109.037 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -116.38 132.42 56.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.408 -0.808 . . . . 0.11 109.38 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -115.59 172.82 6.88 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 0.12 108.783 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.88 146.75 33.24 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.069 -1.086 . . . . 1.31 108.069 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -142.75 140.44 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.014 -1.054 . . . . 0.14 110.733 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.0 t70 -98.28 99.25 10.44 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.291 -1.003 . . . . 1.08 108.291 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.2 m -56.87 -2.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.27 111.342 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 58' ' ' ASP . 17.0 m-20 -112.42 -43.38 3.51 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.207 -0.933 . . . . 1.11 110.455 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.18 -10.03 37.23 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.025 -1.047 . . . . 1.12 109.226 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.25 45.05 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.642 -0.873 . . . . 0.17 108.642 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.603 ' NE2' HH11 ' B' ' 4' ' ' ARG . 77.3 mt-30 -55.68 -14.61 2.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.465 -0.772 . . . . 2.22 109.866 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.27 -43.39 70.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.0 . . . . 1.11 109.207 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.35 -45.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.304 -0.873 . . . . 0.19 108.733 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.66 76.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.349 -0.844 . . . . 0.22 108.903 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -64.76 -49.92 68.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.262 -0.899 . . . . 1.29 109.291 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -63.09 -36.46 83.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.302 -0.874 . . . . 2.2 109.359 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.64 -3.9 58.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.288 -0.883 . . . . 0.33 109.451 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 46.79 54.04 9.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.388 -0.82 . . . . 2.34 110.298 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 10.4 t -79.09 134.71 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.166 -0.959 . . . . 0.28 109.17 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -130.29 4.21 4.76 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.342 -0.849 . . . . 2.4 109.95 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.596 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.47 125.51 8.55 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.907 -1.121 . . . . 0.22 109.105 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE1' ' B' ' 5' ' ' TYR . 10.9 p -111.07 151.86 43.32 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.368 -0.833 . . . . 0.22 109.148 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.421 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.52 142.45 73.13 Favored 'Cis proline' 0 N--CA 1.483 0.902 0 C-N-CA 124.825 -0.906 . . . . 0.2 110.137 -2.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -113.07 115.18 27.93 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 107.819 -1.178 . . . . 0.18 107.819 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.581 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -91.25 120.28 32.02 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.112 -0.992 . . . . 0.15 108.797 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.408 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 10.5 mt-30 -118.48 134.23 55.24 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.857 -1.164 . . . . 1.03 107.857 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.1 m-85 -108.57 128.09 54.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.63 -0.668 . . . . 0.11 109.817 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.4 156.93 36.29 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.498 -0.927 . . . . 0.17 108.498 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -155.19 125.34 6.69 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.525 -1.287 . . . . 1.48 107.525 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 55.59 30.85 16.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.486 -0.759 . . . . 1.67 109.931 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.16 5.56 89.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.243 -1.143 . . . . 0.22 110.243 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.94 147.12 37.75 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.314 -1.109 . . . . 2.08 110.119 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -85.39 145.46 27.47 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.161 -0.962 . . . . 1.7 109.138 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.7 -31.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.431 -0.793 . . . . 0.26 110.011 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.22 177.64 44.03 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.597 -1.287 . . . . 0.18 110.421 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -173.12 157.33 3.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.429 -1.042 . . . . 2.04 110.086 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.9 p90 -168.72 132.39 1.46 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.14 110.255 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -104.28 -170.34 1.76 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.214 -0.929 . . . . 0.17 109.011 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 125.72 3.98 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.109 -1.596 . . . . 0.13 109.109 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.55 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -1.199 . . . . 0.2 110.332 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.62 73.97 1.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.399 -0.963 . . . . 1.15 108.399 178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HZ2' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -60.83 -28.83 69.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.19 109.863 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -66.43 -31.28 71.93 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.981 . . . . 1.95 109.149 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -68.59 -34.71 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 2.05 109.372 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.581 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.6 mt -50.74 -36.23 35.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.982 -1.074 . . . . 0.15 108.454 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -67.01 -57.37 6.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.59 -0.694 . . . . 2.15 109.753 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.71 87.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.802 . . . . 0.15 110.875 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -67.03 -46.52 74.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.13 110.242 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.3 -52.08 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.19 -0.944 . . . . 0.18 108.864 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -59.96 -17.13 35.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.03 109.704 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -76.33 -62.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 2.02 110.084 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.4 mt -93.79 22.81 5.25 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 0.35 110.568 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 120.884 -1.135 . . . . 1.18 109.176 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.7 mtp180 -120.01 75.12 1.07 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.525 -0.735 . . . . 0.0 109.395 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.571 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.4 m-85 -130.05 159.18 37.54 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.316 -0.865 . . . . 0.0 109.239 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.603 HH11 ' NE2' ' A' ' 63' ' ' GLN . 11.0 tpt180 -149.17 -93.2 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE1' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -116.03 -166.29 1.13 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.893 -1.129 . . . . 0.0 110.457 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -71.28 150.99 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.904 0.859 . . . . 0.0 112.72 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.04 91.25 4.47 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.596 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -84.54 42.91 0.93 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 110.569 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.97 -135.36 0.09 OUTLIER Glycine 0 N--CA 1.483 1.8 0 N-CA-C 106.895 -2.482 . . . . 0.0 106.895 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.39 24.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 CA-C-N 119.297 1.549 . . . . 0.0 109.39 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.9 t -89.42 -57.2 2.97 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.339 -0.85 . . . . 0.0 109.371 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -79.66 131.47 35.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.612 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.576 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.471 -0.566 . . . . 2.89 109.471 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.2 t -94.68 168.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.295 -0.878 . . . . 0.3 109.696 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.612 ' N ' HG12 ' A' ' 2' ' ' VAL . 38.8 tptt -154.73 122.37 5.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.7 -0.852 . . . . 1.97 108.7 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -89.72 132.18 35.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.928 . . . . 0.98 109.629 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.01 112.72 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.059 -1.089 . . . . 0.19 108.059 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -103.27 -14.06 16.48 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -0.936 . . . . 1.97 109.871 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -152.38 159.48 43.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.071 -1.018 . . . . 0.23 109.935 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -52.6 -31.79 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.523 -0.736 . . . . 1.9 109.946 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -59.71 -45.7 91.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 0.25 110.111 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -28.72 66.7 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.2 109.879 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.24 -67.33 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.092 -1.005 . . . . 0.21 109.986 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.55 -43.77 76.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.871 . . . . 2.47 109.82 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -59.28 -36.04 74.83 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 2.1 109.696 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.47 97.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.068 . . . . 0.2 109.465 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.98 -47.32 80.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.358 -0.839 . . . . 0.62 109.829 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -63.62 -37.06 85.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 1.09 109.472 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -16.84 54.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.3 109.82 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.93 -9.91 54.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.24 109.779 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.71 -109.96 2.96 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.638 -1.385 . . . . 0.28 109.638 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -138.46 1.93 2.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -1.064 . . . . 2.21 109.609 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -69.4 167.91 15.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.045 -1.034 . . . . 1.9 108.899 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.69 163.16 9.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.187 -0.946 . . . . 0.17 108.567 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.2 t -145.4 103.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.018 -1.051 . . . . 0.12 109.505 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -102.08 133.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.402 -0.962 . . . . 0.09 108.402 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.22 134.9 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.592 -0.693 . . . . 0.17 109.669 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -106.07 102.84 12.24 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.966 -0.753 . . . . 0.96 108.966 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.499 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 41.1 m-85 -85.83 79.6 9.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.61 -1.256 . . . . 0.24 107.61 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -113.24 149.59 33.6 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.421 0.629 . . . . 1.03 109.843 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.77 130.26 38.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.26 108.677 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -66.88 -28.12 68.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.338 -0.851 . . . . 0.32 110.527 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 61.7 p-90 -87.86 -12.73 43.99 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.969 -1.082 . . . . 0.44 110.188 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.4 t -94.65 127.35 40.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.345 -0.847 . . . . 0.32 109.626 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.508 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.88 -56.34 8.32 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 120.805 -0.712 . . . . 0.36 111.614 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.8 Cg_exo -46.51 -37.12 19.44 Favored 'Trans proline' 0 C--N 1.319 -0.995 0 C-N-CA 121.898 1.732 . . . . 0.44 111.752 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.73 -58.62 3.18 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.844 -1.16 . . . . 0.81 108.953 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.47 -21.02 61.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 1.92 109.946 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.439 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.7 tpt -59.8 -21.07 60.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.283 -0.885 . . . . 3.13 109.85 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.0 mt -97.56 6.06 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.168 -0.958 . . . . 0.28 110.325 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.67 -33.1 7.92 Favored Pre-proline 0 C--N 1.306 -1.305 0 O-C-N 120.484 -1.385 . . . . 1.62 111.95 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.5 Cg_exo -61.15 -5.36 4.92 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.037 1.049 . . . . 0.25 109.828 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -110.39 -72.19 0.73 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.814 -0.81 . . . . 0.3 108.814 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -46.44 -56.84 5.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.414 -0.804 . . . . 0.13 110.468 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -65.72 -30.62 71.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.41 109.681 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -64.04 -41.2 97.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.939 -1.1 . . . . 0.97 109.576 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 71.4 mt -51.14 -16.61 0.51 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.192 -0.943 . . . . 0.5 109.506 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.2 m -56.57 -34.59 67.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.165 -0.96 . . . . 0.51 109.549 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -95.96 -18.4 20.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.241 -0.912 . . . . 2.0 110.304 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -88.99 -21.55 23.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.939 -1.101 . . . . 2.16 109.343 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -136.43 72.1 1.43 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.485 -0.759 . . . . 0.24 109.298 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.1 p -67.55 -6.01 17.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.355 -0.841 . . . . 0.17 109.157 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 19.5 t-20 -95.36 3.54 54.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.318 -0.864 . . . . 0.34 109.597 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -117.94 149.2 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.017 -0.735 . . . . 0.12 109.017 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -100.77 128.37 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.774 . . . . 0.17 109.104 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.0 m-85 -117.07 131.7 56.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.411 -0.806 . . . . 0.11 109.372 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.21 173.65 6.29 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.963 -0.754 . . . . 0.12 108.963 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.18 143.27 30.23 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.09 -1.078 . . . . 1.31 108.09 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.8 t -139.24 139.08 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.177 -0.952 . . . . 0.14 110.256 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -98.91 96.71 8.04 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.06 -1.089 . . . . 1.08 108.06 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG11 ' OH ' ' B' ' 5' ' ' TYR . 6.3 m -54.14 -6.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.27 111.38 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.507 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 30.9 m-20 -103.74 -46.5 4.5 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.928 -1.108 . . . . 1.11 110.519 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -92.67 -8.39 44.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.105 -0.997 . . . . 1.12 109.484 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.3 43.56 3.02 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.789 -0.819 . . . . 0.17 108.789 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -56.44 -13.71 2.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.356 -0.84 . . . . 2.22 109.925 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.3 p30 -69.58 -39.76 77.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.044 -1.035 . . . . 1.11 108.996 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -74.05 -44.97 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.493 -0.929 . . . . 0.19 108.493 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.85 -33.68 76.24 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.488 -0.758 . . . . 0.22 109.297 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -64.36 -51.71 61.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 1.29 109.654 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -63.29 -35.57 80.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 2.2 109.676 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.34 -3.13 58.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.184 -0.948 . . . . 0.33 109.644 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 48.11 56.18 7.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.2 -0.938 . . . . 2.34 110.113 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.35 133.0 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.258 -0.901 . . . . 0.28 109.259 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.27 4.77 4.79 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 2.4 109.575 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.54 128.81 11.23 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.132 -0.98 . . . . 0.22 108.786 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.575 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.4 p -115.61 150.7 45.17 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.349 -0.844 . . . . 0.22 108.818 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -78.1 143.62 73.65 Favored 'Cis proline' 0 N--CA 1.484 0.939 0 C-N-CA 124.834 -0.903 . . . . 0.2 110.204 -1.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.78 111.74 22.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.713 -1.217 . . . . 0.18 107.713 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.6 m-85 -86.76 124.29 32.85 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.967 -1.093 . . . . 0.15 108.857 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.5 mt-30 -122.3 133.72 54.67 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.546 -1.279 . . . . 1.03 107.546 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 27.8 m-85 -108.1 127.44 53.81 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.551 0.691 . . . . 0.11 109.817 -178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.87 157.56 35.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.342 -0.984 . . . . 0.17 108.342 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -154.91 122.14 5.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.864 -1.161 . . . . 1.48 107.864 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? 56.27 27.38 11.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.524 -0.735 . . . . 1.67 109.759 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.56 5.28 86.95 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -112.33 146.9 37.45 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.285 -1.127 . . . . 2.08 109.998 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -85.61 143.24 28.56 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.393 -0.817 . . . . 1.7 109.212 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 m -128.18 -26.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.487 -0.758 . . . . 0.26 110.279 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.99 174.42 45.86 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.477 -1.344 . . . . 0.18 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -173.49 152.33 2.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.413 -1.051 . . . . 2.04 109.949 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.1 p90 -169.07 132.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.14 110.154 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -103.07 -163.7 1.01 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.139 -0.975 . . . . 0.17 108.743 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 84.42 126.02 1.36 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.576 -1.41 . . . . 0.13 109.576 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.09 94.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.263 -1.139 . . . . 0.2 110.459 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -140.24 73.64 1.43 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.889 -1.152 . . . . 1.15 107.889 178.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.06 -34.39 77.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.47 -0.769 . . . . 1.19 110.713 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -64.87 -26.1 68.18 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.902 -1.123 . . . . 1.95 109.145 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -69.0 -38.42 79.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.5 -0.75 . . . . 2.05 109.667 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.752 HD21 ' CD1' ' A' ' 77' ' ' PHE . 62.3 mt -51.11 -39.44 56.16 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.893 -1.129 . . . . 0.15 109.009 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -65.33 -54.45 28.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.764 . . . . 2.15 109.441 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.84 93.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.15 110.382 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.2 m -68.14 -45.5 73.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.224 -0.923 . . . . 0.13 109.943 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.9 -52.19 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 0.18 109.171 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -59.83 -16.17 26.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.03 109.649 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -78.35 -62.27 1.74 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 2.02 110.369 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.6 mt -92.6 19.2 7.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.503 -0.748 . . . . 0.35 111.117 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.836 -1.165 . . . . 1.18 109.137 179.22 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.8 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 8.5 mmm-85 -127.39 79.68 1.9 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.547 -0.721 . . . . 0.0 109.142 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.5 m-85 -137.76 151.91 48.65 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.207 -0.933 . . . . 0.0 109.269 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -150.23 -99.88 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 109.599 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.575 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -108.95 -175.98 2.92 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.065 -1.022 . . . . 0.0 110.463 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.76 151.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.938 0.875 . . . . 0.0 112.15 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.27 97.44 7.94 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.583 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -82.97 46.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.968 . . . . 0.0 110.281 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.19 -128.23 0.12 Allowed Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.24 25.52 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 119.001 1.401 . . . . 0.0 109.119 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.614 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.1 t -96.57 -47.23 6.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.333 -0.854 . . . . 0.0 110.087 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -144.13 134.88 25.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.532 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.289 0.566 . . . . 2.89 109.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.554 HG12 ' N ' ' A' ' 3' ' ' LYS . 42.0 t -94.77 167.13 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.873 . . . . 0.3 109.483 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.554 ' N ' HG12 ' A' ' 2' ' ' VAL . 47.1 tttm -153.63 120.32 5.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.239 -0.913 . . . . 1.97 109.125 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -90.17 132.51 35.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 0.98 109.855 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.5 mm -107.12 113.05 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.005 -1.109 . . . . 0.19 108.005 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -101.23 -9.74 20.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.25 -0.906 . . . . 1.97 109.895 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 p -152.97 155.55 37.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.23 109.855 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 42.9 tttm -52.05 -25.4 8.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.479 -0.763 . . . . 1.9 109.728 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.3 m -61.1 -49.38 77.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.107 -0.996 . . . . 0.25 110.15 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.12 -22.14 63.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.343 -0.848 . . . . 0.2 109.841 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.52 -66.41 0.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.061 -1.025 . . . . 0.21 110.069 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -55.66 -44.35 77.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 2.47 109.824 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -58.75 -35.97 73.6 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.947 . . . . 2.1 109.881 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -45.8 93.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.018 -1.051 . . . . 0.2 109.376 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.96 -48.14 77.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.44 -0.787 . . . . 0.62 109.475 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.9 -35.87 82.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 1.09 109.656 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.87 -19.5 48.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.3 109.661 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.77 -5.2 19.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.24 109.721 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.22 -110.53 3.42 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.459 -1.456 . . . . 0.28 109.459 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.55 3.96 2.34 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.359 -1.083 . . . . 2.21 109.489 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.9 mttp -70.62 172.85 7.91 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.19 -0.944 . . . . 1.9 109.505 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.94 161.16 19.1 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.137 -1.06 . . . . 0.17 108.137 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.99 103.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.909 -1.119 . . . . 0.12 109.561 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -100.34 132.77 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.705 -0.85 . . . . 0.09 108.705 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -108.34 138.58 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.501 -0.749 . . . . 0.17 109.837 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -108.49 99.4 8.8 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.161 -0.681 . . . . 0.96 109.161 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.94 76.72 9.35 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.83 -1.174 . . . . 0.24 107.83 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.4 m -113.35 151.16 31.6 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.675 -0.641 . . . . 1.03 109.673 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.84 129.18 37.85 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.589 -0.893 . . . . 0.26 108.589 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -66.58 -25.67 66.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.32 110.319 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.554 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.4 p-90 -90.78 -13.78 33.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.082 -1.011 . . . . 0.44 110.467 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.0 t -93.98 113.22 25.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.108 -0.995 . . . . 0.32 109.82 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -54.72 -55.82 25.56 Favored Glycine 0 N--CA 1.487 2.086 0 CA-C-O 119.518 -0.601 . . . . 0.36 111.994 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.8 Cg_exo -49.96 -39.49 49.71 Favored 'Trans proline' 0 C--N 1.316 -1.147 0 C-N-CA 121.459 1.439 . . . . 0.44 111.56 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.93 -59.62 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.828 -1.17 . . . . 0.81 108.948 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -60.83 -18.54 56.21 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.576 -0.703 . . . . 1.92 110.649 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 ttt -59.05 -16.58 19.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.098 -1.002 . . . . 3.13 110.531 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 38' ' ' ILE . 61.4 mt -99.86 15.17 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.152 -0.967 . . . . 0.28 111.082 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.06 -33.34 5.75 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 120.193 -1.567 . . . . 1.62 112.834 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.9 Cg_exo -66.11 -2.69 7.26 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 CA-C-N 119.648 0.91 . . . . 0.25 110.792 -176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.577 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 35.4 m-85 -113.57 -70.36 0.81 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.424 -0.798 . . . . 0.3 109.995 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -44.39 -49.96 9.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.401 -0.812 . . . . 0.13 110.413 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.42 -35.27 75.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.41 110.277 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -61.39 -41.25 96.81 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.782 -1.198 . . . . 0.97 110.562 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -50.69 -18.23 0.67 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.04 -1.037 . . . . 0.5 109.422 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -58.05 -29.95 65.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.51 109.809 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.03 -22.94 17.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.239 -0.913 . . . . 2.0 110.21 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -90.65 -18.75 24.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.005 -1.059 . . . . 2.16 109.497 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -136.22 67.39 1.46 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.437 -0.789 . . . . 0.24 109.358 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -68.36 -3.9 12.7 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.373 -0.829 . . . . 0.17 109.238 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 7.2 t30 -95.25 0.72 54.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.261 -0.899 . . . . 0.34 109.852 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.7 t -117.67 150.84 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.77 -0.826 . . . . 0.12 108.77 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -100.11 130.8 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.387 -0.821 . . . . 0.17 109.403 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.1 m-85 -118.14 130.17 55.95 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.51 -0.744 . . . . 0.11 109.217 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.69 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.989 -0.745 . . . . 0.12 108.989 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -143.36 145.41 32.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.014 -1.106 . . . . 1.31 108.014 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.8 t -144.36 140.08 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.008 -1.058 . . . . 0.14 111.079 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.9 t70 -100.49 111.48 23.74 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.286 -1.005 . . . . 1.08 108.286 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.88 -10.13 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.27 111.182 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.518 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 62.3 m-20 -99.72 -43.12 6.57 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.016 -1.052 . . . . 1.11 111.021 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' HB2' HH12 ' B' ' 2' ' ' ARG . 1.5 t70 -93.4 -14.75 26.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 1.12 109.409 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -121.25 46.45 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.6 -0.889 . . . . 0.17 108.6 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -55.01 -13.94 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 2.22 109.958 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 p-10 -70.52 -41.09 73.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.201 -0.937 . . . . 1.11 109.397 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.06 -46.46 45.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.321 -0.862 . . . . 0.19 108.869 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.3 75.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.326 -0.859 . . . . 0.22 109.319 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -64.01 -52.62 58.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 1.29 109.549 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -64.02 -31.53 72.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 2.2 109.763 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -0.6 57.35 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.234 -0.916 . . . . 0.33 110.078 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 47.12 52.13 12.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 2.34 110.111 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.86 132.18 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.179 -0.95 . . . . 0.28 109.369 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -129.36 2.52 5.11 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.409 -0.807 . . . . 2.4 109.807 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 129.84 11.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.181 -0.95 . . . . 0.22 109.199 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.2 p -114.44 150.34 43.67 Favored Pre-proline 0 N--CA 1.504 2.249 0 O-C-N 121.423 -0.798 . . . . 0.22 108.855 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.551 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.91 143.81 74.56 Favored 'Cis proline' 0 N--CA 1.484 0.916 0 C-N-CA 125.014 -0.828 . . . . 0.2 110.008 -1.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -113.67 110.89 20.93 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.909 -1.145 . . . . 0.18 107.909 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -88.06 117.14 26.72 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.046 -1.034 . . . . 0.15 108.873 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -116.39 135.31 53.96 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.738 -1.208 . . . . 1.03 107.738 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' HG22 ' A' ' 24' ' ' VAL . 24.9 m-85 -108.36 125.98 52.34 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.547 0.689 . . . . 0.11 110.054 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.22 156.39 32.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.106 -1.072 . . . . 0.17 108.106 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -155.5 123.27 5.67 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.361 -1.348 . . . . 1.48 107.361 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.5 mttt 58.19 19.79 6.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.706 -0.621 . . . . 1.67 109.643 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.77 2.8 74.95 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.776 -1.329 . . . . 0.22 109.776 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.07 149.03 31.37 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.465 -1.02 . . . . 2.08 109.699 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -86.61 144.63 27.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.224 -0.923 . . . . 1.7 109.551 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.01 -12.91 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.456 -0.777 . . . . 0.26 110.226 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.89 174.4 40.76 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.394 -1.384 . . . . 0.18 110.678 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.76 156.77 2.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -1.062 . . . . 2.04 110.232 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.78 130.49 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.725 . . . . 0.14 109.874 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 p -103.04 -161.45 0.84 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.138 -0.976 . . . . 0.17 109.084 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 128.12 0.58 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.192 -1.563 . . . . 0.13 109.192 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.64 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -1.2 . . . . 0.2 110.297 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.19 68.2 1.36 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.971 -1.122 . . . . 1.15 107.971 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.3 ptpt -60.12 -37.69 80.79 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.682 -0.636 . . . . 1.19 110.982 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.98 -27.96 69.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.806 -1.184 . . . . 1.95 109.514 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -70.15 -34.06 72.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 2.05 109.625 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.5 mt -49.32 -35.53 18.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 0.15 108.827 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.77 -55.12 14.26 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.732 -0.787 . . . . 2.15 109.497 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.15 110.945 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 48.8 m -65.8 -44.48 85.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.993 -1.067 . . . . 0.13 110.519 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.22 -51.97 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.995 -1.066 . . . . 0.18 108.845 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -61.04 -17.31 51.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.192 -0.943 . . . . 1.03 109.582 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.01 -62.36 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 2.02 109.991 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.7 mt -91.35 22.43 3.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.403 -0.811 . . . . 0.35 110.348 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 1.18 109.308 179.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 27.9 p90 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.3 mtt-85 -121.88 72.68 1.04 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.554 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -124.06 154.57 39.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.446 -0.783 . . . . 0.0 109.03 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -148.15 -104.27 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.329 -0.857 . . . . 0.0 109.244 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.9 p90 -112.23 -167.53 1.2 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.139 -0.975 . . . . 0.0 110.529 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.44 146.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.861 0.839 . . . . 0.0 112.264 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.31 95.25 6.39 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.63 42.95 0.8 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.0 109.745 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.57 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -70.76 24.7 0.2 Allowed 'Trans proline' 0 C--N 1.322 -0.828 0 CA-C-N 119.297 1.549 . . . . 0.0 108.949 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.57 ' H ' ' C ' ' B' ' 9' ' ' GLY . 13.1 t -89.8 -18.64 25.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -55.58 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 109.63 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 CA-C-O 117.997 -1.446 . . . . 0.0 109.606 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.405 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.476 -0.564 . . . . 2.89 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.7 t -94.57 153.74 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.205 -0.934 . . . . 0.3 109.272 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -154.61 126.96 7.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.217 -0.927 . . . . 1.97 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -90.2 135.05 33.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.848 . . . . 0.98 110.035 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.2 mm -108.81 112.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.097 -1.075 . . . . 0.19 108.097 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 19.3 mp0 -101.52 -13.22 17.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.144 -0.973 . . . . 1.97 109.48 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 p -152.39 156.15 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.23 109.898 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.69 -23.8 4.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.48 -0.762 . . . . 1.9 109.637 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -60.28 -51.74 68.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.25 110.134 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.8 -22.34 63.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -0.832 . . . . 0.2 109.803 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.15 -66.09 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.057 -1.027 . . . . 0.21 109.906 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -54.58 -45.73 73.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.294 -0.879 . . . . 2.47 109.605 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -59.02 -36.34 74.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.357 -0.839 . . . . 2.1 110.189 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.2 109.286 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.91 -44.11 90.65 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.431 -0.793 . . . . 0.62 109.677 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -63.48 -39.67 95.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.09 109.475 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.7 -15.58 57.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.3 109.742 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -5.74 20.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.24 109.576 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.7 -107.55 2.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.28 109.643 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -139.9 4.18 2.07 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.254 -1.145 . . . . 2.21 109.459 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 39.2 mttp -69.58 169.68 12.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.13 -0.981 . . . . 1.9 109.16 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.78 163.67 13.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.673 -1.232 . . . . 0.17 107.673 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.4 t -146.57 106.56 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.759 -1.213 . . . . 0.12 109.628 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -102.51 133.35 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.325 -0.859 . . . . 0.09 108.875 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -110.41 139.28 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.671 -0.643 . . . . 0.17 109.707 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -108.6 98.57 8.06 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.194 -0.669 . . . . 0.96 109.194 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 74' ' ' THR . 43.4 m-85 -85.38 77.72 9.88 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.961 -1.126 . . . . 0.24 107.961 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.2 m -105.05 -164.52 1.05 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.527 0.679 . . . . 1.03 109.192 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.86 123.06 15.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.611 -0.885 . . . . 0.26 108.611 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -64.15 -28.27 69.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.54 -0.725 . . . . 0.32 110.787 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 49.5 p-90 -88.26 -14.4 38.5 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.919 -1.113 . . . . 0.44 110.093 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.19 123.28 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.193 -0.942 . . . . 0.32 109.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.37 -54.27 27.61 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 120.911 -0.661 . . . . 0.36 111.911 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -50.27 -39.84 52.58 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.602 1.535 . . . . 0.44 111.758 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.08 -56.15 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.782 -1.199 . . . . 0.81 108.958 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -59.74 -21.31 60.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.578 -0.701 . . . . 1.92 109.842 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.9 ttt -61.93 -18.07 59.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 3.13 110.778 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -100.75 16.12 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.109 -0.995 . . . . 0.28 110.9 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.27 -33.01 3.03 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.301 -1.5 . . . . 1.62 113.037 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -64.2 -9.21 18.84 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 CA-C-N 119.563 0.88 . . . . 0.25 110.866 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -103.16 -71.57 0.72 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.287 -0.883 . . . . 0.3 109.506 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -43.3 -51.1 6.46 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.641 -0.662 . . . . 0.13 110.963 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -69.07 -36.44 77.63 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.964 -1.085 . . . . 0.41 110.601 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 46' ' ' SER . 56.2 p -61.26 -39.14 89.26 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.79 -1.194 . . . . 0.97 110.67 -179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.5 mt -50.55 -15.68 0.29 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.5 109.646 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.405 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.3 m -57.62 -30.79 65.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.51 109.889 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -95.04 -18.92 20.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.06 -1.025 . . . . 2.0 110.078 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -90.95 -21.79 21.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.143 -0.973 . . . . 2.16 109.462 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -133.89 69.31 1.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.534 -0.729 . . . . 0.24 109.284 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.4 p -67.04 -4.26 9.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.363 -0.835 . . . . 0.17 108.96 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.1 t30 -95.9 -0.93 50.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.34 109.817 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.18 149.67 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.462 -0.774 . . . . 0.12 109.762 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.6 mm -99.87 128.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.507 -0.746 . . . . 0.17 109.038 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.5 m-85 -111.63 129.7 56.0 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.384 -0.823 . . . . 0.11 109.129 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -113.01 171.08 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.934 -0.765 . . . . 0.12 108.934 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.86 143.49 33.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.167 -1.049 . . . . 1.31 108.167 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.9 t -141.53 136.07 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.103 -0.998 . . . . 0.14 110.737 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.99 105.91 18.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.836 -1.172 . . . . 1.08 107.836 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 108' ' ' HOH . 21.2 m -63.44 -8.51 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -0.918 . . . . 0.27 111.156 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -102.36 -42.43 6.0 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.988 -1.07 . . . . 1.11 110.481 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -93.89 -10.16 34.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 1.12 109.749 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.75 48.68 1.74 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.341 -0.85 . . . . 0.17 108.894 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -55.91 -15.54 3.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.453 -0.779 . . . . 2.22 110.158 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -42.96 70.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.067 -1.021 . . . . 1.11 109.256 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -73.06 -45.51 54.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.19 108.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.53 73.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.32 -0.863 . . . . 0.22 109.124 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 m -64.01 -55.53 21.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.823 . . . . 1.29 109.354 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.1 -30.36 71.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 2.2 109.672 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -4.47 58.52 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.308 -0.87 . . . . 0.33 109.646 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 45.8 50.68 10.91 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.215 -0.928 . . . . 2.34 110.17 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.1 t -80.18 133.02 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.28 109.137 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -131.03 5.92 4.55 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.365 -0.834 . . . . 2.4 109.878 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.3 126.4 9.16 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.166 -0.959 . . . . 0.22 108.841 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.6 p -113.53 150.7 43.65 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.375 -0.828 . . . . 0.22 109.019 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.501 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.27 144.73 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.051 0 C-N-CA 124.876 -0.885 . . . . 0.2 109.818 -1.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -115.22 111.85 21.59 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 107.873 -1.158 . . . . 0.18 107.873 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.503 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -86.35 125.33 33.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.813 -1.18 . . . . 0.15 108.875 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -123.13 133.47 54.27 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.89 -1.152 . . . . 1.03 107.89 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 24' ' ' VAL . 26.2 m-85 -107.9 126.04 52.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.518 -0.739 . . . . 0.11 109.675 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -123.16 157.85 32.06 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.833 -0.803 . . . . 0.17 108.833 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -154.42 122.72 6.05 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.137 -1.431 . . . . 1.48 107.137 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? 55.97 34.48 23.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 1.67 109.455 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 5.31 78.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.089 -1.204 . . . . 0.22 110.089 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -109.86 145.98 35.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.321 -1.105 . . . . 2.08 110.37 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.05 141.89 29.95 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.227 -0.921 . . . . 1.7 109.557 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.99 -20.23 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.398 -0.814 . . . . 0.26 110.429 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 173.03 46.0 Favored Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.46 -1.352 . . . . 0.18 110.433 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -173.99 152.37 1.91 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.269 -1.136 . . . . 2.04 110.141 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.2 p90 -168.98 132.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.14 110.312 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.6 p -103.15 -167.29 1.37 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.201 -0.937 . . . . 0.17 108.784 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.61 126.76 2.72 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.504 -1.438 . . . . 0.13 109.504 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.542 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.1 93.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.2 110.555 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -141.15 75.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.025 -1.102 . . . . 1.15 108.025 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.67 -31.52 72.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.54 -0.725 . . . . 1.19 110.269 -178.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.35 -28.16 68.45 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.103 -0.998 . . . . 1.95 109.452 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.77 -34.5 75.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 2.05 109.304 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.4 mt -51.36 -36.61 43.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.15 108.651 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -67.29 -56.01 11.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 2.15 109.666 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.24 91.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.809 . . . . 0.15 110.71 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 m -66.89 -48.01 70.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 0.13 110.487 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -60.91 -50.99 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.18 109.113 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -60.6 -17.24 45.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 1.03 109.539 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -77.29 -61.46 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 2.02 109.985 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.21 21.37 4.41 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.493 -0.755 . . . . 0.35 110.24 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.493 1.687 0 O-C-N 120.901 -1.124 . . . . 1.18 109.294 179.553 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.1 p90 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 84.6 mtt180 -147.07 55.01 1.1 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.089 -1.007 . . . . 0.0 109.467 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.492 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.5 m-85 -103.96 159.01 16.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.33 -0.856 . . . . 0.0 109.09 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.54 -110.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.122 -0.986 . . . . 0.0 109.472 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.8 p90 -108.68 -170.28 1.64 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.619 -1.301 . . . . 0.0 110.645 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.28 145.84 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.71 0.767 . . . . 0.0 112.518 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 m -101.48 95.02 6.2 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.84 46.71 1.12 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.033 -1.042 . . . . 0.0 110.033 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.13 -128.76 0.12 Allowed Glycine 0 N--CA 1.485 1.922 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 24.99 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.398 1.599 . . . . 0.0 109.515 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.8 t -87.61 -18.45 29.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -74.97 129.16 37.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.174 -0.954 . . . . 0.0 109.604 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.606 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.438 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 2.89 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.4 t -96.52 158.03 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.366 -0.834 . . . . 0.3 109.3 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.8 tptp -155.81 125.6 6.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.231 -0.918 . . . . 1.97 109.048 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.99 132.0 36.25 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.35 -0.843 . . . . 0.98 110.086 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -111.17 108.27 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.151 -1.055 . . . . 0.19 108.151 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -99.68 -8.7 24.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.224 -0.922 . . . . 1.97 109.867 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.8 p -152.28 152.87 32.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.114 -0.991 . . . . 0.23 109.71 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 34.4 tttt -51.6 -26.59 9.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 1.9 109.694 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 m -59.0 -48.56 81.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.25 109.953 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.31 -23.9 62.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.335 -0.853 . . . . 0.2 109.897 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.55 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.21 110.145 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -55.74 -45.84 77.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.082 -1.011 . . . . 2.47 109.368 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -59.11 -36.83 75.84 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.396 -0.815 . . . . 2.1 110.347 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.9 87.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.925 -1.109 . . . . 0.2 109.441 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -63.57 -39.71 95.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 0.62 109.561 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.59 -40.39 95.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.125 -0.984 . . . . 1.09 109.713 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -15.76 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.3 109.873 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -6.39 28.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.139 -0.975 . . . . 0.24 109.654 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.04 -111.73 4.33 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.253 -1.539 . . . . 0.28 109.253 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -137.14 4.56 2.72 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.295 -1.12 . . . . 2.21 109.405 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 58.1 mttt -70.56 167.62 18.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.04 . . . . 1.9 108.854 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.17 160.74 12.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.115 -0.991 . . . . 0.17 108.916 -179.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.7 t -143.53 109.12 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.274 -0.891 . . . . 0.12 109.701 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.86 134.32 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.91 -0.774 . . . . 0.09 108.91 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -110.71 134.85 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.625 -0.672 . . . . 0.17 109.552 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -106.03 102.01 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.566 -0.709 . . . . 0.96 109.196 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -86.55 78.02 9.28 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.815 -1.18 . . . . 0.24 107.815 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 m -113.49 148.23 36.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.802 -0.561 . . . . 1.03 109.612 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.06 124.83 35.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.26 108.336 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -65.27 -24.79 67.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.32 110.536 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 59.1 p-90 -89.85 -11.46 41.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.891 -1.131 . . . . 0.44 110.211 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.92 123.44 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.211 -0.931 . . . . 0.32 109.814 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.01 -62.91 5.55 Favored Glycine 0 N--CA 1.489 2.188 0 O-C-N 121.68 -0.638 . . . . 0.36 111.534 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.5 Cg_exo -45.67 -37.52 15.84 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.899 1.732 . . . . 0.44 111.447 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.17 -57.67 3.71 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.619 -1.301 . . . . 0.81 108.499 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -59.09 -21.12 58.73 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.584 -0.698 . . . . 1.92 109.971 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.482 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.8 tmt? -61.23 -22.02 64.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 3.13 110.607 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -97.63 10.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.224 -0.922 . . . . 0.28 111.535 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.39 -35.14 11.09 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 119.978 -1.701 . . . . 1.62 112.967 -178.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.1 -11.4 21.66 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 119.38 0.814 . . . . 0.25 110.903 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -103.0 -70.51 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.405 -0.809 . . . . 0.3 109.857 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -45.28 -52.63 9.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.465 -0.772 . . . . 0.13 110.425 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.88 -33.83 75.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 0.41 110.014 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.92 -40.48 93.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.946 -1.096 . . . . 0.97 109.52 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 87.0 mt -53.42 -18.69 2.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.5 109.745 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.5 m -55.71 -36.63 67.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.183 -0.948 . . . . 0.51 109.834 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.35 -14.9 24.87 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 2.0 110.1 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -89.2 -21.55 23.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.036 -1.04 . . . . 2.16 108.745 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -135.22 69.61 1.44 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.227 -0.657 . . . . 0.24 109.227 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 p -66.14 -3.15 5.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.128 -0.983 . . . . 0.17 108.916 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.4 t30 -96.77 -1.5 46.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.474 -0.766 . . . . 0.34 109.367 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.8 t -114.12 149.58 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.54 -0.725 . . . . 0.12 109.156 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.8 mm -101.2 128.47 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.402 -0.811 . . . . 0.17 109.224 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.0 m-85 -114.95 133.89 55.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.452 -0.78 . . . . 0.11 109.61 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -116.23 170.51 8.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.477 -0.764 . . . . 0.12 108.998 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -141.87 145.09 34.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.11 -1.07 . . . . 1.31 108.11 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.4 t -141.68 137.23 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.335 -0.853 . . . . 0.14 110.615 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -98.26 99.52 10.74 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.3 -1.0 . . . . 1.08 108.3 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.8 m -55.77 -9.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.27 110.701 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 10.4 m-20 -100.93 -45.97 5.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.84 -1.162 . . . . 1.11 110.891 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.2 OUTLIER -93.48 -10.48 34.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.073 -1.017 . . . . 1.12 109.715 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.86 41.7 3.45 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.591 -0.892 . . . . 0.17 108.591 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -55.52 -15.33 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.529 -0.732 . . . . 2.22 110.053 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.402 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.1 p-10 -69.26 -36.6 77.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.962 -1.086 . . . . 1.11 108.811 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -74.87 -46.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.567 -0.901 . . . . 0.19 108.567 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.6 -34.73 78.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.811 . . . . 0.22 109.195 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -64.4 -47.89 77.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 1.29 109.251 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -63.35 -35.64 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 2.2 109.431 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.68 -7.34 52.87 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.169 -0.957 . . . . 0.33 109.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 66' ' ' ALA . 15.0 mt-10 53.51 57.0 6.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.954 . . . . 2.34 110.592 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 22.5 t -81.42 125.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.063 -1.023 . . . . 0.28 109.211 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -116.0 -0.84 12.66 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.395 -0.816 . . . . 2.4 110.077 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.67 136.09 16.87 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.081 -1.012 . . . . 0.22 109.175 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -117.4 152.15 48.98 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 108.605 -0.887 . . . . 0.22 108.605 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -77.15 145.38 80.67 Favored 'Cis proline' 0 C--N 1.321 -0.876 0 C-N-CA 125.007 -0.831 . . . . 0.2 110.134 -2.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.2 115.06 26.1 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.342 -0.984 . . . . 0.18 108.342 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 74.9 m-85 -92.1 115.02 27.72 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.687 -0.857 . . . . 0.15 108.687 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -114.96 136.51 53.04 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.702 -1.222 . . . . 1.03 107.702 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 29.4 m-85 -109.4 126.35 53.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.11 109.829 -177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.11 158.45 29.26 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.403 -0.962 . . . . 0.17 108.403 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -154.49 120.5 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 56.42 33.92 23.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 1.67 109.06 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.51 8.9 87.12 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.349 -1.1 . . . . 0.22 110.349 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -114.78 148.0 39.01 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.262 -1.14 . . . . 2.08 110.226 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -86.32 141.96 28.86 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.28 -0.888 . . . . 1.7 109.425 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.16 -21.97 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.515 -0.741 . . . . 0.26 110.795 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.34 173.05 45.84 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.492 -1.337 . . . . 0.18 110.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -173.16 153.31 2.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.208 -1.172 . . . . 2.04 110.395 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -169.56 132.99 1.26 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.275 -0.89 . . . . 0.14 110.156 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -104.82 -170.59 1.78 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.174 -0.954 . . . . 0.17 109.15 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.53 125.78 2.5 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.545 -1.422 . . . . 0.13 109.545 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -50.5 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.271 -1.134 . . . . 0.2 110.282 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.96 69.89 1.36 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.415 -0.957 . . . . 1.15 108.415 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -35.01 78.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.153 -0.967 . . . . 1.19 110.702 -178.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -66.1 -29.29 69.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.607 -1.308 . . . . 1.95 109.082 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -68.06 -35.19 77.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.492 -0.755 . . . . 2.05 109.404 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.1 mt -49.63 -37.31 27.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.042 -1.036 . . . . 0.15 108.904 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -66.55 -55.78 13.89 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.816 -0.754 . . . . 2.15 109.464 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.0 83.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.344 -0.848 . . . . 0.15 110.79 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.2 m -69.01 -47.33 65.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.091 -1.006 . . . . 0.13 110.579 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.38 -49.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.948 . . . . 0.18 109.262 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.06 -19.16 61.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 1.03 109.296 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -76.57 -62.18 1.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 2.02 110.4 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -90.74 22.14 3.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.358 -0.839 . . . . 0.35 110.325 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.007 . . . . 1.18 109.172 179.432 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.553 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER -131.22 75.49 1.66 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.55 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.6 m-85 -134.65 150.59 50.67 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.15 -0.969 . . . . 0.0 109.68 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -150.49 -102.07 0.07 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.6 p90 -109.01 -175.72 2.84 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.037 -1.04 . . . . 0.0 111.277 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.422 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -68.98 148.45 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.83 0.824 . . . . 0.0 112.19 -176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 m -101.43 97.39 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.52 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.6 pt-20 -83.57 42.82 0.86 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.014 . . . . 0.0 109.789 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.03 -130.66 0.05 OUTLIER Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.417 -2.273 . . . . 0.0 107.417 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.53 24.55 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.936 0 CA-C-N 118.52 1.16 . . . . 0.0 109.185 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.4 t -86.36 -5.97 59.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.524 -0.735 . . . . 0.0 109.485 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.64 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 1.3 t60 -65.4 -148.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.333 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.64 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.505 -0.554 . . . . 2.89 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 3' ' ' LYS . 65.4 t -94.55 158.04 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.3 109.195 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 2' ' ' VAL . 77.6 tttt -154.61 125.46 7.12 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.91 . . . . 1.97 109.305 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -89.56 133.38 34.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.98 109.761 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.0 mm -106.63 108.6 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.304 -0.999 . . . . 0.19 108.304 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -101.12 -6.19 24.66 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.233 -0.917 . . . . 1.97 109.948 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 p -151.89 153.03 33.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.969 -1.082 . . . . 0.23 110.08 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 81.6 tttt -53.0 -33.39 51.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.463 -0.773 . . . . 1.9 109.926 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -59.45 -41.98 90.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.996 -1.065 . . . . 0.25 109.666 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.93 63.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.865 . . . . 0.2 109.844 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.24 -67.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.955 -1.091 . . . . 0.21 109.827 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -54.32 -44.97 72.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.225 -0.922 . . . . 2.47 109.715 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.83 -36.58 74.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.179 -0.951 . . . . 2.1 109.86 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.94 83.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 0.2 109.066 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.1 mt -64.37 -38.8 92.32 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.471 -0.768 . . . . 0.62 109.371 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.54 -44.1 91.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 1.09 109.726 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.33 -13.89 59.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.3 109.917 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.21 -6.9 26.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.959 . . . . 0.24 109.669 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.38 -112.63 4.62 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.517 -1.433 . . . . 0.28 109.517 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.13 2.76 2.58 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.367 -1.078 . . . . 2.21 109.607 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' HOH . 75.5 mttt -69.0 167.39 15.99 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.018 -1.051 . . . . 1.9 108.648 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.94 162.75 10.75 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.044 -1.035 . . . . 0.17 108.434 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.1 t -144.19 104.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.027 -1.045 . . . . 0.12 109.353 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.6 t -102.47 130.84 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.737 -0.838 . . . . 0.09 108.737 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.1 136.89 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.17 109.781 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -109.85 103.69 12.52 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.959 -0.756 . . . . 0.96 108.959 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' THR . 39.0 m-85 -85.23 81.96 8.58 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.231 -1.026 . . . . 0.24 108.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.4 m -113.49 146.25 39.91 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.768 -0.582 . . . . 1.03 109.723 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.92 131.09 36.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.324 -0.86 . . . . 0.26 108.825 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t -66.92 -25.33 66.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.37 -0.831 . . . . 0.32 110.576 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.9 p-90 -89.2 -13.6 37.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.058 -1.026 . . . . 0.44 110.417 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.43 130.16 42.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32 109.941 -178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.91 -54.62 7.01 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 121.597 -0.689 . . . . 0.36 111.736 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -47.86 -34.53 22.32 Favored 'Trans proline' 0 C--N 1.318 -1.044 0 C-N-CA 121.763 1.642 . . . . 0.44 111.214 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.91 -61.18 2.06 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.967 -1.083 . . . . 0.81 109.081 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -59.38 -18.37 38.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.506 -0.746 . . . . 1.92 110.013 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.8 ttt -59.47 -21.1 59.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.066 -1.021 . . . . 3.13 110.199 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 38' ' ' ILE . 65.6 mt -100.38 13.41 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.287 -0.883 . . . . 0.28 110.56 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -31.9 3.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.379 -1.451 . . . . 1.62 112.865 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.9 Cg_exo -63.75 -4.33 7.0 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 CA-C-N 119.699 0.928 . . . . 0.25 109.844 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.4 m-85 -111.04 -77.6 0.59 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.123 -0.695 . . . . 0.3 109.123 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 85.7 t80 -41.02 -57.67 1.95 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.13 110.859 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.7 -33.5 75.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.41 109.933 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.5 t -65.0 -34.87 79.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.887 -1.133 . . . . 0.97 110.161 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -51.75 -20.61 2.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.5 109.633 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -56.94 -26.88 60.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -0.999 . . . . 0.51 109.693 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.35 -22.95 17.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.222 -0.924 . . . . 2.0 109.88 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -90.24 -20.09 23.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.137 -0.977 . . . . 2.16 109.377 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -136.27 67.54 1.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.512 -0.742 . . . . 0.24 109.299 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.8 p -66.2 -2.86 4.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -0.879 . . . . 0.17 108.682 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.1 t-20 -95.72 -0.38 51.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.34 109.427 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.4 t -117.49 149.88 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.538 -0.726 . . . . 0.12 109.655 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -98.95 134.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.887 -0.783 . . . . 0.17 108.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 87.0 m-85 -121.85 133.55 54.88 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.568 -0.707 . . . . 0.11 109.204 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -114.75 172.63 6.92 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.347 -0.845 . . . . 0.12 108.901 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -144.78 141.0 28.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.927 -1.138 . . . . 1.31 107.927 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 78.3 t -136.02 139.95 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.202 -0.936 . . . . 0.14 110.56 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.7 t70 -99.61 98.21 9.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.008 -1.108 . . . . 1.08 108.008 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.39 -2.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.29 -0.882 . . . . 0.27 111.135 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 58' ' ' ASP . 11.9 m-20 -109.27 -45.75 3.68 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.073 -1.017 . . . . 1.11 111.211 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -90.92 -12.35 36.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.953 -1.092 . . . . 1.12 109.795 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.31 48.55 1.64 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.359 -0.978 . . . . 0.17 108.359 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -54.62 -19.42 5.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 2.22 110.146 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.56 -40.16 73.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.04 -1.038 . . . . 1.11 109.462 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.6 t -72.6 -47.43 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.19 108.609 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.49 -38.8 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.469 -0.769 . . . . 0.22 109.373 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -64.17 -46.11 85.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 1.29 109.553 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -63.04 -39.93 96.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.88 . . . . 2.2 109.497 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 0.7 55.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.172 -0.955 . . . . 0.33 109.464 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 49.06 51.92 15.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 2.34 110.348 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 23.4 t -80.14 130.28 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.25 -0.906 . . . . 0.28 108.711 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -128.29 9.47 6.15 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.311 -0.868 . . . . 2.4 109.501 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.266 -0.896 . . . . 0.22 108.791 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.558 HG23 ' HE1' ' B' ' 5' ' ' TYR . 21.8 p -130.32 149.17 72.59 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HG3' HD12 ' A' ' 38' ' ' ILE . 11.4 Cg_endo -80.23 142.23 60.49 Favored 'Cis proline' 0 C--N 1.32 -0.94 0 C-N-CA 124.935 -0.86 . . . . 0.2 110.048 -1.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -111.88 113.72 26.22 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 107.893 -1.151 . . . . 0.18 107.893 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.755 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -88.91 122.71 32.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.957 -1.089 . . . . 0.15 109.326 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 35.4 mt-30 -121.6 135.97 54.97 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.787 -1.19 . . . . 1.03 107.787 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.4 m-85 -111.25 129.8 55.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.644 -0.66 . . . . 0.11 109.98 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.93 158.56 38.47 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.627 -0.879 . . . . 0.17 108.627 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -154.92 124.13 6.33 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? 55.07 27.57 9.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 1.67 110.073 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.94 1.9 86.58 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 120.125 -1.036 . . . . 0.22 110.902 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -109.39 145.39 36.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.225 -1.162 . . . . 2.08 110.126 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -85.46 143.0 28.82 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.689 -0.856 . . . . 1.7 108.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.9 m -125.88 -23.78 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.429 -0.794 . . . . 0.26 110.43 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.41 178.2 48.57 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.413 -1.375 . . . . 0.18 110.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -173.75 156.62 2.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.336 -1.096 . . . . 2.04 110.24 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.5 p90 -168.76 131.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.14 110.314 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.8 p -102.42 -163.04 0.97 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.159 -0.963 . . . . 0.17 108.988 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 125.77 0.93 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.203 -1.559 . . . . 0.13 109.203 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.58 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.2 110.186 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -139.6 75.04 1.49 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.107 -1.071 . . . . 1.15 108.107 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -63.01 -38.15 90.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.89 -0.506 . . . . 1.19 110.974 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.95 -27.49 68.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.952 -1.093 . . . . 1.95 109.72 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 2.05 109.919 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.755 HD21 ' CD1' ' A' ' 77' ' ' PHE . 57.5 mt -51.61 -34.99 39.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.683 -1.261 . . . . 0.15 108.679 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -67.37 -56.78 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.501 -0.749 . . . . 2.15 109.539 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.18 -42.86 91.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.15 110.682 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.2 m -65.22 -46.08 82.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.027 -1.046 . . . . 0.13 110.404 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.94 -52.3 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.062 -1.024 . . . . 0.18 108.968 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.56 -18.36 52.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.895 . . . . 1.03 109.597 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 2.02 110.069 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -92.7 24.83 3.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.645 -0.66 . . . . 0.35 110.528 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.043 -1.036 . . . . 1.18 109.271 179.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -159.13 61.96 0.4 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.54 156.49 17.26 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.062 -1.023 . . . . 0.0 109.291 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -150.29 -102.92 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.082 -1.011 . . . . 0.0 109.398 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.558 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -117.71 -174.05 2.55 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.75 -1.218 . . . . 0.0 111.18 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.41 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -67.2 145.89 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 CA-C-O 121.85 0.833 . . . . 0.0 112.789 -176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 m -101.71 94.12 5.68 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.63 45.79 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.826 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.635 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.61 -129.72 0.09 OUTLIER Glycine 0 N--CA 1.484 1.896 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.3 22.68 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 119.253 1.526 . . . . 0.0 109.261 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.635 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.4 t -85.88 -41.46 14.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.459 -0.776 . . . . 0.0 109.228 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -68.82 122.79 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.415 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.518 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.43 -0.582 . . . . 2.89 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' H ' ' A' ' 3' ' ' LYS . 12.8 t -94.58 173.91 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.846 . . . . 0.3 109.263 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' H ' HG12 ' A' ' 2' ' ' VAL . 55.5 tttp -153.16 129.11 10.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.223 -0.923 . . . . 1.97 109.087 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.53 137.4 32.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.98 109.725 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.7 mm -112.56 96.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.393 -0.966 . . . . 0.19 108.393 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -98.44 -6.75 29.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.143 -0.973 . . . . 1.97 109.622 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.3 p -153.0 152.57 31.54 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.102 -0.999 . . . . 0.23 109.929 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -28.13 22.17 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.503 -0.748 . . . . 1.9 109.906 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.6 m -59.59 -47.86 83.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.239 -0.913 . . . . 0.25 110.193 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.73 66.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.304 -0.872 . . . . 0.2 109.978 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.35 -66.6 0.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.211 -0.93 . . . . 0.21 109.995 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -55.64 -43.59 76.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 2.47 109.713 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -58.77 -36.83 75.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.211 -0.93 . . . . 2.1 109.887 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.77 89.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.009 -1.057 . . . . 0.2 109.597 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.38 -41.15 96.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.346 -0.846 . . . . 0.62 110.312 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.91 -44.81 91.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.956 . . . . 1.09 110.573 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.83 -14.92 58.98 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.09 -1.007 . . . . 0.3 110.486 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -7.28 31.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.073 -1.017 . . . . 0.24 109.743 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.72 -126.66 30.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.192 -1.563 . . . . 0.28 109.192 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -116.71 5.41 13.16 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.548 -0.972 . . . . 2.21 109.292 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.715 ' CE ' HD11 ' A' ' 53' ' ' ILE . 13.6 mtmm -68.87 162.02 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.147 -0.971 . . . . 1.9 109.459 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 159.4 19.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.231 -0.918 . . . . 0.17 108.754 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.511 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.3 t -145.05 106.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.286 -0.883 . . . . 0.12 109.285 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -103.0 134.16 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.588 -0.893 . . . . 0.09 108.588 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.42 135.39 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.573 -0.704 . . . . 0.17 109.407 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -106.23 103.9 13.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.646 -0.659 . . . . 0.96 109.301 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 74' ' ' THR . 40.8 m-85 -87.68 79.67 8.17 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.73 -1.211 . . . . 0.24 107.73 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.2 m -114.78 148.17 38.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.828 -0.545 . . . . 1.03 109.538 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.79 125.49 36.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.26 108.474 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 t -66.01 -24.77 66.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.2 -0.938 . . . . 0.32 110.346 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.9 p-90 -88.26 -11.95 45.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.019 -1.051 . . . . 0.44 109.987 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.4 t -94.6 131.48 40.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.32 109.907 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.46 -60.35 5.53 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 111.159 -0.776 . . . . 0.36 111.159 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.2 Cg_exo -46.79 -40.18 24.54 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 C-N-CA 121.862 1.708 . . . . 0.44 111.562 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.95 -56.09 5.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.726 -1.233 . . . . 0.81 108.951 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.31 -21.81 60.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.767 . . . . 1.92 109.768 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.6 tpt -60.86 -23.26 65.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 3.13 110.497 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 38' ' ' ILE . 51.7 mt -97.22 13.69 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.025 -1.047 . . . . 0.28 111.559 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.44 -32.72 5.61 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 118.194 -1.403 . . . . 1.62 112.378 179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.8 Cg_exo -65.33 -9.59 22.74 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 CA-C-N 119.695 0.927 . . . . 0.25 111.093 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -103.48 -71.78 0.72 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.273 -0.892 . . . . 0.3 109.782 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -44.88 -52.53 8.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.52 -0.738 . . . . 0.13 110.593 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -68.19 -34.43 76.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.878 -1.139 . . . . 0.41 109.857 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 0.97 109.894 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -52.58 -15.11 0.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.5 109.402 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.404 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.5 m -57.08 -37.06 71.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.51 109.989 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.6 -15.86 24.96 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.193 -0.942 . . . . 2.0 110.266 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -90.41 -21.22 22.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.902 -1.124 . . . . 2.16 109.136 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -136.04 74.04 1.49 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.482 -0.761 . . . . 0.24 109.137 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.2 p -67.76 -5.33 15.71 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.26 -0.9 . . . . 0.17 109.249 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -97.08 -3.67 40.85 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.374 -0.828 . . . . 0.34 110.054 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.54 151.46 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.429 -0.794 . . . . 0.12 109.136 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.715 HD11 ' CE ' ' A' ' 21' ' ' LYS . 6.6 mm -105.12 121.97 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.468 -0.77 . . . . 0.17 109.398 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.577 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.6 m-85 -108.68 130.32 55.34 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.62 -0.881 . . . . 0.11 108.62 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.95 174.52 5.86 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -0.791 . . . . 0.12 109.012 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -141.23 139.31 33.74 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.03 -1.1 . . . . 1.31 108.03 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.4 t -137.13 134.84 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.221 -0.924 . . . . 0.14 110.413 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.31 101.94 13.53 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.13 -1.063 . . . . 1.08 108.13 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG11 ' OH ' ' B' ' 5' ' ' TYR . 30.0 m -58.93 -2.85 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.27 111.183 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 14.3 m-20 -111.94 -41.34 4.01 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.158 -0.964 . . . . 1.11 110.913 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.6 -17.3 23.45 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.043 -1.035 . . . . 1.12 108.988 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.71 45.77 2.16 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.117 -1.068 . . . . 0.17 108.117 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.509 HE21 ' NH2' ' B' ' 4' ' ' ARG . 1.4 pt20 -55.22 -16.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.599 -0.688 . . . . 2.22 110.334 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.2 p30 -68.77 -38.38 80.0 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.798 -1.189 . . . . 1.11 109.551 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -74.6 -48.98 32.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.068 -1.02 . . . . 0.19 108.868 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.07 86.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.22 109.676 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 63.1 m -63.16 -49.37 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.922 . . . . 1.29 109.184 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -64.64 -31.49 72.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.371 -0.831 . . . . 2.2 109.67 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.88 -1.46 57.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.33 109.88 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 48.99 53.39 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.128 -0.983 . . . . 2.34 110.209 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.0 t -78.81 133.33 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.13 -0.981 . . . . 0.28 108.936 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -127.07 -0.48 6.5 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.384 -0.822 . . . . 2.4 110.075 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.88 132.12 12.76 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.049 -1.032 . . . . 0.22 109.177 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.722 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.0 p -115.8 151.39 46.29 Favored Pre-proline 0 N--CA 1.503 2.177 0 N-CA-C 108.627 -0.879 . . . . 0.22 108.627 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.563 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.3 Cg_endo -76.96 144.54 78.86 Favored 'Cis proline' 0 N--CA 1.482 0.844 0 C-N-CA 124.631 -0.987 . . . . 0.2 110.296 -1.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.76 112.6 23.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.845 -1.169 . . . . 0.18 107.845 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.6 m-85 -89.89 121.04 31.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.049 -1.032 . . . . 0.15 108.601 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -117.88 134.09 55.28 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.891 -1.151 . . . . 1.03 107.891 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.9 m-85 -109.55 126.94 54.1 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.593 0.711 . . . . 0.11 109.718 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -123.65 156.74 35.29 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.137 -1.06 . . . . 0.17 108.137 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -154.83 122.01 5.59 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.843 -1.169 . . . . 1.48 107.843 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt 57.13 23.01 8.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.677 -0.64 . . . . 1.67 109.959 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.57 3.25 74.91 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.124 -1.19 . . . . 0.22 110.124 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -111.67 148.4 33.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.369 -1.077 . . . . 2.08 110.247 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -85.82 138.42 32.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.349 -0.844 . . . . 1.7 108.982 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.07 -15.06 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.392 -0.818 . . . . 0.26 110.418 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.72 170.48 41.47 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.22 -1.466 . . . . 0.18 110.724 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -173.59 152.5 2.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -1.021 . . . . 2.04 109.841 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 7.0 p90 -169.01 132.96 1.4 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.382 -0.824 . . . . 0.14 109.964 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -103.4 -168.72 1.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.34 -0.85 . . . . 0.17 108.968 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.8 125.33 1.89 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.262 -1.535 . . . . 0.13 109.262 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.49 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -1.2 . . . . 0.2 110.385 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.51 70.98 1.36 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.148 -1.056 . . . . 1.15 108.148 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.54 -33.71 76.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 1.19 110.787 -178.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.856 -1.153 . . . . 1.95 109.143 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -69.08 -35.15 76.19 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.516 -0.74 . . . . 2.05 109.668 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 77' ' ' PHE . 31.6 mt -50.15 -39.09 42.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.943 -1.098 . . . . 0.15 108.598 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -66.69 -54.57 21.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.631 -0.668 . . . . 2.15 109.492 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.21 91.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.15 110.462 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -66.73 -45.45 78.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.235 -0.915 . . . . 0.13 110.055 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -60.94 -52.11 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.148 -0.97 . . . . 0.18 108.637 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -60.78 -18.03 52.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.178 -0.951 . . . . 1.03 109.447 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -76.69 -61.6 1.91 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 2.02 109.726 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.43 23.28 4.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.526 -0.734 . . . . 0.35 110.376 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.493 1.711 0 O-C-N 120.976 -1.078 . . . . 1.18 109.268 179.554 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 34.3 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 88.2 mtt180 -141.89 76.04 1.52 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.249 -0.907 . . . . 0.0 109.186 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -126.97 145.58 50.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.509 ' NH2' HE21 ' A' ' 63' ' ' GLN . 5.8 tpt180 -141.97 -84.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.132 -0.98 . . . . 0.0 109.289 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.722 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -125.31 -169.39 1.99 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 120.966 -1.084 . . . . 0.0 110.4 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.79 151.65 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.38 -0.825 . . . . 0.0 112.506 -177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -102.07 96.06 6.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.37 44.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.973 -1.079 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.23 -128.46 0.12 Allowed Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.98 25.73 0.13 Allowed 'Trans proline' 0 C--N 1.325 -0.684 0 CA-C-N 119.081 1.441 . . . . 0.0 109.396 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.2 t -101.93 3.77 39.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.387 -0.82 . . . . 0.0 109.675 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -160.72 -61.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.8 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.373 -0.602 . . . . 2.89 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 3' ' ' LYS . 98.0 t -94.63 162.12 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.3 109.639 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.517 ' N ' HG12 ' A' ' 2' ' ' VAL . 81.2 tttt -153.8 124.38 7.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.155 -0.965 . . . . 1.97 109.427 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.5 133.83 34.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.98 109.744 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mm -106.42 115.38 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.4 -0.963 . . . . 0.19 108.4 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 17.3 mp0 -104.27 -9.63 18.44 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.239 -0.913 . . . . 1.97 109.784 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -151.32 155.55 38.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.062 -1.024 . . . . 0.23 109.941 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -53.15 -31.37 42.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 1.9 109.815 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -59.84 -44.07 94.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.052 -1.03 . . . . 0.25 109.798 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -25.04 63.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.2 109.554 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -60.72 -68.85 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.112 -0.993 . . . . 0.21 109.877 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -53.84 -44.74 70.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 2.47 109.714 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -57.66 -36.99 72.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.214 -0.929 . . . . 2.1 109.733 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.33 -45.47 94.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.997 -1.064 . . . . 0.2 109.157 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.89 -43.87 91.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.795 . . . . 0.62 109.732 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -63.98 -41.23 97.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.082 -1.011 . . . . 1.09 109.619 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -13.58 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.212 -0.93 . . . . 0.3 109.879 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.03 51.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.179 -0.95 . . . . 0.24 109.68 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 -111.15 3.44 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.648 -1.381 . . . . 0.28 109.648 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -138.61 1.81 2.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.383 -1.069 . . . . 2.21 109.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.1 mttt -68.87 168.75 12.87 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.064 -1.022 . . . . 1.9 108.857 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.1 163.07 10.59 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.224 -0.922 . . . . 0.17 108.595 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.9 t -145.1 104.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.12 109.713 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.62 128.19 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.801 -0.814 . . . . 0.09 108.801 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.84 137.69 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.601 -0.687 . . . . 0.17 109.579 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -106.86 100.06 9.59 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.16 -0.681 . . . . 0.96 109.16 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.2 m-85 -84.69 80.17 9.35 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.805 -1.183 . . . . 0.24 107.805 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.447 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 51.8 m -108.72 -164.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.658 0.742 . . . . 1.03 109.715 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.71 120.22 13.21 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.453 -0.943 . . . . 0.26 108.453 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -64.3 -23.93 67.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.398 -0.814 . . . . 0.32 110.708 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.563 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 42.9 p-90 -87.8 -20.64 25.84 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.936 -1.103 . . . . 0.44 109.952 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.09 130.48 36.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.32 109.663 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.83 -61.46 5.25 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.883 -0.675 . . . . 0.36 111.7 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 25.0 Cg_exo -45.29 -33.75 9.1 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.812 1.674 . . . . 0.44 111.461 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -78.01 -56.86 4.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.905 -1.122 . . . . 0.81 108.665 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -59.5 -19.06 45.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.538 -0.726 . . . . 1.92 109.581 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -61.54 -27.76 68.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.163 -0.96 . . . . 3.13 110.529 -178.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.71 HG23 ' HZ3' ' A' ' 94' ' ' LYS . 91.9 mt -95.69 12.62 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.041 -1.037 . . . . 0.28 111.618 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.73 -32.38 3.0 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 119.864 -1.772 . . . . 1.62 112.851 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.05 -11.65 28.44 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 CA-C-N 119.759 0.949 . . . . 0.25 110.433 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.616 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 29.5 m-85 -103.62 -69.83 0.79 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.334 -0.854 . . . . 0.3 109.86 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -44.01 -51.39 7.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.441 -0.787 . . . . 0.13 110.577 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -34.26 73.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.015 -1.053 . . . . 0.41 110.231 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 m -61.07 -42.32 98.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.93 -1.106 . . . . 0.97 109.957 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.39 -16.16 0.32 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.024 -1.048 . . . . 0.5 109.392 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.422 ' N ' ' C ' ' A' ' 44' ' ' SER . 40.0 m -58.47 -34.5 70.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.264 -0.897 . . . . 0.51 109.793 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -94.29 -17.81 22.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.218 -0.926 . . . . 2.0 110.286 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -90.62 -22.34 21.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.037 -1.039 . . . . 2.16 109.212 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -133.95 68.13 1.5 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.482 -0.761 . . . . 0.24 109.101 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.4 p -66.59 -2.29 4.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.422 -0.799 . . . . 0.17 109.051 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.3 t30 -95.0 -1.73 51.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.47 -0.769 . . . . 0.34 109.39 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.7 t -117.18 148.82 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.643 -0.661 . . . . 0.12 109.54 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.6 mm -99.09 124.76 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.473 -0.767 . . . . 0.17 109.327 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -113.02 129.18 56.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.316 -0.865 . . . . 0.11 109.248 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -112.25 171.39 7.54 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.24 -0.913 . . . . 0.12 109.364 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -140.02 142.41 36.24 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.754 -1.202 . . . . 1.31 107.754 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -141.42 134.93 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.074 -1.016 . . . . 0.14 110.739 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.34 111.12 23.04 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.562 -1.273 . . . . 1.08 107.562 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -69.4 -11.49 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.27 111.317 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.424 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.8 m-20 -102.31 -38.67 7.54 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.001 -1.062 . . . . 1.11 110.974 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB2' HH11 ' B' ' 2' ' ' ARG . 3.7 t70 -92.54 -14.67 28.0 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.005 -1.059 . . . . 1.12 109.533 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.86 49.43 1.96 Allowed 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.76 -0.83 . . . . 0.17 108.76 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -55.38 -11.56 0.84 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.435 -0.79 . . . . 2.22 110.261 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.58 -41.09 72.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.068 . . . . 1.11 109.167 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.71 -47.29 44.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.19 108.861 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.13 -35.34 78.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.22 108.833 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -63.67 -50.55 68.8 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.369 -0.832 . . . . 1.29 108.792 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -64.31 -33.63 76.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.387 -0.82 . . . . 2.2 109.039 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.45 -5.94 58.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.323 -0.861 . . . . 0.33 109.195 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 66' ' ' ALA . 42.0 mt-10 45.97 55.79 6.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.47 -0.769 . . . . 2.34 110.199 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.98 138.52 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.139 -0.976 . . . . 0.28 109.287 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -124.98 -4.78 7.48 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.504 -0.748 . . . . 2.4 109.6 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.7 131.4 12.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.13 -0.981 . . . . 0.22 109.238 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.694 HG23 ' CE2' ' B' ' 5' ' ' TYR . 7.7 p -113.09 151.3 44.07 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.684 -0.858 . . . . 0.22 108.684 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.7 145.49 79.52 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 C-N-CA 124.818 -0.909 . . . . 0.2 109.77 -1.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.59 111.68 21.03 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.304 -0.998 . . . . 0.18 108.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.9 m-85 -87.44 120.62 28.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.91 -1.119 . . . . 0.15 108.956 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.598 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.7 mt-30 -118.97 136.72 53.95 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.874 -1.158 . . . . 1.03 107.874 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.3 m-85 -108.66 127.57 54.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.559 -0.713 . . . . 0.11 109.973 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -122.87 157.03 33.39 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.295 -1.002 . . . . 0.17 108.295 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 32.1 tttp -155.02 120.74 5.09 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.025 -1.472 . . . . 1.48 107.025 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt 56.4 34.99 25.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.46 -0.775 . . . . 1.67 109.111 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.99 6.38 78.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.164 -1.174 . . . . 0.22 110.164 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.64 144.14 41.38 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.319 -1.106 . . . . 2.08 110.225 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -85.55 145.02 27.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 1.7 109.333 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.91 -27.98 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.479 -0.763 . . . . 0.26 110.364 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.68 177.39 43.2 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.502 -1.332 . . . . 0.18 110.297 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.16 155.58 2.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -1.11 . . . . 2.04 110.051 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.73 130.46 1.27 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.14 110.154 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -101.69 -161.78 0.88 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.267 -0.895 . . . . 0.17 109.025 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.55 129.45 0.86 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.089 -1.604 . . . . 0.13 109.089 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.15 99.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -1.186 . . . . 0.2 110.152 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.455 HD22 ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -140.8 69.91 1.35 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.405 -0.961 . . . . 1.15 108.405 178.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.71 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -61.63 -36.88 82.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.611 -0.681 . . . . 1.19 110.941 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -65.28 -28.87 69.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.845 -1.159 . . . . 1.95 109.467 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' H ' HD22 ' A' ' 93' ' ' ASN . 1.0 OUTLIER -69.76 -32.49 71.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 2.05 109.746 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.9 mt -50.3 -35.43 27.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.844 -1.16 . . . . 0.15 108.856 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.24 -56.06 10.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.487 -0.758 . . . . 2.15 109.686 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.18 86.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.15 110.667 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.0 m -66.55 -46.2 76.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.183 -0.948 . . . . 0.13 110.38 -178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.62 -52.46 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.18 109.015 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -60.57 -16.53 38.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 1.03 109.719 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -76.55 -61.25 2.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 2.02 109.987 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.5 mt -91.58 20.9 5.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.35 110.289 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.928 -1.108 . . . . 1.18 109.367 179.495 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.1 p90 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.498 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 55.3 mtm180 -152.01 62.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.034 -1.041 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.563 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 21.9 m-85 -103.45 157.41 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -144.53 -102.9 0.11 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.694 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -113.6 -171.64 1.93 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.92 -1.112 . . . . 0.0 110.492 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.92 145.08 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-O 121.831 0.824 . . . . 0.0 112.354 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.7 m -100.79 93.63 5.65 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.608 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 pt-20 -83.2 44.42 0.94 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.842 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.06 -134.13 0.05 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 106.876 -2.49 . . . . 0.0 106.876 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.58 24.87 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.885 0 CA-C-N 118.864 1.332 . . . . 0.0 108.985 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 47.0 t -81.2 -15.76 54.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.565 -0.709 . . . . 0.0 109.228 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 51.54 -92.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 0.0 109.522 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 11' ' ' SER . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.41 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.328 -0.619 . . . . 2.89 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -94.85 153.38 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.255 -0.903 . . . . 0.3 109.309 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -155.74 124.5 6.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.91 -1.145 . . . . 1.97 107.91 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 ' N ' ' HD3' ' A' ' 3' ' ' LYS . 23.9 tt0 -87.97 137.46 32.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.98 110.431 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mm -108.17 115.41 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 107.86 -1.163 . . . . 0.19 107.86 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -103.0 -16.15 15.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.342 -0.849 . . . . 1.97 109.726 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 p -153.85 162.02 41.57 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.98 -1.075 . . . . 0.23 109.941 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -53.15 -27.85 23.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.445 -0.784 . . . . 1.9 109.744 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -60.68 -47.72 84.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.25 109.869 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -26.29 64.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.372 -0.83 . . . . 0.2 110.158 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.98 -66.35 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.99 -1.069 . . . . 0.21 109.949 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -55.89 -45.62 78.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 2.47 109.679 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -57.7 -35.37 70.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.275 -0.891 . . . . 2.1 109.69 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.21 97.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.029 -1.044 . . . . 0.2 109.072 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.34 -47.52 79.04 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.297 -0.877 . . . . 0.62 109.397 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.28 -34.76 78.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 1.09 109.352 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.36 -19.7 45.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.3 109.416 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -6.83 29.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.24 109.6 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.22 -111.55 3.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.28 109.51 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -137.95 3.21 2.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.284 -1.127 . . . . 2.21 109.321 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -70.14 168.1 16.37 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.177 -0.952 . . . . 1.9 108.948 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -61.46 161.65 9.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.292 -1.003 . . . . 0.17 108.292 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.647 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -144.55 106.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.855 -1.153 . . . . 0.12 109.687 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.8 t -103.08 133.81 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.562 -0.903 . . . . 0.09 108.562 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.25 138.92 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.568 -0.708 . . . . 0.17 109.557 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -110.6 102.9 11.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.044 -0.724 . . . . 0.96 109.044 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -86.73 80.38 8.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.815 -1.18 . . . . 0.24 107.815 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.4 m -113.28 148.44 35.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.527 -0.545 . . . . 1.03 109.527 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.01 131.54 36.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.872 . . . . 0.26 108.747 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 t -66.38 -27.82 68.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.827 . . . . 0.32 110.632 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.503 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.4 p-90 -87.6 -15.88 36.11 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 0.44 110.103 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.7 t -92.45 125.81 37.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.213 -0.93 . . . . 0.32 109.12 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.68 -52.34 16.12 Favored Glycine 0 N--CA 1.488 2.129 0 O-C-N 121.519 -0.738 . . . . 0.36 112.014 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.8 Cg_exo -47.96 -39.45 32.52 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.944 1.763 . . . . 0.44 111.447 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.68 -61.81 1.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.766 -1.209 . . . . 0.81 109.057 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.86 -19.49 42.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 1.92 109.826 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -59.51 -20.33 54.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 3.13 109.963 -179.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.7 mt -98.74 11.92 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.354 -0.841 . . . . 0.28 110.185 -178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.56 -31.76 4.55 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.351 -1.468 . . . . 1.62 112.669 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.83 -4.9 8.0 Favored 'Trans proline' 0 C--N 1.322 -0.858 0 CA-C-N 119.718 0.935 . . . . 0.25 109.736 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -111.19 -72.6 0.71 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.059 -0.719 . . . . 0.3 109.059 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -45.66 -57.53 4.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.772 . . . . 0.13 110.513 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.79 -30.45 70.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 0.41 110.088 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.409 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.7 t -64.19 -41.57 97.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.812 -1.18 . . . . 0.97 109.899 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.1 mt -51.26 -14.42 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.99 -1.069 . . . . 0.5 109.501 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.409 ' N ' ' C ' ' A' ' 44' ' ' SER . 52.3 m -57.24 -34.08 68.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -0.952 . . . . 0.51 109.778 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -95.07 -18.77 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.076 -1.015 . . . . 2.0 110.329 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -90.33 -21.52 21.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.966 -1.084 . . . . 2.16 109.408 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.3 68.92 1.47 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.446 -0.784 . . . . 0.24 109.315 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.09 -3.83 8.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 0.17 109.16 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.63 -1.46 53.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 0.34 109.502 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.6 t -117.03 150.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 109.11 -0.7 . . . . 0.12 109.11 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 mm -100.67 127.87 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.401 -0.812 . . . . 0.17 109.241 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.573 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.5 m-85 -114.26 131.49 56.48 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.836 -0.802 . . . . 0.11 108.836 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -114.05 173.65 6.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.297 -0.877 . . . . 0.12 108.837 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.38 142.13 30.15 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.073 -1.084 . . . . 1.31 108.073 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.46 141.05 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.227 -0.92 . . . . 0.14 110.613 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -99.33 99.7 10.67 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.538 -0.912 . . . . 1.08 108.538 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 108' ' ' HOH . 10.6 m -59.07 -2.94 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.231 -0.918 . . . . 0.27 111.024 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -108.45 -43.57 4.29 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.017 -1.052 . . . . 1.11 110.567 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB2' HH11 ' B' ' 2' ' ' ARG . 5.2 t70 -94.31 -13.53 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.156 -0.965 . . . . 1.12 109.683 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.07 46.59 2.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.831 -0.804 . . . . 0.17 108.831 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -56.61 -12.97 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.437 -0.79 . . . . 2.22 110.064 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -69.73 -41.72 74.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.119 -0.988 . . . . 1.11 109.328 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.27 -45.77 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.19 108.739 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.41 -33.68 76.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 0.22 109.322 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 m -63.94 -53.56 48.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 1.29 109.393 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.72 -32.51 74.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.876 . . . . 2.2 109.482 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.43 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.26 -2.72 58.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.161 -0.962 . . . . 0.33 109.753 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 48.35 51.3 15.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 2.34 110.306 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.4 t -79.38 133.18 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.28 108.857 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.17 4.45 5.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.521 -0.737 . . . . 2.4 109.405 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.34 145.88 24.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.202 -0.936 . . . . 0.22 109.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.506 HG23 ' HE1' ' B' ' 5' ' ' TYR . 35.7 p -126.99 149.9 70.49 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.707 -0.849 . . . . 0.22 108.707 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -78.66 144.37 74.24 Favored 'Cis proline' 0 C--N 1.317 -1.131 0 O-C-N 122.912 0.954 . . . . 0.2 110.18 -1.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -111.84 111.98 23.33 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 107.99 -1.115 . . . . 0.18 107.99 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.627 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.5 m-85 -88.71 118.9 28.71 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.15 108.776 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.6 mt-30 -116.87 135.31 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.65 -1.241 . . . . 1.03 107.65 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.9 m-85 -110.01 121.64 45.73 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.506 0.669 . . . . 0.11 109.392 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -120.83 159.32 25.71 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -156.59 122.06 4.76 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.71 -1.218 . . . . 1.48 107.71 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.9 mttt 56.37 36.17 27.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 1.67 109.534 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.94 7.84 76.73 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.9 -1.143 . . . . 0.22 110.336 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -113.56 146.28 39.93 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.512 -0.993 . . . . 2.08 109.974 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -86.07 144.6 27.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.149 -0.969 . . . . 1.7 109.348 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 m -129.86 -24.89 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.484 -0.76 . . . . 0.26 110.248 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 174.93 46.03 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.421 -1.371 . . . . 0.18 110.27 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.86 153.38 2.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.442 -1.034 . . . . 2.04 110.171 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.2 p90 -169.22 131.43 1.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.14 109.665 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -102.51 -160.77 0.8 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.901 -1.124 . . . . 0.17 109.241 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 78.89 135.26 1.03 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.37 . . . . 0.13 109.676 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.65 89.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -1.079 . . . . 0.2 110.026 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 91' ' ' GLY . 20.5 t-20 -131.77 72.48 1.5 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.962 -1.125 . . . . 1.15 107.962 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 94' ' ' LYS . 13.5 ptpt -64.38 -39.98 94.91 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.932 -0.576 . . . . 1.19 111.101 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.95 -28.4 69.49 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.829 -1.169 . . . . 1.95 109.713 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.0 tttp -68.58 -32.65 72.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 2.05 109.363 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.627 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.3 mt -52.07 -39.69 60.07 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.851 -1.156 . . . . 0.15 108.555 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -65.51 -55.7 16.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.622 -0.674 . . . . 2.15 109.375 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.5 93.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.15 110.49 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -66.94 -43.39 83.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.13 110.139 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.59 -52.4 61.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.063 -1.023 . . . . 0.18 108.327 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -62.78 -15.31 53.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 1.03 109.372 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -76.61 -61.36 1.99 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 2.02 110.201 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -92.2 21.02 5.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.35 110.343 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.024 -1.047 . . . . 1.18 109.246 179.514 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.503 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 7.4 mtm180 -171.53 78.27 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.249 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.543 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 50.7 m-85 -100.11 162.26 13.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.953 -1.092 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.7 OUTLIER -150.45 -108.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.506 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -109.72 -178.08 3.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.71 -1.244 . . . . 0.0 110.779 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -65.37 144.28 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.948 0.88 . . . . 0.0 113.253 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.28 94.56 6.0 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.74 44.98 1.02 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.001 -1.062 . . . . 0.0 110.443 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -128.58 0.07 OUTLIER Glycine 0 CA--C 1.543 1.808 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.45 20.78 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 CA-C-N 119.057 1.428 . . . . 0.0 108.912 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.7 t -89.15 -49.97 6.43 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.406 -0.808 . . . . 0.0 109.207 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -69.87 172.26 8.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.496 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.427 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.445 -0.576 . . . . 2.89 109.445 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 92.8 t -94.83 161.54 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.303 -0.873 . . . . 0.3 109.624 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.2 tttp -155.8 123.34 5.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 1.97 109.163 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.38 135.12 33.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.873 . . . . 0.98 109.659 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 10' ' ' ALA . 11.8 mm -108.56 109.05 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.099 -1.074 . . . . 0.19 108.099 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -99.32 -4.61 31.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.092 -1.005 . . . . 1.97 109.436 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -151.69 144.96 24.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.267 -0.896 . . . . 0.23 109.321 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -52.13 -24.7 7.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.9 109.736 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.62 -43.51 98.73 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.829 -1.169 . . . . 0.25 109.469 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.15 -22.84 62.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.2 109.831 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -58.78 -66.02 0.57 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.21 109.774 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.13 -45.14 79.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.264 -0.897 . . . . 2.47 109.971 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -57.86 -35.78 71.42 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 2.1 109.432 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.45 -48.48 80.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.2 109.153 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 9.2 mt -64.18 -42.49 96.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.413 -0.804 . . . . 0.62 109.882 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -63.45 -38.44 91.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 1.09 109.475 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.2 -16.73 54.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.3 109.781 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.71 -5.36 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.198 -0.939 . . . . 0.24 109.822 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.09 -108.81 2.59 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.605 -1.398 . . . . 0.28 109.605 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -137.94 3.84 2.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.35 -1.088 . . . . 2.21 109.711 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.3 mttt -70.18 165.92 21.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.991 -1.068 . . . . 1.9 108.887 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.0 161.14 13.6 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.136 -0.978 . . . . 0.17 108.638 -179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -143.83 106.82 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.117 -0.989 . . . . 0.12 109.27 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.38 133.41 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.035 -1.098 . . . . 0.09 108.035 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.13 140.01 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.433 -0.792 . . . . 0.17 110.048 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -109.52 99.97 9.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.115 -0.698 . . . . 0.96 109.115 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -87.33 78.47 8.73 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.794 -1.188 . . . . 0.24 107.794 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 58.0 m -107.53 -163.73 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.629 0.728 . . . . 1.03 109.46 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.01 123.67 16.05 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.52 -0.919 . . . . 0.26 108.52 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -64.84 -25.58 67.96 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.491 -0.756 . . . . 0.32 110.546 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.536 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 39.6 p-90 -89.12 -14.75 35.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.912 -1.118 . . . . 0.44 110.169 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -94.0 131.19 39.72 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.993 -1.067 . . . . 0.32 109.844 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.71 -59.23 5.74 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.66 -0.65 . . . . 0.36 111.617 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -47.26 -36.31 22.12 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.793 1.662 . . . . 0.44 111.239 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -77.67 -54.0 6.9 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.764 -1.21 . . . . 0.81 108.615 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -59.79 -23.91 63.68 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.484 0.659 . . . . 1.92 109.808 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 14.8 tpt -61.09 -24.06 65.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.618 -0.676 . . . . 3.13 110.539 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 38' ' ' ILE . 46.2 mt -99.13 5.51 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.184 -0.948 . . . . 0.28 112.483 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -63.97 -35.13 14.05 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 117.836 -1.546 . . . . 1.62 111.757 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -60.84 -12.78 23.48 Favored 'Trans proline' 0 C--O 1.213 -0.736 0 CA-C-N 119.688 0.924 . . . . 0.25 110.929 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -99.67 -69.8 0.75 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.322 -0.861 . . . . 0.3 109.324 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -46.22 -51.2 14.77 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.632 -0.668 . . . . 0.13 110.515 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.66 -35.19 78.41 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.746 -1.221 . . . . 0.41 109.48 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t -60.51 -39.58 88.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.002 -1.061 . . . . 0.97 109.927 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.2 mt -51.82 -16.5 0.7 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.947 . . . . 0.5 109.328 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 67.5 m -58.12 -34.63 70.44 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.267 -0.896 . . . . 0.51 109.741 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -94.94 -19.39 20.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.113 -0.992 . . . . 2.0 110.412 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -90.3 -20.77 22.53 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.938 -1.101 . . . . 2.16 109.216 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -134.88 67.83 1.49 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.923 -0.769 . . . . 0.24 108.923 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 p -66.64 -3.05 5.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.352 -0.843 . . . . 0.17 108.983 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.0 t30 -95.5 -0.9 51.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.718 . . . . 0.34 109.307 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.53 152.92 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.555 -0.716 . . . . 0.12 109.481 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.5 mm -102.92 131.97 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 N-CA-C 108.875 -0.787 . . . . 0.17 108.875 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.612 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.7 m-85 -118.47 133.66 55.7 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.412 -0.805 . . . . 0.11 109.285 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.612 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -115.37 171.73 7.52 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.063 -0.717 . . . . 0.12 109.063 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -143.09 142.81 31.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.844 -1.169 . . . . 1.31 107.844 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.88 137.19 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.106 -0.996 . . . . 0.14 110.855 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -96.84 110.4 22.9 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.888 -1.152 . . . . 1.08 107.888 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.403 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.8 m -67.73 -10.29 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.184 -0.947 . . . . 0.27 111.178 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 5.6 m-20 -103.58 -40.6 6.26 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.097 -1.002 . . . . 1.11 110.974 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -93.6 -13.39 27.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.073 -1.017 . . . . 1.12 109.689 -179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.16 49.27 1.9 Allowed 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.306 -0.998 . . . . 0.17 108.306 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.08 -13.14 1.78 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.597 -0.69 . . . . 2.22 110.462 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 7.8 p-10 -70.01 -40.15 75.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.913 -1.117 . . . . 1.11 109.479 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 65' ' ' VAL . 2.9 t -73.4 -47.81 44.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.196 -0.94 . . . . 0.19 108.86 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.47 73.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.39 -0.819 . . . . 0.22 109.271 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.4 m -63.54 -55.84 20.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 1.29 109.386 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.54 -29.51 70.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.377 -0.827 . . . . 2.2 109.533 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.4 -6.81 56.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.268 -0.895 . . . . 0.33 109.89 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 48.88 53.0 13.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 2.34 110.568 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.24 137.14 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.076 -1.015 . . . . 0.28 109.063 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -129.84 3.2 4.9 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.442 -0.786 . . . . 2.4 109.684 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.36 135.46 15.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.22 108.842 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.642 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.5 p -120.23 149.95 50.49 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.423 -0.798 . . . . 0.22 109.249 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.542 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -76.27 149.0 90.8 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.69 -0.962 . . . . 0.2 109.892 -1.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.93 110.86 18.84 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 107.158 -1.423 . . . . 0.18 107.158 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.9 m-85 -87.21 125.3 34.09 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.096 -1.042 . . . . 0.15 108.52 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.449 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.4 mt-30 -121.77 137.72 54.65 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.55 -1.278 . . . . 1.03 107.55 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.3 m-85 -111.91 126.54 55.23 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.492 0.663 . . . . 0.11 109.72 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.87 157.92 38.08 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.814 -0.809 . . . . 0.17 108.814 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -154.71 122.04 5.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.377 -1.342 . . . . 1.48 107.377 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt 56.37 34.42 24.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.353 -0.842 . . . . 1.67 109.736 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.68 10.32 84.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.147 -1.181 . . . . 0.22 110.147 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -115.25 144.53 43.58 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.459 -1.024 . . . . 2.08 110.387 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -85.41 143.58 28.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.22 -0.925 . . . . 1.7 109.432 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.5 m -125.18 -22.17 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.658 -0.651 . . . . 0.26 109.918 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.42 -178.76 48.69 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.551 -1.309 . . . . 0.18 110.469 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -173.85 155.21 2.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.428 -1.042 . . . . 2.04 109.962 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.5 p90 -168.97 131.81 1.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.396 -0.815 . . . . 0.14 109.881 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -103.64 -162.49 0.91 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.04 -1.038 . . . . 0.17 109.114 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.1 137.95 3.64 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.49 -1.444 . . . . 0.13 109.49 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -63.57 95.39 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.112 -1.228 . . . . 0.2 110.743 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.07 71.41 1.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.881 -1.155 . . . . 1.15 107.881 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.431 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -36.26 82.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.795 . . . . 1.19 110.915 -178.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -64.74 -26.29 68.3 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.955 -1.091 . . . . 1.95 109.21 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -37.87 80.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.336 -0.852 . . . . 2.05 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.5 HD21 ' CD1' ' A' ' 77' ' ' PHE . 21.8 mt -50.73 -36.26 35.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.895 -1.128 . . . . 0.15 108.771 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -67.09 -56.13 11.32 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.474 -0.766 . . . . 2.15 109.35 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.66 93.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.448 -0.783 . . . . 0.15 110.483 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 m -65.97 -43.7 87.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.182 -0.949 . . . . 0.13 109.62 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.3 mt -61.65 -53.85 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 0.18 108.781 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' O ' HG12 ' A' ' 105' ' ' VAL . 18.0 t-20 -60.3 -17.88 45.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.336 -0.852 . . . . 1.03 109.837 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -76.4 -58.33 3.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 2.02 110.288 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.6 mt -92.82 16.98 11.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.503 -0.748 . . . . 0.35 110.262 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.1 p . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.903 -1.046 . . . . 1.18 109.288 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 55.5 t80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.419 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 48.4 mtm180 -138.01 67.2 1.42 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 28.4 m-85 -102.47 157.68 16.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.376 -0.828 . . . . 0.0 109.21 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.54 -107.87 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.323 -0.86 . . . . 0.0 108.976 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.642 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.5 p90 -110.33 -175.88 2.84 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.253 -0.905 . . . . 0.0 110.443 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.9 t -66.12 145.97 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 121.972 0.891 . . . . 0.0 112.541 -177.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 59.6 m -101.06 94.65 6.1 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.426 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.7 pt-20 -83.7 42.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.066 -1.021 . . . . 0.0 110.648 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.16 -131.36 0.04 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.89 21.45 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 119.487 1.644 . . . . 0.0 108.977 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.8 m -97.06 2.53 51.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -0.854 . . . . 0.0 109.964 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.666 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 2.6 t60 -165.79 -144.04 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.937 -1.102 . . . . 0.0 109.561 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.666 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.402 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.1 mtm . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.449 -0.574 . . . . 2.89 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.5 t -94.35 165.82 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.244 -0.91 . . . . 0.3 109.277 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.4 tttm -153.68 120.87 5.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.125 -0.984 . . . . 1.97 109.568 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -89.21 138.28 31.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -0.864 . . . . 0.98 109.484 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.22 106.38 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.056 -1.09 . . . . 0.19 108.056 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -96.25 -5.75 39.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 1.97 108.968 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.1 p -154.15 145.06 22.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.327 -0.858 . . . . 0.23 109.497 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -52.93 -23.74 7.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 1.9 109.566 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 m -61.71 -41.58 97.8 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.874 -1.141 . . . . 0.25 108.853 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.94 -21.42 60.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.2 109.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.16 -67.95 0.32 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.052 -1.03 . . . . 0.21 110.129 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.71 -44.56 77.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 2.47 109.696 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -58.59 -35.95 73.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.165 -0.959 . . . . 2.1 109.837 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.83 88.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.995 -1.066 . . . . 0.2 109.035 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mt -64.41 -41.14 96.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.393 -0.817 . . . . 0.62 109.421 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -64.08 -42.67 96.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 1.09 109.633 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -16.51 55.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.3 109.716 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -6.5 24.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.24 109.674 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.27 -129.31 28.67 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.228 -1.549 . . . . 0.28 109.228 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -120.12 4.49 10.86 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.567 -0.961 . . . . 2.21 109.71 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.7 mttp -69.11 169.66 11.5 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.897 -1.127 . . . . 1.9 109.015 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.81 162.42 16.17 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.222 -0.991 . . . . 0.17 108.445 -179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.605 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.4 t -145.39 104.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.965 -1.085 . . . . 0.12 109.739 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.9 t -103.62 133.07 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.09 108.697 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.8 138.95 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.512 -0.743 . . . . 0.17 109.795 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -109.55 99.96 9.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.12 -0.696 . . . . 0.96 109.12 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -85.97 79.44 9.2 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.272 -1.01 . . . . 0.24 108.272 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.87 149.73 34.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.739 -0.601 . . . . 1.03 109.453 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.74 133.15 35.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.182 -0.949 . . . . 0.26 108.831 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -68.05 -27.52 66.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.32 110.614 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.21 -11.63 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.972 -1.08 . . . . 0.44 110.524 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.74 130.41 39.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.32 109.913 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.88 -54.9 7.74 Favored Glycine 0 N--CA 1.49 2.266 0 O-C-N 121.661 -0.649 . . . . 0.36 111.763 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.47 -38.08 43.2 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.535 1.49 . . . . 0.44 111.202 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.39 -56.7 4.33 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.943 -1.098 . . . . 0.81 108.87 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -59.08 -19.86 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.712 . . . . 1.92 109.816 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 37' ' ' MET . 2.0 tmt? -61.25 -22.32 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 3.13 110.304 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.3 mt -98.42 17.66 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.212 -0.93 . . . . 0.28 110.846 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.15 -33.23 3.87 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 120.032 -1.668 . . . . 1.62 112.789 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_endo -66.52 -9.19 23.3 Favored 'Trans proline' 0 C--N 1.319 -1.011 0 CA-C-N 119.583 0.887 . . . . 0.25 111.12 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.37 -77.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.037 -1.04 . . . . 0.3 109.68 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -41.35 -52.92 3.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.13 111.094 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -67.48 -38.7 84.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.751 -1.218 . . . . 0.41 110.231 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 p -60.65 -37.92 83.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.792 -1.193 . . . . 0.97 110.262 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.1 mt -52.29 -17.64 1.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.802 -1.186 . . . . 0.5 108.994 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -59.2 -31.38 68.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.084 -1.01 . . . . 0.51 109.45 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -94.99 -20.09 19.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.198 -0.939 . . . . 2.0 110.047 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -91.13 -21.84 20.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.122 -0.986 . . . . 2.16 109.162 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -133.14 68.5 1.5 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.036 -0.727 . . . . 0.24 109.036 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.93 -4.94 10.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.279 -0.888 . . . . 0.17 109.014 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -95.67 5.65 50.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.503 -0.748 . . . . 0.34 109.29 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.46 147.69 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.654 -0.654 . . . . 0.12 109.26 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.39 126.06 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -0.888 . . . . 0.17 109.02 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.8 m-85 -115.55 131.62 56.88 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.821 . . . . 0.11 109.231 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.3 mp -113.77 170.59 8.15 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.456 -0.778 . . . . 0.12 108.999 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -141.35 144.48 34.57 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.89 -1.152 . . . . 1.31 107.89 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.28 141.52 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.994 -1.066 . . . . 0.14 111.039 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -100.29 103.71 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.568 -0.901 . . . . 1.08 108.568 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.2 m -62.46 -1.76 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.27 111.56 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -112.19 -44.86 3.35 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.057 -1.027 . . . . 1.11 111.265 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.26 -14.41 30.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.893 -1.13 . . . . 1.12 109.435 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.92 44.41 2.73 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.19 -1.041 . . . . 0.17 108.19 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -55.17 -12.38 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.586 -0.696 . . . . 2.22 110.128 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.9 p30 -68.78 -38.99 80.41 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 1.11 108.914 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.4 -47.18 41.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.775 -0.824 . . . . 0.19 108.775 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.44 -33.17 74.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.22 109.347 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.7 m -63.49 -54.86 29.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.189 -0.945 . . . . 1.29 109.277 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -64.09 -30.54 71.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 2.2 109.508 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.16 -5.67 58.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.103 -0.998 . . . . 0.33 109.465 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 48.98 53.34 12.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 2.34 110.681 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 t -81.78 132.92 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.215 -0.928 . . . . 0.28 109.005 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 1.52 7.15 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.305 -0.872 . . . . 2.4 109.968 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.74 130.06 11.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.871 -1.143 . . . . 0.22 109.362 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.577 HG23 ' CE2' ' B' ' 5' ' ' TYR . 69.7 p -112.78 150.46 42.81 Favored Pre-proline 0 N--CA 1.504 2.249 0 N-CA-C 108.587 -0.894 . . . . 0.22 108.587 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.35 142.03 67.52 Favored 'Cis proline' 0 N--CA 1.484 0.947 0 C-N-CA 125.023 -0.824 . . . . 0.2 110.11 -1.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -112.23 112.54 24.22 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.965 -1.124 . . . . 0.18 107.965 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -90.71 114.69 27.08 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.152 -0.967 . . . . 0.15 109.0 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -113.03 135.69 53.5 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.469 -1.308 . . . . 1.03 107.469 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.8 m-85 -108.99 123.24 48.82 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.539 0.685 . . . . 0.11 109.71 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -121.24 156.7 31.91 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.58 -0.896 . . . . 0.17 108.58 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -154.84 123.01 5.91 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.309 -1.367 . . . . 1.48 107.309 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 56.15 31.0 17.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.564 -0.71 . . . . 1.67 109.788 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.62 3.65 90.2 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 120.132 -1.032 . . . . 0.22 110.758 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -112.22 147.86 35.32 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -1.185 . . . . 2.08 110.18 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -85.88 142.38 28.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 1.7 109.541 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 m -125.45 -21.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.531 -0.731 . . . . 0.26 110.054 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.36 175.87 47.37 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.662 -1.256 . . . . 0.18 110.345 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.504 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.07 156.13 3.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -1.08 . . . . 2.04 110.541 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -169.01 132.13 1.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.494 -0.754 . . . . 0.14 109.984 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -103.5 -168.52 1.52 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.197 -0.939 . . . . 0.17 109.158 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.06 131.78 3.76 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.518 -1.433 . . . . 0.13 109.518 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.58 95.77 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.204 -1.174 . . . . 0.2 110.338 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.15 72.49 1.39 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.167 -1.049 . . . . 1.15 108.167 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.25 -34.18 76.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.511 -0.743 . . . . 1.19 110.606 -178.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.9 -28.02 69.25 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.949 -1.094 . . . . 1.95 109.212 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -69.06 -36.15 77.34 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.442 -0.786 . . . . 2.05 109.716 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.0 mt -53.92 -35.73 61.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.697 -1.252 . . . . 0.15 108.528 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.83 -57.1 7.69 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.228 -0.92 . . . . 2.15 109.587 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.15 95.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -0.809 . . . . 0.15 110.746 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -66.5 -46.35 76.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.152 -0.967 . . . . 0.13 110.248 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.78 -51.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.08 -1.013 . . . . 0.18 108.77 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -61.9 -15.68 44.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.172 -0.955 . . . . 1.03 109.523 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.91 -62.91 1.52 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 2.02 110.552 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -90.29 21.0 4.04 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.35 -0.844 . . . . 0.35 110.587 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.492 1.669 0 O-C-N 120.903 -1.123 . . . . 1.18 109.222 179.532 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 92.0 mtt180 -144.97 73.56 1.37 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.451 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.8 m-85 -131.15 148.94 52.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.593 -0.692 . . . . 0.0 109.244 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -145.59 -86.86 0.11 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.121 -0.987 . . . . 0.0 109.352 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.1 p90 -123.82 -167.01 1.56 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.124 -0.985 . . . . 0.0 110.494 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.52 149.78 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 121.873 0.844 . . . . 0.0 112.595 -177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 96.64 7.25 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.472 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.947 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.32 -129.76 0.05 OUTLIER Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.97 18.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.524 1.662 . . . . 0.0 109.218 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.4 t -88.91 5.78 42.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.43 -0.793 . . . . 0.0 109.576 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -164.18 132.9 3.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.445 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.235 0.54 . . . . 2.89 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t -94.4 169.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.838 -0.801 . . . . 0.3 108.838 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.2 tttm -154.62 125.16 6.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.046 . . . . 1.97 109.541 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -89.39 130.24 35.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.332 -0.855 . . . . 0.98 109.614 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.59 110.31 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.123 -1.066 . . . . 0.19 108.123 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -100.03 -11.1 20.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.958 . . . . 1.97 109.533 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 p -153.58 152.37 30.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.23 109.331 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -51.5 -23.31 3.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 1.9 109.785 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -60.11 -47.37 86.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.113 -0.992 . . . . 0.25 109.474 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.53 -24.46 61.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.2 109.927 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -58.82 -68.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.081 -1.012 . . . . 0.21 109.986 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -55.08 -44.13 74.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 2.47 109.786 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -59.12 -37.26 76.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.234 -0.916 . . . . 2.1 110.128 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.06 93.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.948 -1.095 . . . . 0.2 109.262 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.97 -43.52 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.452 -0.78 . . . . 0.62 109.841 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.62 -38.7 92.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.103 -0.998 . . . . 1.09 109.78 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.02 -15.71 57.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.3 109.938 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.02 50.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.24 109.665 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.27 -106.32 1.81 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.856 -1.298 . . . . 0.28 109.856 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.56 2.73 2.04 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.369 -1.077 . . . . 2.21 109.402 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -70.06 166.36 19.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.949 -1.094 . . . . 1.9 109.026 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.38 162.0 10.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.143 -1.058 . . . . 0.17 108.143 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.655 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.62 108.58 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.964 -1.085 . . . . 0.12 109.338 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.83 133.95 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.866 -0.79 . . . . 0.09 108.866 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.68 135.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.234 -0.654 . . . . 0.17 109.234 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -107.81 103.74 13.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.62 -0.675 . . . . 0.96 109.18 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.421 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 41.7 m-85 -85.66 79.73 9.25 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.809 -1.182 . . . . 0.24 107.809 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -113.07 147.74 36.65 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.203 0.525 . . . . 1.03 109.759 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.3 129.57 38.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.26 108.971 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.1 t -67.3 -27.71 67.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.32 110.563 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.565 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 60.6 p-90 -87.7 -9.51 53.89 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.081 -1.012 . . . . 0.44 110.199 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.01 128.85 44.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.283 -0.886 . . . . 0.32 109.7 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.98 -54.41 11.84 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.579 -0.701 . . . . 0.36 111.599 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.8 -41.83 45.64 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.605 1.537 . . . . 0.44 111.598 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -56.04 5.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.604 -1.31 . . . . 0.81 108.89 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -58.56 -23.22 57.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.57 -0.706 . . . . 1.92 109.751 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' GLY . 21.4 ttm -60.15 -19.1 52.23 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.91 . . . . 3.13 110.914 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 75' ' ' PRO . 41.5 mt -99.83 13.45 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.035 -1.041 . . . . 0.28 111.212 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.33 -32.31 4.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.308 -1.495 . . . . 1.62 112.93 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.32 -8.49 18.93 Favored 'Trans proline' 0 C--N 1.319 -1.009 0 CA-C-N 119.628 0.903 . . . . 0.25 110.423 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -104.51 -72.67 0.7 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.388 -0.82 . . . . 0.3 109.566 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -44.04 -53.85 5.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.49 -0.756 . . . . 0.13 110.685 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -68.04 -32.87 73.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.042 -1.036 . . . . 0.41 110.034 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.408 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.1 t -62.05 -39.1 91.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.787 -1.196 . . . . 0.97 109.905 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 77.7 mt -51.9 -15.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.5 109.19 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 44' ' ' SER . 68.0 m -58.53 -29.5 66.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.338 -0.851 . . . . 0.51 109.674 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -95.49 -23.84 16.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.0 109.943 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -91.41 -19.8 22.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 2.16 109.717 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -136.17 65.7 1.52 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.431 -0.793 . . . . 0.24 109.384 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.3 p -67.21 -2.68 6.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 0.17 109.195 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 1.7 t30 -93.6 -4.97 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.467 -0.771 . . . . 0.34 109.627 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.69 148.03 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.12 108.951 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.49 124.1 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.967 -0.753 . . . . 0.17 108.967 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.598 ' C ' HD12 ' A' ' 55' ' ' LEU . 78.5 m-85 -109.0 132.28 54.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.36 -0.838 . . . . 0.11 109.184 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.8 mp -114.36 173.47 6.44 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.628 -0.878 . . . . 0.12 108.628 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -143.12 143.62 31.9 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.162 -1.051 . . . . 1.31 108.162 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.2 t -140.59 136.59 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.182 -0.949 . . . . 0.14 110.487 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -97.34 102.42 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.5 -0.926 . . . . 1.08 108.5 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 108' ' ' HOH . 17.1 m -60.38 -7.4 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.304 -0.873 . . . . 0.27 111.177 -178.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.493 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 23.5 m-20 -103.08 -47.52 4.32 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.022 -1.049 . . . . 1.11 111.135 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' HB2' HH12 ' B' ' 2' ' ' ARG . 0.6 OUTLIER -92.94 -7.84 44.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.003 . . . . 1.12 109.846 -178.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.99 49.13 1.9 Allowed 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.703 -0.851 . . . . 0.17 108.703 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -56.61 -15.92 5.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.447 -0.783 . . . . 2.22 110.336 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.62 -41.38 75.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.043 -1.036 . . . . 1.11 109.392 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 t -73.58 -46.98 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.163 -0.96 . . . . 0.19 108.842 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.66 -36.0 81.47 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.428 -0.795 . . . . 0.22 108.96 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.8 m -64.22 -44.33 92.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.865 . . . . 1.29 109.046 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.39 -42.79 98.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 2.2 109.088 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.53 -1.59 58.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.328 -0.857 . . . . 0.33 109.259 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' ALA . 63.8 mt-10 48.1 52.93 12.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.425 -0.797 . . . . 2.34 110.142 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.71 127.4 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.28 109.328 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -120.96 9.01 10.51 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.544 -0.723 . . . . 2.4 109.345 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.43 147.94 26.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.22 109.016 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -131.24 150.05 75.4 Favored Pre-proline 0 N--CA 1.5 2.037 0 N-CA-C 108.436 -0.95 . . . . 0.22 108.436 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.578 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -79.16 143.11 69.61 Favored 'Cis proline' 0 C--N 1.319 -0.982 0 O-C-N 122.708 0.846 . . . . 0.2 110.437 -1.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -112.98 112.72 24.39 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.931 -1.136 . . . . 0.18 107.931 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.7 m-85 -89.41 116.78 27.85 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.076 -1.015 . . . . 0.15 109.155 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.491 HE22 ' HB1' ' A' ' 69' ' ' ALA . 25.8 mt-30 -115.9 133.19 56.29 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.578 -1.267 . . . . 1.03 107.578 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 100' ' ' THR . 31.9 m-85 -107.15 122.8 47.23 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.574 0.702 . . . . 0.11 109.805 -177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -119.65 158.97 25.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.531 -0.915 . . . . 0.17 108.531 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -156.52 124.33 5.54 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.034 -1.099 . . . . 1.48 108.034 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 55.43 32.16 18.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 1.67 109.725 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.04 6.06 87.26 Favored Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.986 -1.071 . . . . 0.22 110.437 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -113.1 146.08 39.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.237 -1.154 . . . . 2.08 109.948 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -86.19 147.73 25.99 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.32 -0.863 . . . . 1.7 109.303 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -131.69 -27.76 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.402 -0.811 . . . . 0.26 110.307 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.99 178.2 45.95 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.47 -1.348 . . . . 0.18 110.26 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -173.04 158.65 3.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -1.135 . . . . 2.04 110.244 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -169.75 131.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.433 -0.792 . . . . 0.14 109.952 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -104.31 -167.07 1.31 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.342 -0.849 . . . . 0.17 109.129 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.22 131.59 3.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.28 -1.528 . . . . 0.13 109.28 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.85 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -1.189 . . . . 0.2 110.645 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -141.39 75.76 1.51 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.515 -0.92 . . . . 1.15 108.515 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.68 -32.2 73.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 1.19 110.401 -178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -66.63 -29.38 69.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.937 -1.102 . . . . 1.95 109.181 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -68.57 -34.52 75.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.507 -0.746 . . . . 2.05 109.799 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.52 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.8 mt -50.51 -34.76 26.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.15 108.975 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -67.58 -56.39 9.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.897 -0.721 . . . . 2.15 109.684 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.17 90.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.316 -0.865 . . . . 0.15 110.644 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.443 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.3 m -66.73 -45.41 78.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.13 110.126 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.2 mt -60.95 -52.11 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.07 -1.019 . . . . 0.18 108.783 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -60.94 -17.42 51.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 1.03 109.612 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.62 -54.67 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 2.02 109.924 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HB2' HD11 ' A' ' 22' ' ' LEU . 10.3 mt -94.83 12.27 28.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.454 -0.779 . . . . 0.35 110.569 -178.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 120.862 -1.149 . . . . 1.18 109.291 -179.733 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 5.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.53 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 11.5 mtt-85 -127.15 68.36 1.28 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.285 -0.885 . . . . 0.0 109.983 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.565 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.9 m-85 -123.97 141.34 52.13 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.315 -0.866 . . . . 0.0 109.832 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -143.06 -99.45 0.12 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -110.19 -172.21 1.99 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.169 -0.957 . . . . 0.0 110.988 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.02 151.67 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 122.04 0.924 . . . . 0.0 113.011 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.81 96.68 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.401 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.87 46.77 1.21 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.79 -1.194 . . . . 0.0 109.805 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.11 -131.98 0.13 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 106.956 -2.458 . . . . 0.0 106.956 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -70.11 26.84 0.19 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 N-CA-C 108.753 -1.287 . . . . 0.0 108.753 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.595 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.4 t -88.5 -35.19 17.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.293 -0.879 . . . . 0.0 109.638 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.419 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 38.2 t-80 -81.06 159.29 24.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.344 -0.848 . . . . 0.0 109.341 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.419 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.367 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.42 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.335 0.588 . . . . 2.89 109.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.6 t -94.62 161.19 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.248 -0.907 . . . . 0.3 109.016 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.3 tttt -154.38 125.87 7.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.043 -1.035 . . . . 1.97 109.408 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -89.59 132.53 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.297 -0.877 . . . . 0.98 109.756 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.9 mm -107.43 109.73 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 107.96 -1.126 . . . . 0.19 107.96 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -100.99 -13.1 18.4 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.215 -0.928 . . . . 1.97 109.615 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 p -153.02 157.58 40.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 0.23 109.529 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 72.7 tttt -52.57 -24.56 8.47 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 1.9 109.58 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 m -60.49 -48.57 81.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.25 109.523 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.82 -26.36 64.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.2 109.439 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -59.88 -69.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.21 109.747 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -54.09 -43.29 70.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 2.47 109.911 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -59.26 -37.02 76.55 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.135 -0.978 . . . . 2.1 109.777 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.84 96.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.061 -1.024 . . . . 0.2 109.445 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.19 -45.49 88.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.415 -0.803 . . . . 0.62 109.699 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -64.77 -42.08 95.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -0.928 . . . . 1.09 109.773 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.91 -14.96 58.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.3 109.734 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.03 -6.78 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.24 109.584 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.53 -118.32 8.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.513 -1.435 . . . . 0.28 109.513 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -133.4 4.09 3.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.439 -1.036 . . . . 2.21 109.201 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.4 mttt -69.88 167.94 16.28 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.112 -0.992 . . . . 1.9 108.668 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.19 159.12 18.32 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.07 -1.085 . . . . 0.17 108.07 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.17 105.91 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.125 -0.984 . . . . 0.12 109.352 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.68 132.12 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.778 . . . . 0.09 109.013 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.17 132.49 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.739 -0.601 . . . . 0.17 109.488 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -105.04 100.09 9.69 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.95 -0.759 . . . . 0.96 108.95 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 74' ' ' THR . 39.8 m-85 -83.55 78.76 9.62 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.762 -1.199 . . . . 0.24 107.762 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 m -103.74 -163.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.133 -0.692 . . . . 1.03 109.133 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.35 121.25 14.52 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.514 -0.921 . . . . 0.26 108.514 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -64.42 -25.82 68.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.41 -0.806 . . . . 0.32 110.754 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 52.2 p-90 -89.64 -14.71 34.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.841 -1.162 . . . . 0.44 110.143 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.52 131.78 41.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.257 -0.902 . . . . 0.32 109.85 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.05 -56.8 6.72 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 120.839 -0.696 . . . . 0.36 111.378 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -49.2 -33.03 26.66 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.706 1.604 . . . . 0.44 111.265 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.67 -61.78 1.85 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.942 -1.099 . . . . 0.81 108.816 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.8 tttm -60.99 -18.34 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.457 -0.777 . . . . 1.92 110.186 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 tpt -59.82 -22.8 62.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.132 -0.98 . . . . 3.13 110.259 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 38' ' ' ILE . 60.3 mt -97.32 12.37 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.083 -1.011 . . . . 0.28 111.009 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.32 -32.25 4.43 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 120.434 -1.417 . . . . 1.62 112.408 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -62.31 -5.54 6.86 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 120.0 1.036 . . . . 0.25 109.929 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -109.69 -77.1 0.6 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.746 -0.835 . . . . 0.3 108.746 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -41.52 -56.77 2.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.666 -0.646 . . . . 0.13 110.949 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -67.33 -30.78 70.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.08 -1.013 . . . . 0.41 110.028 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.4 m -65.06 -40.47 94.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.814 -1.179 . . . . 0.97 109.976 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.7 mt -49.63 -14.99 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.069 -1.019 . . . . 0.5 109.78 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 44' ' ' SER . 68.7 m -57.06 -33.54 67.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.077 -1.015 . . . . 0.51 109.667 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -94.96 -17.6 21.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.166 -0.958 . . . . 2.0 110.158 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -90.87 -22.03 21.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.029 -1.045 . . . . 2.16 109.28 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.47 69.56 1.46 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.453 -0.779 . . . . 0.24 109.222 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -67.33 -4.88 12.08 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.201 -0.937 . . . . 0.17 109.083 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.06 -1.11 49.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.895 . . . . 0.34 109.581 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.21 147.58 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.512 -0.743 . . . . 0.12 109.357 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.94 126.06 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.347 -0.846 . . . . 0.17 108.729 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.567 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.2 m-85 -112.43 133.17 54.66 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.177 -0.952 . . . . 0.11 109.5 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -115.38 171.46 7.69 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.509 -0.922 . . . . 0.12 108.509 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -141.67 141.13 33.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.64 -1.245 . . . . 1.31 107.64 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG11 ' CE2' ' A' ' 27' ' ' PHE . 53.6 t -139.33 137.57 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.112 -0.993 . . . . 0.14 110.705 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.01 109.05 21.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.239 -1.023 . . . . 1.08 108.239 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 m -63.27 -4.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.27 111.008 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -110.74 -41.06 4.38 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.177 -0.952 . . . . 1.11 111.083 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.0 -11.4 33.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.999 -1.063 . . . . 1.12 109.54 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.8 50.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.234 -1.024 . . . . 0.17 108.234 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.476 ' CG ' HH12 ' B' ' 4' ' ' ARG . 40.0 mt-30 -55.66 -17.39 5.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.659 -0.651 . . . . 2.22 110.147 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -70.72 -41.85 71.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.066 . . . . 1.11 109.424 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.95 -45.82 53.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.218 -0.926 . . . . 0.19 108.792 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.78 85.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.81 . . . . 0.22 109.021 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.8 m -64.07 -50.13 69.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.293 -0.88 . . . . 1.29 109.371 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.06 -34.93 79.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.44 -0.788 . . . . 2.2 109.832 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 -1.37 57.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.169 -0.957 . . . . 0.33 109.844 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 47.7 50.81 14.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 2.34 110.207 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.52 136.89 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -0.888 . . . . 0.28 109.06 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -132.01 3.49 4.06 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.373 -0.829 . . . . 2.4 109.907 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.49 143.12 23.64 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 27' ' ' PHE . 16.2 p -125.42 150.32 67.28 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.165 -0.959 . . . . 0.22 108.837 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -78.92 144.38 73.59 Favored 'Cis proline' 0 N--CA 1.485 1.015 0 C-N-CA 124.816 -0.91 . . . . 0.2 109.848 -1.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.31 112.02 22.41 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 107.76 -1.2 . . . . 0.18 107.76 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.526 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -85.49 119.2 25.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.935 -1.103 . . . . 0.15 109.247 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -118.69 132.33 56.16 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.773 -1.195 . . . . 1.03 107.773 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CZ ' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -106.66 129.03 54.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.527 -0.733 . . . . 0.11 110.427 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -124.34 154.85 39.7 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.022 -1.103 . . . . 0.17 108.022 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -154.91 122.71 5.77 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.139 -1.43 . . . . 1.48 107.139 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? 55.79 36.48 27.34 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 1.67 109.326 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.52 9.23 77.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.265 -1.134 . . . . 0.22 110.265 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.44 142.0 47.29 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.303 -1.116 . . . . 2.08 110.902 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -86.03 143.02 28.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -0.797 . . . . 1.7 108.949 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -129.45 -23.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.433 -0.792 . . . . 0.26 110.435 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.14 174.52 45.96 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.329 -1.415 . . . . 0.18 110.412 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -173.16 155.91 3.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.354 -1.086 . . . . 2.04 109.987 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.2 p90 -168.96 132.84 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.14 110.52 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.0 p -103.61 -165.64 1.18 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.241 -0.912 . . . . 0.17 108.864 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.48 123.7 1.84 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.175 -1.57 . . . . 0.13 109.175 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.551 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.53 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -1.19 . . . . 0.2 110.701 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -142.52 77.94 1.6 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.187 -1.042 . . . . 1.15 108.187 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.45 -31.47 72.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.445 -0.785 . . . . 1.19 110.292 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.33 -28.55 68.76 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.95 -1.094 . . . . 1.95 109.557 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -68.77 -34.82 76.21 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.333 -0.854 . . . . 2.05 109.266 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.0 mt -50.76 -37.96 45.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.15 108.825 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.08 -55.71 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.823 -0.751 . . . . 2.15 109.291 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.49 -42.83 93.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.447 -0.783 . . . . 0.15 110.508 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.427 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.1 m -65.58 -46.33 79.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.106 -0.996 . . . . 0.13 110.331 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.5 mt -61.76 -50.0 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 0.18 108.671 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 41.5 t-20 -62.03 -18.01 59.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 1.03 109.392 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.04 -59.9 2.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.252 -0.905 . . . . 2.02 110.37 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -90.92 20.1 5.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.376 -0.827 . . . . 0.35 110.413 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.493 1.697 0 O-C-N 120.986 -1.071 . . . . 1.18 109.197 179.477 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.546 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.6 mtt180 -140.56 70.69 1.36 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.5 m-85 -122.08 151.95 40.35 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.24 -81.82 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.035 -1.04 . . . . 0.0 109.371 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.49 ' HE1' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -133.69 165.07 25.8 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.133 -0.979 . . . . 0.0 110.933 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.04 146.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 CA-C-O 122.176 0.989 . . . . 0.0 113.406 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.78 94.49 5.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -82.43 44.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.941 -1.099 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.602 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.95 -133.15 0.06 OUTLIER Glycine 0 N--CA 1.483 1.811 0 N-CA-C 106.497 -2.641 . . . . 0.0 106.497 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -69.65 22.84 0.17 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 CA-C-N 119.178 1.489 . . . . 0.0 108.876 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.602 ' H ' ' C ' ' B' ' 9' ' ' GLY . 43.3 t -83.67 -31.83 25.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.532 -0.73 . . . . 0.0 109.332 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -52.31 161.88 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.416 -0.803 . . . . 0.0 109.541 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.92 -1.489 . . . . 0.0 109.586 179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.35 -0.611 . . . . 2.89 109.35 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.782 HG12 ' H ' ' A' ' 3' ' ' LYS . 18.7 t -97.22 -178.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.359 -0.838 . . . . 0.3 109.571 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.782 ' H ' HG12 ' A' ' 2' ' ' VAL . 16.7 tptp -154.46 121.51 5.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.555 -0.906 . . . . 1.97 108.555 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -92.13 130.83 37.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -0.836 . . . . 0.98 109.481 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.7 mm -109.24 108.61 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.762 -1.199 . . . . 0.19 107.762 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.0 -10.17 23.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.993 -1.067 . . . . 1.97 109.486 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 p -154.11 155.4 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.23 109.724 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -52.51 -25.29 9.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 1.9 109.865 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.4 m -59.77 -46.81 88.04 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.024 -1.048 . . . . 0.25 109.724 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.64 62.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.2 109.9 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.88 -67.56 0.35 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.111 -0.993 . . . . 0.21 110.099 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -55.85 -44.44 78.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 2.47 109.731 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -58.28 -36.59 73.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 2.1 109.817 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -48.1 83.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.02 -1.05 . . . . 0.2 109.01 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -65.19 -41.58 94.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.528 -0.733 . . . . 0.62 109.805 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.69 -46.24 89.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.251 -0.905 . . . . 1.09 109.715 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -11.53 59.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -0.946 . . . . 0.3 109.67 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -6.46 22.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.24 109.519 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.3 -111.24 3.87 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.419 . . . . 0.28 109.551 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -137.73 4.8 2.6 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.354 -1.086 . . . . 2.21 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.612 ' HZ1' ' ND2' ' A' ' 51' ' ' ASN . 56.6 mttm -69.58 172.59 7.13 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.059 -1.025 . . . . 1.9 109.845 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 159.3 32.59 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.833 -1.173 . . . . 0.17 107.833 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.79 105.41 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 0.12 109.23 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -101.99 132.8 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.529 -0.915 . . . . 0.09 108.529 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.21 135.46 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.472 -0.768 . . . . 0.17 109.862 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -106.18 101.7 11.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.662 -0.866 . . . . 0.96 108.662 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.554 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 38.5 m-85 -85.09 81.99 8.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.441 -1.318 . . . . 0.24 107.441 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -114.55 149.93 35.72 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.373 0.606 . . . . 1.03 109.599 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.33 128.23 38.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.26 108.545 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.9 t -66.49 -25.89 66.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.32 110.661 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 65.8 p-90 -88.97 -12.69 40.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.062 -1.024 . . . . 0.44 110.133 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.64 130.4 42.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.291 -0.881 . . . . 0.32 109.807 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.66 -52.57 9.63 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.489 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -50.09 -34.5 38.83 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 121.506 1.471 . . . . 0.44 111.289 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -63.41 1.41 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.058 -1.027 . . . . 0.81 109.189 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' CB ' ' A' ' 36' ' ' LYS . 6.3 ttpm? -58.54 -18.14 27.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 1.92 109.693 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.465 ' SD ' ' O ' ' A' ' 37' ' ' MET . 5.2 tpp -59.38 -21.23 59.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 3.13 109.845 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 38' ' ' ILE . 36.7 mt -98.11 9.4 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.28 110.129 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.36 -32.87 7.91 Favored Pre-proline 0 C--N 1.302 -1.471 0 C-N-CA 118.23 -1.388 . . . . 1.62 111.814 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -62.44 -6.37 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 CA-C-N 120.576 1.241 . . . . 0.25 110.331 -177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -108.64 -77.23 0.6 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.073 -0.714 . . . . 0.3 109.073 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -42.22 -56.58 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.601 -0.687 . . . . 0.13 110.7 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -65.55 -33.62 76.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.41 109.622 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 t -63.92 -38.02 89.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.937 -1.102 . . . . 0.97 109.733 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.8 mt -51.49 -17.99 0.96 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.5 109.604 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.6 m -55.72 -34.87 65.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.169 -0.957 . . . . 0.51 109.844 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -94.16 -14.18 25.91 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 2.0 110.186 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -92.66 -25.25 18.35 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.024 . . . . 2.16 109.749 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -134.07 69.12 1.47 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.389 -0.819 . . . . 0.24 109.541 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.9 p -67.28 -3.48 8.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.17 108.854 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.612 ' ND2' ' HZ1' ' A' ' 21' ' ' LYS . 20.1 t-20 -94.49 1.91 55.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.957 -0.757 . . . . 0.34 108.957 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.7 t -122.37 151.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 108.82 -0.807 . . . . 0.12 108.82 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 mm -101.01 134.57 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.232 -0.917 . . . . 0.17 109.134 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.545 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.4 m-85 -119.68 132.47 55.68 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.506 -0.746 . . . . 0.11 109.121 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -113.34 173.74 6.25 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.897 -0.779 . . . . 0.12 108.897 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -144.13 143.07 30.95 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.384 -1.339 . . . . 1.31 107.384 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.1 t -140.5 136.46 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.024 -1.047 . . . . 0.14 110.77 -177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.68 94.06 7.09 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.515 -1.291 . . . . 1.08 107.515 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 108' ' ' HOH . 12.2 m -52.05 -9.81 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.27 111.306 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -101.59 -45.39 5.29 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.95 -1.094 . . . . 1.11 110.965 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 -9.48 40.82 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.0 -1.062 . . . . 1.12 108.92 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.74 39.54 3.93 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.17 108.622 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -55.57 -11.43 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.786 . . . . 2.22 109.909 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.0 -41.03 74.9 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.997 -1.065 . . . . 1.11 108.529 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.3 t -74.23 -44.62 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.35 -0.981 . . . . 0.19 108.35 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.02 76.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.412 -0.805 . . . . 0.22 109.002 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.426 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 27.8 m -64.38 -52.32 58.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.373 -0.829 . . . . 1.29 109.4 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -63.43 -32.06 73.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 2.2 109.732 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.09 0.66 55.72 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.166 -0.959 . . . . 0.33 109.9 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 67' ' ' SER . 12.1 mp0 46.98 51.64 12.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.124 -0.985 . . . . 2.34 109.93 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.8 t -79.64 132.22 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.28 109.229 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -130.36 1.34 4.6 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.468 -0.77 . . . . 2.4 109.964 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.11 128.69 11.46 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.238 -0.914 . . . . 0.22 108.684 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.651 HG23 ' CE2' ' B' ' 5' ' ' TYR . 5.6 p -114.73 150.7 44.45 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.287 -1.005 . . . . 0.22 108.287 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -77.23 144.23 77.34 Favored 'Cis proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.715 -0.952 . . . . 0.2 110.581 -1.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -115.63 115.04 25.72 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.041 -1.096 . . . . 0.18 108.041 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -89.57 120.12 30.59 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.201 -1.0 . . . . 0.15 108.43 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 40.5 mt-30 -118.1 135.22 54.34 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.855 -1.165 . . . . 1.03 107.855 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.5 m-85 -109.82 126.4 53.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.584 -0.697 . . . . 0.11 109.822 -177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.0 156.68 36.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.295 -1.002 . . . . 0.17 108.295 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -155.66 123.02 5.5 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.549 -1.278 . . . . 1.48 107.549 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 55.82 30.45 15.82 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 120.109 -0.636 . . . . 1.67 109.862 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.48 4.96 90.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.275 -1.13 . . . . 0.22 110.275 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.89 146.24 39.29 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.422 -1.046 . . . . 2.08 110.182 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -86.28 145.49 26.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.26 -0.9 . . . . 1.7 109.407 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.64 -16.75 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 0.26 110.104 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 173.45 179.29 44.02 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.337 -1.411 . . . . 0.18 110.477 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -174.3 156.65 2.61 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.51 -0.994 . . . . 2.04 109.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.8 p90 -168.74 131.82 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.469 -0.769 . . . . 0.14 109.817 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -104.36 -166.99 1.3 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.227 -0.921 . . . . 0.17 108.921 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.99 130.42 3.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.15 95.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -1.181 . . . . 0.2 110.708 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -140.95 75.92 1.53 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.322 -0.992 . . . . 1.15 108.322 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.28 75.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.19 110.417 -178.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.38 -27.19 68.39 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.963 -1.085 . . . . 1.95 109.18 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -68.83 -36.61 78.4 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.485 -0.759 . . . . 2.05 109.289 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -51.62 -39.21 57.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.099 -1.001 . . . . 0.15 108.917 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.44 -58.95 4.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -0.774 . . . . 2.15 109.803 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.31 74.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.15 110.45 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.6 m -68.53 -47.65 66.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.109 -0.994 . . . . 0.13 110.038 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.35 -50.19 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 0.18 108.992 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 52.2 t-20 -61.08 -17.46 52.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.03 109.559 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.28 -61.84 1.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 2.02 110.316 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.4 mt -91.89 21.51 4.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.77 . . . . 0.35 110.597 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 1.18 109.311 179.345 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 p90 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 15.5 mtt-85 -140.71 79.86 1.72 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.04 133.68 49.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.306 -0.871 . . . . 0.0 108.671 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -132.67 -106.88 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.561 -0.712 . . . . 0.0 109.165 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.651 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.2 p90 -109.27 -176.71 3.1 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.367 -0.833 . . . . 0.0 110.304 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.9 t -66.67 150.1 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.923 0.868 . . . . 0.0 112.528 -177.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.6 m -100.88 95.84 6.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.651 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.3 pt-20 -83.31 45.33 1.03 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.618 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.49 -127.17 0.12 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 106.804 -2.519 . . . . 0.0 106.804 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.87 20.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.77 0 CA-C-N 119.698 1.749 . . . . 0.0 109.922 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.615 ' H ' ' C ' ' B' ' 9' ' ' GLY . 6.1 t -91.73 12.46 21.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.653 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.449 ' ND1' ' OXT' ' B' ' 13' ' ' GLY . 39.3 t-80 -161.54 -70.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 0.0 109.398 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.449 ' OXT' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.331 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.597 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mtm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.441 -0.578 . . . . 2.89 109.441 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 3' ' ' LYS . 70.1 t -94.77 166.99 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.23 -0.919 . . . . 0.3 109.555 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.592 ' N ' HG12 ' A' ' 2' ' ' VAL . 65.5 tttt -153.61 126.85 8.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 1.97 109.248 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.46 129.95 35.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.89 . . . . 0.98 109.703 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.3 mm -113.31 88.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.605 -0.887 . . . . 0.19 108.605 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.52 5.2 52.54 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.961 -1.087 . . . . 1.97 109.591 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -150.77 142.29 23.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.23 109.808 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -52.64 -29.6 27.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 1.9 109.86 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 m -60.61 -44.29 96.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.086 . . . . 0.25 109.669 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.16 63.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.365 -0.834 . . . . 0.2 109.817 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -58.82 -68.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.21 109.877 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -53.38 -45.12 69.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.109 -0.995 . . . . 2.47 109.767 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.18 -36.98 76.29 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.224 -0.923 . . . . 2.1 110.107 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.6 89.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.982 -1.073 . . . . 0.2 109.327 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.4 mt -64.3 -41.94 96.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.433 -0.792 . . . . 0.62 109.433 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.58 -44.47 90.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 1.09 110.149 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 -12.96 59.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.967 -1.083 . . . . 0.3 109.831 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.64 26.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.981 . . . . 0.24 109.81 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.71 -115.44 5.28 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.631 -1.388 . . . . 0.28 109.631 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.93 5.19 2.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.356 -1.085 . . . . 2.21 109.336 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.8 mttt -69.15 168.36 14.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.18 -0.95 . . . . 1.9 108.809 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 162.98 10.8 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.725 -1.213 . . . . 0.17 107.725 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.67 104.34 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.859 -1.151 . . . . 0.12 109.507 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.79 128.41 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.655 -0.868 . . . . 0.09 108.655 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.8 140.86 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.628 -0.67 . . . . 0.17 109.655 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.88 100.27 9.27 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.176 -0.676 . . . . 0.96 109.176 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 49.8 m-85 -85.17 78.43 9.84 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.979 -1.119 . . . . 0.24 107.979 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.0 m -104.88 -164.89 1.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.576 -0.702 . . . . 1.03 109.235 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.21 126.49 19.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.532 -0.914 . . . . 0.26 108.532 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -63.87 -34.3 77.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.616 -0.677 . . . . 0.32 111.665 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.549 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 41.1 p-90 -85.5 -18.02 34.72 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.44 110.135 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.31 115.18 27.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.093 -1.005 . . . . 0.32 109.6 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.03 -50.95 61.85 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 121.643 -0.661 . . . . 0.36 111.951 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.1 Cg_exo -50.0 -33.67 35.14 Favored 'Trans proline' 0 C--N 1.319 -0.999 0 C-N-CA 121.538 1.492 . . . . 0.44 111.045 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.96 -64.09 1.24 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.066 -1.021 . . . . 0.81 109.155 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -59.06 -16.92 21.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 1.92 110.142 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 ttm -59.28 -21.26 59.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.083 -1.011 . . . . 3.13 110.502 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 38' ' ' ILE . 80.0 mt -100.04 12.96 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.172 -0.955 . . . . 0.28 110.948 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.42 -32.15 3.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 120.456 -1.402 . . . . 1.62 112.73 179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.2 Cg_exo -62.1 -5.81 7.01 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 CA-C-N 119.768 0.953 . . . . 0.25 109.921 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -110.29 -73.67 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.071 -0.715 . . . . 0.3 109.071 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -42.62 -57.72 2.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.499 -0.751 . . . . 0.13 110.635 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.66 -31.49 72.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -0.969 . . . . 0.41 110.301 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' SER . 5.5 m -64.99 -39.93 94.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.697 -1.252 . . . . 0.97 110.202 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 mt -49.05 -13.1 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.965 -1.085 . . . . 0.5 109.58 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' SER . 15.7 m -58.13 -29.67 65.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.079 -1.013 . . . . 0.51 109.64 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -95.21 -21.88 18.18 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.193 -0.942 . . . . 2.0 110.054 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -90.39 -20.23 23.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 2.16 109.535 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.97 69.9 1.44 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.476 -0.765 . . . . 0.24 109.179 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 95.6 p -67.49 -5.38 14.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.17 109.17 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 30.5 t-20 -95.76 0.8 52.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.34 109.487 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.03 145.83 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.253 -0.905 . . . . 0.12 109.778 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -99.05 123.44 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.095 -0.705 . . . . 0.17 109.095 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.8 m-85 -109.01 132.06 54.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.451 -0.781 . . . . 0.11 109.002 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.83 174.86 5.76 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.639 -0.874 . . . . 0.12 108.639 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -143.16 140.34 30.75 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.422 -0.955 . . . . 1.31 108.422 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -138.8 135.97 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.334 -0.854 . . . . 0.14 110.279 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -97.37 105.46 17.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.209 -1.034 . . . . 1.08 108.209 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 74' ' ' THR . 30.3 m -65.73 -4.55 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.268 -0.895 . . . . 0.27 110.35 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.549 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 2.9 m-20 -102.94 -45.07 5.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.328 -0.857 . . . . 1.11 110.886 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -95.89 -13.97 23.52 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.095 -1.003 . . . . 1.12 110.399 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.7 48.83 1.46 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.241 -0.912 . . . . 0.17 109.094 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -54.9 -12.05 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.532 -0.73 . . . . 2.22 110.197 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.31 -43.24 70.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.974 -1.079 . . . . 1.11 109.569 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -73.32 -45.38 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.19 108.861 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.83 -31.45 72.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.443 -0.786 . . . . 0.22 109.088 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.9 m -64.78 -52.51 56.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.296 -0.877 . . . . 1.29 109.395 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.5 -35.26 79.87 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 2.2 109.371 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.96 -2.75 58.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.307 -0.871 . . . . 0.33 109.573 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 46.05 54.34 8.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 2.34 110.186 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.49 135.67 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.278 -0.888 . . . . 0.28 109.076 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -129.01 1.6 5.28 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.462 -0.774 . . . . 2.4 109.865 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.65 137.61 16.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.22 109.03 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.56 HG23 ' CE2' ' B' ' 5' ' ' TYR . 40.3 p -119.44 149.8 48.44 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.365 -0.834 . . . . 0.22 108.8 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -78.48 145.29 76.93 Favored 'Cis proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.932 -0.862 . . . . 0.2 109.923 -1.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -114.82 115.19 26.59 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 107.83 -1.174 . . . . 0.18 107.83 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.5 m-85 -90.83 119.24 30.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.0 -1.062 . . . . 0.15 109.169 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.52 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.7 mt-30 -118.2 134.55 54.91 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.666 -1.235 . . . . 1.03 107.666 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.6 m-85 -108.44 126.09 52.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.496 -0.752 . . . . 0.11 109.66 -178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -123.38 157.65 32.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.695 -0.854 . . . . 0.17 108.695 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.58 122.94 6.04 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.274 -1.38 . . . . 1.48 107.274 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 55.62 34.58 23.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.348 -0.845 . . . . 1.67 109.318 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.57 83.13 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.369 -1.092 . . . . 0.22 110.369 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.7 144.1 42.79 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.333 -1.098 . . . . 2.08 110.449 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -84.9 144.18 28.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.242 -0.911 . . . . 1.7 109.241 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.3 m -130.12 -20.26 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.415 -0.803 . . . . 0.26 110.219 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.81 174.47 46.88 Favored Glycine 0 N--CA 1.497 2.724 0 C-N-CA 119.589 -1.291 . . . . 0.18 110.325 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER -173.07 155.29 2.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -1.108 . . . . 2.04 110.284 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.89 131.91 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.444 -0.785 . . . . 0.14 110.21 178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -103.2 -161.34 0.83 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.156 -0.965 . . . . 0.17 109.009 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.89 127.44 0.78 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.157 -1.577 . . . . 0.13 109.157 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.58 98.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.161 -1.199 . . . . 0.2 110.279 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.82 69.99 1.35 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.484 -0.932 . . . . 1.15 108.484 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -61.64 -35.92 79.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 1.19 110.698 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -65.72 -30.21 70.85 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.994 -1.066 . . . . 1.95 109.53 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -33.63 74.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.355 -0.84 . . . . 2.05 109.877 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.5 mt -50.27 -32.93 18.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.927 -1.108 . . . . 0.15 108.752 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.38 -59.34 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 2.15 109.706 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -40.08 84.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.843 . . . . 0.15 110.703 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.41 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 17.3 m -65.71 -46.98 76.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.151 -0.968 . . . . 0.13 110.385 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.7 mt -60.73 -52.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.18 108.967 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -61.25 -16.26 43.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 1.03 109.703 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -77.17 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 2.02 110.73 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.19 19.25 7.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.548 -0.72 . . . . 0.35 110.795 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.061 . . . . 1.18 109.361 179.411 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.408 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -169.2 94.48 0.31 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.151 -0.968 . . . . 0.0 109.972 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.51 ' CD2' ' CH2' ' A' ' 31' ' ' TRP . 26.3 m-85 -102.49 171.77 7.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.0 OUTLIER -150.71 -110.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.293 -0.879 . . . . 0.0 108.691 179.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.56 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.4 p90 -109.0 -170.84 1.73 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 120.565 -1.335 . . . . 0.0 110.385 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.6 t -71.05 146.55 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.939 0.876 . . . . 0.0 112.803 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 12.4 m -101.23 93.3 5.37 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.422 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 pt-20 -83.85 48.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.995 -1.065 . . . . 0.0 110.154 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -75.98 -125.76 0.21 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 106.922 -2.471 . . . . 0.0 106.922 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -66.48 21.59 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.728 0 CA-C-N 119.381 1.591 . . . . 0.0 109.414 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.629 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.3 t -93.57 -6.4 46.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 0.0 109.363 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -163.61 133.12 4.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.393 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.327 0.584 . . . . 2.89 109.537 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 3' ' ' LYS . 97.3 t -94.79 164.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.248 -0.908 . . . . 0.3 109.511 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.574 ' N ' HG12 ' A' ' 2' ' ' VAL . 9.4 tmtm? -153.07 120.92 6.07 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.04 -1.096 . . . . 1.97 108.04 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -88.46 138.56 31.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.331 -0.855 . . . . 0.98 110.207 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.67 108.45 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.207 -1.034 . . . . 0.19 108.207 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -100.7 -8.04 23.22 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.124 -0.985 . . . . 1.97 109.488 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 p -153.81 157.29 39.14 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.115 -0.991 . . . . 0.23 110.067 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 44.6 tttm -52.65 -32.78 43.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.517 -0.74 . . . . 1.9 110.228 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -60.27 -41.97 94.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.25 110.485 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.29 65.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.258 -0.901 . . . . 0.2 109.915 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.22 -68.27 0.31 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.093 -1.005 . . . . 0.21 109.899 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -53.92 -43.84 70.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 2.47 109.881 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.94 -37.97 77.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.178 -0.951 . . . . 2.1 110.025 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.38 86.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.058 -1.026 . . . . 0.2 109.653 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 mt -65.07 -38.83 92.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.387 -0.821 . . . . 0.62 110.244 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -63.94 -49.22 73.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 1.09 110.285 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.7 -8.94 59.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.3 110.073 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.97 -5.33 16.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.153 -0.967 . . . . 0.24 109.827 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.68 -113.55 4.87 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.672 -1.371 . . . . 0.28 109.672 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.3 5.04 2.25 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.374 -1.074 . . . . 2.21 109.047 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 62.3 mttt -69.78 168.48 14.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.061 -1.024 . . . . 1.9 108.996 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -63.02 164.22 8.64 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.351 -0.981 . . . . 0.17 108.351 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.8 t -146.12 106.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.9 -1.125 . . . . 0.12 109.351 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -102.94 135.41 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.378 -0.827 . . . . 0.09 108.8 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.93 132.43 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.703 . . . . 0.17 109.467 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -106.23 104.18 13.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.686 -0.634 . . . . 0.96 109.44 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 51.0 m-85 -86.34 79.03 9.16 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.662 -1.236 . . . . 0.24 107.662 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 m -113.11 147.06 38.1 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.37 0.605 . . . . 1.03 109.756 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.41 125.58 36.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.327 -0.858 . . . . 0.26 108.713 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -66.18 -23.09 66.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.32 110.334 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.87 -13.88 38.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.038 -1.038 . . . . 0.44 109.986 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.96 116.36 29.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.338 -0.851 . . . . 0.32 110.048 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -56.24 -55.82 27.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 111.365 -0.694 . . . . 0.36 111.365 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.0 Cg_exo -47.49 -34.19 19.18 Favored 'Trans proline' 0 C--N 1.319 -1.001 0 C-N-CA 121.417 1.412 . . . . 0.44 111.037 -178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.23 -56.44 4.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.018 -1.051 . . . . 0.81 108.912 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -59.4 -18.94 43.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 1.92 109.831 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -58.58 -20.28 45.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 3.13 110.119 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 38' ' ' ILE . 78.7 mt -97.59 4.03 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.019 -1.05 . . . . 0.28 110.902 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.44 5.99 Favored Pre-proline 0 C--N 1.307 -1.281 0 O-C-N 120.258 -1.526 . . . . 1.62 112.129 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.2 Cg_exo -67.39 0.65 3.77 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 CA-C-N 119.699 0.928 . . . . 0.25 110.03 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 42' ' ' PHE . 50.8 m-85 -119.0 -78.42 0.59 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.885 -0.784 . . . . 0.3 108.885 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' PHE . 83.9 t80 -40.97 -55.69 2.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.761 -0.587 . . . . 0.13 110.659 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.75 -30.76 70.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.41 109.846 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 46' ' ' SER . 58.3 p -66.43 -41.9 88.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.892 -1.13 . . . . 0.97 110.349 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.0 mt -49.25 -16.72 0.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.924 -1.11 . . . . 0.5 109.729 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.49 -26.03 60.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.51 110.205 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -97.55 -25.22 15.23 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.053 -1.029 . . . . 2.0 110.789 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -90.8 -19.26 23.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.78 -1.2 . . . . 2.16 109.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -132.35 64.16 1.61 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -0.798 . . . . 0.24 109.372 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.1 p -67.33 -3.3 7.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.43 -0.794 . . . . 0.17 108.926 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -94.46 1.28 55.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.453 -0.779 . . . . 0.34 109.379 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -119.29 148.24 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.861 -0.792 . . . . 0.12 108.861 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -98.94 125.19 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.17 109.424 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.55 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -113.1 130.83 56.05 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.419 -0.801 . . . . 0.11 109.295 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -112.42 173.53 6.33 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.45 -0.781 . . . . 0.12 108.979 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -144.26 141.6 29.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.233 -1.025 . . . . 1.31 108.233 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.0 t -138.13 140.66 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.119 -0.988 . . . . 0.14 110.267 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 12.7 t70 -100.15 96.48 7.51 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.147 -1.057 . . . . 1.08 108.147 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG21 HG21 ' A' ' 74' ' ' THR . 16.6 m -56.94 -0.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.27 111.39 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 15.1 m-20 -109.91 -43.39 4.01 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.031 -1.043 . . . . 1.11 110.702 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.25 -23.82 17.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.099 -1.0 . . . . 1.12 109.448 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.01 43.26 1.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.416 -0.957 . . . . 0.17 108.416 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB3' HH12 ' B' ' 4' ' ' ARG . 10.5 pt20 -53.72 -12.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.57 -0.706 . . . . 2.22 110.279 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.2 p-10 -71.12 -39.28 72.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.062 -1.024 . . . . 1.11 109.153 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.54 -47.11 40.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.73 -0.841 . . . . 0.19 108.73 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.19 -32.78 74.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.22 109.044 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 m -63.9 -47.79 79.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.347 -0.845 . . . . 1.29 109.143 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -63.74 -39.58 94.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.296 -0.878 . . . . 2.2 109.289 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.84 -4.98 58.82 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.25 -0.906 . . . . 0.33 109.53 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.1 mt-10 48.11 57.21 6.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 2.34 110.19 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.6 131.23 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.28 109.007 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -125.23 4.57 7.81 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.397 -0.814 . . . . 2.4 109.733 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.26 130.64 12.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.228 -0.92 . . . . 0.22 108.959 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.6 p -116.03 150.01 44.36 Favored Pre-proline 0 N--CA 1.502 2.14 0 N-CA-C 108.293 -1.002 . . . . 0.22 108.293 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -79.77 144.35 70.18 Favored 'Cis proline' 0 N--CA 1.484 0.92 0 C-N-CA 125.09 -0.796 . . . . 0.2 110.105 -1.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -115.77 114.51 24.88 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.89 -1.152 . . . . 0.18 107.89 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.1 m-85 -91.07 124.56 35.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.985 -1.072 . . . . 0.15 109.052 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.451 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.4 mt-30 -121.29 136.49 54.96 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.986 -1.116 . . . . 1.03 107.986 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.3 m-85 -110.93 128.63 55.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.527 -0.733 . . . . 0.11 110.01 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -126.97 161.3 28.66 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.669 -0.863 . . . . 0.17 108.669 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.35 127.37 7.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.962 -1.125 . . . . 1.48 107.962 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 81.8 mttt 57.05 9.42 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.455 -0.778 . . . . 1.67 109.662 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.535 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 102.16 1.78 51.31 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 110.183 -1.167 . . . . 0.22 110.183 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.535 HE21 ' C ' ' A' ' 83' ' ' GLY . 35.1 mm-40 -109.15 149.49 29.27 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.319 -1.107 . . . . 2.08 109.996 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.3 ttpm? -84.91 143.22 29.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.369 -0.832 . . . . 1.7 109.402 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.69 -18.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.428 -0.795 . . . . 0.26 110.475 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.02 174.95 47.22 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.391 -1.385 . . . . 0.18 110.424 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.4 154.96 2.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -1.13 . . . . 2.04 110.279 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.99 131.81 1.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.298 -0.876 . . . . 0.14 110.417 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.9 p -102.07 -163.76 1.03 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.184 -0.948 . . . . 0.17 108.987 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.12 125.12 1.18 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.13 109.128 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.62 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.158 -1.201 . . . . 0.2 110.712 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -141.72 75.84 1.51 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.084 -1.08 . . . . 1.15 108.084 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.16 -35.09 79.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 1.19 110.595 -178.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -65.23 -28.3 69.26 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.988 -1.07 . . . . 1.95 109.515 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -68.84 -34.5 75.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.261 -0.899 . . . . 2.05 109.733 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.8 mt -52.52 -32.99 43.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.809 -1.182 . . . . 0.15 108.82 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -54.13 18.9 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.584 -0.847 . . . . 2.15 109.313 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.29 97.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.15 110.73 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.7 m -66.34 -44.7 82.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.13 109.815 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.4 mt -61.63 -52.31 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.868 . . . . 0.18 108.836 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -60.31 -16.53 35.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.03 109.831 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -76.82 -56.34 4.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 2.02 110.358 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HB2' HD11 ' A' ' 22' ' ' LEU . 20.6 mt -93.63 13.21 22.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -0.894 . . . . 0.35 110.587 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.493 1.722 0 O-C-N 120.878 -1.139 . . . . 1.18 109.296 179.638 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 29.5 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 4.4 mtt-85 -123.73 46.71 2.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.508 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.4 m-85 -103.61 155.51 18.5 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.873 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.45 -88.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.13 -0.981 . . . . 0.0 109.314 179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.2 p90 -124.46 -171.08 2.27 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.642 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.11 148.2 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.958 0.885 . . . . 0.0 112.219 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -101.6 95.03 6.18 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.431 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -83.3 49.45 1.56 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -0.983 . . . . 0.0 110.002 -179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -79.59 -126.96 0.58 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 107.181 -2.368 . . . . 0.0 107.181 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.61 25.57 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 CA-C-N 119.311 1.555 . . . . 0.0 109.588 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 46.8 t -85.11 -7.56 59.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.621 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 10.2 t-160 51.56 -127.67 2.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.867 . . . . 0.0 109.382 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.621 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.056 -1.413 . . . . 0.0 109.569 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.0 mmm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.406 -0.59 . . . . 2.89 109.406 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.4 t -94.76 161.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.191 -0.943 . . . . 0.3 109.654 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 2' ' ' VAL . 69.9 tttt -155.16 121.03 5.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.344 -0.848 . . . . 1.97 109.217 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -89.16 131.13 35.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.98 109.579 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.82 111.89 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.181 -1.044 . . . . 0.19 108.181 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -102.81 -8.79 20.5 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.3 -0.875 . . . . 1.97 109.968 -179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.8 p -151.65 155.34 38.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.996 -1.065 . . . . 0.23 109.919 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.81 -30.72 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.486 -0.758 . . . . 1.9 109.982 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 m -59.42 -45.91 90.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.033 -1.042 . . . . 0.25 109.807 -179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.7 -26.28 64.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.2 109.574 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -59.86 -69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.088 -1.008 . . . . 0.21 109.97 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -53.62 -42.11 67.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.843 . . . . 2.47 109.636 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.42 -38.46 80.69 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.127 -0.983 . . . . 2.1 109.804 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -47.44 86.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.12 -0.988 . . . . 0.2 109.243 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.16 -46.29 84.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.35 -0.844 . . . . 0.62 109.816 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.47 -42.29 98.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.066 -1.021 . . . . 1.09 109.483 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 -13.58 59.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.89 . . . . 0.3 109.741 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.37 -19.19 64.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.217 -0.927 . . . . 0.24 109.684 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.61 -116.33 4.21 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.794 -1.322 . . . . 0.28 109.794 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -134.86 2.66 3.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.417 -1.049 . . . . 2.21 109.526 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -68.84 167.92 14.55 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.069 -1.019 . . . . 1.9 108.718 179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.19 164.13 9.17 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.953 -1.129 . . . . 0.17 107.953 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 ' H ' HD23 ' A' ' 22' ' ' LEU . 19.1 t -145.24 102.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.978 -1.076 . . . . 0.12 109.443 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.1 t -99.9 131.18 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.379 -0.825 . . . . 0.09 108.82 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.27 137.0 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.567 -0.708 . . . . 0.17 109.57 -179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -107.98 102.02 11.23 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.128 -0.693 . . . . 0.96 109.128 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 43.5 m-85 -86.3 80.31 8.77 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.016 -1.105 . . . . 0.24 108.016 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.1 m -113.29 149.91 33.22 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.348 0.594 . . . . 1.03 109.544 -179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.02 124.21 35.09 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.553 -0.906 . . . . 0.26 108.553 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -65.47 -23.08 66.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.32 110.3 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 54.0 p-90 -88.08 -16.18 34.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.979 -1.076 . . . . 0.44 109.754 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.87 128.09 42.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.36 -0.838 . . . . 0.32 109.38 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.81 -53.26 16.24 Favored Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.508 -0.745 . . . . 0.36 111.8 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.3 Cg_exo -47.62 -37.27 26.72 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.737 1.624 . . . . 0.44 111.476 -178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.51 -59.99 2.53 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.989 -1.069 . . . . 0.81 109.065 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.28 -18.56 50.08 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.59 -0.694 . . . . 1.92 110.463 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.9 tmt? -58.48 -19.51 37.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.966 -1.084 . . . . 3.13 110.313 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 38' ' ' ILE . 44.2 mt -96.85 15.03 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.189 -0.945 . . . . 0.28 111.085 -178.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.2 -32.88 6.01 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.012 -1.68 . . . . 1.62 112.405 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.2 Cg_exo -65.3 -6.98 14.43 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 CA-C-N 119.902 1.001 . . . . 0.25 110.274 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -107.63 -76.51 0.61 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.435 -0.791 . . . . 0.3 109.331 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -42.86 -54.72 4.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.13 110.925 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -67.14 -33.68 75.96 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.962 -1.086 . . . . 0.41 109.743 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 t -62.36 -42.69 99.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.98 -1.075 . . . . 0.97 110.145 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -51.31 -15.58 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.061 -1.024 . . . . 0.5 109.724 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -57.73 -31.77 66.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -0.998 . . . . 0.51 109.543 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -95.34 -19.72 19.72 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 2.0 110.123 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -89.75 -21.93 22.42 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.071 -1.018 . . . . 2.16 109.281 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -133.8 68.77 1.48 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.908 -0.775 . . . . 0.24 108.908 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.6 p -66.41 -4.1 7.47 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.272 -0.892 . . . . 0.17 108.964 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.37 -0.77 52.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.34 109.248 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.5 t -114.28 147.07 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.559 -0.713 . . . . 0.12 109.375 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.81 123.8 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.38 -0.825 . . . . 0.17 108.798 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.6 m-85 -110.74 130.53 55.55 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.43 -0.794 . . . . 0.11 109.3 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.6 mp -113.68 173.23 6.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.425 -0.797 . . . . 0.12 108.984 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -142.82 139.44 30.92 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.604 -1.258 . . . . 1.31 107.604 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.85 138.06 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.231 -0.918 . . . . 0.14 110.657 -178.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.43 106.11 18.13 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.174 -1.047 . . . . 1.08 108.174 178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 HG11 ' OH ' ' B' ' 5' ' ' TYR . 22.9 m -60.64 -10.52 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.315 -0.866 . . . . 0.27 111.566 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -104.29 -40.33 6.15 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.931 -1.106 . . . . 1.11 110.866 -179.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.81 -11.98 35.03 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.87 -1.144 . . . . 1.12 109.529 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.32 50.13 1.82 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.649 -0.871 . . . . 0.17 108.649 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.559 HE22 ' CZ ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -55.1 -18.22 5.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.436 -0.79 . . . . 2.22 109.995 -179.606 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.2 p30 -70.09 -40.96 74.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.12 -0.987 . . . . 1.11 109.379 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.78 -46.62 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.09 -1.006 . . . . 0.19 108.854 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.887 . . . . 0.22 108.899 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.1 m -63.77 -50.13 70.24 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.32 -0.862 . . . . 1.29 108.915 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.04 -33.62 76.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.821 . . . . 2.2 109.294 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.36 -6.32 57.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.299 -0.876 . . . . 0.33 109.718 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.1 mt-10 47.51 55.47 8.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 2.34 110.337 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.2 t -78.9 136.79 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.17 -0.956 . . . . 0.28 109.116 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -124.65 -5.34 7.59 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.448 -0.782 . . . . 2.4 110.122 -179.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.71 130.57 12.47 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.844 -1.16 . . . . 0.22 109.769 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.701 HG23 ' CE2' ' B' ' 5' ' ' TYR . 14.1 p -112.52 150.66 42.99 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.855 -0.795 . . . . 0.22 108.855 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -76.52 143.99 77.77 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 C-N-CA 124.796 -0.918 . . . . 0.2 110.364 -2.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.67 118.8 34.67 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.024 -1.102 . . . . 0.18 108.024 178.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' CD1' HD21 ' A' ' 97' ' ' LEU . 73.4 m-85 -94.08 118.35 31.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.112 -0.992 . . . . 0.15 108.601 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.482 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 8.1 mt-30 -116.5 135.35 53.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.962 -1.125 . . . . 1.03 107.962 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 30.7 m-85 -110.18 124.11 50.98 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.656 -0.652 . . . . 0.11 109.706 -178.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -120.9 158.8 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.488 -0.93 . . . . 0.17 108.488 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -155.44 121.49 5.13 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.437 -1.32 . . . . 1.48 107.437 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? 55.32 39.97 31.4 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.375 -0.828 . . . . 1.67 109.541 -178.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.22 7.08 62.5 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.291 -1.124 . . . . 0.22 110.291 179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -113.69 144.69 42.51 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.276 -1.132 . . . . 2.08 110.543 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -86.08 142.37 28.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.257 -0.902 . . . . 1.7 109.397 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.73 -26.38 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.455 -0.778 . . . . 0.26 110.086 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.82 177.55 46.07 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.415 -1.374 . . . . 0.18 110.419 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.24 155.3 2.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 2.04 110.198 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -169.45 134.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.14 110.184 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -104.68 -171.54 1.94 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.18 -0.95 . . . . 0.17 109.053 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.38 131.3 6.18 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.455 -1.458 . . . . 0.13 109.455 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.527 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.87 92.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -1.183 . . . . 0.2 110.162 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.51 75.29 1.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.052 -1.092 . . . . 1.15 108.052 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.498 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.21 -32.96 74.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.772 . . . . 1.19 110.377 -178.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.92 -27.78 67.76 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.787 -1.196 . . . . 1.95 109.25 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -67.93 -35.2 78.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.805 . . . . 2.05 109.18 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 77' ' ' PHE . 32.6 mt -52.31 -38.95 59.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.15 108.69 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -66.13 -57.63 7.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.496 -0.753 . . . . 2.15 109.779 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.01 -41.3 87.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.37 -0.831 . . . . 0.15 110.269 -179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.3 m -67.04 -45.03 78.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.251 -0.905 . . . . 0.13 110.269 -179.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -60.32 -52.47 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.18 108.437 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -60.6 -18.84 55.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 1.03 109.431 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -76.76 -60.75 2.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 2.02 110.116 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.0 mt -91.15 21.18 4.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.444 -0.785 . . . . 0.35 110.476 -178.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 1.18 109.132 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.5 t80 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 29.9 mtm180 -154.1 69.06 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 0.0 108.812 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.558 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 26.4 m-85 -103.6 156.12 18.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.554 -0.716 . . . . 0.0 109.564 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.559 ' CZ ' HE22 ' A' ' 63' ' ' GLN . 3.4 mmm180 -143.57 -101.05 0.12 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.701 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -114.72 -165.43 1.02 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.161 -0.962 . . . . 0.0 110.669 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.7 148.89 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.258 -0.901 . . . . 0.0 112.773 -176.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.1 m -101.4 94.09 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.7 pt-20 -83.8 41.99 0.83 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.867 -1.146 . . . . 0.0 110.389 -178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.93 -138.53 0.04 OUTLIER Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.107 -2.397 . . . . 0.0 107.107 178.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -66.85 25.71 0.11 Allowed 'Trans proline' 0 C--N 1.319 -0.98 0 CA-C-N 118.927 1.363 . . . . 0.0 109.258 178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.633 ' H ' ' C ' ' B' ' 9' ' ' GLY . 15.0 t -86.96 -33.46 19.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.418 -0.802 . . . . 0.0 109.274 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -55.83 140.72 41.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.636 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.999 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 2.89 109.5 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.4 t -94.42 166.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.3 108.898 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 2' ' ' VAL . 27.3 tptp -154.46 122.49 5.95 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.002 -1.061 . . . . 1.97 109.397 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -91.5 134.87 34.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.98 109.837 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -109.17 110.54 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.232 -1.025 . . . . 0.19 108.232 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.77 -9.74 20.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 1.97 109.654 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.7 p -153.19 157.46 40.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.016 -1.052 . . . . 0.23 110.147 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -53.68 -31.91 49.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 1.9 110.222 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -59.22 -44.99 92.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.25 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.48 63.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.2 109.756 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -61.09 -67.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.21 110.324 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -55.57 -41.25 73.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.985 . . . . 2.47 109.726 -179.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.93 -36.53 79.56 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.102 -0.999 . . . . 2.1 109.884 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.58 -46.79 88.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.031 -1.043 . . . . 0.2 109.495 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -62.53 -41.77 99.08 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.357 -0.839 . . . . 0.62 109.089 179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.84 -40.73 92.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.278 -0.889 . . . . 1.09 109.494 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.86 -17.39 53.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.3 109.604 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -4.93 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.24 109.527 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.12 30.25 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.14 -1.584 . . . . 0.28 109.14 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -116.87 4.71 12.92 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.465 -1.02 . . . . 2.21 109.356 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 109' ' ' HOH . 80.6 mttt -70.36 168.66 15.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.046 -1.034 . . . . 1.9 109.135 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.66 163.76 13.24 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.339 -0.944 . . . . 0.17 108.508 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.594 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -146.0 108.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.968 -1.083 . . . . 0.12 109.861 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.7 128.65 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.368 -0.832 . . . . 0.09 108.879 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.41 135.33 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.684 -0.635 . . . . 0.17 109.42 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -106.51 99.06 8.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.111 -0.699 . . . . 0.96 109.111 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.528 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 48.6 m-85 -84.67 83.76 7.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.91 -1.145 . . . . 0.24 107.91 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -111.94 -162.21 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.516 0.674 . . . . 1.03 109.183 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.49 119.69 12.9 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.361 -0.977 . . . . 0.26 108.361 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 -23.44 67.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.73 . . . . 0.32 110.582 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -90.36 -13.68 34.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.881 -1.137 . . . . 0.44 110.122 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.98 134.65 38.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.221 -0.924 . . . . 0.32 109.715 -179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -74.07 -58.43 4.37 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.602 -0.686 . . . . 0.36 111.764 -179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.78 -43.19 24.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.66 1.573 . . . . 0.44 111.894 -178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.85 -54.98 6.3 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.663 -1.273 . . . . 0.81 108.884 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -59.47 -18.84 43.09 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.57 -0.706 . . . . 1.92 109.768 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.9 tmt? -62.02 -21.88 65.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.904 . . . . 3.13 110.703 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.606 HG22 ' O ' ' A' ' 38' ' ' ILE . 54.4 mt -97.23 14.67 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.027 -1.046 . . . . 0.28 111.198 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.31 -33.48 4.81 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 120.141 -1.599 . . . . 1.62 112.859 179.745 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.0 Cg_exo -65.04 -8.63 18.84 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 CA-C-N 119.628 0.903 . . . . 0.25 110.481 -176.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 41.9 m-85 -105.97 -73.27 0.69 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.396 -0.815 . . . . 0.3 109.442 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 90.9 t80 -41.96 -54.84 3.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.672 -0.642 . . . . 0.13 110.877 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.73 -35.36 78.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.41 110.115 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t -60.85 -38.33 85.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.867 -1.146 . . . . 0.97 110.18 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.2 mt -51.66 -17.41 0.87 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.5 109.383 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -57.65 -30.04 65.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.51 109.813 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -95.45 -21.98 17.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 2.0 110.116 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -89.85 -20.21 23.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.232 -0.918 . . . . 2.16 109.476 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -135.08 68.75 1.46 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.508 -0.745 . . . . 0.24 109.297 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.7 p -67.52 -6.25 18.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.868 . . . . 0.17 109.097 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.26 2.68 55.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.427 -0.795 . . . . 0.34 109.426 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.16 146.45 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.919 -0.771 . . . . 0.12 108.919 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 mm -98.64 127.96 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.365 -0.834 . . . . 0.17 109.131 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.5 m-85 -114.32 131.78 56.41 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.334 -0.854 . . . . 0.11 109.179 179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -113.27 172.0 7.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 0.12 109.07 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -141.82 142.51 33.17 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.709 -1.219 . . . . 1.31 107.709 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.9 t -140.03 135.62 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.111 -0.993 . . . . 0.14 111.106 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -96.19 103.11 14.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.568 -1.271 . . . . 1.08 107.568 178.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 m -59.48 -8.57 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.237 -0.914 . . . . 0.27 110.814 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 45.6 m-20 -105.08 -43.2 5.1 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.127 -0.983 . . . . 1.11 110.569 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.8 -12.46 36.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.076 -1.015 . . . . 1.12 109.176 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.73 43.69 3.01 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.486 -0.931 . . . . 0.17 108.486 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.23 -17.11 3.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 2.22 109.908 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.1 p30 -69.86 -38.97 76.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.153 -0.967 . . . . 1.11 109.153 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 t -75.3 -44.85 42.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.116 -0.99 . . . . 0.19 108.57 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.03 78.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.22 108.68 179.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 m -64.34 -44.6 90.98 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 1.29 109.162 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.88 -37.8 88.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 2.2 109.479 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -0.83 57.5 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.244 -0.91 . . . . 0.33 110.04 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 24.8 mp0 49.64 55.86 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.134 -0.979 . . . . 2.34 109.647 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 12.0 t -79.27 135.37 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.28 109.526 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -132.91 -0.04 3.45 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.426 -0.796 . . . . 2.4 109.768 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.21 127.79 10.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.085 -1.009 . . . . 0.22 108.827 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.702 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.9 p -113.24 151.61 44.43 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.408 -0.807 . . . . 0.22 108.899 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.12 143.71 76.1 Favored 'Cis proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.787 -0.922 . . . . 0.2 110.13 -1.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.26 113.71 24.24 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.989 -1.115 . . . . 0.18 107.989 178.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.505 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -89.65 122.57 32.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.978 -1.076 . . . . 0.15 108.75 179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 38.9 mt-30 -122.31 134.6 54.66 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.491 -1.3 . . . . 1.03 107.491 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 23.6 m-85 -105.01 134.89 47.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.527 -0.733 . . . . 0.11 110.039 -178.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.64 153.57 47.14 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.812 -0.81 . . . . 0.17 108.812 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -155.18 123.98 6.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.555 -1.276 . . . . 1.48 107.555 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 55.89 25.8 9.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.608 -0.682 . . . . 1.67 109.861 -178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.05 1.63 84.44 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 120.081 -1.057 . . . . 0.22 110.65 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.23 146.5 38.04 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.16 -1.2 . . . . 2.08 110.493 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.06 139.42 30.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.819 -0.808 . . . . 1.7 108.819 178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.23 -10.76 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.313 -0.867 . . . . 0.26 110.616 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.37 167.75 39.89 Favored Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.371 -1.395 . . . . 0.18 110.532 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER -173.22 153.54 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.32 -1.106 . . . . 2.04 110.419 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -168.92 131.96 1.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.521 -0.737 . . . . 0.14 110.3 178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 p -102.29 -164.82 1.12 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.179 -0.95 . . . . 0.17 109.273 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.75 130.53 1.5 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.496 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.51 98.85 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -1.18 . . . . 0.2 110.298 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -140.89 74.77 1.47 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.216 -0.927 . . . . 1.15 108.571 178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -65.22 -38.23 89.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.814 -0.554 . . . . 1.19 110.902 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.43 -30.08 70.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 1.95 109.917 -179.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -69.26 -32.08 71.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 2.05 109.749 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.0 mt -50.44 -34.82 26.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.85 -1.156 . . . . 0.15 108.902 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -67.93 -57.59 5.96 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.84 -0.744 . . . . 2.15 109.91 -179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.95 80.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.15 110.792 -179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 6.7 m -66.64 -45.03 80.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.978 -1.076 . . . . 0.13 110.205 -178.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -61.15 -52.65 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.124 -0.985 . . . . 0.18 108.946 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -60.72 -16.27 37.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.149 -0.969 . . . . 1.03 109.655 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.25 -64.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.313 -0.867 . . . . 2.02 110.341 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.2 mt -90.71 21.92 3.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 0.35 110.676 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.867 -1.146 . . . . 1.18 109.462 179.594 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 17.0 mmt180 -121.13 60.34 0.92 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.487 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -105.89 152.64 23.02 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.41 -101.05 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.377 -0.827 . . . . 0.0 108.829 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.702 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -117.32 -169.37 1.65 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.157 -0.964 . . . . 0.0 110.37 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.3 148.54 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.316 -0.865 . . . . 0.0 112.252 -177.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.17 94.82 6.16 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -83.0 46.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.903 -1.123 . . . . 0.0 109.936 -179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.68 -132.85 0.17 Allowed Glycine 0 N--CA 1.484 1.865 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 177.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.37 26.32 0.14 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 CA-C-N 119.243 1.521 . . . . 0.0 109.037 178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.604 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.4 t -84.01 -31.92 25.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -98.86 -163.38 1.03 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.29 -0.881 . . . . 0.0 109.379 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.236 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.371 -0.603 . . . . 2.89 109.371 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 3' ' ' LYS . 61.6 t -94.73 157.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.3 109.641 -179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.6 tttm -154.59 122.66 5.93 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 1.97 109.24 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 10.5 tt0 -89.64 135.96 33.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.445 -0.785 . . . . 0.98 109.575 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.22 113.49 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.159 -1.052 . . . . 0.19 108.159 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' N ' ' OE2' ' A' ' 6' ' ' GLU . 1.6 mp0 -102.13 -10.34 19.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.075 -1.015 . . . . 1.97 110.204 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 p -152.12 153.8 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.843 -1.16 . . . . 0.23 110.116 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -51.85 -28.69 16.74 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.532 -0.73 . . . . 1.9 109.55 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -61.05 -45.29 95.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.087 -1.008 . . . . 0.25 109.818 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.06 -23.39 62.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.2 110.134 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -59.67 -65.98 0.59 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.0 -1.062 . . . . 0.21 110.192 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -55.93 -44.35 78.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.107 -0.996 . . . . 2.47 109.641 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -58.95 -36.15 74.31 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.369 -0.832 . . . . 2.1 110.112 -179.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.15 86.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.988 -1.07 . . . . 0.2 109.405 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.2 mt -63.1 -42.27 99.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.475 -0.765 . . . . 0.62 109.235 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -64.27 -39.61 94.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.313 -0.867 . . . . 1.09 109.468 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.12 -15.07 58.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.3 109.595 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -11.01 60.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.24 109.732 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.45 -112.58 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.427 -1.469 . . . . 0.28 109.427 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.48 1.89 2.42 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.387 -1.066 . . . . 2.21 109.614 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' HOH . 40.8 mttp -69.29 171.54 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.095 -1.003 . . . . 1.9 109.094 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.52 161.43 17.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.796 -1.187 . . . . 0.17 107.796 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.1 t -144.92 104.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.915 -1.116 . . . . 0.12 109.232 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.8 t -102.19 127.82 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.733 -0.84 . . . . 0.09 108.733 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -105.8 139.71 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.584 -0.697 . . . . 0.17 109.676 -178.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -110.91 100.17 8.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.685 -0.635 . . . . 0.96 109.33 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -84.31 78.51 9.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.63 -1.248 . . . . 0.24 107.63 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.8 m -103.37 -162.88 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.521 -0.737 . . . . 1.03 109.564 -179.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.54 125.08 17.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.953 -0.758 . . . . 0.26 108.953 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.41 -33.8 76.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.659 -0.65 . . . . 0.32 111.531 -178.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.577 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 54.6 p-90 -85.82 -16.46 38.65 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.712 -1.242 . . . . 0.44 110.291 -178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.31 129.41 38.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.1 -1.0 . . . . 0.32 109.977 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.6 -58.53 5.82 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 120.877 -0.678 . . . . 0.36 111.617 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -45.71 -38.2 16.9 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.818 1.678 . . . . 0.44 111.931 -178.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.76 -60.74 2.23 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.817 -1.177 . . . . 0.81 109.085 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -59.43 -16.36 23.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.45 -0.782 . . . . 1.92 109.926 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 33' ' ' GLY . 14.5 tpt -60.89 -20.41 61.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 3.13 110.082 -179.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.25 14.84 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.084 -1.01 . . . . 0.28 110.966 -178.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.95 -31.87 2.2 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.197 -1.564 . . . . 1.62 112.734 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -65.04 -4.88 9.77 Favored 'Trans proline' 0 C--N 1.324 -0.748 0 CA-C-N 119.696 0.927 . . . . 0.25 110.315 -178.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.8 m-85 -110.66 -78.02 0.59 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.37 -0.832 . . . . 0.3 108.878 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.4 t80 -40.41 -57.33 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.878 -0.514 . . . . 0.13 110.775 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.36 -31.3 71.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.045 . . . . 0.41 109.988 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.433 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -64.92 -40.24 94.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.826 -1.171 . . . . 0.97 109.942 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.4 mt -49.39 -16.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.5 109.309 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 44' ' ' SER . 19.6 m -57.73 -32.49 67.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.51 109.741 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -95.0 -20.58 19.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.113 -0.992 . . . . 2.0 110.149 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -90.67 -19.59 23.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 2.16 109.297 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -136.62 71.75 1.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.389 -0.819 . . . . 0.24 109.318 179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.6 p -67.72 -6.98 23.48 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.296 -0.877 . . . . 0.17 109.079 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.1 t30 -95.85 8.56 43.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.336 -0.853 . . . . 0.34 109.727 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.5 t -123.43 145.41 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.938 -0.764 . . . . 0.12 108.938 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.41 131.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.17 109.361 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.7 m-85 -118.71 131.69 56.15 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.478 -0.764 . . . . 0.11 109.195 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.76 172.26 7.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.264 -0.898 . . . . 0.12 108.704 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -144.09 141.1 29.85 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.245 -1.02 . . . . 1.31 108.245 179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.7 t -135.8 137.08 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.33 -0.856 . . . . 0.14 109.942 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -98.66 99.15 10.24 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.354 -0.98 . . . . 1.08 108.354 178.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 108' ' ' HOH . 26.9 m -61.4 -6.08 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.903 . . . . 0.27 110.752 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.577 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 3.7 m-20 -96.72 -47.87 5.71 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.913 -1.117 . . . . 1.11 110.391 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -95.74 -16.06 22.19 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.176 -0.953 . . . . 1.12 109.662 -179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.2 44.33 1.56 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.328 -0.858 . . . . 0.17 109.06 179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -55.02 -13.98 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 2.22 109.961 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.89 -40.55 75.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.065 -1.022 . . . . 1.11 109.155 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.51 -46.73 47.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.198 -0.939 . . . . 0.19 108.603 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.29 -34.93 79.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.22 109.325 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 m -63.93 -51.42 64.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 1.29 109.526 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -63.2 -37.11 85.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 2.2 109.466 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 -3.68 58.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.33 109.443 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.7 mt-10 46.67 57.12 5.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 2.34 110.234 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.47 122.55 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.12 -0.988 . . . . 0.28 108.744 179.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -112.44 -1.17 15.08 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.253 -0.904 . . . . 2.4 110.585 -179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.17 129.95 12.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.771 -1.205 . . . . 0.22 109.404 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.689 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.7 p -115.28 151.06 45.45 Favored Pre-proline 0 N--CA 1.501 2.087 0 N-CA-C 108.693 -0.855 . . . . 0.22 108.693 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.77 144.54 76.88 Favored 'Cis proline' 0 N--CA 1.485 0.992 0 C-N-CA 124.874 -0.886 . . . . 0.2 110.108 -1.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -115.02 113.46 24.11 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 107.954 -1.128 . . . . 0.18 107.954 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.645 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.7 m-85 -87.67 122.08 30.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.843 -1.16 . . . . 0.15 109.128 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -118.15 131.76 56.39 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.514 -1.291 . . . . 1.03 107.514 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.9 m-85 -107.23 122.33 46.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.513 -0.742 . . . . 0.11 109.741 -178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -121.01 158.46 27.73 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.742 -0.836 . . . . 0.17 108.742 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -154.67 122.94 5.99 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.629 -1.249 . . . . 1.48 107.629 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? 55.92 31.43 17.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.888 -0.725 . . . . 1.67 109.168 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.71 6.34 89.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.161 -1.176 . . . . 0.22 110.161 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -111.44 144.24 40.97 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.399 -1.059 . . . . 2.08 110.633 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -84.75 142.62 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 1.7 109.333 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.29 -24.01 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.499 -0.751 . . . . 0.26 110.277 -179.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.58 174.26 46.07 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.418 -1.372 . . . . 0.18 110.302 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.3 pm0 -172.98 151.59 2.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.376 -1.073 . . . . 2.04 110.062 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -168.68 132.05 1.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.14 110.306 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -102.53 -170.57 1.82 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.219 -0.925 . . . . 0.17 108.759 179.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.75 127.54 3.29 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.256 -1.538 . . . . 0.13 109.256 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.83 96.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.141 -1.211 . . . . 0.2 110.285 -179.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.85 72.25 1.39 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.092 -1.077 . . . . 1.15 108.092 178.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 1.19 110.998 -178.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -64.22 -27.88 69.36 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.941 -1.099 . . . . 1.95 109.434 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -69.75 -35.7 75.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.246 -0.909 . . . . 2.05 109.874 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 77' ' ' PHE . 22.7 mt -52.22 -33.6 42.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.746 -1.221 . . . . 0.15 108.663 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -67.17 -57.21 7.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.443 -0.786 . . . . 2.15 109.535 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.21 92.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.15 110.336 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.9 m -65.02 -46.47 81.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.13 109.672 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.3 mt -60.14 -52.04 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.945 . . . . 0.18 108.69 179.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.72 -18.24 53.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 1.03 109.514 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -75.79 -58.24 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 2.02 109.953 -179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 mt -93.22 19.5 8.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.534 -0.729 . . . . 0.35 110.283 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.494 1.754 0 O-C-N 120.978 -1.076 . . . . 1.18 109.221 179.607 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 94.98 4.2 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.978 -1.076 . . . . 0.0 108.681 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.538 ' CE1' ' CE1' ' B' ' 1' ' ' PHE . 32.0 m-85 -99.09 164.87 11.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.458 -0.776 . . . . 0.0 109.906 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -138.07 -108.48 0.18 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.466 -0.771 . . . . 0.0 109.024 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.689 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.1 p90 -116.75 -173.04 2.31 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.288 -0.883 . . . . 0.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.415 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.6 t -63.13 145.35 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.965 0.888 . . . . 0.0 112.578 -177.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 27.4 m -101.35 95.28 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 177.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -82.89 45.49 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.486 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.75 -131.5 0.07 OUTLIER Glycine 0 N--CA 1.486 1.977 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 177.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.31 24.53 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.951 0 CA-C-N 119.255 1.527 . . . . 0.0 109.263 178.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.7 t -83.22 -45.66 13.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 -179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 33.3 t-80 -90.51 -176.57 4.8 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.276 -0.89 . . . . 0.0 109.509 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.63 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 118.065 -1.408 . . . . 0.0 109.664 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.431 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mmt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 2.89 109.501 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 3' ' ' LYS . 86.1 t -94.36 159.97 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.3 109.1 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.474 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.9 tttp -155.05 130.3 9.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.005 -1.059 . . . . 1.97 109.42 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -87.73 132.52 34.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.98 109.144 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.1 mm -111.95 87.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.058 -0.719 . . . . 0.19 109.058 -179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -97.12 5.43 50.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.989 -1.069 . . . . 1.97 109.812 -179.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.1 p -151.43 145.45 25.24 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.985 -1.072 . . . . 0.23 109.999 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 71.5 tttt -53.06 -38.33 62.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.476 -0.765 . . . . 1.9 109.954 -179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.7 m -59.31 -39.38 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.98 -1.075 . . . . 0.25 109.701 -179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.28 69.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.2 109.621 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.92 -69.21 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.21 109.713 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -54.82 -44.31 73.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 2.47 109.736 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.54 -37.52 73.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.184 -0.947 . . . . 2.1 109.722 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.01 97.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.2 109.288 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -64.24 -43.12 95.9 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.62 109.824 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.5 -43.22 94.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 1.09 109.645 -179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.26 -14.0 59.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.3 109.678 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.82 -5.31 20.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.129 -0.982 . . . . 0.24 109.724 -179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.7 -133.76 29.93 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.413 -1.475 . . . . 0.28 109.413 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -116.83 6.0 13.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -1.043 . . . . 2.21 109.475 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 109' ' ' HOH . 41.0 mttp -70.28 167.86 17.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.997 -1.064 . . . . 1.9 109.158 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.7 163.56 13.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.102 -1.073 . . . . 0.17 108.102 179.481 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.668 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.3 t -145.34 105.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.971 -1.08 . . . . 0.12 109.759 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.24 132.96 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.687 -0.857 . . . . 0.09 108.687 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -109.31 138.5 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.597 -0.689 . . . . 0.17 109.824 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.44 102.53 11.62 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.68 -0.637 . . . . 0.96 109.297 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.0 m-85 -88.01 79.74 7.91 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.09 -1.078 . . . . 0.24 108.09 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -113.22 148.74 34.9 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.677 -0.64 . . . . 1.03 109.406 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.22 124.63 35.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.368 -0.833 . . . . 0.26 108.756 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -65.37 -23.71 67.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.4 -0.812 . . . . 0.32 110.413 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.4 p-90 -89.48 -10.86 44.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.969 -1.082 . . . . 0.44 110.134 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.3 t -96.94 141.32 30.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.249 -0.907 . . . . 0.32 109.658 -179.036 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -80.55 -56.95 3.02 Favored Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.468 -0.77 . . . . 0.36 111.404 -179.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.7 Cg_exo -48.36 -37.65 32.88 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 C-N-CA 121.729 1.619 . . . . 0.44 111.383 -178.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.85 5.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.645 -1.285 . . . . 0.81 108.851 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.85 -21.68 61.27 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.77 -0.581 . . . . 1.92 110.441 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.7 tpt -59.49 -22.17 61.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 3.13 110.993 -178.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.5 mt -99.11 15.0 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 120.935 -1.103 . . . . 0.28 111.174 -177.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.92 -33.47 5.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.177 -1.577 . . . . 1.62 112.861 -179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -64.2 -9.03 18.12 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.478 0.849 . . . . 0.25 110.932 -175.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -104.66 -70.12 0.78 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.381 -0.824 . . . . 0.3 109.484 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -44.91 -53.24 7.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -0.846 . . . . 0.13 110.689 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -67.07 -35.12 79.14 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -0.987 . . . . 0.41 109.878 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -61.26 -41.1 96.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.892 -1.13 . . . . 0.97 110.118 -179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.5 mt -51.89 -19.47 1.77 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.868 -1.145 . . . . 0.5 109.416 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.6 m -58.29 -32.25 68.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.132 -0.98 . . . . 0.51 109.611 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.07 -21.08 18.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 2.0 110.274 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -90.16 -19.9 23.7 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.033 -1.042 . . . . 2.16 108.835 179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.04 68.39 1.47 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.998 -0.741 . . . . 0.24 108.998 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.0 p -66.4 -3.22 5.62 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -0.891 . . . . 0.17 108.831 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.3 t30 -95.8 2.17 53.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.768 . . . . 0.34 109.362 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.0 t -116.97 150.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.061 -0.718 . . . . 0.12 109.061 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -101.06 128.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.037 -0.727 . . . . 0.17 109.037 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.7 m-85 -116.23 133.68 55.76 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.324 -0.86 . . . . 0.11 109.4 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.587 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -115.81 173.0 6.78 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.829 -0.804 . . . . 0.12 108.829 -179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -143.92 140.56 29.77 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.32 -0.993 . . . . 1.31 108.32 179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 27' ' ' PHE . 77.8 t -137.21 140.06 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.155 -0.966 . . . . 0.14 110.398 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -100.05 97.94 8.73 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.581 -1.266 . . . . 1.08 107.581 177.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.0 m -55.16 -14.74 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -0.927 . . . . 0.27 111.421 -177.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.01 -38.92 7.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.984 -1.073 . . . . 1.11 111.265 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -14.36 27.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.924 -1.11 . . . . 1.12 109.664 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.47 49.5 1.91 Allowed 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.344 -0.984 . . . . 0.17 108.344 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.5 -14.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.582 -0.699 . . . . 2.22 109.875 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 13.4 p-10 -69.85 -39.11 76.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 1.11 109.422 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.96 -46.62 39.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.214 -0.929 . . . . 0.19 108.586 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.83 -34.2 76.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.392 -0.817 . . . . 0.22 109.069 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.3 m -63.77 -45.27 90.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.372 -0.83 . . . . 1.29 109.067 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.7 -41.13 98.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.892 . . . . 2.2 109.457 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.24 58.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.191 -0.943 . . . . 0.33 109.718 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 59.2 mt-10 48.58 52.96 12.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.11 -0.994 . . . . 2.34 110.133 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -79.74 131.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.28 109.145 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 84.5 mttt -130.21 9.68 5.26 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.378 -0.826 . . . . 2.4 109.884 -179.394 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.21 128.85 10.06 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.062 -1.024 . . . . 0.22 108.879 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.538 HG23 ' CE2' ' B' ' 5' ' ' TYR . 76.8 p -115.18 150.31 44.13 Favored Pre-proline 0 N--CA 1.502 2.171 0 O-C-N 121.242 -0.911 . . . . 0.22 109.12 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.2 Cg_endo -78.58 144.55 74.86 Favored 'Cis proline' 0 N--CA 1.485 0.996 0 C-N-CA 125.021 -0.825 . . . . 0.2 110.074 -1.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.33 114.86 26.48 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.967 -1.123 . . . . 0.18 107.967 178.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -92.06 118.81 31.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.15 108.799 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 33.1 mt-30 -117.4 136.53 53.1 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.985 -1.117 . . . . 1.03 107.985 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.8 m-85 -110.78 126.19 54.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.494 0.664 . . . . 0.11 109.647 -178.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -125.87 158.42 35.13 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.437 -0.949 . . . . 0.17 108.437 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -154.82 124.47 6.53 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.797 -1.186 . . . . 1.48 107.797 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 56.38 22.96 6.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.484 -0.76 . . . . 1.67 109.989 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 4.56 75.73 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.253 -1.139 . . . . 0.22 110.253 179.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -112.08 148.38 34.03 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.386 -1.067 . . . . 2.08 109.772 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.6 ttpm? -85.76 141.77 29.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.211 -0.93 . . . . 1.7 109.464 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.29 -19.29 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.56 -0.712 . . . . 0.26 110.23 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.36 174.99 45.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.439 -1.362 . . . . 0.18 110.332 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -173.51 155.2 2.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -1.133 . . . . 2.04 110.02 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.3 p90 -169.09 134.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.465 -0.772 . . . . 0.14 109.936 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -107.49 -168.44 1.39 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.388 -0.82 . . . . 0.17 108.84 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 88.45 125.62 2.44 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.277 -1.529 . . . . 0.13 109.277 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.534 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -49.34 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -1.104 . . . . 0.2 110.235 -179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 91' ' ' GLY . 12.9 t-20 -137.78 72.67 1.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.131 -1.063 . . . . 1.15 108.131 178.24 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -62.59 -37.3 85.69 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.996 -0.547 . . . . 1.19 110.734 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.77 -28.16 68.82 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.986 -1.072 . . . . 1.95 109.581 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -68.35 -33.31 74.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 2.05 109.392 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 77' ' ' PHE . 45.9 mt -51.75 -38.0 53.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.821 -1.175 . . . . 0.15 108.211 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.3 tt0 -66.23 -53.48 36.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.952 -0.759 . . . . 2.15 108.952 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.29 91.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.562 -0.711 . . . . 0.15 110.473 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 21.2 m -66.56 -46.94 74.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.13 110.428 -178.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.33 -51.14 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.18 108.85 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.14 -17.76 54.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 1.03 109.546 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.05 -62.23 1.74 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.286 -0.884 . . . . 2.02 110.063 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.68 22.03 3.74 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.722 . . . . 0.35 110.351 -178.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.019 -1.051 . . . . 1.18 109.078 179.323 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -147.52 76.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.302 -0.874 . . . . 0.0 108.926 -179.891 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.519 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.6 m-85 -110.17 148.7 31.29 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.901 -1.125 . . . . 0.0 109.753 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.29 -105.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.0 p90 -109.67 -167.21 1.17 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.152 -0.968 . . . . 0.0 110.427 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.27 150.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.873 0.844 . . . . 0.0 112.343 -177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.19 96.55 7.28 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 pt-20 -83.43 44.76 0.98 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.225 -178.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.14 -131.85 0.09 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.2 24.66 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 118.773 1.286 . . . . 0.0 109.045 178.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 33.7 t -80.55 -25.94 38.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.583 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -168.11 96.64 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.621 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.848 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.386 -0.598 . . . . 2.89 109.386 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 26.7 t -95.46 171.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.3 109.609 -179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 45.8 tttp -154.25 119.64 5.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 1.97 108.925 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 12.5 tt0 -88.66 134.78 33.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.98 109.29 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.1 mm -105.23 121.44 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.113 -1.069 . . . . 0.19 108.113 179.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 4' ' ' GLN . 2.5 mp0 -102.75 -15.88 16.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.218 -0.926 . . . . 1.97 109.929 -178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 p -152.62 157.91 41.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.23 109.653 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -51.68 -28.07 13.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 1.9 109.698 179.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.3 m -58.69 -47.39 84.67 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.098 -1.002 . . . . 0.25 109.48 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.54 -25.47 63.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.2 109.777 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -59.0 -66.32 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.011 . . . . 0.21 110.16 -179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -55.85 -43.43 77.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 2.47 109.535 -179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -59.35 -37.88 78.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.853 . . . . 2.1 109.836 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.11 86.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.2 109.481 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.71 -43.0 97.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.49 -0.756 . . . . 0.62 110.036 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.32 -41.98 98.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.149 -0.969 . . . . 1.09 109.55 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.76 -12.43 60.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.3 109.444 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.24 -4.31 13.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.24 109.627 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.5 -113.91 6.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.334 -1.506 . . . . 0.28 109.334 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 43.4 t0 -137.08 5.1 2.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -1.141 . . . . 2.21 109.362 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -71.88 167.01 20.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -0.913 . . . . 1.9 109.115 179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.95 160.07 13.01 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.363 -0.977 . . . . 0.17 108.363 179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -143.36 103.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.12 109.35 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.3 t -101.33 133.9 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.549 -0.908 . . . . 0.09 108.549 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 t -110.23 135.46 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.608 -0.683 . . . . 0.17 109.913 -178.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.32 102.51 11.98 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.707 -0.849 . . . . 0.96 108.707 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.2 m-85 -87.13 81.49 7.99 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.992 -1.114 . . . . 0.24 107.992 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 m -112.84 171.38 7.57 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.711 -0.618 . . . . 1.03 109.786 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.61 127.64 56.15 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.911 -0.774 . . . . 0.26 108.911 179.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -66.48 -24.97 66.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.32 110.317 -179.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.1 p-90 -88.92 -13.65 38.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.135 -0.978 . . . . 0.44 110.114 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.71 128.73 45.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.32 109.308 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.603 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.46 -51.82 15.26 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.703 -0.761 . . . . 0.36 111.237 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.0 Cg_exo -48.02 -33.08 19.74 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.155 1.903 . . . . 0.44 111.225 -178.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.99 -62.35 1.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.017 -1.052 . . . . 0.81 108.828 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -59.47 -16.88 26.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.545 -0.722 . . . . 1.92 110.237 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.2 tpt -57.8 -23.82 54.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 3.13 110.314 -178.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 38' ' ' ILE . 93.1 mt -98.63 10.09 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.28 111.026 -178.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -63.35 -35.02 14.83 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 120.7 -1.25 . . . . 1.62 112.436 -179.013 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -61.67 -5.97 6.6 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 CA-C-N 119.044 0.694 . . . . 0.25 110.48 -177.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 39.2 m-85 -111.88 -74.36 0.64 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.3 109.513 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -46.04 -55.8 6.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.648 -0.657 . . . . 0.13 110.122 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.69 -32.55 73.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.41 109.676 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.3 m -65.03 -37.94 89.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.083 -1.01 . . . . 0.97 110.479 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 81.2 mt -49.14 -15.97 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.005 -1.059 . . . . 0.5 109.586 -178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 11.1 m -57.43 -28.92 63.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.51 110.074 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -96.75 -24.09 16.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.899 . . . . 2.0 110.315 -178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -90.31 -20.51 22.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 2.16 109.3 -179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -134.77 66.96 1.52 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.24 109.52 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -67.03 -3.22 6.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.254 -0.904 . . . . 0.17 108.859 179.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -95.53 -3.25 46.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.462 -0.774 . . . . 0.34 109.573 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.1 t -116.04 151.97 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.894 -0.78 . . . . 0.12 108.894 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 mm -102.63 131.09 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.228 -0.92 . . . . 0.17 109.727 -179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.605 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.9 m-85 -118.01 132.31 56.39 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.461 -0.774 . . . . 0.11 109.064 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -114.65 172.58 6.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.12 109.238 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -143.63 139.9 29.85 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.96 -1.126 . . . . 1.31 107.96 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -138.1 140.04 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.198 -0.939 . . . . 0.14 110.411 -177.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -98.72 107.48 19.93 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.086 -1.079 . . . . 1.08 108.086 178.173 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.04 -10.83 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.27 111.189 -178.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -104.03 -39.77 6.44 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.033 -1.042 . . . . 1.11 110.68 -178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -93.71 -12.76 28.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.147 -0.971 . . . . 1.12 109.397 -179.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.09 48.51 2.0 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.363 -0.836 . . . . 0.17 108.747 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -56.07 -16.14 4.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 2.22 110.369 -179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -38.16 78.32 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.899 -1.125 . . . . 1.11 109.082 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 t -74.72 -47.77 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.19 108.587 178.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -32.92 73.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.36 -0.837 . . . . 0.22 109.07 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 m -64.4 -53.62 45.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 1.29 109.102 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.95 -34.58 78.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.84 . . . . 2.2 109.642 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.8 -5.4 58.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.145 -0.972 . . . . 0.33 109.261 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ALA . 85.2 mt-10 42.25 63.64 1.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.526 -0.734 . . . . 2.34 110.462 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.1 t -78.48 140.82 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.483 -0.932 . . . . 0.28 108.483 179.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -122.75 -9.84 8.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.315 -0.865 . . . . 2.4 109.64 -178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.26 135.69 15.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.22 109.809 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.773 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.3 p -115.32 151.7 46.14 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.795 -0.817 . . . . 0.22 108.795 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -75.19 146.33 86.09 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 124.492 -1.045 . . . . 0.2 110.078 -1.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.56 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -116.38 118.73 33.52 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.178 -1.045 . . . . 0.18 108.178 178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CD1' HD21 ' A' ' 97' ' ' LEU . 70.1 m-85 -91.99 123.0 35.02 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.553 -0.906 . . . . 0.15 108.553 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 42.1 mt-30 -121.03 133.07 55.24 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.643 -1.243 . . . . 1.03 107.643 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD2' HG22 ' A' ' 24' ' ' VAL . 28.4 m-85 -107.18 127.04 53.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.487 -0.758 . . . . 0.11 109.712 -177.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.52 156.39 37.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.438 -0.949 . . . . 0.17 108.438 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -155.09 120.54 5.01 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.859 -1.163 . . . . 1.48 107.859 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm 59.09 25.89 14.46 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.591 -0.693 . . . . 1.67 109.616 -178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.86 6.08 85.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.334 -1.106 . . . . 0.22 110.334 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -113.48 146.52 39.47 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.138 -1.213 . . . . 2.08 109.837 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -86.82 143.87 27.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 1.7 109.335 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.25 -22.75 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.407 -0.808 . . . . 0.26 110.614 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.02 174.96 46.02 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.335 -1.412 . . . . 0.18 110.551 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -174.37 155.71 2.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.413 -1.051 . . . . 2.04 109.841 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.8 p90 -169.24 131.48 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.14 109.638 178.51 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.4 p -102.58 -167.47 1.4 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.03 -1.044 . . . . 0.17 109.424 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.1 132.47 3.06 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.927 -1.669 . . . . 0.13 108.927 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.69 94.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -1.217 . . . . 0.2 110.703 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -137.11 76.48 1.59 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.348 -0.982 . . . . 1.15 108.348 178.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.5 ptpp? -62.84 -38.97 92.89 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.717 . . . . 1.19 111.003 -178.317 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -64.94 -26.5 68.33 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.015 -1.053 . . . . 1.95 109.469 -178.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -67.72 -37.25 81.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.236 -0.915 . . . . 2.05 109.72 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.48 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.7 mt -52.22 -38.24 57.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.993 -1.067 . . . . 0.15 109.018 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -65.05 -55.82 16.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.384 -0.822 . . . . 2.15 109.493 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.17 96.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.15 110.621 -179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.4 m -67.53 -41.89 83.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.13 110.094 -178.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.7 -51.63 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.086 -1.009 . . . . 0.18 108.56 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 105' ' ' VAL . 49.0 t-20 -62.34 -17.29 58.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.54 -0.725 . . . . 1.03 109.401 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -76.27 -61.6 1.89 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 2.02 110.261 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -91.82 18.95 7.01 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.35 110.431 -178.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.4 p . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.024 -1.047 . . . . 1.18 109.392 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 13.5 p90 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 91.5 mtt180 -145.58 56.19 1.21 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.281 -0.887 . . . . 0.0 109.317 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -108.69 144.02 37.02 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.503 -0.748 . . . . 0.0 109.204 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.635 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -133.43 -91.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 0.0 109.041 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.773 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -125.11 -170.38 2.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.101 -0.999 . . . . 0.0 109.911 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.92 149.36 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.884 0.849 . . . . 0.0 112.094 -176.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.2 m -100.4 94.55 6.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 176.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.612 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.93 42.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.054 -178.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -66.28 -132.03 0.02 OUTLIER Glycine 0 N--CA 1.484 1.841 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 177.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.27 20.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 N-CA-C 109.153 -1.133 . . . . 0.0 109.153 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.4 t -90.18 -38.23 13.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.73 . . . . 0.0 109.549 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.404 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 2.2 t60 -46.79 155.5 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 109.739 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.404 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.346 0 CA-C-O 117.925 -1.486 . . . . 0.0 109.682 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.504 -0.554 . . . . 2.89 109.504 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 3' ' ' LYS . 88.0 t -94.44 164.32 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.288 -0.882 . . . . 0.3 109.166 179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 2' ' ' VAL . 19.3 tptm -154.21 122.86 6.22 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.141 -0.974 . . . . 1.97 109.254 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.9 129.83 37.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.484 -0.76 . . . . 0.98 109.749 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.65 107.9 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.039 -1.097 . . . . 0.19 108.039 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -98.4 -7.03 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.085 -1.009 . . . . 1.97 109.637 -179.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 p -152.92 147.25 25.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.23 109.221 179.695 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -51.89 -23.91 5.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.323 -0.861 . . . . 1.9 109.39 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.2 m -61.36 -45.26 95.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.25 109.348 179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.17 -24.15 63.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.426 -0.796 . . . . 0.2 109.8 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -59.16 -66.67 0.47 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.21 109.849 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -53.16 -46.19 68.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 2.47 109.608 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -59.8 -36.16 76.18 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.322 -0.861 . . . . 2.1 110.309 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.19 90.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.98 -1.075 . . . . 0.2 109.601 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.2 mt -64.19 -44.15 92.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.44 -0.787 . . . . 0.62 110.003 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -64.18 -43.36 95.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.086 -1.009 . . . . 1.09 109.615 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.34 -14.95 58.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.912 . . . . 0.3 109.824 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.66 -20.73 64.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.24 109.62 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 -133.15 11.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.348 -1.501 . . . . 0.28 109.348 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -117.76 2.96 12.29 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.516 -0.991 . . . . 2.21 109.756 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -68.78 166.94 16.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.927 -1.108 . . . . 1.9 109.007 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 162.97 12.27 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.242 -1.021 . . . . 0.17 108.242 179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.626 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.6 t -146.05 106.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.947 -1.095 . . . . 0.12 109.443 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.3 t -103.66 132.84 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.637 -0.875 . . . . 0.09 108.637 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.16 137.86 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.6 -0.687 . . . . 0.17 109.792 -178.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -109.43 101.95 10.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.655 -0.653 . . . . 0.96 109.422 179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.0 m-85 -85.47 80.2 9.17 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.973 -1.121 . . . . 0.24 107.973 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.9 m -112.99 153.88 27.35 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.644 -0.66 . . . . 1.03 109.994 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.14 129.29 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.26 108.861 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -67.4 -26.68 66.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.857 . . . . 0.32 110.433 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.558 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 63.9 p-90 -88.88 -14.77 36.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 0.44 110.202 -179.265 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.61 126.45 40.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.258 -0.901 . . . . 0.32 109.907 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.473 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.13 -53.56 17.82 Favored Glycine 0 N--CA 1.489 2.194 0 O-C-N 121.661 -0.65 . . . . 0.36 111.958 -179.353 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.3 Cg_exo -48.04 -36.23 27.48 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 121.595 1.53 . . . . 0.44 111.493 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -59.86 2.6 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.849 -1.157 . . . . 0.81 108.838 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -60.51 -16.97 42.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.711 -0.618 . . . . 1.92 110.353 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.2 tmt? -59.86 -19.39 50.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.058 -1.026 . . . . 3.13 110.606 -179.201 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.68 17.55 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.989 -1.069 . . . . 0.28 110.911 -178.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.85 -33.38 2.93 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 119.906 -1.746 . . . . 1.62 112.761 179.877 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.8 Cg_exo -63.4 -7.55 12.58 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 CA-C-N 119.617 0.899 . . . . 0.25 110.553 -176.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -107.69 -75.69 0.63 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.382 -0.824 . . . . 0.3 109.296 179.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -41.3 -54.12 3.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.87 -0.519 . . . . 0.13 110.695 -179.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -67.93 -34.75 77.19 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.8 -1.187 . . . . 0.41 109.798 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 m -62.52 -38.58 90.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.129 . . . . 0.97 110.147 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.1 mt -50.16 -13.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.945 -1.097 . . . . 0.5 109.342 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.456 ' N ' ' C ' ' A' ' 44' ' ' SER . 62.3 m -57.98 -34.17 69.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 0.51 109.717 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -94.78 -18.01 21.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.158 -0.964 . . . . 2.0 110.124 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.6 tptt -89.9 -24.23 21.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.107 -0.995 . . . . 2.16 109.14 -179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 46.6 m-85 -136.46 68.74 1.43 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.718 . . . . 0.24 109.388 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.7 p -65.43 -2.01 2.93 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.17 108.618 179.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 49' ' ' TYR . 22.8 t-20 -96.7 -1.86 45.7 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.529 -0.732 . . . . 0.34 109.616 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -115.29 147.68 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.491 -0.756 . . . . 0.12 109.595 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.46 130.05 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.471 -0.768 . . . . 0.17 109.18 -179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.5 m-85 -114.55 131.18 56.75 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 0.11 109.369 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -112.96 173.99 6.11 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.418 -0.801 . . . . 0.12 108.994 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -144.8 143.89 30.87 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.372 -0.973 . . . . 1.31 108.372 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.0 t -140.62 141.55 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.058 -1.026 . . . . 0.14 110.396 -178.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -100.97 104.4 15.58 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 1.08 108.118 178.407 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 59' ' ' VAL . 16.2 m -62.07 -5.05 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.362 -0.836 . . . . 0.27 111.768 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 15.2 m-20 -110.9 -39.45 4.81 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.867 -1.145 . . . . 1.11 110.678 -179.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HB2' HH11 ' B' ' 2' ' ' ARG . 7.3 t70 -94.3 -18.03 22.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.998 -1.064 . . . . 1.12 109.118 -179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.64 43.42 2.64 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.257 -1.016 . . . . 0.17 108.257 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -54.84 -12.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.606 -0.684 . . . . 2.22 110.362 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -39.65 77.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.892 -1.13 . . . . 1.11 108.832 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 65' ' ' VAL . 3.1 t -74.05 -47.97 40.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.746 -0.835 . . . . 0.19 108.746 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.85 74.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.456 -0.778 . . . . 0.22 109.523 179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -62.94 -54.66 35.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 1.29 109.409 -179.829 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.76 -29.79 70.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 2.2 109.711 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -2.22 58.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.138 -0.976 . . . . 0.33 109.999 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 46.16 49.15 12.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 2.34 110.045 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' CE1' ' B' ' 5' ' ' TYR . 9.9 t -80.34 121.7 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.28 108.967 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.19 5.52 10.78 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.489 -0.757 . . . . 2.4 110.003 -179.075 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.78 122.99 7.7 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.922 -1.111 . . . . 0.22 109.216 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.691 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.5 p -108.93 151.31 41.79 Favored Pre-proline 0 N--CA 1.502 2.165 0 N-CA-C 108.73 -0.841 . . . . 0.22 108.73 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.63 144.07 73.55 Favored 'Cis proline' 0 N--CA 1.484 0.955 0 C-N-CA 124.877 -0.885 . . . . 0.2 109.859 -2.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -115.08 109.8 18.6 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.008 -1.108 . . . . 0.18 108.008 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 97' ' ' LEU . 83.5 m-85 -86.15 117.0 24.7 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.96 -1.087 . . . . 0.15 109.242 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -115.31 133.01 56.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.097 -1.445 . . . . 1.03 107.097 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD2' HG22 ' A' ' 24' ' ' VAL . 20.6 m-85 -105.37 133.28 50.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.527 -0.733 . . . . 0.11 109.833 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -128.34 155.92 43.9 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.738 -0.838 . . . . 0.17 108.738 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.1 tttp -156.01 124.91 6.03 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.539 -1.282 . . . . 1.48 107.539 -179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttp 55.37 30.46 14.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.53 -0.731 . . . . 1.67 109.94 -178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 -0.57 88.27 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.948 -1.12 . . . . 0.22 110.737 178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -109.66 148.27 31.63 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.066 -1.255 . . . . 2.08 110.185 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.488 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 2.7 ttmp? -87.92 143.09 27.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 1.7 109.314 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -122.8 -31.33 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.534 -0.729 . . . . 0.26 110.358 -179.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.39 178.23 42.61 Favored Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.356 -1.402 . . . . 0.18 110.325 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -173.0 156.5 3.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -1.061 . . . . 2.04 110.148 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -168.74 133.15 1.54 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 0.14 110.161 178.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.6 p -103.03 -169.75 1.7 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.34 -0.85 . . . . 0.17 109.081 179.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.76 128.78 3.62 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.258 -1.537 . . . . 0.13 109.258 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.08 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.22 -1.164 . . . . 0.2 110.505 -179.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.604 HD22 ' H ' ' A' ' 96' ' ' LYS . 0.1 OUTLIER -141.37 74.21 1.45 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.235 -1.024 . . . . 1.15 108.235 178.405 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.22 -31.68 72.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.439 -0.788 . . . . 1.19 110.207 -178.989 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -65.72 -27.9 68.66 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.078 -1.014 . . . . 1.95 108.886 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.604 ' H ' HD22 ' A' ' 93' ' ' ASN . 23.4 ttmt -69.52 -37.45 77.15 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.368 -0.832 . . . . 2.05 110.01 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 77' ' ' PHE . 13.9 mt -52.28 -35.32 49.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.677 -1.265 . . . . 0.15 108.517 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -67.56 -55.88 11.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.456 -0.777 . . . . 2.15 109.525 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -43.7 93.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.514 -0.741 . . . . 0.15 110.496 -179.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 31.3 m -64.91 -46.9 79.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.13 110.145 -179.071 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.85 -51.8 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.089 -1.007 . . . . 0.18 108.703 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -61.41 -17.88 56.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.03 109.565 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -76.41 -58.77 3.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 2.02 110.052 -179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.4 mt -92.07 18.88 7.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.465 -0.772 . . . . 0.35 110.384 -178.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 1.18 109.302 179.51 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.401 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 26.6 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.558 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 40.6 mtm180 -150.87 72.17 1.06 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.199 -0.938 . . . . 0.0 109.375 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.424 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.4 m-85 -123.39 158.79 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -147.86 -81.28 0.13 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.99 -1.069 . . . . 0.0 109.822 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.691 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.9 p90 -131.61 -168.6 2.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.949 -1.094 . . . . 0.0 110.614 179.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.83 149.8 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.831 0.824 . . . . 0.0 112.196 -177.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -101.85 95.83 6.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.528 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.3 pt-20 -83.2 44.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.213 -179.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.16 -130.37 0.05 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 177.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.16 22.73 0.11 Allowed 'Trans proline' 0 C--N 1.322 -0.867 0 CA-C-N 119.325 1.562 . . . . 0.0 109.259 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -92.13 -50.15 5.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -92.68 158.59 15.85 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.356 -0.84 . . . . 0.0 109.632 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.54 179.864 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.372 -0.603 . . . . 2.89 109.372 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 67.6 t -94.93 162.34 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.85 . . . . 0.3 109.988 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.7 tttp -154.78 123.69 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.754 -0.832 . . . . 1.97 108.754 179.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -89.61 134.13 34.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.088 -1.008 . . . . 0.98 110.212 -179.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 mm -106.96 113.86 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 107.622 -1.251 . . . . 0.19 107.622 178.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -101.22 -13.88 17.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.25 -0.906 . . . . 1.97 109.381 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -154.02 158.11 40.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.26 -0.9 . . . . 0.23 109.74 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -51.56 -25.44 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.371 -0.831 . . . . 1.9 109.789 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.4 m -59.97 -49.49 77.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.25 110.274 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.72 63.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.905 . . . . 0.2 110.171 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -59.09 -66.42 0.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.1 -1.0 . . . . 0.21 110.041 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -55.62 -44.92 77.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 2.47 109.622 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -58.7 -35.41 72.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.184 -0.948 . . . . 2.1 109.827 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.63 -46.21 91.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.064 -1.023 . . . . 0.2 109.389 -179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 11.9 mt -64.49 -43.25 94.72 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.62 109.915 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.29 -38.89 92.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 1.09 109.664 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.84 -15.9 56.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.3 109.802 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.3 -5.02 16.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.24 109.627 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.85 -109.83 3.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -139.69 3.36 2.06 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.355 -1.085 . . . . 2.21 109.407 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.07 169.38 13.57 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.12 -0.988 . . . . 1.9 109.084 179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.47 161.14 14.92 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.297 -0.877 . . . . 0.17 108.693 -179.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.8 t -145.06 108.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.907 -1.121 . . . . 0.12 109.812 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 79' ' ' PHE . 5.0 t -105.12 132.34 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.755 -0.831 . . . . 0.09 108.755 179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.87 135.49 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.658 -0.651 . . . . 0.17 109.547 -179.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -108.88 106.53 16.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 0.96 109.366 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -87.01 79.5 8.7 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.227 -1.027 . . . . 0.24 108.227 179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.6 m -113.74 149.42 34.86 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.73 -0.606 . . . . 1.03 109.449 -179.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.93 128.28 36.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.224 -0.922 . . . . 0.26 108.719 179.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -66.0 -25.25 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.32 110.349 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.56 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 50.5 p-90 -88.8 -11.19 45.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.958 -1.089 . . . . 0.44 110.066 -179.429 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 3.5 t -95.8 136.63 35.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.304 -0.872 . . . . 0.32 109.717 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -78.14 -56.83 3.61 Favored Glycine 0 N--CA 1.49 2.259 0 O-C-N 121.535 -0.728 . . . . 0.36 111.45 -179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.9 Cg_exo -48.56 -36.58 32.08 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.002 1.801 . . . . 0.44 111.596 -178.179 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.16 -61.25 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.81 108.618 179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.71 -19.26 38.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.576 -0.703 . . . . 1.92 109.836 179.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -60.57 -18.51 53.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.121 -0.987 . . . . 3.13 109.921 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 38' ' ' ILE . 98.7 mt -97.58 8.56 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.213 -0.929 . . . . 0.28 110.696 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.639 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.53 2.8 Favored Pre-proline 0 N--CA 1.486 1.329 0 O-C-N 120.574 -1.329 . . . . 1.62 112.206 178.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.55 7.04 0.34 Allowed 'Trans proline' 0 C--N 1.321 -0.888 0 N-CA-C 109.736 -0.909 . . . . 0.25 109.736 -179.307 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' LYS . 28.5 m-85 -127.8 -74.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.397 -0.594 . . . . 0.3 109.397 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -44.12 -54.5 5.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.373 -0.829 . . . . 0.13 109.886 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -68.23 -29.43 68.25 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.301 -0.875 . . . . 0.41 109.399 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 9.7 p -64.78 -42.19 95.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.97 109.87 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -49.49 -16.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.045 -1.034 . . . . 0.5 109.524 -179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 38.0 m -58.82 -34.93 72.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.51 109.586 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -94.86 -17.05 22.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.355 -0.841 . . . . 2.0 110.269 -179.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -91.01 -23.84 20.26 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.976 -1.077 . . . . 2.16 109.176 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -133.13 71.52 1.47 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.986 -0.746 . . . . 0.24 108.986 179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -66.83 -4.39 9.13 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.17 109.104 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 3.5 t30 -95.34 -0.46 52.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.82 . . . . 0.34 109.429 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.7 t -115.6 148.7 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.496 -0.752 . . . . 0.12 109.193 179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 mm -98.9 132.64 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.445 -0.785 . . . . 0.17 109.318 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.4 m-85 -119.78 132.38 55.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.391 -0.818 . . . . 0.11 109.252 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.98 173.07 6.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.563 -0.903 . . . . 0.12 108.563 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -144.63 142.66 30.29 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.267 -1.012 . . . . 1.31 108.267 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.4 138.15 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.14 110.439 -178.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 16.5 t70 -100.04 109.86 22.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.218 -1.03 . . . . 1.08 108.218 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.402 HG11 ' OH ' ' B' ' 5' ' ' TYR . 19.6 m -62.76 -11.29 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.29 -0.881 . . . . 0.27 111.211 -178.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -102.65 -42.44 5.91 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.965 -1.084 . . . . 1.11 110.851 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -92.83 -10.71 35.8 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.063 -1.023 . . . . 1.12 109.337 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -124.01 48.29 1.92 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.502 -0.925 . . . . 0.17 108.502 179.035 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.404 ' HB3' HH12 ' B' ' 4' ' ' ARG . 6.3 pt20 -55.85 -20.48 15.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.573 -0.704 . . . . 2.22 110.19 -179.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 6.2 p30 -69.37 -40.21 77.58 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 1.11 109.254 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -73.82 -47.6 42.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.176 -0.953 . . . . 0.19 108.776 179.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.13 -34.19 77.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.22 109.167 179.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 m -64.2 -56.86 11.78 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.315 -0.865 . . . . 1.29 109.426 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -63.61 -27.73 69.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 2.2 109.578 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.84 -5.03 58.8 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.196 -0.94 . . . . 0.33 109.584 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 47.59 52.96 11.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.924 . . . . 2.34 110.037 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.0 t -80.25 134.4 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.276 -0.89 . . . . 0.28 109.081 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -127.68 -2.28 6.04 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.532 -0.73 . . . . 2.4 110.015 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.33 129.72 10.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.906 -1.121 . . . . 0.22 109.465 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 18.0 p -111.84 151.42 43.46 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 108.567 -0.901 . . . . 0.22 108.567 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.45 141.59 68.49 Favored 'Cis proline' 0 N--CA 1.483 0.896 0 C-N-CA 124.749 -0.938 . . . . 0.2 110.212 -1.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.54 116.23 29.89 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.187 -1.042 . . . . 0.18 108.187 179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.8 m-85 -91.57 127.65 37.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 0.15 109.1 179.566 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.472 HE22 ' HB1' ' A' ' 69' ' ' ALA . 44.4 mt-30 -125.56 136.72 53.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.771 -1.196 . . . . 1.03 107.771 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 24' ' ' VAL . 22.0 m-85 -109.94 131.32 55.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.59 0.71 . . . . 0.11 110.128 -177.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -127.69 157.68 39.64 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.357 -0.979 . . . . 0.17 108.357 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HZ3' ' HA ' ' A' ' 22' ' ' LEU . 33.9 tttp -156.21 122.04 4.93 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.78 -1.193 . . . . 1.48 107.78 -179.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? 57.24 20.47 5.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 1.67 109.495 -178.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.467 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.62 1.13 68.69 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.471 -1.051 . . . . 0.22 110.471 179.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.467 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.6 mm-40 -109.76 148.47 31.37 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.216 -1.167 . . . . 2.08 110.188 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -85.13 140.0 31.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.541 -0.724 . . . . 1.7 109.242 179.643 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.04 -19.26 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.448 -0.782 . . . . 0.26 110.508 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.21 170.21 43.31 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.34 -1.409 . . . . 0.18 110.5 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -173.01 150.86 2.05 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -1.035 . . . . 2.04 109.975 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.5 p90 -168.29 131.55 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.14 110.472 179.069 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 p -101.04 -162.47 0.94 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.113 -0.992 . . . . 0.17 108.929 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.75 129.82 0.93 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.039 -1.624 . . . . 0.13 109.039 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.2 96.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -1.147 . . . . 0.2 110.305 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.77 73.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.338 -0.986 . . . . 1.15 108.338 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.517 ' NZ ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -63.14 -37.69 88.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.741 -0.599 . . . . 1.19 110.884 -179.179 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -64.59 -27.89 69.26 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.883 -1.136 . . . . 1.95 109.272 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -68.09 -33.92 75.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 2.05 109.595 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.9 mt -54.0 -33.81 58.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.723 -1.235 . . . . 0.15 108.46 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -66.48 -57.93 6.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 2.15 109.36 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.77 91.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.435 -0.791 . . . . 0.15 110.315 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.418 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 m -65.69 -47.47 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.212 -0.93 . . . . 0.13 109.942 -179.12 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.7 mt -60.94 -51.9 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.18 108.641 179.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -61.23 -15.96 40.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 1.03 109.648 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.9 -61.07 2.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 2.02 109.974 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.458 ' HB2' HD11 ' A' ' 22' ' ' LEU . 54.1 mt -92.41 19.67 6.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.35 110.425 -178.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.995 -1.066 . . . . 1.18 109.284 179.506 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 51.1 p90 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 54.4 mtp180 -135.3 67.23 1.49 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.235 -0.916 . . . . 0.0 109.481 -179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.56 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 31.6 m-85 -118.77 156.03 30.09 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.477 -0.765 . . . . 0.0 109.005 179.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.61 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.86 -92.66 0.09 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.118 -0.989 . . . . 0.0 109.274 -179.795 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -127.22 -169.22 2.0 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.066 -1.021 . . . . 0.0 110.404 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.404 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -71.62 148.15 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.822 0.82 . . . . 0.0 112.238 -176.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 21.0 m -100.53 95.47 6.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.605 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 pt-20 -82.97 45.89 1.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.236 -0.915 . . . . 0.0 109.958 -178.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -135.28 0.09 OUTLIER Glycine 0 N--CA 1.485 1.917 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 177.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.41 27.14 0.14 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 CA-C-N 118.881 1.341 . . . . 0.0 108.897 177.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.9 -14.76 33.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.683 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 15.3 t-80 -146.83 140.02 25.45 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.145 -0.972 . . . . 0.0 109.533 -179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.402 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ptp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.356 -0.609 . . . . 2.89 109.356 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.603 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.6 t -94.49 167.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.906 . . . . 0.3 109.304 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' HG12 ' A' ' 2' ' ' VAL . 16.8 tptm -152.37 120.93 6.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.236 -0.915 . . . . 1.97 108.787 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -89.38 135.65 33.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.98 109.555 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.5 mm -108.63 105.52 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.187 -1.042 . . . . 0.19 108.187 179.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -97.96 -6.01 33.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.182 -0.949 . . . . 1.97 109.708 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.0 p -153.58 154.88 35.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.122 -0.986 . . . . 0.23 109.992 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -53.34 -31.4 44.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.437 -0.789 . . . . 1.9 110.302 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 m -60.16 -43.02 96.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.962 -1.086 . . . . 0.25 110.107 -179.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.94 -24.53 63.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.2 109.821 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -60.93 -68.31 0.32 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.897 -1.127 . . . . 0.21 109.906 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -55.26 -43.56 74.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.9 . . . . 2.47 109.911 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -58.04 -36.55 72.89 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.165 -0.96 . . . . 2.1 109.74 -179.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -45.67 93.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.994 -1.066 . . . . 0.2 109.204 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.42 -50.76 66.34 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.351 -0.843 . . . . 0.62 109.834 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -63.15 -33.2 74.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.029 -1.044 . . . . 1.09 109.073 179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.01 -18.62 42.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.3 109.731 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -6.46 23.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.24 -0.912 . . . . 0.24 109.769 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.33 -109.02 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.89 -1.284 . . . . 0.28 109.89 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.515 ' OD1' ' NZ ' ' A' ' 82' ' ' LYS . 14.4 t0 -139.32 -0.05 1.84 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.314 -1.11 . . . . 2.21 109.594 -179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' NZ ' ' ND2' ' A' ' 51' ' ' ASN . 0.8 OUTLIER -69.88 167.78 16.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 1.9 109.27 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.4 163.38 8.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.2 -1.037 . . . . 0.17 108.2 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.691 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.4 t -145.43 103.78 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.959 -1.088 . . . . 0.12 109.361 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.7 t -101.79 129.99 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.3 -0.875 . . . . 0.09 108.676 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.96 144.99 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.387 -0.821 . . . . 0.17 109.853 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -114.29 95.89 5.51 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.433 -0.951 . . . . 0.96 108.433 179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.441 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 47.3 m-85 -82.96 77.67 9.66 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.727 -1.212 . . . . 0.24 107.727 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.4 m -103.05 -164.21 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.555 0.693 . . . . 1.03 109.249 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.18 124.68 18.0 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.559 -0.904 . . . . 0.26 108.559 179.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -64.19 -29.29 70.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.32 111.135 -178.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.534 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.7 p-90 -87.51 -17.46 32.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.833 -1.167 . . . . 0.44 110.047 -179.341 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.15 127.94 37.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 0.32 109.875 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.61 -53.57 9.76 Favored Glycine 0 N--CA 1.49 2.236 0 CA-C-O 119.421 -0.655 . . . . 0.36 111.589 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.9 Cg_exo -49.24 -36.71 37.87 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.744 1.629 . . . . 0.44 111.404 -178.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.31 -61.96 1.73 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.844 -1.16 . . . . 0.81 108.935 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -60.34 -19.61 56.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.484 -0.76 . . . . 1.92 110.053 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' GLY . 9.2 tpt -58.96 -18.36 33.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.088 -1.008 . . . . 3.13 110.121 -178.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 38' ' ' ILE . 50.5 mt -100.16 14.1 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.155 -0.966 . . . . 0.28 110.526 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.41 -31.32 3.03 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.49 -1.381 . . . . 1.62 113.0 -179.763 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -64.32 -2.56 5.08 Favored 'Trans proline' 0 C--N 1.323 -0.789 0 CA-C-N 119.958 1.021 . . . . 0.25 109.72 -178.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -111.43 -79.51 0.58 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.557 -0.715 . . . . 0.3 109.315 179.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -41.67 -55.45 2.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.681 -0.637 . . . . 0.13 110.867 -179.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -67.64 -31.05 70.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.41 109.943 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 17.2 m -64.77 -41.49 95.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.831 -1.168 . . . . 0.97 109.93 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.5 mt -50.93 -14.67 0.23 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.009 -1.057 . . . . 0.5 109.319 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.7 m -58.73 -28.68 66.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.51 109.903 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -95.9 -24.98 16.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.24 -0.912 . . . . 2.0 110.303 -179.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -91.08 -17.86 25.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.05 -1.031 . . . . 2.16 109.607 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -136.62 63.2 1.58 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.409 -0.807 . . . . 0.24 109.342 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.4 p -68.17 -4.39 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.503 -0.748 . . . . 0.17 109.203 179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.619 ' ND2' ' NZ ' ' A' ' 21' ' ' LYS . 10.3 t30 -92.27 -1.43 57.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.309 -0.869 . . . . 0.34 109.033 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.4 t -116.14 147.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.433 -0.951 . . . . 0.12 108.433 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 53' ' ' ILE . 4.1 mm -97.78 123.92 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.224 -0.923 . . . . 0.17 109.466 -179.167 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -109.24 126.79 53.68 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.745 -0.835 . . . . 0.11 108.745 179.363 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.6 mp -109.53 169.21 8.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.12 108.889 -179.494 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -140.85 139.0 34.39 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.803 -1.184 . . . . 1.31 107.803 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.44 140.46 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.123 -0.986 . . . . 0.14 110.821 -178.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.69 112.13 24.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.968 -1.123 . . . . 1.08 107.968 179.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 74' ' ' THR . 27.5 m -70.96 -10.32 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.27 110.906 -178.689 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.534 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 13.9 m-20 -104.85 -36.64 7.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.152 -0.967 . . . . 1.11 110.806 -179.017 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.59 -21.72 18.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.957 -1.089 . . . . 1.12 109.752 -179.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.3 47.7 1.64 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.398 -0.964 . . . . 0.17 108.398 179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -54.08 -12.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.678 . . . . 2.22 110.254 -179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' OD2' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -69.89 -41.37 74.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.99 -1.069 . . . . 1.11 109.282 -179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG23 ' OD2' ' A' ' 64' ' ' ASP . 7.0 t -74.12 -46.02 46.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.246 -0.909 . . . . 0.19 108.788 179.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.5 -36.26 81.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.22 108.735 179.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 m -63.5 -44.08 95.38 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.663 -0.866 . . . . 1.29 108.663 179.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -65.0 -40.96 95.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 2.2 109.319 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.69 57.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.277 -0.89 . . . . 0.33 109.723 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 66' ' ' ALA . 41.2 mt-10 47.47 52.8 11.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 2.34 110.305 179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 t -80.13 136.04 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.28 108.986 179.117 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.0 2.64 5.28 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.319 -0.863 . . . . 2.4 109.744 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 128.88 11.31 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.024 -1.047 . . . . 0.22 109.22 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.628 HG23 ' CE2' ' B' ' 5' ' ' TYR . 59.4 p -112.99 150.69 43.27 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.497 -0.752 . . . . 0.22 109.406 -179.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -78.47 144.95 76.14 Favored 'Cis proline' 0 N--CA 1.486 1.074 0 N-CA-C 109.76 -0.9 . . . . 0.2 109.76 -2.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.55 112.63 23.87 Favored 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.142 -1.058 . . . . 0.18 108.142 178.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.51 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.8 m-85 -86.79 118.73 26.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.937 -1.102 . . . . 0.15 109.416 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.8 mt-30 -117.83 133.65 55.72 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.108 -1.071 . . . . 1.03 108.108 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' HG22 ' A' ' 24' ' ' VAL . 23.0 m-85 -108.16 124.61 50.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.696 -0.627 . . . . 0.11 109.31 -178.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -122.81 156.12 35.17 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.855 -0.794 . . . . 0.17 108.855 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.4 tttm -154.13 125.22 7.31 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.991 -1.485 . . . . 1.48 106.991 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 35.9 mttp 54.05 39.72 30.89 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.243 -0.911 . . . . 1.67 109.705 -178.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.34 7.71 57.93 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.952 -1.118 . . . . 0.22 110.366 179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 144.31 41.78 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.248 -1.148 . . . . 2.08 110.229 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -85.42 145.53 27.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.253 -0.904 . . . . 1.7 108.986 179.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.93 -3.83 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.434 -0.791 . . . . 0.26 110.154 -179.605 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.35 176.07 29.99 Favored Glycine 0 N--CA 1.497 2.708 0 C-N-CA 119.731 -1.223 . . . . 0.18 110.305 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -173.46 161.31 4.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.391 -1.064 . . . . 2.04 110.146 179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.3 p90 -168.9 131.55 1.31 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.458 -0.776 . . . . 0.14 109.994 178.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.1 p -102.59 -161.51 0.85 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.148 -0.97 . . . . 0.17 109.026 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.92 130.96 0.87 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.062 -1.615 . . . . 0.13 109.062 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.71 97.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -1.206 . . . . 0.2 110.872 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -141.37 76.1 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.011 -1.107 . . . . 1.15 108.011 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.08 -31.31 72.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.464 -0.772 . . . . 1.19 110.711 -178.603 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -65.39 -26.69 68.11 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.766 -1.209 . . . . 1.95 108.794 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ttmm -69.4 -36.76 77.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.559 -0.713 . . . . 2.05 109.116 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.51 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.0 mt -53.25 -40.31 64.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.15 109.142 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.05 -57.35 8.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.396 -0.815 . . . . 2.15 109.633 -179.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.64 85.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.414 -0.804 . . . . 0.15 110.753 -179.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.6 m -67.25 -48.23 68.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.158 -0.964 . . . . 0.13 110.35 -178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.71 -50.59 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.116 -0.99 . . . . 0.18 108.988 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -60.95 -17.1 49.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -0.987 . . . . 1.03 109.433 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -78.54 -59.98 2.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 2.02 110.388 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.25 20.05 6.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.467 -0.77 . . . . 0.35 110.841 -178.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.49 1.55 0 O-C-N 120.889 -1.132 . . . . 1.18 109.361 179.821 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 20.3 p90 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.672 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -132.39 76.23 1.68 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.441 -0.787 . . . . 0.0 109.145 179.479 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.456 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.5 m-85 -130.31 143.67 50.91 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.423 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 5.9 tpt180 -136.17 -79.85 0.41 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.232 -0.918 . . . . 0.0 109.198 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.628 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.8 p90 -129.02 -167.48 1.79 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.112 -0.993 . . . . 0.0 110.205 179.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.23 151.34 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.218 -0.926 . . . . 0.0 112.461 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.74 95.17 6.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.18 47.18 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.75 -1.219 . . . . 0.0 110.053 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.73 -127.37 0.1 OUTLIER Glycine 0 N--CA 1.485 1.954 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -69.01 20.93 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.794 0 CA-C-N 119.34 1.57 . . . . 0.0 108.875 178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.593 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.0 t -84.15 -43.43 14.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.32 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.524 ' CD2' ' H ' ' B' ' 13' ' ' GLY . 11.2 t-80 -58.57 169.81 0.87 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.372 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.524 ' H ' ' CD2' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.302 0 CA-C-O 118.005 -1.442 . . . . 0.0 109.592 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 mtm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.564 -0.532 . . . . 2.89 109.564 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 3' ' ' LYS . 35.7 t -94.42 169.03 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.237 -0.914 . . . . 0.3 109.116 179.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.557 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.5 tttt -153.52 126.93 8.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.995 . . . . 1.97 109.443 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -89.19 132.97 34.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -0.852 . . . . 0.98 109.808 -179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.6 mm -106.75 110.11 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.088 -1.079 . . . . 0.19 108.088 179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -101.53 -11.24 19.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.198 -0.939 . . . . 1.97 110.056 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.4 p -153.39 157.4 39.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.031 -1.043 . . . . 0.23 109.875 179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 23.6 tttp -52.25 -27.72 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.372 -0.83 . . . . 1.9 109.542 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.8 m -60.07 -46.88 88.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.059 -1.025 . . . . 0.25 109.74 -179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.38 63.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.2 109.685 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -59.5 -68.31 0.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.061 -1.024 . . . . 0.21 109.873 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -53.8 -44.87 70.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.897 . . . . 2.47 109.742 -179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -58.99 -36.34 74.73 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.19 -0.944 . . . . 2.1 109.935 -179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.47 -45.29 94.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.002 -1.061 . . . . 0.2 109.712 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.94 -44.11 96.96 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.341 -0.85 . . . . 0.62 109.62 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -63.9 -38.79 92.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.157 -0.964 . . . . 1.09 109.633 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.6 -16.06 57.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.3 109.576 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.45 -10.52 58.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.243 -0.911 . . . . 0.24 109.46 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.01 -110.58 3.31 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.421 -1.472 . . . . 0.28 109.421 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -138.02 3.42 2.43 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -1.115 . . . . 2.21 109.416 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -69.56 172.61 7.07 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.165 -0.959 . . . . 1.9 109.274 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.67 161.67 20.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.926 -1.139 . . . . 0.17 107.926 179.609 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.02 105.49 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.657 -1.277 . . . . 0.12 109.521 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.6 t -103.86 129.08 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.732 -0.84 . . . . 0.09 108.732 179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.41 141.12 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.66 -0.65 . . . . 0.17 109.659 -179.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -111.74 102.81 11.08 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.398 -0.593 . . . . 0.96 109.398 179.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -86.11 79.31 9.18 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.072 -1.084 . . . . 0.24 108.072 179.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.4 m -113.59 151.29 31.88 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.386 0.612 . . . . 1.03 109.813 -179.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.56 126.12 37.5 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.448 -0.945 . . . . 0.26 108.448 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.4 t -65.71 -23.25 66.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.341 -0.849 . . . . 0.32 110.409 -179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.556 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -89.95 -16.12 30.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.076 -1.015 . . . . 0.44 110.285 -179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -93.13 129.35 39.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.32 110.052 -178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.55 -58.18 8.11 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 120.921 -0.657 . . . . 0.36 111.62 -179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.1 Cg_exo -47.74 -35.48 23.67 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.672 1.581 . . . . 0.44 111.661 -178.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -60.33 2.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.838 -1.164 . . . . 0.81 108.879 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -59.61 -19.2 47.34 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.537 -0.727 . . . . 1.92 109.943 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.489 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.63 -22.27 63.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 3.13 110.044 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.467 HD12 ' HG3' ' A' ' 75' ' ' PRO . 2.9 mt -96.9 11.63 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.123 -0.985 . . . . 0.28 110.188 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.94 -31.76 2.16 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.548 -1.345 . . . . 1.62 112.462 -179.996 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -64.39 -2.98 5.63 Favored 'Trans proline' 0 C--O 1.213 -0.749 0 CA-C-N 119.743 0.944 . . . . 0.25 109.865 -178.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 47.7 m-85 -111.46 -78.0 0.59 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.843 -0.799 . . . . 0.3 108.843 179.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.1 t80 -40.92 -58.76 1.62 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.667 -0.646 . . . . 0.13 110.692 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.17 -31.43 72.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.071 -1.018 . . . . 0.41 109.872 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -65.19 -39.4 92.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.911 -1.118 . . . . 0.97 110.135 179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.4 mt -49.05 -14.1 0.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.946 -1.096 . . . . 0.5 109.591 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' SER . 58.5 m -57.87 -27.41 63.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.51 109.886 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -97.09 -24.99 15.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.133 -0.979 . . . . 2.0 110.228 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -90.15 -18.86 25.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.081 . . . . 2.16 109.756 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.57 67.09 1.53 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.388 -0.82 . . . . 0.24 109.372 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 87.5 p -67.96 -4.11 12.08 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.373 -0.829 . . . . 0.17 109.206 179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -97.0 2.61 51.7 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.351 -0.843 . . . . 0.34 110.046 -179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.4 t -119.65 149.17 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.524 -0.735 . . . . 0.12 109.454 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.2 mm -99.02 124.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.17 109.218 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.515 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.9 m-85 -111.19 128.48 55.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.259 -0.901 . . . . 0.11 109.164 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.0 mp -110.48 173.41 6.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.824 -0.806 . . . . 0.12 108.824 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -144.18 142.89 30.81 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.464 -0.939 . . . . 1.31 108.464 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -138.02 136.09 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.195 -0.941 . . . . 0.14 110.453 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -97.3 100.2 11.65 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.961 -1.126 . . . . 1.08 107.961 178.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 m -53.43 -8.9 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.378 -0.826 . . . . 0.27 111.38 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -103.7 -45.7 4.73 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 120.937 -1.102 . . . . 1.11 111.01 -179.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.95 -8.0 50.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.873 -1.142 . . . . 1.12 109.596 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 44.94 2.69 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.619 -0.882 . . . . 0.17 108.619 179.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -56.19 -17.48 7.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.415 -0.803 . . . . 2.22 110.097 -179.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.4 p-10 -70.52 -39.33 74.15 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.035 -1.041 . . . . 1.11 109.109 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -74.4 -47.43 40.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.614 -0.884 . . . . 0.19 108.614 179.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.8 78.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.37 -0.831 . . . . 0.22 108.94 179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 m -64.73 -46.49 82.0 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.48 -0.762 . . . . 1.29 109.387 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -63.94 -38.46 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.859 . . . . 2.2 109.427 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.87 -2.38 58.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.33 109.605 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 48.22 58.14 5.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 2.34 109.951 179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 16.6 t -79.48 135.22 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.186 -0.946 . . . . 0.28 109.131 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -129.97 1.16 4.79 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.394 -0.816 . . . . 2.4 109.897 -179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.629 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.64 126.65 9.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.975 -1.078 . . . . 0.22 109.241 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 13.9 p -111.08 151.46 43.06 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.333 -0.854 . . . . 0.22 108.757 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -77.81 143.42 73.77 Favored 'Cis proline' 0 N--CA 1.485 1.006 0 C-N-CA 124.858 -0.893 . . . . 0.2 110.023 -1.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.27 110.87 20.6 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.224 -1.028 . . . . 0.18 108.224 179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.781 ' CD1' HD21 ' A' ' 97' ' ' LEU . 87.0 m-85 -86.64 121.0 28.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.15 109.116 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -117.74 135.28 54.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.746 -1.205 . . . . 1.03 107.746 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -109.53 129.26 55.58 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.58 0.705 . . . . 0.11 109.777 -178.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -126.56 158.96 34.84 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.563 -0.903 . . . . 0.17 108.563 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -156.63 123.75 5.27 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.748 -1.205 . . . . 1.48 107.748 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt 56.19 24.38 8.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.537 -0.727 . . . . 1.67 109.909 -179.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.26 81.76 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 119.967 -1.111 . . . . 0.22 110.449 179.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -109.59 149.47 29.63 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.311 -1.111 . . . . 2.08 109.977 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -85.61 142.3 29.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.362 -0.836 . . . . 1.7 109.447 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.3 -16.48 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.499 -0.751 . . . . 0.26 110.33 -179.518 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.3 43.18 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.512 -1.328 . . . . 0.18 110.259 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -174.07 155.36 2.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 2.04 110.116 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.3 p90 -168.34 130.36 1.39 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.14 110.295 179.032 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.83 -169.56 1.67 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.293 -0.879 . . . . 0.17 108.889 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.19 130.75 4.85 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.378 -1.489 . . . . 0.13 109.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.585 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.78 96.96 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -1.145 . . . . 0.2 110.54 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' ND2' ' NZ ' ' A' ' 96' ' ' LYS . 16.3 t-20 -142.3 74.09 1.43 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.023 -1.103 . . . . 1.15 108.023 178.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.64 -34.66 78.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.396 -0.815 . . . . 1.19 110.523 -178.637 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -65.25 -28.21 69.19 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.05 -1.031 . . . . 1.95 109.386 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' NZ ' ' ND2' ' A' ' 93' ' ' ASN . 2.4 ttmp? -69.58 -36.63 76.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -0.858 . . . . 2.05 109.73 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD21 ' CD1' ' A' ' 77' ' ' PHE . 36.2 mt -51.4 -35.28 38.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.731 -1.231 . . . . 0.15 108.587 -179.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -66.94 -52.18 46.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.488 -0.758 . . . . 2.15 109.256 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.65 96.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.475 -0.766 . . . . 0.15 110.323 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.2 m -67.09 -47.18 72.0 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.208 -0.932 . . . . 0.13 109.959 -179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.5 mt -59.49 -51.09 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.209 -0.932 . . . . 0.18 108.98 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -61.76 -15.22 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.168 -0.957 . . . . 1.03 109.515 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -78.63 -58.94 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 110.494 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 ' HB2' HD11 ' A' ' 22' ' ' LEU . 14.3 mt -91.37 15.62 11.79 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.298 -0.876 . . . . 0.35 110.625 -178.587 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.301 -1.5 0 O-C-N 120.884 -1.135 . . . . 1.18 109.301 179.958 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.556 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 73.8 mtt180 -157.39 60.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.85 . . . . 0.0 109.162 -179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.433 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.2 m-85 -98.28 161.92 13.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.102 -0.999 . . . . 0.0 109.183 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -150.99 -112.27 0.05 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.094 -1.003 . . . . 0.0 109.588 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -108.21 -172.82 2.14 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.623 -1.298 . . . . 0.0 110.742 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -64.23 146.03 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.888 0.852 . . . . 0.0 112.427 -177.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 17.8 m -101.3 94.86 6.15 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.629 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -82.82 41.8 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 110.233 -178.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -67.9 -134.56 0.05 OUTLIER Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.539 -2.624 . . . . 0.0 106.539 177.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -68.07 27.92 0.14 Allowed 'Trans proline' 0 C--N 1.321 -0.912 0 CA-C-N 119.098 1.449 . . . . 0.0 109.377 178.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.8 t -86.0 -23.4 26.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 109.35 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -68.09 161.2 27.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.992 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.468 -0.568 . . . . 2.89 109.468 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 3' ' ' LYS . 14.4 t -94.5 166.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.3 109.219 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' VAL . 49.7 tttp -153.33 121.47 6.16 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.216 -0.928 . . . . 1.97 109.464 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -90.37 134.23 34.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 0.98 109.52 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.9 mm -104.37 111.8 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.045 -1.095 . . . . 0.19 108.045 179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 16.2 mp0 -99.3 -9.95 22.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.244 -0.91 . . . . 1.97 109.657 -179.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -153.77 155.98 36.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.999 -1.063 . . . . 0.23 110.122 -179.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 58.7 tttm -52.5 -25.92 11.6 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.586 -0.696 . . . . 1.9 109.898 179.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.48 -48.57 80.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 0.25 110.249 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.58 -20.96 62.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 0.2 109.999 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.22 -66.38 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.21 109.93 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -55.73 -45.3 77.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.904 . . . . 2.47 109.732 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -58.61 -37.04 75.03 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 2.1 110.423 -179.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.22 90.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.935 -1.103 . . . . 0.2 109.612 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.38 -42.28 96.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.306 -0.871 . . . . 0.62 109.598 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.19 -41.15 97.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 1.09 109.97 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.17 -17.87 56.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.01 -1.056 . . . . 0.3 109.492 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.87 -6.62 28.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.24 109.374 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.82 -113.33 5.56 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.405 -1.478 . . . . 0.28 109.405 -179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 50.3 t0 -136.06 5.88 3.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.374 -1.074 . . . . 2.21 109.085 179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -70.08 168.82 14.72 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.219 -0.926 . . . . 1.9 108.752 179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.12 158.07 20.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.171 -0.956 . . . . 0.17 108.588 -179.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.434 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.5 t -144.06 107.54 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.954 -1.091 . . . . 0.12 109.465 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.43 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.9 134.97 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.795 -0.816 . . . . 0.09 108.795 179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.19 131.64 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.695 -0.628 . . . . 0.17 109.57 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -105.42 103.76 13.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 0.96 109.22 179.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 74' ' ' THR . 48.6 m-85 -86.28 79.42 9.06 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.091 -1.077 . . . . 0.24 108.091 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -105.55 -164.7 1.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.638 0.732 . . . . 1.03 109.447 -179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.79 125.82 18.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.452 -0.944 . . . . 0.26 108.452 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 t -64.23 -30.03 71.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.562 -0.711 . . . . 0.32 110.897 -178.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 48.2 p-90 -87.57 -16.1 35.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.88 -1.138 . . . . 0.44 110.097 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.52 118.37 31.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.233 -0.917 . . . . 0.32 109.637 -179.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.0 -59.91 9.31 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 120.9 -0.667 . . . . 0.36 111.681 -179.568 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.9 Cg_exo -45.4 -37.64 14.68 Favored 'Trans proline' 0 C--N 1.319 -0.986 0 C-N-CA 121.993 1.795 . . . . 0.44 111.702 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.79 -61.77 1.81 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.817 -1.177 . . . . 0.81 108.881 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -61.37 -15.06 32.48 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.515 -0.741 . . . . 1.92 110.731 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 39.3 tpp -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.019 -1.051 . . . . 3.13 109.865 -179.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 38' ' ' ILE . 52.3 mt -94.93 21.42 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.148 -0.97 . . . . 0.28 111.261 -178.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.22 -32.9 3.0 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.259 -1.525 . . . . 1.62 112.547 179.186 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.3 Cg_exo -65.54 -8.78 20.19 Favored 'Trans proline' 0 C--N 1.321 -0.884 0 CA-C-N 119.418 0.828 . . . . 0.25 110.555 -176.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -104.37 -73.93 0.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.367 -0.833 . . . . 0.3 109.453 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -41.76 -52.86 3.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.806 -0.559 . . . . 0.13 110.674 -179.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -69.47 -36.18 76.31 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.942 -1.099 . . . . 0.41 109.946 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.434 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.2 t -58.81 -42.64 89.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.016 -1.052 . . . . 0.97 110.194 -179.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.0 mt -51.56 -13.43 0.23 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.026 -1.046 . . . . 0.5 109.224 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' N ' ' C ' ' A' ' 44' ' ' SER . 70.9 m -58.95 -34.61 71.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 0.51 109.459 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -93.85 -18.3 22.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.238 -0.914 . . . . 2.0 109.913 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -89.76 -22.26 22.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.112 -0.992 . . . . 2.16 108.942 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -135.65 70.56 1.43 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.609 -0.682 . . . . 0.24 109.255 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.0 p -67.67 -4.23 11.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.17 109.312 179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 22.3 t-20 -95.96 -2.43 47.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.297 -0.877 . . . . 0.34 109.928 -179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.4 t -114.71 148.72 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.502 -0.749 . . . . 0.12 109.467 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -99.76 128.57 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.565 -0.71 . . . . 0.17 109.285 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.528 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.7 m-85 -113.88 128.04 56.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.389 -0.82 . . . . 0.11 109.091 179.567 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.528 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.7 mp -111.19 169.06 9.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.152 -0.684 . . . . 0.12 109.152 -179.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -140.58 142.28 35.12 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.688 -1.227 . . . . 1.31 107.688 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.2 t -141.7 137.65 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.178 -0.951 . . . . 0.14 110.536 -178.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' CG ' HH21 ' B' ' 2' ' ' ARG . 10.9 t70 -96.55 117.24 30.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.332 -0.988 . . . . 1.08 108.332 179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -71.65 -12.38 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.285 -0.885 . . . . 0.27 110.906 -178.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -101.05 -38.58 8.11 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.041 -1.037 . . . . 1.11 110.919 -178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.18 -17.35 21.84 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.079 -1.013 . . . . 1.12 109.811 -179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -118.9 47.09 1.72 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.32 -0.862 . . . . 0.17 108.852 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -54.28 -14.87 1.3 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.457 -0.777 . . . . 2.22 109.77 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.09 -41.88 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.239 -0.913 . . . . 1.11 108.944 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.09 -45.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.671 -0.863 . . . . 0.19 108.671 179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.9 -35.4 79.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.22 108.767 179.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 26.2 m -64.06 -45.36 89.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.43 -0.794 . . . . 1.29 109.071 179.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.68 -41.38 96.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 2.2 109.595 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.63 -4.91 58.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.221 -0.924 . . . . 0.33 109.766 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 66' ' ' ALA . 43.9 mt-10 49.83 55.43 9.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.219 -0.926 . . . . 2.34 110.286 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.56 132.4 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.916 . . . . 0.28 109.205 179.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -122.42 1.74 9.6 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.499 -0.751 . . . . 2.4 109.754 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -150.51 144.84 25.61 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.192 -0.942 . . . . 0.22 108.689 -179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.553 HG23 ' HE2' ' B' ' 5' ' ' TYR . 18.8 p -128.22 149.64 71.83 Favored Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.235 -0.916 . . . . 0.22 108.615 179.236 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -79.19 143.06 69.29 Favored 'Cis proline' 0 N--CA 1.486 1.058 0 O-C-N 122.749 0.868 . . . . 0.2 110.06 -1.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 3.7 m -112.2 116.04 29.81 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 108.201 -1.037 . . . . 0.18 108.201 178.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.484 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.3 m-85 -91.33 111.56 23.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.093 -1.005 . . . . 0.15 109.151 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -113.86 137.45 51.65 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.283 -1.377 . . . . 1.03 107.283 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.1 m-85 -106.65 135.06 48.83 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.689 0.757 . . . . 0.11 110.202 -177.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -127.25 153.6 45.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.456 -0.942 . . . . 0.17 108.456 179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -155.01 120.61 5.06 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.038 -1.468 . . . . 1.48 107.038 179.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? 55.44 37.72 29.28 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.483 -0.761 . . . . 1.67 109.317 -178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.7 6.27 76.85 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.37 -1.092 . . . . 0.22 110.37 179.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.17 142.22 46.03 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.29 -1.124 . . . . 2.08 110.93 -179.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -87.1 138.3 31.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.833 -0.802 . . . . 1.7 108.833 178.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.9 m -124.21 -19.2 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.363 -0.835 . . . . 0.26 110.496 -179.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.66 172.58 45.34 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.44 -1.362 . . . . 0.18 110.269 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -172.81 153.34 2.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 2.04 110.334 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.1 p90 -169.09 133.64 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.445 -0.785 . . . . 0.14 110.213 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -103.38 -162.97 0.95 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.065 -1.022 . . . . 0.17 109.171 179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 129.75 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.342 -1.503 . . . . 0.13 109.342 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.72 93.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.236 . . . . 0.2 110.294 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.39 74.27 1.46 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.15 -1.056 . . . . 1.15 108.15 178.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.07 -31.14 71.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.496 -0.753 . . . . 1.19 110.297 -178.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -65.99 -26.74 67.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.946 -1.096 . . . . 1.95 108.97 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -68.73 -37.01 79.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.51 -0.743 . . . . 2.05 109.219 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.8 mt -50.97 -37.39 44.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.15 108.777 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.63 -57.4 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 2.15 109.561 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.49 92.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.358 -0.838 . . . . 0.15 110.635 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.7 m -65.09 -45.04 86.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.023 -1.048 . . . . 0.13 110.537 -178.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.0 mt -61.78 -54.13 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.18 108.872 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -58.17 -19.62 34.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 1.03 109.66 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -77.06 -60.46 2.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 2.02 110.323 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.1 mt -91.63 20.08 5.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.35 110.832 -178.176 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 120.806 -1.184 . . . . 1.18 109.376 179.852 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 34.6 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.55 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 43.1 mtp180 -140.56 76.86 1.57 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.276 -0.89 . . . . 0.0 109.313 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.518 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.2 m-85 -129.73 143.18 50.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -140.72 -102.19 0.15 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.858 . . . . 0.0 109.538 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.553 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -109.27 -169.85 1.55 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.351 -0.843 . . . . 0.0 111.072 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.46 149.38 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.915 0.864 . . . . 0.0 112.738 -176.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 m -101.88 95.6 6.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.14 46.13 1.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.009 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.16 -130.61 0.12 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 177.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -67.84 25.35 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.221 1.511 . . . . 0.0 109.094 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 44.9 t -83.09 -9.55 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.415 ' ND1' ' C ' ' B' ' 12' ' ' HIS . 5.2 t-80 -159.35 108.14 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.099 -1.389 . . . . 0.0 109.735 -179.931 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_